AES ANNUAL MEETING abstract- FINAL-low... · THIS GUIDE TO POSTER ABSTRACTS IS SUPPORTED BY GREENWICH BIOSCIENCES, INC. AES ANNUAL MEETING 2018 NEW ORLEANS NOV 30 - DEC 4 AES WEBSITE

Guide to Poster Abstracts72ND ANNUAL MEETING | ERNEST N. MORIAL CONVENTION CENTER

THIS GUIDE TO POSTER ABSTRACTS IS SUPPORTED BY GREENWICH BIOSCIENCES, INC.

AESANNUALMEETING 2018

NEW ORLEANSNOV 30 - DEC 4

Fonts: Azo SansImages: Epidiolex_bottle.psd (CMYK; 300 ppi, -300 ppi; Users:rdrozdalski:Desktop:EPID... Folder:Links:Epidiolex_bottle.psd), GREENWICH BIOSCIENCES PLC_4c.ai (Users:rdrozdalski:Desktop:EPID...ks:GREENWICH BIOSCIENCES PLC_4c.ai), Epiodiolex_Tagline_Sch_4C_v01 copy (1).ai (Users:rdrozdalski:Desktop:EPID...lex_Tagline_Sch_4C_v01 copy (1).ai)

EPIDIO25369_ AES_ProgramAd_REL_C00_01.indd Radek D 10-26-2018 12:53 PMPrint Scale: NoneInk Density: 300%

Bleed: 8.75" x 11.25"Trim: 8.5" x 11"Safety: 7" x 10"

Folded Size: NoneGutter: NoneScale: 1" = 1"

Colors: Cyan Magenta Yellow Black

Client: GREENWICH

BIOSCIENCE

Job Description: EPIDIOLEX AES

Program AD - NO Brief

Summary

Job #: EPIDIO25369

Stage: DISK RELEASE

Round: C00_01

©2018 Greenwich Biosciences Inc. All rights reserved. EPX-03796-1018

Pavilion D

NOWAVAILABLE

Finally, there’s a whole new path to explore

Greenwich Biosciencesis growing innovationStep into the growing and manufacturing process with a virtual reality experience all day on Saturday and Sunday. Additional presentations include:

• EPIDIOLEX Product Overview | Saturday 1-2 PM• Patient Support Resources Overview | Sunday 3-4 PM

Visit EPIDIOLEXhcp.com

Booth 401

Follow the footprints in the exhibit hall and discover EPIDIOLEX® (cannabidiol) Cv

S:7”

S:10”

T:8.5”

T:11”

B:8.75”

B:11.25”

AES program cover.indd 1 10/30/18 3:39 PM

FIND IT FAST!Quick Ways to Search for the Abstract You Want

2018 AES GUIDE TO POSTER ABSTRACTS

Over 1,350 posters in New Orleans? Browse through this abstract guide to

target the science you don’t want to miss.

Indexed two ways for your convenience. Find the science you seek by author or by

poster number within category.

Abstract search is also available on the AES mobile app.

AES GUIDE TO POSTER ABSTRACTS 88 MEETING.AESNET.ORG





AES WEBSITE

The latest epilepsy science is at your fingertips when you visit the AES

Annual Meeting abstracts database.

Find all the 2018 poster session abstracts online. Search by author,

topic, title, and more. Previous years (back to 2007) are also available.

Search now:aesnet.org/abstracts

Session 1: Saturday, 12 PM–6 PMFirst authors present 12 PM–2 PM

Session 2: Sunday, 10 AM–4 PMFirst authors present 12 PM–2 PM

Session 3: Monday, 8 AM–2 PMFirst authors present 12 PM–2 PM

The 2018 Guide to Poster Abstracts and 2018 AES Online Abstract Searchare supported by Greenwich™ Biosciences, Inc.

At Eisai, human health care is our goal. We give

our fi rst thoughts to patients and their families

as well as helping to increase the benefi ts health

care provides. Our therapies are designed

to make a difference and have an impact on

patients’ lives. We are Eisai, where medicine is

more than just our business — it’s our passion.

Our passion ignites progress

CORP-US2153 ©2018 Eisai Inc. All rights reserved. Oct 2018 www.eisai.com/us

CORP-US2151 Our passion ignites progress.indd 1 10/30/18 1:06 PMAES program cover.indd 2 10/30/18 3:39 PM

TO VIEW ABSTRACTS OR SEARCH BY KEYWORDS, PLEASE VISIT AESNET.ORG/ABSTRACTS 1

TABLE OF CONTENTS

Welcome

Welcome From The Chairs ......................................................... 2

Poster Schedules ........................................................................ 3

Poster Abstract Floor Plan .......................................................... 4

Abstracts

Saturday, December 1 ............................................................. 6

Basic Mechanisms ................................................................. 6

Translational Research ........................................................... 8

Neurophysiology ................................................................. 10

Clinincal Epilepsy ................................................................ 12

Neuroimaging .................................................................... 14

Antiepileptic Drugs ............................................................. 15

Surgery ............................................................................... 18

Behavior/Neuropsychology/Language .................................. 19

Genetics ............................................................................. 19

Sunday, December 2 ............................................................. 23


Clinical Epilepsy .................................................................. 26

Neuroimaging .................................................................... 28


Surgery ............................................................................... 33


Genetics ............................................................................. 35

Monday, December 3 ............................................................ 39

Basic Mechanisms ............................................................... 39

Translational Research ......................................................... 41


Clinical Epilepsy .................................................................. 45

Neuroimaging .................................................................... 47


Surgery ............................................................................... 50


Genetics ............................................................................. 52

Author Index

Alphabetical Listing .................................................................. 56

2 TO VIEW ABSTRACTS OR SEARCH BY KEYWORDS, PLEASE VISIT AESNET.ORG/ABSTRACTS

WELCOME FROM THE CHAIRS

Dear Colleagues,

Welcome to the 72nd Annual Meeting of the American Epilepsy Society in New Orleans. We are excited to provide you with highlights of what you can expect in the poster sessions over the course of the Annual Meeting this year. The Guide to Poster Abstracts is your roadmap to the latest in cutting-edge research, featuring accepted abstracts and encouraging interaction between presenters and attendees as you navigate through the hall.

Don’t miss the daily walking tours offered Saturday through Monday and lead by content experts. Immerse yourself in the contributions of a diverse professional community and presentations by authors and possibly launch your next big research project idea. We are continually striving to improve our poster sessions and welcome any feedback that arises as you peruse the cutting-edge epilepsy research being presented.

We hope you enjoy the 72nd Annual Meeting and the poster abstracts and come away with newfound knowledge!

Kevin E. Chapman, MD

Scientific Program Committee Chair

Alica M. Goldman, MD, PhD

Scientific Program Committee Vice Chair

Dedicated to eradicating epilepsy and its consequences

AES is a medical and scientific society that provides professionals working in epilepsy with the resources needed to deliver unparalleled patient care, advance their research efforts, and make a difference for people living with epilepsy. For more than 75 years, AES has provided a dynamic global forum where professionals from across the field of epilepsy can learn, network, and collaborate.

aesnet.orgExecutive Office135 South LaSalle StreetSuite 2850Chicago, IL 60603

(312) 883-3800


POSTER SCHEDULES

Authors PresentSaturday, Sunday, and Monday12:00 PM – 2:00 PM

View Full Text of AbstractsThere are two ways to access abstracts presented during this poster session:

1. Visit aesnet.org/abstracts for our searchable abstract database 2. Download the AES annual meeting app with all abstracts at

meeting.aesnet.org/mobile-app

Saturday, December 1

Poster Session 112:00 PM – 6:00 PMConvention Center, Hall H, First Floor

Numbers shown indicate the poster hall board assignment.

Basic Mechanisms . . . . . . . . . . . . . . . . . . . . . . . . . 1.001 – 1.073Translational Research . . . . . . . . . . . . . . . . . . . . . . 1.074 – 1.130Neurophysiology . . . . . . . . . . . . . . . . . . . . . . . . . . 1.131 – 1.190Clinical Epilepsy . . . . . . . . . . . . . . . . . . . . . . . . . . 1.191 – 1.245Neuroimaging . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.246 – 1.267Comorbidities (Somatic and Psychiatric) . . . . . . . . 1.268 – 1.279Antiepileptic Drugs . . . . . . . . . . . . . . . . . . . . . . . . 1.280 – 1.334Surgery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.335 – 1.370Behavior | Neuropsychology | Language . . . . . . . . 1.371 – 1.388Genetics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.389 – 1.403Health Services . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.404 – 1.424Epidemiology . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.425 – 1.434Public Health . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.435 – 1.440Case Studies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.441 – 1.450Late Breaking . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.451 – 1.470

Sunday, December 2

Poster Session 210:00 AM – 4:00 PMConvention Center, Hall H, First Floor


Neurophysiology . . . . . . . . . . . . . . . . . . . . . . . . . 2.001 – 2.101Clinical Epilepsy . . . . . . . . . . . . . . . . . . . . . . . . . . 2.102 – 2.165Neuroimaging . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.166 – 2.211Comorbidities (Somatic and Psychiatric) . . . . . . . . 2.212 – 2.223Antiepileptic Drugs . . . . . . . . . . . . . . . . . . . . . . . 2.224 – 2.292Non-AED/Non-Surgical Treatments . . . . . . . . . . . . 2.293 – 2.302Surgery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.303 – 2.342Behavior | Neuropsychology | Language . . . . . . . . 2.343 – 2.361Genetics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.362 – 2.377Health Services . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.378 – 2.399Neuropathology of Epilepsy . . . . . . . . . . . . . . . . . 2.400 – 2.405Practice Resources . . . . . . . . . . . . . . . . . . . . . . . . . 2.406 – 2.410 Epidemiology . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.411 – 2.421Public Health . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.422 – 2.427Case Studies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.428 – 2.450Late Breaking . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.451 – 2.465

Monday, December 3


Use alternate entrance to poster session, Hall G, between8:00 AM – 10:00 AM.

Continental breakfast available.


Basic Mechanisms . . . . . . . . . . . . . . . . . . . . . . . . . 3.001 – 3.070Translational Research . . . . . . . . . . . . . . . . . . . . . . 3.071 – 3.114Neurophysiology . . . . . . . . . . . . . . . . . . . . . . . . . 3.115 – 3.172Clinical Epilepsy . . . . . . . . . . . . . . . . . . . . . . . . . . 3.173 – 3.236Neuroimaging . . . . . . . . . . . . . . . . . . . . . . . . . . . 3.237 – 3.258Comorbidities (Somatic and Psychiatric) . . . . . . . . 3.259 – 3.271Antiepileptic Drugs . . . . . . . . . . . . . . . . . . . . . . . 3.272 – 3.318Surgery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3.319 – 3.354Dietary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3.355 – 3.372Behavior | Neuropsychology | Language . . . . . . . . 3.373 – 3.391Genetics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3.392 – 3.406Health Services . . . . . . . . . . . . . . . . . . . . . . . . . . . 3.407 – 3.425Epidemiology . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3.426 – 3.434Case Studies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3.435 – 3.450Late Breaking . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3.451 – 3.470

Poster Walking Tours: Saturday, Sunday, and Monday 12:15 PM – 1:45 PM Convention Center, Hall H, First Floor

Join leading experts as they spotlight interesting posters and facilitate discussion with authors, gaining new and different perspectives on the data presented. To join a walking tour, gather at the poster information table near booth #100 and poster board #001. A schedule of topics and tour leaders will be available.


POSTER ABSTRACT FLOOR PLAN

Late Breaking Abstracts

Exhibitor Offices

Poster Information


Following extended studies by pharmaceuticals? Interested in the evolution of emerging drugs and devices? Stop by industry scientific exhibits at the AES Annual Meeting see the latest data and hear about progress from industry scientists themselves.

Sunday, December 2 8:00 AM – 11:00 AM

A Rare Genetic Epilepsy and The Importance of Early Genetic TestingBioMarin Pharmaceutical Inc.Convention Center, Room 278-279, Second Floor

Research Updates from Eisai Eisai Inc.Convention Center, Room 280-282, Second Floor

Low-Dose Fenfluramine: An Update on Mechanisms, Efficacy, and Safety in the Treatment of Epileptic EncephalopathiesZogenix, Inc.Convention Center, Room 276-277, Second Floor

Sunday, December 22:00 PM – 5:00 PM

Ganaxolone for the Treatment of Refractory Epileptic DisordersMarinus Pharmaceuticals, Inc.Convention Center, Room 278-279, Second Floor

Monday, December 38:00 AM – 11:00 AM

Epidiolex®: The Only FDA-Approved Cannabidiol TreatmentGreenwich Biosciences, Inc.Convention Center, Room 276-277, Second Floor

Monday, December 38:00 AM – 5:00 PM

UCB: Commitment to Epilepsy CareUCB, Inc.Convention Center, Room 280-282, Second Floor

SCIENTIFIC EXHIBITS


ABSTRACTS

Saturday, December 1

Poster Session 112:00 PM – 6:00 PMConvention Center, Hall H, First Floor

Basic Mechanisms

Epileptogenesis of Acquired Epilepsies

1.001 Kindling Epileptogenesis in Rats Is Modified by Microbiome Allotransplant From Donors That Have Undergone Brain Fluid Percussion Injury | A. Mazarati; J. Medel-Matus; C. Santana-Gomez; D. Shin; R. Staba; R. Sankar

1.002 Deconstruction of Thalamic Circuits in a Mouse Model of Post-Traumatic Epilepsy | S. Holden; O. Aboubakr; A. Morningstar; B. Higashikubo; J. Paz

1.003 Selective Astrogliosis Enhances Thalamic Circuit Excitability and Seizure Susceptibility by Enhancing GABA(A)R-Mediated Tonic Inhibition | F. Cho; I. Vainchtein; J. Alcauter; A. Morningstar; J. Anink; E. van Vliet; E. Aronica; A. Molofsky; J. Paz

1.004 Characterization of Neuronal Chloride Microdomains | N. Rahmati; K. P. Normoyle; J. Glykys; K. P. Lillis; K. Staley

1.005 A Novel Model of Post-Traumatic Epilepsy and the Characterization of Post-Traumatic Hippocampal Oxygenation | H. Malik; M. Wolff; R. Mychasiuk; G. Teskey

1.006 The Role of Fyn and Tau in the Early Phase of Epileptogenesis: Studies From Fyn and/or Tau Knockout Mouse Models | M. Putra; S. Puttachary; G. Liu; G. Lee; T. Thippeswamy

1.007 Circuit Mechanisms Underlying Chronic Epileptogenesis in the Freeze Lesion Mouse Model of Focal Cortical Dysplasia | Q. Sun; A. Williams; W. Yang; C. Zhang

1.008 Specific Phosphorylation Changes in Rat and Human HCN1 Channels in Epilepsy Revealed by Mass Spectrometry | F. Concepcion; J. Ojemann; A. Ko; N. Poolos

1.009 Loss of Rac1 Gene in Cortical Excitatory Neural Cells of Mice Induces the Increase of Excitability and Decrease of the Lifespan | L. Zeng

1.010 Injury-Induced Network Confinement Leads to Increased Recurrent Connectivity and Generation of Epileptiform Activity | Y. Berdichevsky; S. Ghiasvand

1.011 Reorganization of Brain Connectomics in an Animal Model of Epilepsy – A Combined DTI and EEG Study | L. Li; M. Patel; U. Kumar; H. Yeh; N. Harris; J. Stern; Z. Waldman; S. Weiss; J. Engel; A. Bragin

1.012 Upregulated lncRNA-Malat1 During Different Time Points of Epileptogenesis | L. Chen; X. Qiu; L. Zhang; W. Lai; A. Peng; X. Zhu; S. He; W. Li

1.013 All-Optical Mapping of Synaptic Connectivity in Epileptogenesis | K. P. Lillis; K. Staley

1.014 Dissecting Ictogenesis in a Model of Post-Traumatic Epilepsy | L. Lau; K. P. Lillis; K. Staley

1.015 Alterations of Cannabinoid Type 1 Receptor Inhibitory Interneuron Boutons in Mesial Temporal Lobe Epilepsy | J. Wang; A. Alhourani; K. Fish; T. Wosny; R. Richardson

1.016 Cell-Type Specific Expression of TLR4 Contributes to Excitotoxic Loss of Interneuron Subtypes After Brain Injury | Y. Li; A. Korgaonkar; V. Santhakumar

1.017 Two Different Semiology Patterns and Epilepsy Networks of FCD Located in the Superior Frontal Sulcus | C. Zhang; W. Hu; X. Wang; B. Zhao; X. Shao; K. Zhang; Y. Ma

1.018 Inhibiting Glycolysis Prevents Inhibitory Network Dysfunction Following Traumatic Brain Injury | C. Dulla; J. Koenig; D. Cantu; C. Low; D. Kong; D. Emerson

Epileptogenesis of Genetic Epilepsies

1.019 Reduced Expression of Perineuronal Nets in the Tish Rat Model of Subcortical Heterotopia | D. Grosenbaugh; H. Goodkin

1.020 A Conditional Neuronal Emx1cre Nprl2 Model of Spontaneous Seizures | B. Dentel; P. Tsai

1.021 Potential Loss of Astrocyte Synaptogenic Function in Human TSC Cortical Tubers | K. Choudhury; K. Sansalone; F. Jensen; D. Talos

1.022 Clinical Spectrum of STX1B-Related Epileptic Disorders | S. Wolking; P. May; D. Mei; R. Møller; S. Balestrini; K. Helbig; C. Kaiwar; K. Stoehr; P. Widdes-Walsh; B. Mendelsohn; A. Numis; M. Cilio; W. Van Paesschen; L. Svendsen; S. Oaetes; E. Hughes; S. Goyal; K. Brown; M. Sifuentes Saenz; T. Dorn; H. Muhle; A. Pagnamenta; D. Vavoulis; S. Knight; M. Canevini; F. Darra; R. Gavrilova; Z. Powis; S. Tang; J. Marquetand; M. Armstrong; D. McHale; E. Klee; G. Kluger. D. Lowenstein; S. Weckhuysen; D. Pal; I. Helbig; R. Guerrini; R. Thomas; M. Mark; S. Sisodiya; Y. Weber; D. Lal; C. Marini; H. Lerche; J. Schubert

1.023 SCN3A Mutations Causing Early Infantile Epileptic Encephalopathy Impact Neuronal Excitability | E. Goldberg; N. Sotuyo; T. Zaman

1.024 High-Throughput Functional and Biochemical Characterization of KCNB1 Variants Associated With Epileptic Encephalopathy | S. Kang; C. Vanoye; K. Fabre; J. Calhoun; J. O’Connor; J. Millichap; A. George; J. Kearney

1.025 Hippocampal Neuronal Hyperexcitability and Epileptic Encephalopathy in Grin2A Loss of Function Mutant Mice | C. Camp; J. White; R. Sanchez; S. Traynelis; S. Koh

1.026 Conditional Deletion of PQ-Type Calcium Channels in Kainate Receptor4 (Grik4)-Expressing Hippocampal Neurons Leads to Adult Onset Absence Epilepsy | Q. Miao; J. Noebels

1.027 Diagnostic Whole-Genome Sequencing in Pediatric Epilepsies | H. Lee; C. Chi; C. Tsai

1.028 The Role of Astrocytes in Seizure Generation in a Brain Slice Model of Mitochondrial Epilepsy | F. Chan; N. Lax; C. Voss; B. Aldana; S. Whyte; S. Nichols; E. Tilley; Z. Powell; H. Waagepetersen; D. Turnbull; M. Cunningham

1.029 Microchromosomal Disorders and Pediatric Epilepsies | C. Chi; H. Lee


Electrophysiology/High-Frequency Oscillations

1.030 Automated Detection and Classification of Interictal HFOs to Improve the Identification of Epileptogenic Zones in Preparation for Epilepsy Surgery | D. Mogul; T. Sobayo; S. Farahmand

1.031 Identifying EEG Biomarkers in a Mouse Model of KCNB1-Associated Encephalopathy | S. Misra; N. Hawkins; J. Kearney

1.032 Ripples (80-200 Hz) in the Human Mesial-Temporal Lobe Exhibit Different Profiles of Phase-Amplitude Coupling in Relation to Slow Waves | S. Weiss; I. Song; S. Vangala; Z. Waldman; M. Donmez; I. Fried; M. Sperling; G. Worrell; A. Bragin; J. Engel, Jr., M.D., Ph.D.; Y. Nir; R. Staba

1.033 Disruption of Verbal Episodic Memory Encoding by Epileptiform Discharges Is Greatest in the Left Perirhinal and Entorhinal Cortex | L. Camarillo-Rodriguez; Z. Waldman; D. Rubinstein; A. Sharan; R. Gorniak; J. Tracey; G. Worrell; B. Lega; R. Gross; K. Davis; B. Jobst; S. Sheth; K. Zaghloul; J. Stein; S. Das; P. Wanda; M. Sperling; S. Weiss

1.034 The Neuroelectrophysiological Mechanisms of Epileptogenesis Induced by Focal Cortical Dysplasia in Humans | L. Cheng; Y. Xing; T. Yu; R. Liu; Y. Piao; D. Ni; H. Ge; X. Wang; C. Liu; G. Zhang; X. Yang

1.035 Comparison of Frequency-Dependent Variation in High-Frequency Oscillation (HFOs) Rates in Intracranial EEG recordings Between Normal and Epileptogenic Brain | H. Guragain; J. Cimbalnik; M. Stead; J. Van Gompel; J. Britton; B. Brinkmann; G. Worrell

1.036 Common Features of High-Frequency Oscillation in Different Ictal EEG Patterns for Seizure Onset and Termination | S. Peng; Y. Hsin

1.037 Ictal High-Frequency Oscillations and Seizure Termination Patterns in Stereo-EEG Predict Multifocal Epileptogenic Zones | S. Tobochnik; L. Bateman; C. Schevon; C. Schevon

1.038 IL-1ß Is Proconvulsive and Dependent of the Src Pathway in Human Brain Slices From Refractory Epilepsy Patients | A. Salah; D. Talos; K. Sansalone; P. Dilsiz; W. Doyle; H. Weiner; R. Tsien; O. Devinsky

1.039 Classification and Assessment of Cortico-Cortical Evoked Potentials | N. Mukae; R. Matsumoto; K. Kobayashi; M. Togo; M. Matsuhashi; T. Nakae; H. Takeyama; A. Shimotake; Y. Yamao; T. Kikuchi; K. Yoshida; K. Iihara; R. Takahashi; A. Ikeda

1.040 Analysis of Coupling Between Fast and Slow Oscillations in Scalp Electroencephalography for Sturge-Weber Syndrome With Contralateral Epileptic Discharges | Y. Iimura; H. Sugano; H. Suzuki; T. Mitsuhashi; H. Arai

1.041 Propagation Patterns of Interictal Spikes and Ripples Are Distinct: Onset Ripples Predict the Epileptogenic Zone Better Than Onset or Spread Spikes in Children with Refractory Epilepsy | C. Papadelis; E. Tamilia; E. Park; J. Bolton; J. Peters; P. Grant; J. Madsen; P. Pearl

1.042 Propagation of Interictal High-Frequency Oscillations in Focal Epilepsy | K. González Otárula; N. von Ellenrieder; C. Cuello-Oderiz; F. Dubeau; J. Gotman

1.043 Localization of High-Frequency Oscillations with Magnetoencephalography and Electroencephalography Prior to Pediatric Epilepsy Surgery | E. Tamilia; M. Dirodi; S. Stufflebeam; P. Grant; J. Madsen; P. Pearl; N. Tanaka; C. Papadelis

Mechanisms of Therapeutic Interventions

1.044 Intravenous Infusion of Mesenchymal Stem Cells Reduces Epileptogenesis in a Rat Model of Status Epilepticus | S. Fukumura; M. Sasaki; Y. Kataoka-Sasaki; H. Tsutsumi; J. D. Kocsis; O. Honmou

1.045 Fyn/Src Tyrosine Kinase Inhibitor, Saracatinib (AZD0530), Suppresses Seizures and Epileptogenesis in the Experimental Models of Temporal Lobe Epilepsy | S. Sharma; M. Gage; S. Carlson; A. Gregory-Flores; A. Olson; A. Hinojo-Perez; T. Thippeswamy

1.046 Resting Electrodermal Activity Decreases in Patients With Epilepsy | T. Horinouchi; K. Sakurai; N. Munekata; T. Kurita; Y. Takeda; I. Kusumi

1.047 Ancient and Modern Anticonvulsants Act Synergistically at the Same Potassium Channel Binding Pocket | R. Manville; G. Abbott

1.048 Chemogenetics in Local and Remote Control of 4-AP Induced Acute Focal Neocortical and Hippocampal Seizures in Rats | X. Yan; D. Li; C. Jiang; J. Wang; Y. Xing; F. Xue; H. Wei; X. Yang

1.049 Increased Expression of WNK3 in Dispersed Granule Cells in Hippocampal Sclerosis of Mesial Temporal Lobe Epilepsy Patients | K. Jeong; S. Kim; Y. Choi; I. Cho; W. Kim

1.050 Prax330 Normalizes Hyperexcitability in Subiculum Neurons From a Mouse Model of SCN8A Encephalopathy | E. Wengert; B. Barker; R. Gaykema; M. Patel

1.051 Targeted Augmentation of Nuclear Gene Output (TANGO) of Scn1aPrevents Seizures and SUDEP in a Mouse Model of Dravet Syndrome | L. Isom; C. Chen; Z. Han; C. Liu; C. Anumonwo; I. Aznarez; A. Christiansen; G. Liau

1.052 Targeting AMPA Receptors for Therapeutic Benefit in Mitochondrial Epilepsy | F. Chan; Y. Ng; N. Lax; R. McFarland; A. Schaefer; G. Gorman; D. Turnbull; M. Cunningham

1.053 Therapeutic Significance of a Focal CYP-NR-Transporter Axis in Human Drug-Resistant Epileptic Brain: Association With Blood-Brain Barrier Tight Junction Proteins | S. Mishra; M. Hossain; S. Williams; J. Gonzalez-Martinez; I. Najm; C. Ghosh

1.054 Postictal Hypoperfusion/Hypoxia as a Mechanism of Sudden Unexpected Death in Epilepsy: Acute Pharmacological Interventions | A. George; A. Wall; G. Teskey

1.055 1400W, an iNOS inhibitor, Mitigates DFP-Induced Long-Term Neurotoxicity | M. Gage; S. Sharma; M. Putra; G. Gasser; A. Gregory-Flores; A. Vellareddy; T. Thippeswamy

1.056 Safety and Efficacy of an Intramuscular Adjunct Therapy for the Treatment of Organophosphate-Induced Status Epilepticus in Rats | L. Deshpande; R. Blair; E. Hawkins; M. Halquist; L. Kosmider; J. Warncke; R. DeLorenzo


Models

1.057 Home Cage Monitoring Reveals the Presence of Comorbid Depression-Related Behavior in Mice with Deletions of Kcna1 | V. Krishnan; M. Jankovic; J. Noebels

1.058 Chd2 Is Necessary for Neural Circuit Development and Long-Term Memory | Y. Kim; S. Khoshkhoo; S. Abbasi; J. Frankowski; S. Lee; B. Zhu; E. Wu; R. Hunt

1.059 Abnormal Orexin and Sleep Disorder in a Mouse Model of Tuberous Sclerosis Complex | B. Zhang; A. Satoh; D. Guo; L. Han; N. Rensing; M. Wong

1.060 Addressing Analysis Questions for a Nonlinear Synaptic System as a Model for Ictogenesis | S. Karamintziou; K. Staley

1.061 Hyperactive mTOR Signaling Results in Sex- and Age-Specific Differences in Early Life Communication | M. Binder; S. Hodges; S. Nolan; A. Holley; J. Lugo

1.062 Variable Impairment of Consciousness During Absence Seizures in Rodents | C. McCafferty; B. Gruenbaum; Z. Kratochvil; R. Akbari; P. Herman; J. Ryu; B. Sanganahalli; P. Antwi; W. Islam; E. Johnson; P. Vitkovskiy; I. Freedman; A. Kundishora; A. Depaulis; F. Hyder; H. Blumenfeld

1.063 Homeostatic Interactions Within Neuron-Glia Networks Underlie State Transitions to Generalized Seizures | S. Myren-Svelstad; C. Verdugo; C. Deneubourg; R. Pelgrims; N. Jurisch-Yaksi; E. Yaksi

1.064 Spontaneous Recurrent Absence Seizure-like Oscillations in Wild-Caught Rats | D. Barth; J. Taylor; J. Reuter; F. Dudek

1.065 An Objective Description of PTZ Kindling in a Standardized Instrumented Home Cage Environment | M. Jankovic; V. Krishnan

1.066 Hippocampal Oxygen Levels During the Development and Expression of Epilepsy in Two Status Epilepticus Models: Intrahippocampal Kainate and Perforant Path Electrical Stimulation | M. Wolff; M. Scantlebury; G. Teskey

1.067 The MED64-Quad II System Accelerates Throughput for Studies of Role of NMDA Receptor in Synaptic Plasticity and Epileptogenesis in Acute Mouse Hippocampal Slice | G. Cheng; S. Yasuoka; R. Arant

Other

1.068 Multi-Day Seizure Cycles: Daily, Weekly, and Monthly Patterns | P. Karoly; D. Goldenholz; D. Freestone; R. Moss; D. Grayden; W. Theodore; M. Cook

1.069 Direct Neurotransmitter Activation of Voltage-Gated Potassium Channels | G. Abbott; M. Papanikolaou; R. Manville

1.070 Chemogenetic Inhibition of Mossy Cells During Status Epilepticus Is Neuroprotective | J. Botterill; J. LaFrancois; H. Bernstein; P. Leary; Y. Lu; S. Jain; H. Scharfman

1.071 Four Commonly Consumed Drugs: Nicotine, Ethanol, Tetrahydrocannabinol and Caffeine in Relation to Postictal Hypoxia | T. Phillips; R. Gom; G. Teskey

1.072 Extrinsic Control of the Hippocampus - The Supramammillary Hypothalamus | N. Pedersen

1.073 Mechanisms of Cardiac Arrhythmia in Dravet Syndrome With Dysfunctional Voltage-Gated Sodium Channel ß1 Subunits | Y. Zhao; J. Parent; L. Isom

Translational Research

Human Studies

1.074 Realistic Simulator-Based Evaluation of Driving Safety in Patients With Generalized Spike-Wave Discharges on EEG but No Clinical Seizures | P. Antwi; B. Banz; C. Arencibia; J. Ryu; E. Atac; N. Saleem; S. Tomatsu; K. Swift; H. Krestel; J. Wu; M. Crowley; F. Vaca; H. Blumenfeld

1.075 Critical Slowing Down Governs the Onset of Epileptic Seizures | M. Matuarna; M. Cook; C. Meisel; D. Freestone

1.076 The Relationship Between the Neural Response to Stress and Perceived Stress Varies in Patients With Left Temporal Lobe Epilepsy | A. Goodman; J. Allendorfer; J. Szaflarski

1.077 Fast Ripple Analysis Sheds Light Into the Dynamics of Seizure Generation in Mesial Temporal Lobe Epilepsy Patients | J. Schönberger; B. Frauscher; N. von Ellenrieder; F. Dubeau; J. Gotman

1.078 Upregulation of Adenosine A2A Receptor in Human Rasmussen’s Encephalitis | T. Li; G. Luan

1.079 Circulating miR-22 Levels and Hippocampal Purinergic Inflammatory Markers in Mesial Temporal Lobe Epilepsy Patients | B. Leal; C. Carvalho; J. Chaves; A. Bettencourt; D. Boleixa; R. Rangel; A. Santos; J. Freitas; J. Lopes; J. Ramalheira; B. Martins da Silva; P. Costa; P. Correia-de-Sá; A. Martins da Silva

1.080 Default Mode Network Displays Reduced Hierarchical Topology in Epilepsy Patients | F. Gomes; J. Fiel; M. Ferreira; E. Melo; R. Pereira; R. Navegantes; B. Gomes; S. Carvalho; A. Pereira

1.081 Human Herpes Virus 6 in Patients With Drug-Resistant Epilepsy | W. Theodore; E. Leibovitch; B. Billioux; S. Inati; S. Sato; K. Zaghloul; J. Heiss; W. Gaillard; S. Jacobson

Devices, Technologies, Stem Cells

1.082 Automatic Seizure Detection by Convolutional Neural Network and Autoencoder | A. Emami; N. Kunii; T. Mtasuo; T. Shinozaki; K. Kawai; H. Takahashi

1.083 Views of Patients With Epilepsy on Wearable Seizure Prediction System Based on Heart Rate Variability | M. Miyajima; T. Yamakawa; K. Fujiwara; Y. Suzuki; M. Watanabe; M. Kano; T. Maehara

1.084 An Assessment on the Efficacy of VNS in Generalized Epilepsy | A. Suller Marti; A. Parrent; R. McLachlan; S. Mirsattari; D. Diosy; D. Steven; K. MacDougall; J. Burneo

1.085 Cerebral Tissue Oximetry in Patients With Epileptic Seizures | B. Moseley; M. Privitera

1.086 Brain Co-Processors: Integrating Brain Implants With Local and Distributed Computing Resources | V. Kremen; B. Brinkmann; I. Kim; H. Guragain; M. Nasseri; T. Pal Attia; A. Magee; S. Chang; J. Herron; T. Adamski; S. Baldassano; J. Cimbalnik; V. Vasoli; E. Fehrmann; T. Chouinard; E. Patterson; B. Litt; B. Sturges; C. Crowe; M. Stead; J. Van Gompel; T. Denison; G. Worrell

1.087 Final Long-Term Safety Results of the SANTE Study: More Than 10 Years of Follow-up | V. Salanova; R. Fisher


1.088 Minimally Invasive Surgical Approach for Subdural Electrode Implantation in Focal Epilepsy | M. Benscoter; S. Grewal; S. Kuehn; J. Kuhlmann; S. Hara; G. Worrell; J. Van Gompel

1.089 Event Prediction Using Wearable Seizure Detectors | J. Bidwell; I. Sánchez Fernández; A. Nathan; T. Loddenkemper

1.090 Heart Rate Variability Analysis-Based Epileptic Seizure Prediction Using Neural Network | K. Fujiwara; F. Sakane; M. Miyajima; T. Yamakawa; M. Kano; T. Maehara

1.091 Autonomic Characterization of Nonconvulsive Seizures Based on Wrist-Worn Sensors | L. Babilliot; G. Regalia; C. Caborni; R. Picard; F. Onorati

Biomarkers

1.092 Deep Learning Applied to Whole Brain Structural Connectome to Determine Seizure Control After Epilepsy Surgery | E. Gleichgerrcht; B. Munsell; S. Bhatia; W. Vandergrift; C. Rorden; J. Edwards; R. Kuzniecky; L. Bonilha

1.093 Changes of Lipid Metabolism in Men of Young Age With Epilepsy | A. Voitiuk; T. Litovchenko; T. Markova; T. Sheynina

1.094 Automatic Detection of HFO and Spikes: Measuring the Biomarker Value of True-HFO, Spikes and Spike-Associated-HFO | D. Lachner-Piza; M. Dümpelmann; K. Kerber; J. Bruder; A. Schulze-Bonhage; T. Stieglitz; J. Jacobs

1.095 A Multi-Modal Approach for Detection of Epileptic Seizures From a Combination of Biomedical Signals | S. Hammond; H. Salehizadeh; F. Mohammadpour Touserkani; R. El Atrache; M. Bendsen-Jensen; T. Loddenkemper

1.096 Standardization of Lateral Fluid-Percussion Injury Model Production and Post-Injury Monitoring for Multicenter Biomarker Studies on Post-Traumatic Epileptogenesis | X. Ndode-Ekane; C. Santana-Gomez; P. Casillas-Espinosa; I. Ali; G. Smith; P. Adrade de Abreu; R. Immonen; N. Puhakka; R. Staba; S. Shultz; T. O’Brien; A. Pitkänen

1.097 Multicenter Harmonization of Preclinical MRI Biomarker Discovery in a Rat Model of Post-Traumatic Epileptogenesis | R. Immonen; G. Smith; R. Brady; D. Wright; L. Johnston; N. Harris; E. Manninen; C. Branch; X. Ndode-Ekane; C. Santana-Gomez; P. Casillas-Espinosa; I. Ali; P. Adrade de Abreu; N. Puhakka; D. Duncan; R. Staba; T. O’Brien; A. Toga; A. Pitkänen; O. Gröhn

1.098 Automated Seizure Detection for Phenotyping Post-Traumatic Epilepsy in a Preclinical Multicenter Trial – EpiBioS4Rx | R. Staba; P. Casillas-Espinosa; P. Adrade de Abreu; C. Santana-Gomez; T. Paananen; G. Smith; P. Perucca; I. Ali; R. Ciszek; X. Ndode-Ekane; R. Immonen; N. Puhakka; A. Pitkänen; T. O’Brien

1.099 Harmonization of Preclinical Multicenter Plasma Protein and miRNA Biomarker Discovery in a Rat Model of Post-Traumatic Epileptogenesis | N. Puhakka; A. Kamnaksh; I. Ali; G. Smith; X. Ndode-Ekane; R. Brady; C. Santana-Gomez; R. Immonen; P. Adrade de Abreu; N. Jones; S. Shultz; R. Staba; T. O’Brien; D. Agoston; A. Pitkänen

1.100 Evaluation of Electrodermal Skin Response and Clinical Semiology of Generalized Tonic-Clonic Seizures in SUDEP Risk Assessment | F. Mohammadpour Touserkani; S. Hammond; R. Sarkis; E. Tamilia; R. El Atrache; S. Vieluf; I. Sánchez Fernández; C. Papadelis; K. Kapur; O. Devinsky; P. Ryvlin; C. Reinsberger; T. Loddenkemper

1.101 Pipeline for Detecting HFOs in Multicenter, Preclinical Biomarker Studies of Post-Traumatic Epilepsy | C. Santana-Gomez; P. Andrade de Abreu; M. Hudson; T. Paananen; R. Ciszek’s; G. Smith; I. Ali; X. Ndode-Ekane; P. Casillas-Espinosa; R. Immonen; N. Puhakka; N. Jones; P. Perucca; A. Pitkänen; T. O’Brien; R. Staba

1.102 Focal Aberrations in Thalamocortical White Matter Development in BECTS | E. Thorn; L. Ostrowski; D. Song; S. Stoyell; M. Parnes; G. Xiao; S. Stufflebeam; C. Chu

Models

1.103 Novel KCNT1 Inhibitors Identified Through Comprehensive High-Throughput Drug Repurposing Screening | G. Stewart; J. Andresen; B. Gay; C. Maher; A. Gerlach; D. Goldstein; O. Devinsky; S. Petrou

1.104 The Small Molecule Wnt Antagonist XAV939 Modulates Neuronal-Network Remodeling in a Translational Mouse Model of Temporal Lobe Epilepsy | K. Gupta; E. Schnell

1.105 Subconvulsive Stimulation in Early Postnatal Life Reduces NeuN and Parvalbumin Antigenicity While Increasing Interneuronal Activity of the Dentate Gyrus and Amygdala Cortical Complex in Juvenile Rats | L. Friedman; B. Kahen; J. Hoffman

1.106 Postnatal-Induced Autism Produces Sex-Related Differences in Social Behavior, Memory, Mood, and the Seizure Threshold During the Juvenile Period | B. Kahen; J. Veliskova; L. Velisek; L. Friedman

1.107 CD40 Deficiency Limits Seizure Severity | A. Musto; T. Anderson; J. Benfield; G. Rasic; A. Rana

1.108 Interactive Automated Software for Reliable Seizure Detection in Rat and Mouse Models of Genetic and Acquired Epilepsies | A. Sargsyan; P. Casillas-Espinosa; W. Frankel; D. Melkonian; T. O’Brien

1.109 Benzodiazepine-Refractory Status Epilepticus, Neuroinflammation, and Interneuron Neurodegeneration After Acute Organophosphate Intoxication | R. Kuruba; X. Wu; D. Reddy

1.110 Midazolam-Resistant Seizures and Brain Injury Following Acute Intoxication of Diisopropylfluorophosphate, an Organophosphate Pesticide and Surrogate for Nerve Agents | X. Wu; R. Kuruba; D. Reddy

1.111 Interictal Spikes and Sleep Dysfunction in Epileptic Syngap1+/- Mice Progress With Age | B. Sullivan; J. Landers; S. Ammanuel; Y. Araki; R. Huganir; S. Kadam

1.112 Electrographic Changes in the Post-Traumatic Epileptic Brain in Wild-Type and Aquaporin-4 Knockout Mice | J. Szu; D. Patel; S. Chaturvedi; C. Jonak; J. Lovelace; D. Binder


1.113 Comparative Electroencephalography (EEG): Canine Skull Morphology and Craniocerebral Topographical Mapping to Design an Analogous Electrode Placement Grid | S. McCarthy; M. Comrie; J. Phillips; R. Dony; A. zur Linden; L. Gaitero; F. James

1.114 Comparative Analysis of Antiseizure Drugs in Dravet and Episodic Ataxia With Epilepsy Zebrafish and Mice Models | K. Ibhazehiebo; C. De La Hoz; R. Rehak; G. Kaushik; P. Santoscoy; D. Kurrasch

1.115 Human Mesenchymal Stem Cells Improve Hypoxic-Ischemic Brain Injury in Neonatal Rats | J. Byeon; E. Lee; N. Lee; C. Yim; B. Eun

1.116 Modeling Gene Specific Therapy of DNM1 Epileptic Encephalopathy | O. Aimiuwu; S. Petri; S. Harper; A. Fowler; N. Pyne; W. Frankel

1.117 Development of an Antiseizure Drug Screening Model for Dravet Syndrome in the Epilepsy Therapy Screening Program | E. Dahle; K. Johnson; L. Handy; S. Edwards; A. Roberts; C. Metcalf; K. Wilcox

1.118 Hyperphosphorylation of Tau Protein in the Cerebral Cortex of Rats With Severe Lateral Fluid Percussion Injury: An EpiBioS4Rx Project 2 Study | P. Saletti; C. Lisgaras; W. Mowrey; Q. Li; W. Liu; P. Casillas-Espinosa; I. Ali; R. Brady; N. Jones; S. Shultz; T. O’Brien; S. Moshé; A. Galanopoulou

1.119 Effectiveness of the Ketogenic Diet for the Control of Seizures in the Triple-Hit Model of the Infantile Spasms Syndrome | A. Choudhary; B. Charkhad; K. Barrett; M. Scantlebury

Other

1.120 Dynamic Tracking of Cardiac Electrical Instability in Patients With Newly Diagnosed or Chronic Epilepsy Using Ambulatory ECG Monitoring and High-Resolution ECG Patches | T. Pang; B. Nearing; K. Krishnamurthy; B. Olin; S. Schachter; R. Verrier

1.121 Generalized Epileptic Seizure Prediction Based on Heart Rate Variability Analysis and Discussion on Its Mechanism | F. Sakane; K. Fujiwara; M. Miyajima; Y. Suzuki; T. Yamakawa; M. Kano; T. Maehara

1.122 Bone Health in Rats with Chronic Temporal Lobe Epilepsy | R. Brady; K. Wong; D. Robinson; P. Lee; J. Wark; P. Casillas-Espinosa; T. O’Brien; S. Shultz

1.123 Evaluation of FDA-Approved NMDAR-Targeted Medications on Epilepsy-Associated GRIN Mutations Located in M2 Transmembrane Domain | J. Li; W. Tang; J. Zhang; V. Hannan; H. Yuan; S. Traynelis

1.124 GRIA Variations Associated With Epilepsy and Intellectual Disabilities | W. XiangWei; H. Yuan; S. Myers; S. Traynelis; Y. Jiang

1.125 A Loss-of-Function De Novo GRIN1 Variant Associated With Myoclonus and Severe Intellectual Disability | Z. Zhu; X. Bozarth; J. Zhang; W. Tang; S. Kim; S. Myers; W. Dobyns; S. Traynelis; H. Yuan

1.126 Rescue Pharmacology of Loss-of-Function GRIN Mutations Associated with Epileptic Encephalopathy | W. Tang; S. Traynelis; H. Yuan

1.127 Functional Evaluation of a GRIN2D Missense Mutation Associated with Epileptic Encephalopathy | H. Yuan; W. XiangWei; V. Hannan; Y. Jiang; S. Traynelis

1.128 A Novel Approach for Accurate Automatic Stereotactic EEG Electrode Identification and Grouping from Post-Implantation Scans | N. Peled; T. Gholipour; A. Paulk; S. Cash; D. Dougherty; E. Eskandar; M. Hamalainen; S. Stufflebeam

1.129 Modulation of mTOR Activity by Amino Acid Deprivation in Neurons | P. Iffland; M. Baybis; B. Allan; P. Crino

1.130 Effect of Carbon Nanotubes on the Volume of Activation During Direct Cortical Stimulation Therapy | P. Wagner-Egea; L. Cendejas-Zaragoza; D. Garibay-Pulido; M. Rossi

Neurophysiology

Video EEG Epilepsy-Monitoring

1.131 The Value of Repeating a Long-Term Video-EEG Monitoring in the Diagnosis of Epilepsy | Y. Kitazawa; K. Jin; Y. Kakisaka; M. Fujikawa; N. Nakasato; F. Tanaka

1.132 Phase-Amplitude Coupling Between Interictal High-Frequency Activity and Slow Wave in Epilepsy Surgery | H. Motoi; M. Miyakoshi; T. Abel; J. Jeong; Y. Nakai; A. Sugiura; A. Luat; R. Agarwal; S. Sood; E. Asano

1.133 What Do Focal Polyspikes Mean? | S. Benbadis; A. Rivera-Cruz; S. MacIver; F. Vale

1.134 Quantitative Spatiotemporal Characterization of Epileptic Spikes Using High-Density EEG: Differences Between NREM Sleep and REM Sleep | X. Kang; M. Boly; C. Williams; G. Findlay; B. Jones; K. Gjini; R. Maganti; A. Struck

1.135 Demographic and Electroclinical Features of Elderly Onset Temporal Lobe Epilepsy | T. Matsudaira; Y. Araki; A. Kondo; H. Ikeda; N. Usui; K. Terada; Y. Inoue

1.136 Temtamy Syndrome: Three New Cases with Abnormal vEEG Findings and Intact Corpus Callosum | M. Protas; Y. Roshchina; E. Segal

1.137 Experience of Outpatient-Based Short Video-EEGs Merits and Demerits: An Indian Experience | A. Diwan; A. Pillai

1.138 Statistical Analysis of Interictal Phase-Amplitude Coupling Improves Prediction of Epilepsy Surgery Outcome | E. Asano; H. Motoi; C. Juhasz; M. Miyakoshi; Y. Nakai; A. Sugiura; A. Luat; S. Sood; J. Jeong

1.139 Mortality in Patients With Psychogenic Non-epileptic Seizures | T. O’Brien; R. Nightscales; L. McCartney; C. Malpas; Z. Chen; A. McIntosh; S. Ignatiadis; S. Jones; S. Adams; M. Cook; P. Kwan; S. Berkovic; W. D’Souza; D. Velakoulis

1.140 Epilepsy and EEG Findings in Children With CDKL5 Deficiency Disorder Under Age 1 Year | S. Poonmaksatit; X. Zhang; E. Pestana Knight

ICU EEG

1.141 Parasagittal Seizures Are Rare in Adult Patients, and They Can Be Detected in Lateral EEG Channels | J. Parvizi; K. Gururangan


1.142 LPDs and NCSE: Comparison of Clinical Outcomes | S. Tantikittichaikul; S. Hocker; J. Britton

1.143 WITHDRAWN

1.144 The Effect of Temperature on EEG Prognostic Predictive Value in Post Cardiac Arrest Patients on Hypothermia Protocol: A Retrospective Analysis | T. Kapoor; E. Kobylarz; G. Thomas

1.145 The Risk of Seizure Recurrence in Patients With Status Epilepticus Requiring Anesthetic Treatment | A. Parsons; A. Crepeau

Other Clinical EEG

1.146 The Diagnostic Utility of Ambulatory EEG Following Non-Diagnostic Epilepsy Monitoring Unit Admissions | J. Fox; S. Ajinkya; P. Chopade; S. Schmitt

1.147 The Yield of Ambulatory EEG-Video Monitoring | A. Rivera-Cruz; S. MacIver; P. Trudeau; L. Sullivan; S. Benbadis

1.148 Connectivity Between Bilateral Mesial Temporal Lobe in Intractable Temporal Lobe Epilepsy Based on Cortico-Cortical Evoked Potential | S. Chen; Y. Han; Y. Lu; J. Wang; G. Luan; J. Zhou

1.149 Electroclinical Features and Incidence of Generalized Paroxysmal Fast Activity (GPFA) in Children With Typical Absence Seizures | L. Bansal; L. Vargas; K. Pawar; D. Nagesh; M. Ilyas; A. Hall; B. Kinnaman; A. Abdelmoity

1.150 Automated Pre-surgical Localization Softwares: Are They Reliable? | U. Amin; A. Nandyala; S. MacIver; S. Benbadis

1.151 Similarities and Differences of Interictal Epileptiform Discharges Waveforms Between Human Neocortical Irritative and Epileptogenic Zones in Routine Intracranial EEGs | R. Serafini

1.152 Events and Discharges: First 24 Hours Have the Highest Diagnostic Yield Among Ambulatory EEGs of All Durations | A. Vaddiparti; M. Karen; Y. Hou

1.153 Clinical Utility of High- Versus Low-Density EEG Source Imaging in Presurgical Evaluation: Impact on Decision Making | M. Foged; T. Martens; N. Hamrouni; L. Pinborg; O. Paulson; M. Fabricius; S. Beniczky

1.154 Epileptology of Juvenile Neuronal Ceroid Lipofucinosis | V. Arntsen; J. Strandheim; T. Sand; E. Brodtkorb

1.155 Automated Invasive Electrode Labeling and Location Validation | K. Taylor; J. Mosher; D. Nair; R. Leahy; A. Joshi

MEG

1.156 Intranasal Dexmedetomidine for Sedation in Patients With Intractable Seizures Undergoing Magnetoencephalography | J. Tenney; J. Miller; D. Rose

1.157 Preoperative Evaluation for Indication of Total Corpus Callosotomy Using Gradient Magnetic Field Topography (GMFT) in Patients With Intractable Epilepsy and Drop Attacks | K. Kagawa; K. Iida; A. Hashizume; M. Katagiri; G. Seyama; H. Otsubo; K. Kurisu

1.158 Comparing the Localization Results From Ictal Magnetoencephalography and Intracranial Electroencephalography in Epilepsy Surgery Candidates | M. Katagiri; M. Aldosari; T. Hirfanoglu; T. Aung; J. Gonzalez-Martinez; A. Alexopoulos; J. Mosher; R. Burgess

1.159 Monaural 40-Hz Auditory Steady-State Magnetic Responses Can Be an Indicative Biomarker for Epileptic Focus in Mesial-Temporal Lobe Epilepsy | T. Matsubara; K. Ogata; N. Hironaga; T. Uehara; T. Mitsudo; H. Shigeto; T. Maekawa; S. Tobimatsu

1.160 Investigating the Relation Between MEG Resting State Connectivity, fMRI Hubs, and Seizure Outcome in Epilepsy Surgery | Ü. Aydin; K. Lee; G. Pellegrino; O. Bin Ka’b Ali; J. Lina; F. Dubeau; E. Kobayashi; J. Gotman; C. Grova

1.161 MEG as a Pre-surgical Tool in Pediatric Drug-Resistant Focal Epilepsies | S. Sinha; G. Bhargava; A. Asheeb; R. Mundlamuri; N. Mariyappa; J. Velmurugan; A. Bhaskar; K. Thennarasu; K. Raghavendra; R. Bharath; J. Saini; A. Arivazhagan; J. Rajan; A. Mahadevan; M. Rao; P. Satishchandra

Brain Stimulation

1.162 Repetitive Transcranial Magnetic Stimulation With a Round Coil as a Potential Diagnostic and Treatment Technique for Refractory Epilepsy and Epilepsia Partialis Continua | F. Ayuga Loro; L. Price; A. Teijeira Azcona; A. Valentin

1.163 The Influence of Anesthesia on Cortico-Cortical Evoked Potential | R. Enatsu; Y. Suzuki; A. Kanno; R. Yokoyama; H. Suzuki; Y. Akiyama; S. Ochi; N. Mikuni

1.164 Concordance Between TMS and fMRI Derived Lateralization and Localization of Language in Clinical Pediatric Cohorts | K. Schiller; A. Choudhri; J. Wheless; S. Narayana

1.165 Responsive Neurostimulator (RNS) Use in Patients With and Without Prior Vagus Nerve Stimulator (VNS) Implantation | C. Drees; S. Sillau; D. McDermott; A. Abosch; S. Ojemann; M. Brown

1.166 Low Frequency Stimulation of Endopiriform Nucleus (EPN) in the Control of Chronic Focal Epilepsy in Rats | D. Li; J. Wang; D. Luo; Z. Yuan; Y. Xing; X. Li; F. Xue; M. Zhang; X. Yang

1.167 Continuous Monitoring Devices and Seizure Patterns by Glucose, Time and Lateralized Seizure Onset | M. Doherty; K. Kinnear; N. Warner; R. Gwinn; A. Haltiner

1.168 Seizure Onset Regions Are Integrators for Network Hyperexcitability | J. Kang; B. Elahian; K. Usami; N. Crone

1.169 Correlation Between Corticocortical Evoked Potential Amplitude and Ictal Propagation Pattern Predicts the Ablation Zone During Surgery for Refractory Epilepsy | A. Dickey; J. Willie; F. Isbane; R. Fasano; B. Cabaniss; R. Gross; J. Gale; N. Pedersen

1.170 Numerical Simulation Proved Safety of the Novel Electrical Stimulation Mapping Protocol | P. Krsek; R. Janca; J. Vrba; D. Vrba; P. Ježdík; B. Benová; A. Jahodová; M. Kudr; V. Komarek; M. Tichý

1.171 Effects of Vagus Nerve Stimulation on Physiological and Sleep Parameters in Refractory Epilepsy Patients | K. Abou Khaled; C. Abou Nader


Animal Studies

1.172 Neuronal Activity During Acute Seizures Associated With Hypoxic-Ischemic Injury in Neonatal Mice | J. Burnsed; D. Skwarzynska; P. Wagley; J. Kapur

1.173 A Highly Sensitive and Specific Generalized Linear Model for Seizure Detection Using a Rat Model of Epilepsy | S. Ebrahim; N. Fumeaux; A. Kadambi; M. Moraes; E. Kimchi; M. Abou Jaoude; S. Nagaraj; S. Arroyo; S. Cash

1.174 SGK1.1 Activation Induces Neuroprotection Against Kainic Acid-Induced Seizures by Upregulation of the M-Current | E. Martin-Batista; L. Maglio; N. Armas-Capote; G. Hernandez; D. Alvarez de la Rosa; T. Giraldez

1.175 Temporal Lobe Seizures Disrupt Subcortical Arousal Networks to Induce Loss of Consciousness | J. Pok; L. Sieu; L. Feng; C. Ma; C. Zhao; J. Cardin; H. Blumenfeld

1.176 Electrical Induction of Focal Limbic Seizures With Impaired Consciousness in Mice | L. Sieu; S. Singla; C. McCafferty; M. Valcarce-Aspegren; A. Niknahad; Q. Perrenoud; J. Cardin; H. Blumenfeld

1.177 Detailed Spectral Profile Analysis of Penicillin G-Induced Epileptiform Discharges During Freezing in Anesthetized Rats | T. Tokiwa; L. Zimin; T. Inoue; S. Nomura; M. Suzuki; T. Yamakawa

1.178 Occurrence of Nonconvulsive Seizures, Periodic Epileptiform Discharges, and Intermittent Rhythmic Delta Activity in Rat Focal Ischemia | H. Yang; A. Guo; Q. Wang

1.179 Ovarian-Cycle-Linked and Sex-Specific Changes in GnRH Neuron Firing and Excitability in a Mouse Model of Temporal Lobe Epilepsy | J. Li; J. Robare; L. Gao; M. Ghane; J. Flaws; M. Nelson; C. Christian

1.180 Tau Loss Modifies Network Excitability in Brain Tumor-Related Epilepsy | A. Hatcher; K. Yu; J. Noebels; B. Deneen

Computational Analysis and Modeling of EEG

1.181 Age-Specific Pediatric Head Atlases for Forward Electrical Modeling | S. Turovets; K. Morgan; D. Hammond; J. Hou; A. McCutcheon; K. Li; H. Kim; K. Smith; T. Nolan; L. Larson-Prior

1.182 Epileptic Network Characterization Based on Resting State Interictal High-Density EEG | E. Martinez Lizana; M. Dümpelmann; A. Brandt; A. Schulze-Bonhage

1.183 Automated Seizure Detection Using Machine Learning: A Tool for Better Patient Care | M. McManis; C. Bodden; P. McManis; M. Lee; P. Ferrari; F. Perkins

1.184 Effects of Sevoflurane Anesthesia on Intraoperative High-Frequency Oscillation in Patients With Hippocampal Sclerosis | A. Orihara; K. Hara; M. Inaji; K. Shimizu; S. Hashimoto; T. Maehara

1.185 Dynamical Connectivity Within Ictal Perfusion Evaluated Using Stereo-EEG | B. Krishnan; S. Tousseyn; C. Satheesh Nayak; T. Aung; Z. Wang; G. Wu; R. Burgess; J. Bulacio; J. Gonzalez-Martinez; I. Najm; A. Alexopoulos

1.186 A Comparison of Interictal MEG and Interictal EEG Source Analysis and Its Relationship to Postsurgical Seizure Outcomes | S. Benard, M.D., M.P.H.; P. Coutin-Churchman, M.D., Ph.D.; D. Eliashiv, M.D.; M. Nuwer, M.D., Ph.D.; N. Salamon, M.D., Ph.D.; J. Stern, M.D.; J. Engel, Jr., M.D., Ph.D.

1.187 Large-Scale Cortical Interactions in Epileptic Networks | N. Ghani; A. Flinker; O. Devinsky; D. Khodagholy; J. Gelinas

1.188 Electroencephalographic Source Imaging at a Pediatric Epilepsy Center: Physician Impressions After One Year | M. Lallas; J. Robinson; M. Van Hirtum-Das; D. Holder

1.189 Spatial Temporal Dynamics of Spike-Wave Complexes in Primary Generalized Epilepsy | M. Wise; M. Holmes

1.190 Ictal and Interictal Spike Propagation Patterns in Human Intracranial EEG | E. Conrad; S. Tomlinson; K. Davis; B. Litt; E. Marsh

Clinincal Epilepsy

Classification and Syndromes

1.191 Electroclinical Features of Nodding Syndrome | R. Mazumder, MD, MPH; K. Tabu; J. Engel, Jr., M.D., Ph.D.; D. Kitara Lagoro, MD, PhD; P. Spencer, PhD, FRCPath; S. Olum, MBChB, MMed; T. Orach, MBChB; D. Eliashiv, M.D.

1.192 A New Prognostic Definition of Seizure Clusters Derived From Survival Analysis of Electronic Patient-Reported Seizure Diaries | S. Chiang; S. Haut; V. Ferastraoaru; R. Moss; D. Goldenholz

1.193 Clinical and Electroencephalographic Characteristics of Repetitive Sleep Starts in Children | Y. Maki; H. Kidokoro; A. Okumura; H. Yamamoto; T. Fukasawa; T. Kubota; M. Kawaguchi; M. Tanaka; Y. Okai; Y. Sakaguchi; T. Nakata; T. Negoro; K. Watanabe; J. Natsume

1.194 Seizure Clusters in Pediatric Epilepsy: The Harvard-Yale Pediatric Epilepsy Cluster Study | S. Jafarpour; J. O’Bryan; S. Lewis; R. Benjamin; A. Hua; X. Wang; M. Gaínza-Lein; P. Pearl; J. Bonito; S. Levy; F. Testa; T. Loddenkemper; L. Hirsch; K. Detyniecki

1.195 Keeping Recommendations Current: Updates to the National Institute of Neurological Disorders and Stroke Epilepsy Common Data Element Recommendations | R. Feldman; J. Austin; J. French; N. Barbaro; D. Lowenstein; M. Sheikh; I. Edun; J. Esterlitz; V. Whittemore

1.196 Symptoms and Impacts in Epilepsy: Findings From Qualitative Patient Interviews | J. French; B. Williams; J. Choi; C. Gwaltney; R. Bruce; J. Paty; D. Friedman

1.197 Hypermotoric Versus Dialeptic Semiology in Patients With Psychogenic Non-Epileptic Seizures (PNES): Inherently Different or Two Sides of the Same Coin? | M. Morton; D. Teagarden; O. Groover; I. Karakis

1.198 Hallucinations in Kabuki Syndrome | R. Liu; E. Grier; L. Lomax

1.199 Case of ‘Pseudo’-Juvenile Myoclonic Epilepsy Associated with CHD2 Gene Mutation | N. Singh; A. Ritaccio

1.200 Evolution and Course of Lennox-Gastaut Syndrome: Opportunities for Prevention? | A. Berg; S. Levy; F. Testa


1.201 Epilepsy of Infancy With Migrating Focal Seizures: A Genetically Heterogeneous Developmental and Epileptic Encephalopathy | I. Scheffer; S. Wang; A. McTague; K. Boysen; X. Yang; Q. Zeng; K. Myers; A. Rochtus; C. Myers; S. Heavin; S. Yendle; J. Symonds; K. Kelley; B. Gelbart; G. Ronen; K. Forrest; I. Andrews; L. Smith; A. McLellan; C. Burke; K. Howell; M. Hayman; J. Freeman; M. Mackay; M. Salih; T. Stodberg; E. Wirrell; A. Brunklaus; S. Zuberi; M. Mehaffey; M. Giardino; L. Sadleir; D. Gill; R. Guerrini. C. Marini; Y. Zhang; H. Mefford; M. Kurian; A. Poduri; R. Burgess

Clinical Diagnosis

1.202 A Unique Presentation of Non-Convulsive Status Epilepticus Secondary to Acute Porphyria Crisis | S. Dawit; S. Bhatt; A. Pines; D. Das; H. Shiue; B. Goodman; J. Drazkowski; J. Sirven

1.203 Neonatal Status Epilepticus: An Under-Recognized Phenomenon | C. Samantha; S. Shabbir; M. Cornet; T. Sands; E. Armour; T. McDonough; C. Akman; M. Cilio

1.204 Co-existence of TBCK Epileptic Encephalopathy and Medium/Short Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency (MCHAD/SCHAD) in a Puerto Rican Girl | S. Chitnis; T. Reynolds; J. Vidaurre

1.205 Appraisal of a Clinical Scoring System for Neurodiagnostic Evaluation of Patients Presenting With New Onset Seizures to the Pediatric Emergency Department | N. Chourasia; C. Becu; L. Zhu; R. Lapus; G. Von Allmen

1.206 SUDEP Awareness in Patients With Epilepsy: It’s Worth Knowing | J. Ojeda; S. López-Gallardo; G. Gutiérrez-Gutiérrez; J. Maza; G. Chiclana; A. Miralles

1.207 Defining the Seizure Burden: A Lack of Common Lexicon and Meaning of the Epilepsy Experience | N. Santilli; P. Osborne Shafer

1.208 Wake EEG Criteria Predictive of Continuous Spike-and-Wave During Sleep (CSWS) in Epilepsy With Centro-temporal Spikes (ECTS) | A. Aeby; R. Santalucia; A. Van Hecke; A. Nebbioso; N. Deconinck; X. De Tiège; P. Van Bogaert; A. Aeby

1.209 Evolutive Changes in the Electroclinical Profile of Children With Congenital Zika Virus Infection Syndrome | H. van der Linden; V. van der Linden; K. Valente; F. Arruda

1.210 Epileptic Networks Monitoring Based on Multi-Step EEG Source Localization | J. Hou; M. Holmes; M. Wise

1.211 Music and Emotion: Clinical Profile and Outcome of Glutamic Acid Decarboxylase 65 kD (GAD65)-Positive Temporal Lobe Epilepsy | A. Staack; A. Wendling; T. Intravooth; C. Bien; B. Steinhoff

1.212 Predicting TLE Laterality Using Machine Learning of Hippocampal Dynamic Functional Connectivity | S. Chiang; E. Vankov; H. Yeh; J. Stern

1.213 Acute Symptomatic Neonatal Seizure Secondary to Congenital Hyperinsulinism | I. Molinero; C. Fernandez-Carbonell; E. Yozawitz

1.214 Epilepsy in North Africa and Middle East Region: Epidemiology, Causes, Treatment and Scientific Research | L. Elsheikh; M. Ali; H. Alhussein; H. Al Hail; G. Melikyan; N. Haddad; G. Alarcón; Y. Ali; D. Deleu; J. Davis Perkins; S. Nada; Z. Souirti; R. Ouazzani; N. Kissani; ,. Mesraoua

1.215 Parietal Lobe Epilepsy? A Review of the Semiology of Epilepsy Surgery Cases Involving the Parietal Lobe at Westmead Hospital Between 1993 and 2018 | T. Farrar; C. Wong; M. Bartley; M. Dexter; M. Wijayath; Z. Rahman; A. Bleasel

1.216 Acute Seizures and Epilepsy in Children With Arterial Ischemic Stroke | H. Bektas; S. Unal Cangul; T. Karagoz; K. Karli Oguz; R. Gocmen; D. Yalnizoglu

1.217 Refractory Left Focal Motor Status Epilepticus as Initial Clinical Presentation of Acute Basilar Artery Thrombosis | S. Dawit; E. Okazaki; K. Noe

Clinical Treatments

1.218 A 6-Month Prospective Randomized Controlled Trial of Remotely Delivered Group-Format Epilepsy Self-Management vs. Wait-List Control for High-Risk People With Epilepsy | M. Sajatovic; K. Colon-Zimmermann; M. Kahriman; E. Fuentes-Casiano; H. Liu; C. Tatsuoka; K. Cassidy; S. Lhatoo; D. Einstadter; P. Chen

1.219 Outcomes of Adults and Adolescents Evaluated in the University of Virginia Ketogenic Diet Clinic | R. Guha; J. Langer; D. Lehner-Gulotta

1.220 Prophylactic Use of Vigabatrin in Infants with Tuberous Sclerosis | V. Jadhav

1.221 Systematic Review and Network Meta-analysis of Resective Surgery for Mesial Temporal Lobe Epilepsy | P. Jain; G. Tomlinson; C. Snead; B. Sander; E. Widjaja

1.222 Effect of Endovascular Treatment on Post Stroke Seizures | J. Singh; W. Leesch; L. Leemis

1.223 Optimization of Channel Structure and Operating Condition of Neuroprotective Focal Brain Cooling Device | T. Abe; T. Inoue; K. Fujiwara; S. Nomura; H. Imoto; M. Suzuki; M. Kano

1.224 Efficacy and Safety of Rapid Cycling Vagus Nerve Stimulation in Children With Intractable Epilepsy, Especially Myoclonic Seizures | H. Kayyali; K. Smith; E. Fecske; A. Elbermawy; L. Bansal; M. Gustafson; K. Pawar; A. Hall; A. Abdelmoity

1.225 Computationally Targeted Non-Invasive Neurostimulation Provides Meaningful Reduction in Seizure Frequency in Adult and Pediatric Patients Not Responsive to Medication | G. Ruffini; H. Kaye; C. Santiago; R. Salvador; P. Pyzowski; L. Morales Quezada; R. Díaz Peregrino; D. Oswaldo Dávila; K. Marquez; D. San Juan Orta; M. Shafi; A. Rotenberg

1.226 Treatment and Outcomes After Stereoencephalography: Initial Experience at a Large-Volume Epilepsy Center | N. Bentley; R. Gupta; J. Willie; R. Gross

1.227 Timing of Immunotherapy in a Cohort of NORSE Patients at Stanford University Hospital | M. Mausolf; K. Werbaneth; S. Le

1.228 Management of Neonatal Seizures Following Hospitalization | A. Oh; H. Kim


1.229 A Nationwide Survey of the Impact of the Guidelines for Management of Febrile Seizures 2015 on Japanese Pediatricians | M. Tanaka; J. Natsume; S. Hamano; K. Iyoda; H. Kanemura; M. Kubota; M. Mimaki; S. Niijima; T. Tanabe; H. Yoshinaga; N. Kojimahara; H. Komaki; K. Sugai; T. Fukuda; Y. Maegaki; H. Sugie

1.230 Epilepsy and Neuronal Nicotinic Acetylcholine Receptor Gene Variants – Is Nicotine a Precision Therapy? | J. Fox; D. Thodeson; A. Dolce

1.231 Benzodiazepine Dosing in Pediatric Refractory Convulsive Status Epilepticus (the pSERG Cohort) | A. Vasquez; M. Gaínza-Lein; I. Sánchez Fernández; N. Abend; M. Amengual Gual; A. Anderson; R. Arya; J. Brenton; J. Carpenter; K. Chapman; J. Clark; W. Gaillard; T. Glauser; J. Goldstein; H. Goodkin; K. Kapur; Y. Lai; T. McDonough; M. Mikati; L. Morgan; E. Novotny; A. Ostendorf; E. Payne; K. Peariso; J. Piantino; J. Riviello; R. Tasker; D. Tchapyjnikov; A. Topjian; M. Wainwright; A. Wilfong; K. Williams; T. Loddenkemper

1.232 Transition From Benzodiazepines to Non-Benzodiazepine Antiseizure Medication in Pediatric Refractory Convulsive Status Epilepticus (the pSERG Cohort) | T. Sheehan; I. Sánchez Fernández; J. Clark; N. Abend; M. Amengual Gual; A. Anderson; R. Arya; J. Brenton; J. Carpenter; K. Chapman; W. Gaillard; M. Gaínza-Lein; T. Glauser; J. Goldstein; H. Goodkin; M. Jackson; K. Kapur; Y. Lai; T. McDonough; M. Mikati; L. Morgan; E. Novotny; A. Ostendorf; E. Payne; K. Peariso; J. Riviello, Jr; R. Tasker; D. Tchapyjnikov; A. Topjian; A. Vasquez; M. Wainwright; A. Wilfong; K. Williams; T. Loddenkemper

1.233 The DREAMS Study: A Randomized Controlled Trial of Melatonin for Dravet Syndrome Sleep Disturbance | K. Myers; M. Davey; M. Ching; C. Ellis; B. Grinton; A. Roten; P. Lightfoot; I. Scheffer

1.234 Cannabinoid-Based Therapeutics in Epilepsy: An Assessment of Knowledge and Attitudes of Neurologists, Pediatricians, and PCPs | T. Finnegan; S. Hughes; B. Gidal

1.235 Prehospital Pediatric Convulsive Status Epilepticus Care Often Falls Short of Guideline Recommendations (the pSERG Cohort) | M. Amengual Gual; I. Sánchez Fernández; A. Vasquez; J. Clark; N. Abend; A. Anderson; R. Arya; J. Brenton; J. Carpenter; K. Chapman; W. Gaillard; T. Glauser; J. Goldstein; H. Goodkin; Y. Lai; M. Mikati; L. Morgan; E. Novotny; K. Peariso; J. Piantino; J. Riviello; R. Tasker; D. Tchapyjnikov; A. Topjian; M. Wainwright; A. Wilfong; K. Williams; T. Loddenkemper

1.236 Questionnaire Survey of Seizures and Medical Treatment on Patients Group with Dravet Syndrome in Japan | K. Imai; H. Ikeda; H. Ikeda; Y. Yamamoto; Y. Takahashi; Y. Inoue

1.237 Use of Artisanal Cannabidiol Among Children With Treatment-Resistant Epilepsy in Southern Alberta | L. Bello-Espinosa; J. Appendino; A. Ho; J. Rho; M. Scantlebury

Prognosis

1.238 National Surveillance of Mortality in Children With Epilepsy in the United Kingdom and Ireland | O. Abdel-mannan; A. Sutcliffe

1.239 Interictal Epileptiform Activity During Rapid Eye Movement Sleep in the Epilepsy Monitoring Unit as a Predictor of Patient Outcomes | M. McKenzie; M. Ng

1.240 WITHDRAWN

1.241 Machine Learning for Outcome Prediction in EEG-Monitored Children in the Intensive Care Unit | I. Sánchez Fernández; A. Sansevere; M. Gaínza-Lein; K. Kapur; T. Loddenkemper

1.242 Evaluation and Risk Factors of Cardiac Electrical and Autonomic Function in Children With Dravet Syndrome | Y. Lee; G. Kim; J. Kong; A. Ko; Y. Kim; G. Yeon; S. Nam

1.243 Children with Epilepsy Have a Remarkable Number of Bilateral Tonic-Clonic Seizures With Loss of Awareness: A Population-Based Study With 25 Years of Follow Up | C. Camfield; P. Camfield

1.244 The Clinical Course of Dravet Syndrome From Childhood to Adulthood. A Long-Term Follow-up Study With 51 patients | T. Mayer

1.245 Leptomeningeal Enhancement Is a Potential Prognostic Factor for New-Onset Refractory Status Epilepticus (NORSE) | H. Kim; H. Kim; S. Lee; Y. Koo

Neuroimaging

Structural Imaging

1.246 Microstructural Imaging in Mesial Temporal Lobe Epilepsy: Role of Neurite Density and Myelination | G. Winston; S. Vos; B. Caldairou; S. Hong; M. Czech; T. Wood; S. Wastling; G. Barker; B. Bernhardt; S. Ourselin; N. Bernasconi; J. Duncan; A. Bernasconi

1.247 Hippocampal Subfield Measurement and ILAE Hippocampal Sclerosis Subtype Classification With In Vivo 4.7 Tesla MRI | T. Steve; E. Misaghi; T. Nowacki; L. Schmitt; B. Wheatley; D. Gross

1.248 Extracellular Chondroitin Sulfate and Neuron Density Correlates With Hippocampal Magnetization Transfer in Temporal Lobe Epilepsy Patients | J. Peixoto-Santos; T. Velasco; J. Assirati; C. Carlotti; C. Matias; R. Scandiuzzi; C. Salmon; A. Santos; J. Leite

1.249 Automated Fibre Tractography for Surgical Planning | S. Vos; M. Mancini; V. Vakharia; R. Sparks; G. Winston; S. Ourselin; J. Duncan

1.250 Multi-Centre Epilepsy Lesion Detection (MELD) Project: Conducting Clinical Research in an Open-Science Framework | S. Adler; K. Whitaker; M. Semmelroch; M. Consortium; Z. Wang; J. Cross; T. Baldeweg; K. Wagstyl

1.251 Feasibility of Guiding sEEG Implantation in Focal Epilepsy Using Automated Surface-Based Analysis and Machine Learning | K. Wagstyl; S. Adler; B. Pimpel; S. Lorio; K. Seunarine; R. Gunny; R. Thornton; J. Cross; T. Baldeweg; M. Tisdall

1.252 Unlike Brain Stem Functional Connectivity Improvement, Functional MRI Signal Fluctuations and Structural Connectivity Do Not Change After Epilepsy Surgery | D. Englot; H. Gonzalez; S. Goodale; M. Jacobs; K. Haas; B. Landman; V. Morgan

1.253 High-Resolution 3D MR Fingerprinting for Detection and Characterization of Epileptic Lesions | Z. Wang; S. Jones; A. Deshmane; K. Sakaie; E. Pierre; D. McGivney; I. Blumcke; B. Krishnan; M. Lowe; V. Gulani; I. Najm; M. Griswold; D. Ma


1.254 Comparison of Hippocampal Volume Measurement Accuracy and Reliability Between Manual Tracing, and NeuroQuant and Freesurfer Atlas-Based Measurements | B. Brinkmann; H. Guragain; K. Daniel; J. Mandrekar; W. Robert; K. Welker; J. Britton; R. Witte

1.255 Diffuse Cortical Thinning in BECTS Is Evident by 2 Years After Diagnosis | S. Stoyell; M. Parnes; D. Song; L. Ostrowski; E. Thorn; G. Xiao; B. Emerton; A. Morgan; S. Stufflebeam; C. Chu

1.256 Hippocampal Volume Is Predictive of Story Memory But Not Word List Memory Decline Following Left Anterior Temporal Lobe Surgery | P. Bauer; S. Swanson; D. Sabsevitz; C. Humphries; M. Rozman; M. Raghavan; W. Mueller; L. Allen; L. Conant; W. Gross; C. Anderson; C. Carlson; L. Schwartz; R. Busch; M. Lowe; J. Langfitt; M. Tivarus; D. Drane; D. Loring; M. Jacobs; V. Morgan; J. Szaflarski; L. Bonilha; J. Binder

1.257 Relation Between Lesion Topography and Sulcal Pits in Focal Cortical Dysplasia Type II | S. Hong; H. Lee; R. Gill; B. Bernhardt; N. Bernasconi; A. Bernasconi

Functional Imaging

1.258 Brainstem Functional Connectivity Improvement After Epilepsy Surgery Is Related to Preoperative Disease Severity | H. Gonzalez; S. Goodale; M. Jacobs; K. Haas; B. Landman; B. Abou-Khalil; D. Englot

1.259 Do Functional Networks Evolve After TLE Surgery? | B. Abou-Khalil; H. Gonzalez; S. Goodale; D. Englot

1.260 Epileptic Network in Epilepsy Associated with Multiple Nodular Heterotopia: A Study Using fMRI and SEEG | H. Khoo; N. von Ellenrieder; N. Zazubovits; J. Hall; F. Dubeau; J. Gotman

1.261 Imaging Ictal Networks from Scalp EEG by Means of a Fast Spatio-Temporal Iterative Reweighted Edge Sparsity (FAST-IRES) Algorithm | A. Sohrabpour; G. Worrell; B. He

1.262 Surgical Disconnection of Resting State Epilepsy Network Correlates With Seizure Freedom | E. Neal; J. Kim; S. MacIver; F. Vale

1.263 EEG-fMRI With Causal Modelling Can Identify the Driving Node Within Focal Epilepsy Networks | D. Vaughan; M. Kowalczyk; A. Warren; S. Berkovic; J. Archer; G. Jackson

1.264 Regional Asymmetries in Quantitative FDG-PET Predict Poor Surgical Outcome in Medically Refractory Medial Temporal Lobe Epilepsy | S. Mahmud; I. Quraishi; D. Ersahin; M. Chen; H. Blumenfeld; J. Yoo

1.265 Disruptions to Development of Neural Activation During Facial and Vocal Emotion Recognition in Temporal Lobe Epilepsy | E. Nelson; M. Morningstar; W. Mattson; J. Venticinque; S. Singer; S. Gedela

1.266 Noninvasive Imaging Interictal Activity From Scalp EEG by Means of an Iterative Reweighted Edge Sparsity (IRES) Algorithm | Z. Cai; A. Sohrabpour; G. Worrell; B. He

1.267 Dynamic Source Imaging in Focal Epilepsy Patients | S. Ye; A. Sohrabpour; M. Kucewicz; L. Yang; B. Brinkmann; G. Worrell; B. He

Comorbidities (Somatic and Psychiatric)

1.268 Clinical Features and Outcomes of Psychogenic Nonepileptic Seizures: Results of Implementing a “Two-Way Care Model” in a Japanese Neuropsychiatry Setting | G. Taniguchi; M. Fujioka; Y. Okamura; K. Yano; S. Kondo

1.269 Using Implementation Science to Improve Knowledge Translation: Disseminating Evidence-Based Programs from the Managing Epilepsy Well Network (MEWN) to Epilepsy Foundation (EF) Offices | J. Kakacek, MNPM, PhD; S. Schmidt; E. Johnson, PhD; N. Thompson, PhD, MPH; R. Fraser, PhD

1.270 Secure Attachment and Depression Predict 6-Month Outcome in Motor Functional Neurological Disorders: A Prospective Pilot Study | R. Jalilianhasanpour; J. Ospina; B. Williams; J. Mello; J. MacLean; J. Ranford; G. Fricchione; W. LaFrance Jr; D. Perez

1.271 Impact of Physical Activity on the Quality of Life in Patients With Epilepsy | A. Doyle; K. Gadelmola; D. Denney; L. Hynan; R. Zhang; M. Cullum; D. Montemayor; J. Adams; D. Castillo; K. Ding

1.272 Quality of Life in Patients With Psychogenic Non-Epileptic Seizures Compared to Patients With Epilepsy | K. Gadelmola; A. Doyle; L. Hynan; D. Denney; M. Cullum; D. Montemayor; J. Adams; D. Castillo; K. Ding

1.273 Improving Outcomes in Children and Adolescents With Psychogenic Non-Epileptic Events by Implementation of Care Coordination | D. Terry; L. Enciso; K. Trott; M. Burch; L. Parsons; E. Eplin; D. Albert

1.274 Psychiatric Comorbidities and Medications Among Patients in the Epilepsy Monitoring Unit Setting | V. Khatri; S. Zubkov; C. Tsao

1.275 Early Identification of Depression in Patients With Pediatric Epilepsy | E. Fecske; E. Rende

1.276 Screening and Intervention for Anxiety and Depression in an Adult Epilepsy Clinic | R. Doss; S. Mason; K. Caffrey; P. Penovich

1.277 Lessons From a Randomized Trial of Motivational Interviewing for Psychogenic Nonepileptic Seizures | B. Tolchin; G. Baslet; J. Suzuki; S. Martino; H. Blumenfeld; L. Hirsch; H. Altalib; B. Dworetzky

1.278 Experience of Psychogenic Nonepileptic Seizures in Latin America: A Survey Describing Current Practices | L. Ladino; V. Benjumea-Cuartas; R. López-González; Y. Calle-López; D. Castrillón-Velilla; J. Orozco-Hernández; A. Daza-Restrepo; M. Genel-Castillo; J. Tellez-Zenteno; M. Reuber

1.279 Cognitive-Emotional Processing Deficits in Patients With Psychogenic Nonepileptic Seizures and Their Association to Underlying Psychopathology | R. Rosales; B. Dworetzky; G. Baslet

Antiepileptic Drugs

Animal Studies

1.280 LM22A-4, a Small-Molecule BDNF Loop-II Domain Mimetic, Rescues Phenobarbital-Resistant Seizures in a Sex-Dependent Manner | J. Landers; B. Carter; B. Sullivan; S. Kadam


1.281 Combination Intramuscular Allopregnanolone and Perampanel Aborts Refractory Diisopropylfluorophosphate (DFP)-Induced Status Epilepticus in Rats: Comparison With Levetiracetam | A. Dhir; M. Rogawski

1.282 Network Pharmacology With Levetiracetam and Different Combination Partners: Promising, but Differential Effects in Antiepileptogenesis Trials Using the Intrahippocampal Kainate Mouse Model | A. Schidlitzki; L. Welzel; D. Bergin; P. Bascuñana; F. Twele; K. Töllner; M. Bankstahl; J. Bankstahl; W. Löscher

1.283 Delayed Midazolam After Soman Exposure Increases Survival but Fails to Prevent Epileptogenesis in Carboxylesterase Knockout Mice | L. Lumley; B. Marrero-Rosado; C. Schultz; M. Stone; E. Kundrick; K. Walker; S. O’Brien; M. Furtado

1.284 Anticonvulsant Effects of Cannabidiol in Mouse Models of Epilepsy | P. Rodrigues; J. Pfammatter; S. Konduru; C. Aldrich; E. Wallace; M. Jones; R. Maganti

1.285 Efficacy of Sodium Channel Inhibitors as Anticonvulsants in the Mouse MES Assay Is Predictive of the Therapeutic Plasma Concentration in Humans | C. Cohen; P. Karimi Tari; K. Nelkenbrecher; M. Waldbrook; C. Dube; G. de Boer; R. Kwan; L. Sojo; T. Focken; C. Dehnhardt; N. Shuart; S. Goodchild; J. Empfield; J. Johnson

1.286 TAK-935 Reduces Seizure Frequency and Severity and Prevents Premature Lethality in Scn1a+/– Dravet Mice | N. Hawkins; T. Nishi; B. Abrahams; M. During; J. Kearney

1.287 Preclinical Safety Margins of the Potent and NaV1.6 Selective Inhibitor, XEN901, in Relation to Non-Selective Sodium Channel Blockers | C. Dube; J. Johnson; T. Focken; R. Namdari; C. Dehnhardt; M. Grimwood; K. Burford; A. Hasan; P. Karimi Tari; R. Winquist; J. Empfield; C. Cohen

1.288 EpiBioS4Rx: Team Science Approach Using Pharmacokinetic Modeling and Simulation to Facilitate Screening and Early-Stage Development of New Therapies to Prevent Post-traumatic Epilepsy | L. Coles; P. Saletti; C. Lisgaras; W. Liu; P. Casillas-Espinosa; N. Jones; S. Shultz; I. Ali; R. Brady; J. Cloyd; S. Moshé; T. O’Brien; A. Galanopoulou

Clinical Trials

1.289 Dissecting the Heterogeneous Clinical Response to Padsevonil in Adults with Drug-Resistant Focal Seizures: Post hoc Responder Analysis of a Proof-of-Concept Trial | W. Van Paesschen; M. Toledo; C. Brandt; B. Steinhoff; M. Majoie; P. Boon; E. Webster; S. De Bruyn; K. Werhahn; P. Muglia; A. Avbersek; C. Otoul

1.290 Efficacy and Tolerability of Lacosamide and Controlled-Release Carbamazepine Monotherapy in Patients With Cerebrovascular Epilepsy Etiology: Post hoc Analysis of a Randomized Double-Blind Trial | R. Kälviäinen; A. Bozorg; S. Dimova; Y. Zhang; B. Steiniger-Brach; B. Ferrò; F. Rosenow

1.291 Long-Term Safety and Efficacy of Lacosamide and Controlled-Release Carbamazepine Monotherapy in Patients with Newly Diagnosed Epilepsy | E. Ben-Menachem; H. Grebe; K. Terada; L. Jensen; T. Li; M. De Backer; T. Gasalla; M. Brock; V. Biton

1.292 Behavioral and Cognitive Effects of Long-Term Adjunctive Brivaracetam in Children With Epilepsy | L. Lagae; T. Gasalla; S. Borghs; M. Martin; J. Cleveland; V. Badalamenti; J. Elshoff; J. Piña-Garza

1.293 Long-Term Effectiveness of Adjunctive Brivaracetam in Children With Epilepsy: Pooled Analysis of Data From Two Open-Label Trials | T. Gasalla; M. Martin; S. Elmoufti; V. Badalamenti; J. Elshoff; A. Patel

1.294 Long-Term Retention on Adjunctive Brivaracetam in Adults With Focal Seizures Previously Exposed to Carbamazepine, Lamotrigine, Levetiracetam, or Topiramate: A Post hoc Analysis | M. Martin; S. Dimova; S. Elmoufti; C. Laloyaux; S. Chung

1.295 Cannabidiol (CBD) Reduces Seizure Frequency in Patients with Dravet Syndrome Who Had No Response to Prior Medications: Subgroup Analysis of Phase 3 Study GWPCARE1 | A. Wilfong; C. Cances; J. Cross; O. Devinsky; E. Marsh; I. Miller; R. Nabbout; F. Sahebkar; M. Zolnowska; C. Stott

1.296 Time to Onset of Efficacy of Cannabidiol (CBD) During Titration in Patients with Lennox–Gastaut Syndrome (LGS) and Dravet Syndrome (DS) Enrolled in 3 Randomized Controlled Trials | M. Privitera; E. Marsh; M. Mazurkiewicz-Beldzinska; V. Villanueva; K. VanLandingham; D. Checketts; V. Knappertz

1.297 A Phase 1 Investigation Into the Potential Effects of Cannabidiol on CYP3A4-Mediated Drug-Drug Interactions in Healthy Volunteers | G. Morrison; L. Taylor; J. Crockett; D. Critchley; B. Tayo

1.298 Long-Term Safety and Efficacy of Add-on Cannabidiol (CBD) Treatment in Patients with Lennox-Gastaut Syndrome (LGS) in an Open-Label Extension (OLE) Trial (GWPCARE5) | A. Patel; A. Gil-Nagel; R. Chin; W. Mitchell; M. Perry; A. Weinstock; C. Roberts; L. Whyte; K. VanLandingham

1.299 Effect of SCN1A Mutation Type on Cannabidiol (CBD) Response in Patients with Dravet Syndrome: Subgroup Analysis of Phase 3 Trial GWPCARE1 | S. Zuberi; J. Symonds; A. Brunklaus; C. Roberts; D. Checketts; F. Sahebkar; O. Devinsky

1.300 A Phase 1 Single Ascending Dose, Multiple Dose, and Food Effect Trial in Healthy Volunteers | K. VanLandingham; B. Gidal; G. Blakey; L. Taylor; G. Morrison

1.301 Cognitive Assessment After Multiple Ascending Doses of TAK-935 in Healthy Subjects | M. Asgharnejad; L. Leahy; P. Maruff; B. Harel

1.302 Bioavailability and Safety of NRL-1 (Diazepam Intranasal Solution) Compared to Oral and Rectal Diazepam | R. Hogan; B. Gidal; B. Koplowitz; L. Pesco Koplowitz; R. Lowenthal; E. Carrazana

1.303 Safety of Cenobamate (YKP3089) as Adjunctive Treatment for Uncontrolled Partial Seizures in a Large, Multicenter, Open-Label Study | M. Sperling; P. Klein; M. Kamin

Cohort Studies

1.304 Antiepileptic Drug Errors in Hospitalized Epilepsy Patients | A. Bank; A. Pack; H. Choi

1.305 Clobazam Retention Rate in Pediatric Epilepsy | E. Gonzalez-Giraldo; A. Nutt; N. Baner; E. Kossoff; S. Kessler


1.306 Long-Term Effectiveness of Add-on Perampanel Treatment in Patients With Drug-Resistant Epilepsy: An Italian Multicenter Retrospective Observational Cohort Study | S. Matricardi; S. Siliquini; S. Lattanzi; E. Cesaroni; C. Cagnetti; F. Deleo; A. Stabile; F. Ragona; E. Freri; S. Cappanera; G. Anibaldi; N. Foschi; F. Villani; T. Granata; N. Zamponi

1.307 Effectiveness and Tolerability of Perampanel in Adolescents and Adults as a First Add-on Therapy. An Observational Multicentre Study | V. Bertol Alegre; V. Garayoa Irigoyen; M. García Gomara; I. Garamendi-Ruiz; E. Santamarina; P. Giner; I. Aranzábal Alustiza; A. Piera Balbastre; C. Arcos Sanchez; P. Esteve; A. Marinas Alejo; A. Garcia Escrivá; A. Viloria Alebesque; F. Ayuga Loro; A. Ponz de Tienda; J. Olivan Usieto; M. Bonet Valls; P. Dávila-González; R. Sivera Mascaró; A. Molins Albanell; G. Sansa Fayos; M. Falip; J. José Carlos Roche Bueno; A. Martínez; S. Monteagudo; T. Casadevall; M. López Cavanillas

1.308 Efficacy and Tolerability of Brivaracetam as an Adjunctive Treatment of Focal Onset Seizures in Daily Practice | B. Bridoux; C. Depondt; N. Gaspard; B. Legros

1.309 Treatment of KCNB1-Related Epilepsy: A Parent Survey | J. O’Connor; S. Kang; E. Bryant; A. Berg; J. Kearney; L. Laux; J. Millichap

1.310 A 1-Year Real-World Audit of Eslicarbazepine Acetate (ESL) as Initial Monotherapy in Patients With Focal Epilepsy | J. Serratosa; B. Giraldez; I. Garamendi-Ruiz; J. Zurita; A. García; R. Querol; D. Campos; C. Cabeza; P. Serrano; F. López-González; A. Molins; P. Martínez-Ulloa; L. Olivie

Drug Side Effects

1.311 Do Computerized Assessment and Paper-Pencil Testing Have Equivalent Sensitivity to Drug Load Effects of Antiepileptic Pharmacotherapy? | C. Helmstaedter; P. Durch; J. Witt

1.312 Testing Balance and Reaction Time in the Epilepsy Monitoring Unit: A Pilot Study | A. Hartshorn; K. Bujarski; A. Andrew; E. Kobylarz

1.313 The Effects of Paternal Seizure Disorders and Anti-Epileptic Drug Use on Offspring Conception Times | M. Casale; M. Fields; S. Faktorovich; B. Mueller; L. Marcuse; J. Yoo

1.314 Incidence of Hypertension in Children Treated With ACTH or Prednisolone for Infantile Spasms | L. McGarry; R. Messer; K. Knupp

1.315 Impact of Enzyme-Inducing Antiepileptic Drugs on Vitamin D Dose Requirements in Veterans With Epilepsy | B. Gidal; N. Menninga; Y. Koukounas; A. Margolis; R. Breslow

1.316 Cannabidiol Impairs Mitochondrial Function Independent of CB1 and GPR55 Receptors | Y. Ahn; C. Drummond-Main; I. Kiroski; J. Rho

1.317 The Effects of Dibenzazepines on Plasma Sodium and Lipid Concentrations, Blood Cell Count and Liver Function: A Real-World, Retrospective Comparison of Carbamazepine, Oxcarbazepine and Eslicarbazepine Acetate | M. Ley; A. Principe; R. Rocamora

1.318 Tolerability of Perampanel in Pediatric Patients: A Review of Our Experience | C. Lastra; E. Khan; C. Miskin

Other

1.319 Clobazam Efficacy, Tolerability and Adverse Event in 367 Saudi Children With Intractable Epilepsy | S. Alyamani; S. Alharthi; A. Alsulami; E. De Vol; H. Alothaimeen; I. Ghanam; E. Tous; M. Almuhaizea; M. Abukhalid; O. Dabbagh; H. Aldhalaan; A. Chedrawi; S. Khan

1.320 Dosing of Perampanel in Children: Correlation With Serum Levels | E. Gaudio; J. Wheless

1.321 Improved Irritability, Mood and Quality of Life Following Introduction of Perampanel in a ‘Continuously Refractory’ Epilepsy Cohort | W. D’Souza; J. Moraes; G. Hepworth; U. Seneviratne; S. Ignatiadis; M. Cook

1.322 Safety and Efficacy of Long-Term Treatment With Perampanel in Japanese Adults With Partial-Onset Seizures (With or Without Secondarily Generalized Seizures) or Primary Generalized Tonic-Clonic Seizures in a Real-World Setting | T. Nishida; Y. Inoue; K. Sumitomo; M. Takeuchi; K. Matsutani; M. Ishii

1.323 Treatment Decision Support Systems (TDSS) in Epilepsy – Exploring Proxy Validity and Overall Clinical Outcome Success Related to TDSS-Predicted Antiepileptic Drug (AED) Choices | E. Han-Burgess; A. Bozorg; J. Hixson; B. Pierre-Louis; S. Joshi; S. Yates

1.324 Adequacy of Patient Information in Electronic Medical Records and Claims Sources – An Exploratory, Retrospective Record Review to Guide Development of an Antiepileptic Drug Treatment Decision Support System (TDSS) | J. Hixson; S. Yates; B. Pierre-Louis; R. Warnock; E. Han-Burgess; S. Joshi; J. Williams; M. Gorges; S. Vandamme; J. Robertson; A. Bozorg

1.325 Predicting Drug-Resistant Epilepsy (DRE) – Use of Big Data From Administrative Claims and Machine-Learning Models | C. Dilley; M. Westover; J. Robertson; J. Valdez; S. An; E. Han-Burgess

1.326 A Machine Learning Approach for Developing Antiepileptic Drug Treatment Decision Support Systems (TDSS) | J. Robertson; E. Han-Burgess; C. Dilley; C. Clark; J. Valdez

1.327 Impact of Psychiatric and Substance Use Disorder Comorbidity on Treatment Success Among Patients With Epilepsy – Retrospective Analysis of Claims Data | J. Duke; E. Choi; E. Han-Burgess

1.328 Predictors of Epilepsy Among the Young | B. Vabson; H. Kim; J. Fishman

1.329 Assessing Efficacy and Adverse Events of Newer Generation Antiepileptic Drugs in Hospitalized Patients | L. Lin; J. Lee; D. Schomer; S. Herman

1.330 Within-Subject Variability of Lamotrigine Bioavailability: Analysis of Equigen Study Data | A. Sykuta; L. Follett; T. Welty; M. Laugerman; B. Gidal; M. Privitera; M. Berg; B. Dworetzky; J. Szaflarski; J. Pollard

1.331 Longitudinal Predictors of Healthcare use in Adults With Epilepsy | J. Fishman; B. Vabson; A. Wilner

1.332 Treatment of Epilepsy by Perampanel at Acute Care Hospitals Through a Comprehensive Epilepsy Center and Its Effectiveness of Early Add-On | T. Yamamoto


1.333 Safety and Efficacy of Brivaracetam Use in Refractory Epilepsy: A Single-Center Clinical Experience | S. McGuire; G. Silva; D. Lal; D. Khurana; A. Legido; D. Hasbani; K. Carvalho; J. Melvin; I. Valencia

1.334 Median Percent Seizure Reduction/28 Days in Patients With Refractory and Super-Refractory Epilepsy: Perampanel Use in Lennox-Gastaut Syndrome | J. Chang; B. Shafran

Surgery

Adult

1.335 The Relationship Between Quantitative MRI and Seizure Outcomes After Temporal Lobe Epilepsy Surgery | M. Morita-Sherman; R. Yardi; W. Bingaman; J. Gonzalez-Martinez; I. Najm; S. Jones; W. Xiaofeng; H. Xiaozhen; D. Vegh; F. Cendes; L. Jehi

1.336 Outcomes After Mesial Temporal Lobe Resection Following Long-Term Ambulatory Recording by the RNS® System | L. Hirsch; E. Mirro; V. Salanova; T. Witt; C. Drees; M. Brown; R. Lee; T. Sadler; E. Felton; P. Rutecki; H. Shin; E. Hadar; C. Heck; J. Greenwood; M. Hegde; V. Rao

1.337 Laser Ablation of Abnormal Neurological Tissue Using Robotic Neuroblate System (LAANTERN) Registry: Interim Results in Epilepsy Patients | P. Landazuri; J. Baumgartner; P. Fecci; E. Leuthardt

1.338 When Laser Fails: The Role for Intracranial Monitoring Following Seizure Recurrence After Stereotactic Laser Amygdalohippocampectomy (SLAH) | K. Bullinger; A. Alwaki; R. Gross; J. Willie

1.339 Detection of Subdural Electrode Displacement in Invasive Epilepsy Surgery Workup Using Intraoperative MRI | B. Sommer; S. Rampp; A. Doerfler; H. Stefan; H. Hamer; M. Buchfelder; K. Roessler

1.340 Treatment and Follow-up Costs Following Gamma-Knife or Temporal Lobectomy: Results from the ROSE Trial | J. Langfitt; G. Yan; M. Quigg; N. Barbaro; M. Ward; E. Chang; D. Broshek; K. Laxer; A. Cole; P. Sneed; C. Hess; W. Yu

1.341 Radiofrequency Thermocoagulation for Refractory Focal Epilepsy | R. Fasano; A. Greven; K. Bullinger; D. Drane; J. Willie; R. Gross

1.342 WITHDRAWN

1.343 Voxel-Based Lesion Mapping Highlights Differences Between Stereotactic Laser Amygdalohippocampotomy and Traditional Open Resection | D. Drane; E. Gleichgerrcht; L. Bonilha; K. Hewitt; D. Qiu; C. Leatherday; N. Voets; N. Kadom; A. Saindane; N. Pedersen; J. Willie; R. Gross

1.344 Surgical Treatment for Intractable Epilepsy in Elderly Patients: A Systematic Review and Our Experience | T. Nakajima; M. Tetsuka; Y. Ishishita; K. Otani; M. Sato; K. Kawai

1.345 Insular Plus Epilepsy and Surgical Treatment | N. Barot; M. Nei; S. Mintzer; C. Skidmore; M. Sperling

Pediatrics

1.346 Children With Intractable Epilepsy and Heterotopia: One Center’s Review of Surgical Outcomes | K. Havens; C. Oluigbo; J. Murnick; W. Gaillard; D. Depositario-Cabacar

1.347 Comparison of Neuropsychometric Results Before and After Resective Pediatric Epilepsy Surgery | K. Daniel; K. Alexandra; M. Zaccariello; T. Brown; B. Brinkmann; E. Payne; K. Nickels; E. Wirrell; L. Wong-Kisiel

1.348 Emergence of Autism Following Epilepsy Surgery: A Network Disorder | R. Chaudhari; R. Dwivedi; V. Padma; D. Dash; M. Tripathi; S. Chandra; M. Tripathi

1.349 Early-Stage Neurosurgical Intervention for Sturge-Weber Syndrome | Y. Guan; Z. Liu; G. Luan

1.350 Prognostic Factors for Seizure Control After Corpus Callosotomy for Children With Intractable Epilepsy | R. Honda; T. Ono; K. Toda; Y. Watanabe; T. Yasu; S. Tanaka; H. Baba

1.351 WITHDRAWN

1.352 Pre-operative fMRI Activation as a Predictor of Language Decline Following Pediatric Epilepsy Surgery | E. Fanto; C. Black; X. You; L. Sepeta; W. Theodore; W. Gaillard; C. Oluigbo; M. Berl

1.353 Temporal Lobectomy Without Amygdalohippocampectomy in a Pediatric Population: A Case Series | T. Vu; K. Havens; C. Oluigbo; W. Gaillard

1.354 Resting state fMRI and Epilepsy Surgery : A Pilot Study in Children | H. Osso-Rivera; M. Fajardo; B. Bernal; M. Guillen; A. Hyslop

1.355 Stereo Implantation of the Thalamus and Cortex in Electrical Status Epilepticus of Sleep: A Pediatric Case Study | A. Hyslop; T. Tierney; I. Miller; J. Ragheb; P. Jayakar

1.356 Pediatric Experience With Responsive Neurostimulation | M. Kokoszka; M. La Vega-Talbott; P. McGoldrick; M. Fields; L. Marcuse; F. Panov; S. Wolf; S. Ghatan

1.357 Changes in Interictal and Ictal EEG Patterns Following Complete Corpus Callosotomy | M. La Vega-Talbott; M. Kokoszka; D. Bolden; P. McGoldrick; K. Lob; H. Raynes; S. Wolf; S. Ghatan

1.358 Complex Seizure Networks: Intracranial EEG Findings of Three Patients With Periventricular Nodular Heterotopias | J. Robinson; M. Lallas; A. Kim; M. Van Hirtum-Das; D. Holder

1.359 The Utility of Intraoperative MRI to Guide Hemispherectomies and Corpus Callosotomies in the Pediatric Population | M. Tsuboyama; C. Harini; J. Madsen; S. Stone; P. Pearl; J. Bolton

All Ages

1.360 Accuracy of DBS Contact’s Location in Patients Submitted to Hippocampal Stimulation Using a Longitudinal Approach | A. Cukiert; C. Cukiert; J. Burattini; P. Mariani

1.361 A Comparison of Cost of Care of Surgical Treatments of Intractable Epilepsy Including Vagal Nerve Stimulator | U. Patel; R. Sankaraneni; S. Singh

1.362 Reevaluation of Postoperative Long-Term Epilepsy-Associated Brain Tumors | W. Zhang; J. Doescher; N. Agarwal; M. Frost; D. Dickens

1.363 The Changing Nature of Epilepsy Surgery: A Review of Practice Profiles | S. Baruah; A. Olivier; J. Hall


1.364 Special Strategy of Stereotactic Radiofrequency Thermocoagulation Using Trans-third Ventricular Approach for Hypothalamic Hamartoma With Attachment to Bilateral Hypothalamus | H. Shirozu; H. Masuda; S. Kameyama

1.365 Surgery for Epilepsy in the Setting of Polymicrogyria: Cleveland Clinic Experience | A. Thandar; J. Bulacio; B. Jin; W. Bingaman; J. Gonzalez-Martinez; I. Najm

1.366 Preoperative Direct Targeting of the Mammillothalamic Tract in Deep Brain Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy Using Fast Gray Matter Acquisition T1 Recovery MRI | S. Grewal; E. Middlebrooks; T. Kaufmann; M. Stead; B. Lundstrom; G. Worrell; C. Lin; S. Baydin; J. Van Gompel

1.367 Intracranial EEG and LASER Ablation in Non-lesional Insular Epilepsy – Case Series | E. D.Gireesh; K. Lee; H. Skinner; S. Joohee; J. Baumgartner

1.368 Granger Causality for Forecasting Neurologists’ Analysis of Stereoelectroencephalography to Define the Epileptogenic Zone: Influence of Sleep and Wakefulness | S. Barrit; E. Park; J. Madsen; M. Hameed; N. Massager; B. Legros; N. Gaspard

1.369 Successful Surgery in a Patient With Bilateral Perisylvian Fast Activity at Ictal Onset | R. Raghupathi; B. Krishnan; W. Bingaman; O. Grinenko; P. Chauvel; J. Bulacio

1.370 Psychosocial Outcomes After Surgery for Refractory Epilepsy due to Focal Cortical Dysplasia | B. Blond; E. Sternberg; E. Stanford; A. Huttner; D. Spencer; P. Farooque

Behavior/Neuropsychology/Language

Adult

1.371 Depressive Symptom Severity in Individuals With Epilepsy and Recent Health Complications | N. Kumar; R. Lhatoo; H. Liu; K. Colon-Zimmermann; C. Tatsuoka; P. Chen; M. Kahriman; M. Sajatovic

1.372 Differential pattern of white matter network abnormalities across cognitive phenotypes in temporal lobe epilepsy | A. Reyes; A. Marshall; A. Balachandra; M. Hegde; B. Paul; C. McDonald

1.373 Changes in Depression and Anxiety After Stereotactic Laser Amygdalohippocampectomy for Temporal Lobe Epilepsy | K. Padda; R. Gross; J. Willie; I. Karakis; E. Staikova; D. Loring; D. Drane; R. Fasano

1.374 Anxiety in People with Epilepsy | A. Scott; L. Sharpe; Z. Thayer; L. Miller; T. Wong; K. Parratt; A. Nikpour; C. Hunt; M. Gandy

1.375 Accelerated Long-Term Forgetting: Impact of Initial Learning and Epilepsy Focus | S. Lah; A. Nikpour; Z. Thayer; L. Miller; E. Meierotto; K. Diamond

1.376 WITHDRAWN

1.377 Sleep and Memory Consolidation in Older Patients With Epilepsy: A Neurophysiologic Analysis | R. Sarkis; N. Puri; S. Putta; C. Caborni; G. Regalia; R. Picard; M. Pavlova; R. Stickgold

1.378 Integrating the Systematic Assessment of Psychological States in the Epilepsy Monitoring Unit: Concept and Compliance | R. Michaelis; H. Schöller; Y. Höller; G. Kalss; M. Kirschner; E. Schmid; E. Trinka; G. Schiepek

1.379 Hippocampal Gamma Supports Associative Memory Performance as Measured by Acute and Chronic Intracranial EEG | A. Liu; S. Henin; A. Shankar; N. Hasulak; D. Friedman; P. Dugan; L. Melloni; A. Flinker; C. Sarac; M. Fang; W. Doyle; T. Tcheng; O. Devinsky; L. Davachi

1.380 Validity of the Liverpool Adverse Events Profile as a Screening Tool for Detecting High Risk of Suicidality in Drug-Resistant Epilepsy | O. Kwon; S. Park

Pediatrics

1.381 Influence of SUDEP Education on Parental Well-Being | D. Edsall; J. Coryell

1.382 The Neural Basis of Executive Functioning Deficits in Adolescents With Epilepsy: A Resting-State fMRI Connectivity Study | A. Gutierrez-Colina; J. Vannest; T. Maloney; A. Combs; S. Wade; T. Horowitz-Kraus; A. Modi

1.383 Behavioral Status After a Trial of Cannabidiol (CBD) in a Pediatric Sample With Pharmacoresistant Epilepsy | M. Thompson; E. Bebin; R. Martin; L. Grayson; G. Cutter; J. Szaflarski

1.384 Cognitive Characteristics and Correlates of ESES/CSWS in Children | J. Appendino; L. Bello-Espinosa; T. Fay-McClymont; B. Brooks; K. Deschamps; M. Scantlebury; W. MacAllister

1.385 Low-Dose CBD With THC: Effectiveness and Tolerability in Intractable Pediatric Epilepsy | Y. Hou; A. Vaddiparti; J. Madan Cohen

1.386 Value of Brief Cognitive Screening in Referring Children With Epilepsy for a Comprehensive Neuropsychological Evaluation | K. Patrick; H. Aleksonis; A. Patel; K. McNally

1.387 Characteristics of the Epilepsies in Pediatric Patients With Nonspecific Mitochondrial Diseases | S. Eom; Y. Lee

1.388 Depression Screening In Pediatric Epilepsy | H. Thomas; L. Suttle; K. Morrison; S. Arnold

Genetics

Human Studies

1.389 Targeted Gene Panel Sequencing of Developmental and Epileptic Encephalopathy From Birth to 3 Months | J. Na; S. Kim; J. Lee; H. Kim; J. Choi; s. Lee; H. Kang

1.390 Mosaicism in Patients With Developmental and Epileptic Encephalopathies | A. Schneider; C. Myers; G. Hollingsworth; A. Muir; C. King; K. Howell; A. Poduri; S. Zuberi; L. Sadleir; H. Mefford; I. Scheffer

1.391 Copy Number Variation in a Community Sample of 3291 Adults With Epilepsy | M. Smith; M. Einon; E. Rees; K. Kendall; G. Kirov; R. Thomas

1.392 Brain Somatic Variants in SLC35A2 in Intractable Neocortical Epilepsy | M. Winawer; N. Griffin; J. Samanamud; E. Baugh; D. Rathakrishnan; S. Ramalingam; A. Spagnolo Allende; D. Zagzag; C. Schevon; P. Dugan; M. Hegde; S. Sheth; G. McKhann; W. Doyle; G. Grant; B. Porter; M. Mikati; C. Muh; C. Malone; A. Bergin; J. Peters; D. McBrian; A. Pack; C. Akman; C. Lacoursiere; K. Keever; J. Madsen; E. Yang; H. Lidov; C. Shain; A. Allen; P. Canoll; P. Crino; A. Poduri. E. Heinzen


1.393 De Novo Variants in Neurodevelopmental Disorders With Epilepsy | H. Heyne; T. Singh; H. Stamberger; A. Poduri; Y. Weber; S. Weckhuysen; S. Sisodiya; M. Daly; I. Helbig; D. Lal; J. Lemke

1.394 SLC19A1 Compound Heterozygosity Leading to Cerebral Folate Deficiency and Treatment-Resistant Seizures | D. Lammert; J. Pelligrino; K. Petropoulou; A. Sankonju; G. Zhang

1.395 Application of Whole Genome Sequencing to a Cohort of Children With Developmental and Epileptic Encephalopathy | R. Sachdev; R. Macintosh; T. Kandula; A. Minoche; C. Puttick; V. Gayevskiy; A. Drew; M. Cowley; M. Dinger; T. Roscioli; E. Kirk; A. Bye; E. Palmer

1.396 A Comparison of Diagnostic Genomic Sequencing in Adults and Children With Epilepsy | K. Benson; N. Allen; G. Cavalleri; E. Comerford; R. Corbridge; D. Costello; N. Delanty; C. Doherty; M. Fitzsimons; N. Ganghadaran; M. Greally; T. Kawasaki; M. King; J. Lynch; M. McCormack; K. Power; M. White; D. Webb

1.397 A Novel Pathogenicity Modelling Approach Allows Differentiation Between Mild and Severe Missense Variants in SCN1A-Related Epilepsies | I. Ghanty; E. Pérez-Palma; S. Schorge; J. Symonds; S. Zuberi; D. Lal; A. Brunklaus

1.398 Deep Sequencing of the Mitochondrial Genome in Adult Patients With Unexplained Epilepsy | T. Araujo; N. Ganghadaran; M. Farrell; C. Doherty; M. McCormack; G. Cavalleri; N. Delanty

1.399 Evaluation of Copy Number Burden in Specific Epilepsy Types From a Genome-wide Study of 18,329 Subjects | L. on behalf of the Epi25 Consortium

1.400 Shiny-ClinVar: An Interactive Online Tool to Explore Disease Genes and Variants Aggregated in the ClinVar Database and Its Application to Epilepsy | E. Perez-Palma; M. Gramm; P. May; D. Lal

1.401 Reginal Specificity of KCNQ2 Missense Variants Causing Benign or Epileptic Encephalopathy Phenotype | A. Ishii; A. Goto; M. Shibata; Y. Ihara; K. Moreira; S. Hirose

1.402 Comprehensive Phenotyping and Genotyping in a Scottish Population-Based Cohort of Children Presenting With Epilepsy <3 Years | J. Symonds; K. Elliott; J. Knight; A. Brunklaus; S. Gardiner; S. Joss; S. McLeod; M. O’Regan; D. Pilz; K. Stewart; S. Zuberi

1.403 Outcome of Genetic Testing for Patients With Epilepsy Is Determined by Age of Seizure Onset, Presence of Other Neurological Comorbidities and Concurrent Testing of Parents | D. McKnight; J. Scuffins; G. Richard; E. Butler

Health Services

1.404 Assessment of Care Transitions and Caregiver Burden in Autoimmune and Infectious Encephalitis | A. Tomlinson; R. Blum; S. Nyamu; N. Jette; A. Yeshokumar

1.405 A 3-Year Review of Epilepsy Foundation 24/7 HELPLINE: Utilization, Constituent Needs, Resource Referral | T. Buckley; E. Kiriakopoulos; C. Cooney; S. Owens; J. Kakacek, MNPM, PhD; P. Shafer, RN, MN; J. Sirven

1.406 Rating the Information on SUDEP Websites | A. Bumbut; B. Kroner; W. Gaillard; H. Goodkin; M. Berl

1.407 Epilepsy Family Support Group | C. Brandt; W. Gaillard; K. Tiplady; M. Acosta; L. Suzanne; T. Vu; P. Shibuya; A. Bumbut; A. Pasupuleti

1.408 Yield of a Limited Duration EEG in Rural Epilepsy Camps in India – Analysis of EEG in 970 Patients | N. Surya; R. Sankaraneni; S. Singh

1.409 New Applications for Telemedicine in Pediatric Epilepsy Care | A. Martyanov; S. Joshi; L. Fletcher; B. Smith; S. Jordan; A. Barnes

1.410 Evaluation of a Care Coordination Checklist for Pediatric Epilepsy Patients | P. Glynn; A. Patel; B. Harridas; J. Seirup; Z. Otgonsuren; Z. Grinspan

1.411 Utilization of a Standardized Discharge Template Is Associated With Lower 30-Day Readmission Among Pediatric Patients With Seizures | J. Benwait; J. Nguyen; M. Chiujdea; A. Antonetty; J. Heath

1.412 A Learning Healthcare System for Epilepsy: Organization and Management | Z. Grinspan; N. Basma; J. Buchhalter; A. Patel; A. Berg; R. Shellhaas; K. Farrell; B. Fureman; J. McCrindle; D. Hesdorffer; J. French; B. Kroner; S. Herman; N. Jette

1.413 A Multidisciplinary Clinic Is a Feasible Model of Care | S. Nangia; Z. Grinspan; K. Gurcharran, MD; R. Uribe-Cardenas; J. LaMothe, MSN, CPNP, RN; K. Padulsky, MSN, CPNP, CNRN; S. Schultz, MPAS, PA-C; M. Montgomery, MS, RD, CDN; R. Jacobs, LMSW; C. Hoffman, MD

1.414 The Importance of a Multidisciplinary Approach During Transition From Pediatric to Adult Epilepsy Care | M. O’Connor; K. Reger; D. Hron; K. Caffrey; A. Hughes-Scalise

1.415 Genetic Counseling Improves Caregiver Empowerment in Early-Life Epilepsy Clinic | R. Hicks; L. Raman; B. Sheidley; A. Berg; S. Koh

1.416 Utilization of Telemedicine in Epilepsy - A Review | U. Menon; R. Abraham; R. Ramsay

1.417 Listening to the Community Voice in a Traumatic Brain Injury Study to Prevent Post-Traumatic Epilepsy: Preliminary Findings of the EpiBioS4Rx Public Engagement Core | D. Correa; C. Kwon; S. Moshé; N. Jette; f. Public Engagement Core

1.418 Post-Acute Symptomatic Seizure (PASS) Clinic: A Unique Outpatient Care Model for Patients With Medical Management Impacted by Continuous EEG (cEEG) Monitoring | P. Parikh; J. Fesler; S. Hantus; V. Punia

1.419 Transition Readiness for Children and Youth With Epilepsy | R. Tang; N. Beimer; S. Clark; L. Fletcher; L. Carbone; A. Patel; S. Joshi

1.420 The AIM-ET Project: Access Improvement and Management of Epilepsy Through Telehealth Project | S. Joshi; K. Galli; C. Wilson; C. Trandifir; C. Wusthoff; M. Goyal; L. Fletcher; S. Hueneke; T. Calabrese; J. Lapp

1.421 Challenges for Families With Children and Youth With Epilepsy | M. Goyal; P. Miller; J. Williams; K. Helms; E. Mixon; K. Fowler

1.422 An Update on the Impact of the International Neurology Foundation’s Annual Medical Mission in the Ecuadorian Amazon Rainforest | S. Barnard, BS; K. Shapiro, MD, PhD; I. Porges, MPH; Y. Garzon, MD; M. Fernández Fernández, MD; P. Espinosa, MD, MPH, FAAN


1.423 Racial Disparities in Epilepsy: Attitudes Toward Care as a Possible Barrier to Surgery | K. Waldron; S. Williams; R. Archer; L. Blank; S. Monroe; H. Huang; B. Litt

1.424 Outpatient Epilepsy Telehealth Coverage for Virginia’s Veterans | K. Ono; N. Jean-Noel; K. Browning

Epidemiology

1.425 The North American SUDEP Registry (NASR): Preliminary Descriptive Analysis of SUDEP Cases | C. Verducci; F. Hussain; D. Friedman; O. Devinsky

1.426 Infertility, Impaired Fecundity and Live Birth Rates in Women with Epilepsy in the USA: Findings of the Epilepsy Birth Control Registry | D. MacEachern; H. Mandle; A. Herzog

1.427 The Risk of New-Onset Epilepsy and Pharmacologically Refractory Epilepsy in Older Adult Stroke Survivors | T. Antaya; J. Burneo; B. Allen; A. Belisle; S. Shariff; G. Saposnik

1.428 Adverse Behavioural Outcomes in Children with Epilepsy and Other Neurodevelopment Disabilities | A. Prasad; B. Corbett

1.429 Prevalence and Incidence of Drug-Resistant Mesial Temporal Lobe Epilepsy in Qatar | M. Ali; L. Elsheikh; D. Deleu; H. Al Hail; G. Melikyan; N. Haddad; G. Alarcón; Y. Ali; J. D.Perkins; A. Ayyad; R. Khodair; A. Asadi-Pooya; B. Mesraoua

1.430 Prognostic Impact of Epilepsy in Multiple Sclerosis | Z. Mahamud; J. Burman; J. Zelano

1.431 Estimating Epilepsy Prevalence in the Veterans Health Administration After Implementation of ICD-10 | R. Rehman; S. Eisenschenk; A. Frontera; A. Husain; P. Kelly; A. Krumholz; M. Lopez; S. Sajan; T. Tran; P. Rutecki

1.432 Validating Epilepsy Cases Using Clinical and Claims Data From a Tertiary Children’s Hospital | H. Kim; A. Oh; D. Thurman

1.433 Longitudinal Efficacy Study of MINDSET: A Clinic Decision-Support Tool for Epilepsy Self-Management of Hispanic Patients | R. Sepulveda, PhD; J. Chong, PhD; D. Labiner, MD; N. Halavacs, MPH; C. Begley, PhD; R. Shegog, PhD; R. Addy, PhD; K. Martin; C. Szabo; M. Torres, MD

1.434 Hospital Admission, Discharges and In-hospital Mortality in Epilepsy Patients: A Population-Based Study | C. Kwon; P. Agarwal; M. Dhamoon; A. Yeshokumar; M. Mazumdar; N. Jette

Public Health

1.435 Essential Oil-Induced (EOIS) and Provoked Seizures (EOPS): A Multicentric Prospective Observational Study From South India | T. Mathew; V. Kamath; R. Jadav; S. Swamy; S. R; G. Adoor; R. Nadig; A. Awati; G. Sarma; S. Badachi; D. D Souza; A. Avati; A. Baptist; A. Shaji; M. T

1.436 Driving with Epilepsy: Attitudes, Behavior, and Risks in an Australian Cohort | R. Guan; A. Burbidge; E. Somerville

1.437 Generalizability of Natural Language Processing Tools (Regular Expressions) for Detection of SUDEP Risk Factors in EMRs | K. Berry; D. Hesdorffer; E. Yozawitz; P. McGoldrick; S. Wolf; T. McDonough; A. Nelson; T. Loddenkemper; N. Basma; S. Johnson; Z. Grinspan

1.438 Lack of Reported Seizure Exacerbation by Football Participation | H. Alexander; N. Fountain

1.439 Utility of an Online Caregiver-Reported Seizure Tracking Tool | A. Fialkow; M. Jackson; K. Gao; M. Chiujdea; A. Antonetty; S. Weas; J. Oppenheimer; E. Fleegler; E. Chan; T. Loddenkemper

1.440 Lifestyle Epilepsy Self-Management in African American Adults With Epilepsy and Depression | J. Chambers-Blair; A. Gray; N. Burris; D. Geiger; L. Johnson, MPH, MLitt; N. Thompson, PhD, MPH; R. Quarells, PhD, MS

Case Studies

1.441 Early-onset Childhood Absence Epilepsy with Paradoxical Response to Valproic Acid | A. Jewell; L. Lasky

1.442 Epilepsy Surgery for a Patient With Neurofibromatosis Type 1 Coexistent Moyamoya Syndrome | N. Kuroda; A. Fujimoto; T. Okanishi; K. Sato; M. Nishimura; S. Baba; S. Itamura; Y. Arai; H. Enoki

1.443 Postictal Psychosis: The Price of Delayed Recognition | A. Ramos; N. Villemarette-Pittman; E. Conrad; E. Mader

1.444 Case Report: Treatment of Intractable Epilepsy with Ketogenic Diet in a Patient With Glycine Encephalopathy | L. Currens; E. Segal; A. Samuels; K. Valdez-Gonzalez; H. Pedro

1.445 A Case of Postpartum New Onset Refractory Status Epilepticus | K. Schwartz; R. Martinez; N. Issa; C. Kramer

1.446 Ictal Hypersalivation and Parotid Gland Hypertrophy as Salient Features of Acquired Frontal Lobe Epilepsy | X. Xiang; D. Miller; P. Olejniczak; E. Mader

1.447 VNS and RNS Neuromodulation Work Synergistically to Improve Seizure Control in Patients With Drug-Resistant Epilepsy | A. Lee; C. Drees; D. Becker

1.448 A Case of Immunoglobulin Responsive Medically Refractory Epilepsy Secondary to GABA B Receptor Antibody Encephalitis With Extra-Limbic MRI FLAIR Lesions | K. Akkineni; H. Aslam; A. Verma; B. McQueen; S. Shroff

1.449 Benign Epileptiform Variants in Critically Ill Patients: Illustrative Cases and Literature Review | G. McLeod; M. Jones; M. Ng

1.450 Increased NREM Sleep Slow Wave Activity Colocalizes with Clinically Suspected Epileptic Focus in a Patient With Reflex Epilepsy: A High-Density EEG Case Study | E. Moffet; B. Jones; G. Findlay; R. Verhagen; E. Juan; T. Bugnon; A. Mensen; A. Struck; G. Tononi; R. Maganti; M. Boly

Late Breaking

1.451 Cerebrospinal Fluid Liquid Biopsy for Detection of Somatic Mosaicism in Brain | Z. Ye; L. Mcquillan; J. Damiano; S. Harvey; S. Malone; H. Do; W. Maixner; A. Schneider; G. Gillies; K. Pope; P. Lockhart; I. Scheffer; A. Dobrovic; M. Bahlo; R. Leventer; S. Berkovic; M. Hildebrand

1.452 Subjective vs Objective Monitoring to Assess The Efficacy of Steady State Closed-Loop Neurostimulation Systems in Treating Medically Refractory Epilepsy | D. Luong; N. Zhong


1.453 Exploration of the Potential for Plasma Protein Binding Displacement and Drug-Drug Interactions of Valproate in Combination with Cannabidiol | B. Tayo; E. Ben-Menachem; B. Gunning; C. Arenas Cabrera; J. Crockett; L. Taylor; D. Critchley; G. Morrison; L. Wray; M. Toledo

1.454 Serum Serotonin Levels as a Potential Biomarker of SUDEP Risk | A. Murugesan; M. Rani; L. Vilella; N. Lacuey; J. Hampson; S. Lhatoo

1.455 An Inhibitor of Receptor-interacting Protein Kinase-1 Protects Hippocampal Neurons from Seizure-induced Neuronal Necrosis | K. Hsieh; D. Fujikawa

1.456 How Often is Drug-free Ketogenic Diet Therapy Achieved and in Whom? | L. Shah; Z. Turner; S. Bessone; P. Winesett; A. Stanfield; E. Kossoff

1.457 A Meta-Analysis of Vagus Nerve Stimulation in Patients with Lennox Gastaut Syndrome | M. Dibue-Adjei; T. Greco; H. Steiger; M. Kamp

1.458 Antisense Oligonucleotide Therapy for Lafora Disease | T. Grossman; S. Ahonen; J. Turnbull; L. Hettrick; H. Kordasiewicz; M. Bell; M. McCaleb; P. Wang; X. Zhao; R. Lane; P. Goldberg; B. Minassian

1.459 Modeling Childhood Epilepsy in Human Cerebral Organoids | V. Nieto Estevez; D. Thodeson; S. Goetsch; P. Varma; Z. Lybrand; J. Schneider; J. Hsieh

1.460 Predictors of 30-Day Readmission Among Patients Admitted for Epilepsy or Seizures | S. Terman; E. Guterman; J. Betjemann; C. Hill; J. Burke

1.461 WITHDRAWN

1.462 Dosage Related Efficacy and Tolerability of Cannabidiol in Children with Treatment Resistant Epileptic Encephalopathy: Preliminary Results of the CARE-E study. | R. Tang-Wai; R. Huntsman; J. Alcorn; S. Vuong; B. Acton; S. Corley; R. Laprairie; H. Lim; A. Lyon; S. Meier; D. Mousseau; D. Newmeyer; E. Prosser-Loose; B. Seifert; J. Tellez-Zenteno

1.463 Cannabidiol Increases Survivability and Reduces Associated Behavioral Comorbidities in a Mouse Model of Dravet Syndrome | P. Patra; E. Serafeimidou; M. Bazelot; B. Whalley; C. Williams; A. McNeish

1.464 Accelerated Long-term Forgetting in Patients with Temporal Lobe Epilepsy After Standard Temporal Lobectomy | A. Gomez-Ibañez; M. Visser; C. Forn; P. Rosell-Negre; V. Villanueva; C. Ávila

1.465 Adult Neurogenesis in the Normal Adult Mouse Protects Against Status Epilepticus, Neuronal Loss and Reduces Epileptogenesis | S. Jain; J. LaFrancois; J. Botterill; D. Alcantara-Gonzalez; H. Scharfman

1.466 Antisense 0ligonucleotide Therapy for SCN2A Gain-of-function Epilepsies | S. Petrou; M. Li; N. Jancovsk; P. Jafar-najad; L. Burbano; A. Nemiroff; K. Dalby; S. Maljevic; C. Reid; F. Rigo

1.467 Structural and Functional Brain Changes in Patients with CDKL5-Gene Related Encephalopathy | S. Sarwar; S. Wang; Z. Wang; E. Pestana Knight

1.468 Higher Cannabidiol Levels are Associated with Better Seizure Response Following Treatment with a Pharmaceutical Grade Cannabidiol | K. Hernando; E. Bebin; T. Gaston; L. Grayson; R. Moreadith; J. Szaflarski

1.469 Suicide Timing Among People with Epilepsy: A Population-Based Study from 18 U.S. States, 2003-2014 | N. Tian; M. Zack; K. Fowler; D. Hesdorffer

1.470 Long-Term Safety and Efficacy of Add-on Cannabidiol (CBD) Treatment in Patients with Dravet Syndrome (DS) in an Open-Label Extension (OLE) Trial (GWPCARE5) | I. Scheffer; J. Halford; R. Nabbout; R. Sanchez-Carpintero; Y. Shiloh-Malawsky; M. Wong; D. Checketts; K. VanLandingham


Sunday, December 2


Neurophysiology


2.001 Outcome of In-Home Diagnostic Video-EEG Monitoring in a ~10,000 Patient Nationwide Cohort | R. El Atrache; T. Syed; W. LaFrance Jr; J. Slater; T. Loddenkemper; H. AlBunni; M. Khan; F. Khan; F. Hussain; A. Syed; M. Koubeissi

2.002 Five-Dimensional Cortical Atlas of Auditory Language Function | Y. Nakai; A. Sugiura; B. Silverstein; J. Jeong; R. Rothermel; E. Asano

2.003 Latency to First Event Is Shorter in Psychogenic Nonepileptic Seizures Than in Epileptic Seizures in an Epilepsy Monitoring Unit | V. Sagi; J. Shoup; R. Chilukuri; S. Evans

2.004 Quantitative EEG Spectrograms: Diagnostic Efficacy in Intensive Care and Epilepsy Monitoring Units and the Common Seizure Mimickers | A. Goenka; A. Boro

2.005 Presentation of PNES in Hawaii’s Ethnoculturally Diverse Patients | R. Ho; J. Ocol; C. Lu; S. Dolim; M. Yang; A. Kaplan; C. Wilson; E. Lee; E. Carrazana; K. Liow

2.006 Unfiltering the Link Between Postictal Tonic EMG and Seizure Pathophysiology: EMG Following Tonic-Clonic Seizures Is Associated With Peri-Ictal Severity of Respiratory Dysfunction and Postictal Generalized EEG Suppression | K. Park; M. Seyal

2.007 Background EEG Activity Differentiates Between Physiological and Epileptic High-Frequency Oscillations and Remains Unaltered Over Several Days | A. Minthe; D. Lachner Piza; W. Janzarik; P. Reinacher; M. Dümpelmann; J. Jacobs

2.008 The Association Between Duration of Video-EEG Recording and Detecting Epileptiform Discharges in Patients with Psychogenic Nonepileptic Seizures and Epilepsy | D. Atteyah; F. Babtain; W. Balubaid; S. Bajammal; N. Madani; H. Kayyali; Y. Al-Said; K. Alqadi

2.009 The Value of Routine EEG Prior to Epilepsy Monitoring Unit Evaluation in Patients With Refractory Epilepsy | D. Atteyah; S. Bajammal; W. Balubaid; F. Babtain; N. Madani; H. Kayyali; Y. Al-Said; K. Alqadi

2.010 Sleep-Disordered Breathing Among Patients Admitted for Video-EEG Monitoring | S. Sivathamboo; S. Farrand; Z. Chen; E. White; A. Pattichis; C. Hollis; J. Carino; C. Roberts; T. Minogue; N. Jones; R. Yerra; C. French; P. Perucca; P. Kwan; D. Velakoulis; T. O’Brien; J. Goldin

2.011 Presurgical Evaluation of Pediatric Epilepsy Patients: Relations Between EEG and MRI Localizations | M. Tacke; S. Shen; J. Remi; C. Vollmar; S. Noachtar; F. Heinen; I. Borggraefe

2.012 The Probability of Seizures During EEG Monitoring in High-Risk Neonates | L. Worden; J. Gold; D. Chinappen; M. Kramer; M. Westover; C. Chu

2.013 Cortical Myoclonus and Dystonia in Angelman Syndrome | S. Gasparini; E. Ferlazzo; C. Sueri; G. Ferrigno; V. Cianci; D. Branca; T. D’Agostino; U. Aguglia

2.014 Automated EEG Source Imaging: A Retrospective, Blinded Clinical Validation Study | P. van Mierlo; A. Ghasemi Baroumand; G. Strobbe; L. Pinborg; M. Fabricius; G. Rubboli; A. Leffers; P. Uldall; B. Jespersen; J. Brennum; O. Henriksen; S. Beniczky

2.015 Defining Surgical Outcome Using Phase-Amplitude Coupling in Electrocorticogram for Human Temporal Lobe Epilepsy | G. Ren; J. Yan; D. Wang; J. Dai; Y. Li; X. Wang; X. Yang; Q. Wang

2.016 Predictive Value of Early EEG in Neonates With Moderate Hypoxic-Ischemic Encephalopathy | A. Singla; M. Nasser; O. Farooq; S. Finnegan; R. Thomas; D. Rochez; P. Chandrasekharan; A. Weinstock

2.017 Scalp Delta Ictal Onset Is Not a Reliable EEG Marker for Neocortical Temporal Lobe Epilepsy | X. Liu; T. Sun; S. Wu; S. Rose; R. Martinez; S. Lai; N. Issa; J. Tao

2.018 Psychomotor Variant as an EEG Marker for Mesial Temporal Lobe Epilepsy | T. Sun; X. Liu; S. Rose; S. Wu; R. Martinez; S. Lai; N. Issa; J. Tao

ICU EEG

2.019 Uncovering Hidden Command Following in the ICU | J. Claassen; K. Doyle; C. Couch; A. Matory; A. Velasquez; J. Okonkwo; K. Burger; S. Park; S. Agarwal; D. Roh; J. King; M. Murad; A. Eliseyev; E. Connolly; B. Rohaut

2.020 Utility of Salzburg Consensus Criteria for Nonconvulsive Status Epilepticus and Amplitude-Integrated Electroencephalography for Monitoring Electroencephalography of Patients With Refractory Status Epilepticus | H. Kim; H. Kim; S. Lee; Y. Koo

2.021 Macroperiodic Oscillations (MOs) Precede Recurrent Seizures Following Acquired Brain Injury in Young Children | R. Guerriero; S. Tomko; A. Ganniger; K. Sputo; A. Shamsuzzaman; K. Guilliams; S. Ching; M. Morrissey

2.022 Neurophysiologic Derangements and Clinical Outcomes Associated with Pediatric Post-Traumatic Seizures | B. Appavu; S. Foldes; A. Jacobson; B. Burrows; D. Brown; P. Adelson

2.023 An Audit of the Clinical, Etiological and Prognostic Variables in Patients with Spindle Coma | G. Dash; B. Chauhan; A. Patanvadiya

2.024 Characteristics of Interictal Slow Wave Activity From Bilateral Invasive EEG During Sleep and Postictal States | B. Lundstrom; M. Boly; R. Duckrow; H. Zaveri; H. Blumenfeld

2.025 Electrographic Predictors of Successful Weaning From IV Anesthetics in Refractory Status Epilepticus | D. Rubin; B. Angelini; M. Shoukat; M. Ghanta; J. Moura; J. Jing; S. Zafar; M. Westover; S. Cash; E. Rosenthal

2.026 Continuous EEG Monitoring for Seizures Post Cardiopulmonary Bypass in Neonatal Cardiac Surgery | R. Rajaraman; J. Matsumoto; C. Giza; M. Federman

2.027 Periodic and Rhythmic EEG Patterns: Is There Clinical Equipoise for Treatment in Hospitalized Patients? | D. Galluzzo; M. Dhakar; L. Hirsch; K. Sheth; E. Gilmore


2.028 Cerebral Dysfunction on EEG: What Does It Really Mean ? | N. Jadeja; A. Ehlert; J. Lee

2.029 Electrographic Seizures in Patients With Acute Encephalitis | T. Viarasilpa; N. Panyavachiraporn; G. Osman; C. Parres; P. Varelas; M. Van Harn; S. Mayer

2.030 Evaluation of Automated Seizure Detection Algorithms in Critically Ill Children | F. Din; S. Lalgudi Ganesan; T. Akiyama; C. Stewart; A. Ochi; H. Otsubo; C. Go; C. Hahn

Other Clinical EEG

2.031 Effect of Perampanel on EEG Clinical Idiopathic Generalized Convulsive Epilepsy, Continuous Spike-Wave in Sleep, and Lennox-Gastaut Syndrome | M. Chez

2.032 Use of Combined Electroencephalography and Tilt Table Testing to Determine Etiology of Loss of Consciousness | N. Singh; A. Ritaccio

2.033 Seizure Spread to the Amygdala Predicts Onset of Central Apnea | W. Nobis; K. Gonzalez Otarula; G. Lane; E. Gerard; C. Zelano; S. Schuele

2.034 Dynamic Changes in Response Synchrony in Childhood Absence Epilepsy | C. Hsu; F. Pei; R. Holt; B. Porter; A. Norcia; J. Tsai

2.035 Diagnostic Added Value of High-Density Versus Low-Density EEG Recordings | A. Justesen; C. Skaarup; S. Beniczky

2.036 Cortex Leads Thalamus in Tonic Seizures of Lennox-Gastaut Syndrome | L. Dalic; A. Warren; A. Roten; W. Thevathasan; K. Bulluss; J. Archer

2.037 Fact or Artifact, 4th Edition | C. Riley

2.038 REM Sleep Abnormalities Are Similarly Prevalent in Temporal Lobe and Extratemporal Lobe Epilepsy - Observations From an EEG-Polysomnography Study | G. Shukla; A. Gupta; K. Chakraverty

2.039 The Use of Collodion Versus Traditional Paste for Reducing Artifact in Ambulatory Electroencephalography Studies in the Pediatric Population | D. Brigham; Y. Shah; I. Pavkovic; S. Karkare; S. Kothare

2.040 Frontal Lobe Seizure Differentiated From Non-Epileptic Seizure by 256 Channel dEEG | H. Hasegawa; C. Colen

2.041 The Value of Ambulatory EEG Monitoring for Evaluation of Syncope | M. Koganti; S. Kamineni

2.042 A New Ictal EEG Finding in Electroconvulsive Therapy: Generalized, High-Amplitude, Central-Positive Sharp Waves | E. Trammel; R. Hogan; N. Farber; M. Avidan; B. Palanca

2.043 Neurophysiological Activity in Different Cortical Areas During Sleep: Development of an Atlas of “Normal” Intracranial EEG | N. von Ellenrieder; R. Zelmann; D. Nguyen; P. Kahane; F. Dubeau; J. Gotman; B. Frauscher

2.044 Simultaneous MEG and EEG to Detect Ripples in People With Focal Epilepsy | N. van Klink; A. Mooij; G. Huiskamp; C. Ferrier; K. Braun; A. Hillebrand; M. Zijlmans

2.045 Epileptic HFOs Are Not Influenced by Propofol Administration | R. Sakuraba; S. Osawa; M. Iwasaki; K. Jin; T. Tominaga; T. Miki; N. Nakasato

2.046 Interictal ECoG Features Correlate With Depression in Individuals With Epilepsy | B. Jarosiewicz; T. Skarpaas; D. Loring; K. Meador; A. Kanner; M. Morrell

2.047 Seizure-Induced Changes Within the Autonomic Nervous System | S. Vieluf; T. Loddenkemper; T. Hasija; F. Mohammadpour Touserkani; S. Hammond; R. El Atrache; M. Bendsen-Jensen; P. Schreier; C. Reinsberger

2.048 Chronic Ambulatory ECoG Seizure Onset Patterns in Mesial Temporal Lobe Epilepsy | G. Nune; B. Razavi; E. Kobylarz; S. Arcot Desai; T. Skarpaas; M. Morrell

2.049 Interictal ECoG Features Correlate With Cognitive Outcomes in Individuals With Epilepsy | D. Loring; K. Meador; B. Jarosiewicz; T. Skarpaas; M. Morrell

2.050 Recurrent Neural Networks for Forecasting Epileptiform Electrographic Activity 24 Hours in Advance | S. Arcot Desai; T. Tcheng; M. Morrell

2.051 Lateralizing, Then Treating Lateralized MTLE With the RNS System: Three Cases and Outcomes Report | P. Weber; E. Mirro; C. Hamilton; D. King-Stephens

2.052 Clinical Seizures Cluster in Relation to Cycles of Interictal Epileptiform Activity | V. Rao; T. Tcheng; M. Baud

MEG

2.053 Very High Frequency Oscillations Using Magnetoencephalography in Patients With Epilepsy | T. Yu; F. Wang; X. Wang; J. Xiang; G. Zhang; Y. Li

2.054 Experience With MEG in a Large Pediatric Cohort From a Tertiary Care Epilepsy Center | T. Hirfanoglu; M. Aldosari; M. Katagiri; T. Aung; J. Mosher; A. Alexopoulos; R. Burgess; A. Gupta

2.055 Magnetoencephalography in Refractory Insular/Peri-Insular Cortex Epilepsy | M. Aldosari; M. Katagiri; T. Hirfanoglu; T. Aung; Z. Wang; J. Gonzalez-Martinez; J. Mosher; A. Alexopoulos; R. Burgess

2.056 Distributed Magnetic Source Imaging for Localization of the Epileptic Focus: A Comparison of Four Methods | G. Pellegrino; T. Hedrich; M. Porras-Bettancourt; C. Grova; E. Kobayashi

2.057 Transient Networks in Mesial Temporal Lobe Epilepsy | G. Bhargava; N. Mariyappa; C. Ramon; K. Thennarasu; K. Raghavendra; R. Mundlamuri; S. Duble; M. Khilari; J. Saini; R. Bharath; J. Rajan; S. Sinha

2.058 Clinical Utility of Magnetic and Electric Source Imaging in the Localization of Interictal Spikes Prior to Pediatric Epilepsy Surgery | M. Alhilani; E. Tamilia; M. Tsuboyama; J. Peters; S. Stufflebeam; P. Grant; J. Madsen; P. Pearl; N. Tanaka; C. Papadelis

Brain Stimulation

2.059 Cingulate Gyrus Function Studied by Electrical Cortical Stimulation: Literature Review and a Surgical Series | A. KacarBayram; D. Spencer; R. Alkawadri

2.060 Brief History of Electrical Cortical Stimulation: A Journey in Time From Volta to Penfield | C. Isitan; C. Benjamin; D. Spencer; R. Alkawadri


2.061 Lobar Connectivity During Wakefulness and Sleep Studied Through Single Pulse Electrical Stimulation in Patients With Focal Epilepsy | A. Arbune; I. Mindruta; I. Popa; D. Maliia; A. Daneasa; J. Ciurea; C. Donos; O. Bajenaru; A. Barborica

2.062 Role of Noninvasive Mapping to Guide Placement of Intracranial Electrodes and Responsive Neurostimulation (RNS) | R. Rezaie; S. Narayana; J. Wheless; A. McGregor; F. Boop; S. Fulton

2.063 Cable Modeling for Maximizing Direct Cortical Neurostimulation Therapy in a Refractory Epileptogenic Network With Two or More Ictogenic Foci | L. Cendejas-Zaragoza; D. Garibay-Pulido; M. Rossi

2.064 Patient-Detectable Responsive Neurostimulation as a Seizure-Warning System | I. Quraishi; L. Hirsch

2.065 Underlying Excitability at the Focus Modulates Network Dynamics of Seizure Propagation: A Single-Pulse Electrical Stimulation Study Time-Locked to Spike and Post-Spike Slow | K. Kobayashi; R. Matsumoto; K. Usami; A. Shimotake; Y. Yamao; T. Kikuchi; K. Yoshida; T. Kunieda; R. Takahashi; A. Ikeda

2.066 Functional Involvement of Periventricular Nodular Heterotopia | K. Houck; Z. Haneef; A. Nayak; J. Gavvala; M. Quach; P. Van Ness; D. Curry; D. Yoshor; A. Goldman

2.067 A Novel Treatment of Left Mesial Temporal Lobe Epilepsy: Implantation of Entorhinal Cortex and Hippocampus Using Responsive Neurostimulation | I. Keselman; S. Dewar; D. Eliashiv, M.D.

2.068 Augmented mGluR5 Activity Facilitates the Antiepileptic Effect by Cathodal Transcranial Direct Current Simulation in a Mouse Pentylenetetrazol (PTZ) Seizure Model | Y. Sun; S. Dhamne; M. Goldenberg; J. Madsen; A. Rotenberg

2.069 Rapid Identification of Cortical Connectivity During Functional Mapping | L. Crowther; P. Brunner; A. Ritaccio; G. Schalk

2.070 Evaluation of Neuromodulation as Treatment for Drug-Resistant Epilepsy: Experience at King’s College Hospital | I. Stavropoulos; R. Selway; R. Elwes; D. Jimenez-Jimenez; G. Alarcón; A. Valentin

2.071 Functional Mapping of Language With High-Gamma Electrocorticography Using a Battery of Five Language Tasks | J. Shum; B. Mahmood; L. Fanda; P. Dugan; D. Friedman; W. Doyle; O. Devinsky; A. Flinker

2.072 Cortical Excitability, Synaptic Plasticity, and Cognition in Benign Epilepsy with Centrotemporal Spikes: A TMS-EMG-EEG Study | F. Baumer; K. Pfeifer; A. Fogarty; C. Rolle; J. Wallace; A. Rotenberg; R. Fisher

2.073 RNS System Treatment in Patients With Regional Neocortical Seizure Onsets | B. Ma; E. Mirro; R. Knowlton; E. Chang; V. Rao

2.074 Neurophysiological Biomarkers of Amygdala Stimulation on Medial Temporal Lobe Networks Supporting Declarative Memory in Patients With Epilepsy | M. Sendi; C. Inman; J. Manns; K. Bijanki; R. Gross; J. Willie; B. Mahmoudi

2.075 Nine-Year Prospective Safety and Effectiveness Outcomes From the Long-Term Treatment Trial of the RNS® System | D. Nair; R. Investigators; M. Morrell

2.076 Anatomic Early Electrographic Seizure Onset Localization in Neocortical-Responsive Neurostimulation | A. Ho; E. Mirro; B. Razavi; K. Miller; D. Hermes; M. Markert; G. Grant; J. Henderson; C. Halpern

2.077 The Clinical Utility of TMS in Localizing Language Specific Cortices: A MEG Comparison Study | K. Ryan; K. Schiller; R. Rezaie; F. Boop; J. Wheless; S. Narayana

2.078 Resting State Networks Deactivation in Focal Epilepsy | D. Maliia; C. Donos; A. Barborica; I. Popa; J. Ciurea; A. Arbune

Animal Studies

2.079 Mice Lacking 5-HT2C Receptors Display a Novel Adult-Onset SUDEP Phenotype and Increased Mortality in Males | C. Massey; J. Noebels

2.080 Ube3a Maternal Deficiency Rat Model of Angelman Syndrome Is Associated With Altered Spectral Power and Seizure Threshold | H. Born; L. Martinez; S. Mehra; S. Harris; W. Lee; S. Dindot; J. Silverman; D. Segal; E. Weeber; A. Anderson

2.081 AMPA Receptor Plasticity Sustains Severe, Fatal Status Epilepticus | J. Kapur; E. Leuwczuk; H. Sun; S. Joshi; J. Williamson

2.082 The Role of Postictal Hypoxia on Seizure-Induced Neurogenesis | K. Addo-Osafo; J. Epp; G. Teskey

2.083 Striatal Direct and Indirect Pathway Modulation for the Control of Experimental Seizures | S. Hyder; P. Forcelli

2.084 Endogenous Epilepsy Cycles in Rats | M. Baud; A. Ghestem; C. Bernard

2.085 Spatial Inhomogeneity in Burst Suppression Pattern Caused by an Acute Epileptic Focus | H. Ma; E. Baird-Daniel; J. Liou; M. Zhao; C. Schevon; T. Schwartz

2.086 Deletion of the Kcna1 Epilepsy Gene Modifies Autistic Behaviors | I. Jagadeeswaran; A. Pruitt; N. Gautier; K. Crane; E. Glasscock

2.087 Nigrotectal and Nigropontine Projections Have Divergent Effects on Seizure Control | E. Wicker; P. Forcelli


2.088 Appropriate Language Task and Features for Physiological Localization During Passive Cortical Mapping | T. Mitsuhashi; H. Sugano; M. Nakajima; T. Higo; Y. Iimura; H. Suzuki; T. Tanaka; H. Arai

2.089 Epileptic Source Detection Using Dense-Array EEG in Patients With Recurrence of Seizures After Temporal Lobectomy | M. Fujii; T. Nagatsuna; S. Nagamitsu; H. Yasuda; M. Urakawa; T. Yamashita; T. Fukusako; T. Hamaoka

2.090 Single EEG Channel Blink Artifact Removal via Deep Learning | D. Groppe; R. Genov; T. Valiante

2.091 Resting-State Functional Connectivity Using Stereo-EEG Helps Identify Epileptogenic Brain Regions | S. Goodale; H. Gonzalez; K. Gupta; H. Yu; J. Rolston; V. Morgan; D. Englot

2.092 Robust Dynamic Community Tracking With Applications to Human Brain Functional Networks During Seizures | M. Kramer; L. Martinet; E. Spencer; N. Perkins; W. Viles; C. Chu; S. Cash; E. Kolaczyk


2.093 Determining Resection Side in Patients With Presumed Bilateral Mesial Temporal Lobe Epilepsy on the Basis of Scalp EEG –Evaluation of Hippocampal Volumetry, Intracranial EEG Findings, and Seizure Outcome | H. Morioka; G. Seyama; K. Iida; K. Kagawa; M. Katagiri; A. Okamura; A. Hashizume; K. Kurisu

2.094 Resting State Connectivity Changes of Normal Brain Structures due to AED Modulation: An SEEG Study | I. Popa; A. Barborica; D. Maliia; C. Donos; A. Arbune; A. Daneasa; J. Ciurea; I. Mindruta

2.095 Analysis of Phase-Amplitude Coupling Between Fast and Slow Oscillations in Scalp EEG in Patient With Epileptic Spasms Without MRI Abnormality | H. Sugano; M. Nakajima; Y. Iimura; T. Mitsuhashi; K. Kawamura; T. Higo; H. Arai

2.096 High-Density EEG Source Connectivity as a Complementary Tool for Identifying Epileptogenic Networks | A. Kabbara; A. Nica; A. Biraben; I. Merlet; F. Wendling; M. Hassan

2.097 Saddle-Node Bifurcation on an Invariant Circle as a Model of Phasic Relationship Between Epileptiform Discharges and Background Activity in Postanoxic Encephalopathy | J. Joe; G. Newman

2.098 Investigation of Phase Amplitude Coupling of Interictal Scalp HFOs in Children with Epileptic Spasms. | D. Bernardo; H. Nariai; S. Hussain; R. Sankar; J. Wu

2.099 A Distinguished Temporal Pattern of HFO Events Characterizes the Seizure Onset Zone in Temporal Lobe Epilepsy | S. Santaniello; S. Sumsky

2.100 Fluctuating Spike Patterns in Long-Term Intracranial Recordings Among Pediatric Patients | S. Tomlinson; C. Bermudez; B. Porter; E. Marsh

2.101 Theory-Informed Deep Learning for Reliable Seizure Susceptibility Assessment From ECoG and EKG Signals | C. Meisel; K. Bailey

Clinical Epilepsy


2.102 Facilitation of Refractory Status Epilepticus and Severe Brain Damage in Patients With Panhypopituitarism and First Time Seizures | M. Eckenweiler; J. Schönberger; H. Fuchs; M. Shah; J. Kirschner; J. Jacobs

2.103 Cat’s Cradle: Reflexive Epilepsy in a Cri du Chat Patient During Epilepsy Monitoring Unit Admission | M. Salim Khan; R. Keating; C. Parres; M. Spanaki-Varelas

2.104 SUDDEF – A New Entity? Sudden Unexpected Death with a Demonstrated Epileptogenic Focus and No Seizure History at All? | I. Muth; R. Macaulay; B. Pohlmann-Eden

2.105 Communication Is Key – Introducing a New Behavioral Science-Based Tool for People With Psychogenic Nonepileptic Seizures | B. Pohlmann-Eden; S. Eden; B. Barrington; R. Smith; K. Hofer

2.106 The Application of an Etiological Classification to an Epilepsy Database in an Irish Tertiary Epilepsy Referral Centre | S. Delaney; M. Fitzsimons; K. Power; S. O’ Donoghue; N. Delanty

2.107 The Utility of Genetic Testing in Reflex Bathing Epilepsy | M. Doshi; I. Pavkovic

2.108 Feasibility of Multicenter Keyword Text Search for Rare Epilepsy Surveillance | D. Hesdorffer; Z. Grinspan; E. Yozawitz; T. McDonough; S. Wolf; P. McGoldrick; S. Johnson; A. Nelson; N. Basma; A. S May

2.109 Research Education Needs for Pediatric Epilepsy Junior Faculty | N. Basma; J. Sullivan; R. Shellhaas; D. Dlugos; K. Knupp; N. Ryan; K. Nickels; Z. Grinspan

2.110 Multi-Stakeholder Prioritization of Clinical Research Questions in Pediatric Epilepsy | D. Boyce; E. Ann Shenkman; Z. Grinspan; C. B Forrest; B. Kroner; D. Hesdorffer

2.111 Cyclic Seizures in a Patient With LGI1-Antibody Limbic Encephalitis | E. Seto

2.112 A Novel Form of Epilepsy in a Chinese Multigenerational Chinese Family: Clinical and Genetic Studies | Y. Zhou; R. Sood; Q. Wang; B. Carrington; D. Birnbaum; L. Gagnon; J. Mullikin; Z. Cen; W. Luo; Z. Liu; T. Ashizawa; M. Koubeissi; P. Liu

Clinical Diagnosis

2.113 Time to Immunotherapy: A New Concept in Pediatric New Onset Refractory Status Epilepticus | K. Husari; K. Labiner; R. Said

2.114 The ADAN Scale: A Proposed Scale for Prehospital Use to Identify Status Epilepticus | E. Santamarina; M. Requena; E. Fonseca; M. Olive; L. Abraira; M. Quintana; M. Toledo; J. Salas-Puig

2.115 Psychogenic Nonepileptic Seizures in a Community Hospital in Dubai | T. Tayah; N. Baig; P. PS; I. Al Thobaity

2.116 Effect on Anesthesia on Electrocorticography: A Pilot Study and Literature Review | A. KacarBayram; Q. Yan; D. Spencer; S. Rao; R. Alkawadri

2.117 Baclofen Toxicity Leading to Nonconvulsive Status Epilepticus | M. Chalia; V. Acharya; J. Acharya

2.118 Characteristics of Confirmed Epilepsy and Psychogenic Nonepileptic Seizure Patients in Qatar | H. Alhussein; M. Ali; L. Elsheikh; S. Wilkons; G. Alarcón; G. Melikyan; N. Haddad; B. Uthman; M. Siddiqi; D. Deleu; A. Alrabi; A. Asadi-Pooya; B. Mesraoua

2.119 Clinical Characteristics and Risk Factors of Epilepsy Associated With Encephalomalacia in Pediatric Patients | J. Kong; Y. Lee; A. Ko; Y. Kim; G. Yeon; S. Nam

2.120 Is There a Quantitative Correlation Between the Ictal and Postictal Recovery Durations in Psychogenic Nonepileptic and Epileptic Seizures? | G. Fahimi; S. Izadyar

2.121 Electrographic Seizures and Brain Injury in Pediatric ECMO Patients | R. Cook; S. Rau; S. Lester; R. Shellhaas; F. Silverstein

2.122 Seizure Severity and Health-Related Quality of Life of Adult Ugandan Patients With Epilepsy | M. Kaddumukasa; M. Kaddumukasa; C. Blixen; N. Sewankambo; S. Lhatoo; M. Sajatovic; E. Katabira


2.123 Clinical Features and Treatment Attitudes in Autoimmune Epilepsy: A Multicenter Retrospective Cohort Study | F. Villani; A. Giallonardo; T. Granata; S. Casciato; R. Michelucci; L. Zuliani; S. Meletti; S. Sartori; A. Gambardella; E. Freri; A. Stabile; G. Pauletto; E. Pasini; M. Nosadini; E. Ferlazzo; S. Matricardi

2.124 Antibody Prevalence in Epilepsy Before Surgery (APES) | S. Tymchuk; J. Barry; S. Muppidi; S. Le

2.125 Improvement Over Time in Diagnosis of Rare Epilepsy Disorders After Seizure Onset | B. Kroner; N. Ho; D. Hesdorffer; B. Fureman; R. Network

2.126 Clinical Features and Treatment Responses of SCN2A-Related Epileptic Encephalopathy Associated With infantile Spasms | J. Millichap; J. O’Connor; E. Bryant; L. Laux; A. George; A. Berg

2.127 Localization Value of Nonclinical Seizures in Surgical Patients With Focal Epilepsy Based on Video-EEG Monitoring | S. Wang; C. Chen; A. Alexopoulos; A. Thandar; B. Jin; I. Najm; M. Ding; S. Wang; Z. Wang

2.128 SMART Syndrome as an Unusual Presentation of Convulsive Status Epilepticus | M. Melo-Bicchi; A. Baten; J. Pritchard

2.129 Electromyography and Nerve Conduction Studies (EMG/NCS) in Dravet Syndrome | E. Dubow; B. High; M. Yang; K. Knupp

Clinical Treatments

2.130 Status Refractory Epilepticus Epidemiology, Etiology, and Outcomes at a Single Tertiary Care Facility | M. Nguyen; M. Rezayee; C. Murchison; M. Kellogg

2.131 External Trigeminal Nerve Stimulation (eTNS) in Drug-Resistant Epilepsy (DRE): Effects on Seizure Frequency and Mood | L. Schrader; D. Murray; C. DeGiorgio

2.132 Blood Concentration and Efficacy of Phenobarbital: A Retrospective Study in Rural China | J. Wang; D. Ding; Z. Hong

2.133 Vigabatrin and High-Dose Prednisolone Add-on Therapy for Patients with West Syndrome | H. Lee; A. Ko; S. Youn; H. Chung; S. Kim; J. Lee; H. Kim; H. Kang

2.134 Diffusion Tensor Imaging Improves Assessment of Postoperative Interhemispheric Connections After Functional Hemispherectomy | M. Shah; K. Egger; M. Reisert; A. Klotz; P. Reinacher; C. Scheiwe; J. Jacobs

2.135 Preventative Antiepileptic Treatment in Infants With Tuberous Sclerosis Complex: Long-Term Impact on Epilepsy and Neurocognition | K. Sadowski; K. Kotulska; D. Domanska-Pakiela; J. Borkowska; D. Chmielewski; D. Kuczynski; S. Józwiak

2.136 Eslicarbazepine in Pediatric Epilepsy: First Experiences in Effectiveness and Safety | P. Smeyers Durá

2.137 Clinical Characteristics and Treatment Responses of Infantile Spasm Patients With Antecedent Neonatal or Infantile Seizures | M. McNally; C. Marti; A. Paris; K. Levitt; K. Mysak; C. Yuskaitis; A. Sansevere; J. Soul; C. Harini

2.138 Monitoring Side Effects in the Daily Clinical Practice by a Brief Screening Tool, EpiTrack | N. Andersen Becser

2.139 Treatment of Medically Refractory Seizures Associated With Tuberous Sclerosis by RNS System | N. Zhong; D. Luong

2.140 Benzodiazepine Prescription Profiles for New Adult Patients Referred Into the Wake Forest Comprehensive Epilepsy Center Clinic | J. Boggs; U. Alam; K. Conner; V. Woodard; G. Popli

2.141 Perampanel in Refractory Idiopathic Generalized Epilepsies | J. Salas-Puig; R. Cambrodí; L. Abraira; M. Quintana; E. Santamarina; M. Jurado; A. Ferrer; O. Romero; M. Toledo

2.142 A Clinical and Cost-Effectiveness Comparison of Traditional VNS Therapy to AspireSR with AutoStimulation | K. Galla; K. Sajja; C. Wichman; H. Wang; D. Madhavan

2.143 Vigabatrin in the Treatment of Refractory Malignant Migrating Partial Seizures in Infancy - A Case Report | P. Maertens; J. Rini

2.144 Treatment of Mitochondrial Dysfunction in Rett Syndrome With Triheptanoin | S. Shakil; H. O’Leary; D. Tarquinio

2.145 Predictors of Seizure Freedom Following Extended Temporal Lobectomy for Medically Refractory Temporal Lobe Epilepsy | D. Cooke; K. Buchanan; J. Andrews; P. Farooque; D. Spencer

2.146 Case Report: Treatment of Super-Refractory Status Epilepticus with Intravenous High-Dose Steroids in a Patient With an SCN2A Mutation and Malignant Migrating Partial Seizures of Infancy | S. Durica; C. Herren; C. Matarese; D. Chrusciel; G. Purcarin

2.147 Comparison of Treatment Outcomes at 24 Months After Monotherapy With Single-Source Bioequivalent Generic Formulations of Lamotrigine and Levetiracetam in Patients with Newly Diagnosed Focal Epilepsy | S. Chayasirisobhon; S. Gurbani; A. Gurbani; U. Vaghasia; E. Pietzsch; B. Spurgeon

2.148 Infantile Spasms: Combination Therapy With High-Dose ACTH and Vigabatrin | S. Weatherspoon; B. Mudigoudar; E. Roark; J. Wheless

2.149 Effectiveness of Perampanel as First Add-on and Monotherapy in Clinical Practice: A Single-Center Observational Study in Spain | A. Teijeira Azcona; F. Ayuga Loro; C. Cabeza Alvarez; R. Almansa Castillo

2.150 Efficacy and Tolerability of Perampanel as an Adjunctive Therapy in Patients With Refractory Lennox-Gastaut Syndrome | S. Marsh; N. Wang; H. Seif-Eddeine; S. Chung

2.151 Is Intravenous Lacosamide a Safe, Well-Tolerated and Effective Option in Refractory Focal Status Epilepticus due to Cerebrovascular Disease? | V. Braatz; K. Socher; L. Raulik; R. Harger; N. Cabral

2.152 Inpatient Hospitalization Rates in Patients Diagnosed with Epilepsy and Treated with Parampanel or Lacosamide | E. Faught; X. Li; J. Choi; M. Malhotra; R. Knoth

2.153 Post-Marketing Perampanel Experience From an Observational Study: Early Add-on vs. Late Add-on Perampanel Therapy in a Community Setting | B. Shafran; J. Chang

2.154 Effective Treatment for GLUT-1 Deficiency Syndrome Using the Medium-Chain Triglyceride Ketogenic Diet | D. Alsowat; H. Lowe; A. Keller; C. Liu; M. Zak; V. Chan; J. Kobayashi; E. Donner; R. Whitney

2.155 Late-Onset Spasms in Association With Temporal Lobe Lesions: Two Different Approaches With Similar Outcome | D. Marafi; M. Quach; R. Coorg


2.156 Does CO2 Treatment Reduce Seizure Length? A Randomised Trial of Inhaled 5% CO2 in Focal Seizures | S. Mullen; A. Roten; M. Forcadela; P. Lightfoot; K. Kaila; S. Petrou; P. Carney; S. Berkovic

Prognosis

2.157 Treatment Efficacy and Prognostic Factors of Patients With Acquired Aphasia | C. Koo; S. Kim; H. Kim; J. Lee; H. Kang

2.158 Longitudinal SUDEP Risk Stratification With Electronic Diaries | N. Ayub; S. Chiang; R. Moss; D. Goldenholz

2.159 Incidence of Later Onset Seizures in Term Babies Who Underwent Therapeutic Hypothermia for Hypoxic-Ischemic Encephalopathy | J. Yoo; M. Garg; R. Sankar; L. Rao

2.160 Analysis of the Time Between the Cessation of Epileptic Seizures and Normalization of the Electroencephalogram in Self-limited Focal Epilepsy of Childhood | C. Miziara; V. Serrano; M. Micheletto; M. Serinolli; D. Nakanishi; M. Manreza

2.161 Concordance Between Interictal Focal Electroencephalography Pattern and Magnetic Resonance Imaging Lesions Predicts Favorable Surgical Outcome in Patients With Epileptic Spasms | C. Xu; T. Yu; G. Zhang; Y. Wang; Y. Li

2.162 A Multi-state or Markov Model of Epilepsy Progression and Dynamics in a Large Patient Cohort | H. Simpson; Z. Chen; M. Brodie; P. Kwan

2.163 Epilepsy Outcome at 3 years of Age in Newborns With Acute Neurologic Presentations | T. Anwar; A. O’Kane; M. McGowan; J. Scafidi; T. Tsuchida; T. Chang

2.164 Importance of Seizure Diary in the Management of Epilepsy Patients With Intellectual Disability and Developmental Delay | M. Zorlu; R. Zarnegar; D. Chuang; H. Kettani

2.165 Delay in Obtaining Electroencephalography Does Not Worsen Mortality in Non-Post Cardiac Arrest, Nonconvulsive Status Epilepticus | D. Chuang; M. Zorlu; R. Zarnegar

Neuroimaging

Structural Imaging

2.166 Abnormal Hippocampal Structure and Function in Patients With Juvenile Myoclonic Epilepsy and Their Unaffected Siblings: A Magnetic Resonance Imaging Study | L. Caciagli; B. Wandschneider; F. Xiao; C. Vollmar; M. Centeno; K. Trimmel; S. Vos; M. Sidhu; P. Thompson; G. Winston; J. Duncan; M. Koepp

2.167 In Vivo High-Resolution DTI Demonstrates Excellent Diagnostic Accuracy and Subfield-Specific Diffusion Abnormalities in Temporal Lobe Epilepsy With Hippocampal Sclerosis | D. Gross; S. Treit; G. Little; T. Steve; L. Schmitt; T. Nowacki; C. Beaulieu

2.168 Structural Connectivity Driven Stereoelectroencephalography (SEEG) Electrode Targeting in Suspected Pseudotemporal and Temporal Plus Epilepsy | M. Della Costanza; V. Vakharia; K. Li; M. Mancini; S. Vos; J. Winston; A. McEvoy; A. Miserocchi; M. Scerrati; F. Chowdhury; B. Diehl; R. Sparks; S. Ourselin; J. Duncan

2.169 Diffuse Cerebral Lesion Including Cortex and White Matter on MRI May Be the Best Predictor of Neurological Outcomes in Tuberous Sclerosis Complex | T. Okanishi; A. Fujimoto; M. Nishimura; H. Enoki

2.170 Brain Volume Alterations in SUDEP | L. Allen; S. Vos; R. Harper; R. Kumar; J. Ogren; S. Balestrini; G. Winston; C. Scott; S. Lhatoo; L. Lemieux; B. Diehl

2.171 Cortical Thinning in Epilepsy Patients With Postictal Generalized EEG Suppression | Y. Tang; D. An; Y. Xiao; R. Niu; X. Tong; W. Liu; Q. Gong; D. Zhou

2.172 Role of MRI Post-Processing in Surgical Treatment of MRI-Negative Localization-Related Orbitofrontal Epilepsy | T. Aung; S. Jones; A. Alexopoulos; I. Najm; Z. Wang

2.173 3D Curved Multiplanar Reformatting Provides Improved Visualization of Hippocampal Anatomy | E. Misaghi; T. Steve; A. Wilman; C. Beaulieu; D. Gross

2.174 Faster Electrical Source Imaging Using AI-Based Tissue Segmentation | N. Flaeschner; F. Wenzel; L. Zagorchev

2.175 Changes In Whole Brain Connectomes With Simulated Laser Interstitial Thermal Therapy Using Seizure-Free and Non-Seizure-Free Ablation Cavities in Mesial Temporal Sclerosis: A Graph Theory Approach | V. Vakharia; M. Mancini; S. Vos; K. Li; C. Wu; A. Sharan; M. Sperling; A. McEvoy; A. Miserocchi; R. Sparks; S. Ourselin; J. Duncan

2.176 WITHDRAWN

2.177 Association Between Drug-Resistant Epilepsy and Structural Lesions on MRI | A. Flores Sobrecueva; J. Reyes-Vaca; H. Hernandez-Rodriguez; I. Rodriguez-Leyva

2.178 CSF Suppressed T2-Weighted Imaging at 7T in Epilepsy | C. Moon; A. Antony; A. Urban; J. Fong; N. Zaher; R. Richardson; A. Bagic; J. Pan

2.179 Voxel-Based Morphometric MRI Post-Processing in the Detection of MRI-Negative Cingulate Epilepsy | S. Wang; B. Jin; A. Thandar; M. Katagiri; I. Najm; A. Alexopoulos; M. Ding; S. Wang; Z. Wang

2.180 3T and 7T Ex Vivo Diffusion Imaging in Tuberous Sclerosis Complex: Correlation with Histopathology | J. Peters; R. Struyven; A. Prohl; J. Bushman; H. Lidov; J. Singh; B. Scherrer; J. Madsen; S. Prabhu; M. Sahin; O. Afacan; S. Warfield

2.181 Diffusion Tensor Imaging Analysis of Corpus Callosum and Its Link to Post Corpus Callosotomy Seizure Lateralization in Generalized Epilepsy | P. Chen; J. Baumgartner; S. Messina; E. Castillo; S. Joohee; H. Skinner; E. D.Gireesh; A. Satish; K. Lee

2.182 Resection of Mesiotemporal Structural Anomalies and Its Relation to Surgical Outcome in Temporal Lobe Epilepsy | F. Fadaie; B. Caldairou; S. Hong; R. Gill; B. Bernhardt; A. Bernasconi; N. Bernasconi

2.183 Shared Hippocampal and Cortical Morphological Abnormalities in Temporal Lobe Epilepsy Patients and Their Asymptomatic Siblings: Evidence for a Neuroimaging Endophenotype | L. Long; M. Galovic; Y. Chen; T. Postma; F. Xiao; W. Wu; Y. Song; M. Koepp; B. Xiao


2.184 Is Epilepsy a Progressive Neurodegenerative Disease? Evidence From a Large Multicentre Longitudinal Neuroimaging Study | M. Galovic; V. Van Dooren; T. Postma; S. Vos; G. Borzi; J. Rosillo; K. Vuong; J. de Tisi; P. Nachev; J. Duncan; M. Koepp

2.185 Longitudinal Microstructural Changes Following Status Epilepticus in the Rat Pilocarpine Model of Epilepsy | L. Concha; L. Marquez-Bravo; H. Luna-Munguia

2.186 Hippocampal Atrophy in Posttraumatic Epilepsy (PTE) | J. Oh; S. Lim

2.187 Quantitative Diffusion Tractography Analysis in the Presurgical Diagnostic Evaluation of Patients With Temporal Lobe Epilepsy | I. Orosz; V. Patel; D. Woodworth; S. Weiss; H. Yokota; I. Fried; G. Mathern; J. Engel, Jr., M.D., Ph.D.; R. Staba; N. Salamon, M.D., Ph.D.

Functional Imaging

2.188 Representation of Cortical Functions in Children and Young Adults With Lesional Epilepsy and Language Cortex Reorganization After Epilepsy Surgery | C. Barba; D. Montanaro; L. Grisotto; F. Frijia; M. Caligiuri; A. Cherubini; S. Pellacani; A. Cavalli; S. Rizzi; M. Lenge; F. Giordano; R. Guerrini

2.189 Asymmetry in Resting State Functional MRI Connectivity Networks for Characterization of Temporal Lobe Epilepsy | T. Gholipour; D. Greve; J. Lee; S. Stufflebeam

2.190 Widespread Alterations in Functional Connectome Embedding Following Temporal Lobe Epilepsy Surgery | S. Lariviere; Y. Wang; R. Vos de Wael; Z. Wang; C. Paquola; A. Bernasconi; N. Bernasconi; Z. Zhang; B. Bernhardt

2.191 Determination of Language Laterality in Children Undergoing Epilepsy Surgical Planning Using Seed-Based Resting State Connectivity Analysis | A. Nath; J. Magnotti; P. Karas; B. Foster; M. Paldino

2.192 Added Value of 18F-FDG PET for Autoimmune Epilepsy and Encephalitis | J. Kuo; S. Le

2.193 Functional Brain Connectivity Is Increased in People With a Pro-Epileptic GABRG2 Mutation | M. Pedersen; M. Kowalczyk; A. Omidvarnia; P. Perucca; S. Gooley; S. Petrou; I. Scheffer; S. Berkovic; G. Jackson

2.194 The Effect of Interictal Epileptiform Discharges on Resting-State Functional Connectivity in Medial Temporal Lobe Epilepsy | N. Ikegaya; M. Iwasaki; Y. Takayama; T. Yamamoto; H. Numazawa; K. Yoshinaga; T. Hanakawa

2.195 Abnormal Functional Connectivity in a Rat Model of Malformation of Cortical Development | M. Kim; M. Yum; Y. Jo; M. Lee; E. Kim; W. Shim; T. Ko

2.196 Utility of FDG-PET in Identifying Subtle Focal Cortical Dysplasia in MRI-Negative Children With Refractory Epilepsy | S. Bhatia; K. Havens; C. Oluigbo; T. Zelleke; J. Murnick; W. Gaillard; D. Depositario-Cabacar

2.197 Functional Connectivity in Idiopathic Generalised Epilepsies: A Systematic Review of EEG and MEG Studies | A. Dharan; S. Bowden; W. D’Souza

2.198 A Proposed Model for Investigating Functional Connectivity and Glutamate/GABA Concentrations as Biomarkers of Epilepsy Using 7T MRI | O. Gonen; P. Kwan; T. O’Brien; P. Desmond; B. Moffat; E. Lui

2.199 Spatial Overlap of Language Networks From Resting State fMRI in Patients With Epilepsy | R. Rolinski; X. You; J. Gonzalez-Castillo; R. Reynolds; S. Inati; W. Theodore

2.200 Diagnostic Usefulness of Arterial Spin Labeling in MR-Negative or Equivocal Children With New-Onset Seizures | Y. Lee; S. Hwang; S. Lee; S. Kwon

2.201 Widespread Interictal Epileptic Discharge More Likely Than Focal Discharges to Unveil the Seizure Onset Zone in EEG-fMRI | T. Yamazoe; N. von Ellenrieder; H. Khoo; Y. Huang; N. Zazubovits; F. Dubeau; J. Gotman

2.202 Post-resective Outcomes Using a 72-Detector Focused Collimator Ring SPECT Scanner System to Identify the Ictogenic Zone | M. Rossi; V. Pylypyuk; O. Jafry

2.203 High-Density EEG Functional Connectivity in Epileptic Network | C. Kuo; P. Luu; D. Tucker; L. Zagorchev

2.204 Resting-State Functional Magnetic Resonance Metrics Differ Between Stroke Patients Who Did and Did Not Develop Post-stroke Epilepsy | G. Leonhardt; L. Allen; S. Vos; N. Sharma; B. Wandschneider; A. Leff; C. Price; L. Lemieux; B. Diehl

2.205 Effect of Surgical Resection for Language Network Reorganization and Language Function Change in Adult Patients with Temporal Lobe Epilepsy | X. You; E. Fanto; A. Zachery; S. Germeyan; G. Norato; E. Emery; L. Sepeta; M. Berl; C. Black; E. Wiggs; K. Zaghloul; S. Inati; W. Theodore; W. Gaillard

2.206 Increased Short-Range Functional MRI Connectivity in Limbic Network Correlates With Seizure Frequency and Cognitive Impairment in Temporal Lobe Epilepsy Patients | J. Pankratz; S. Shuntaro; A. Struck; V. Nair; R. Birn; K. Dabbs; J. Mathis; G. Hwang; R. Maganti; E. Felton; E. DeYoe; C. Humphries; C. Ustine; D. Almane; T. McMillan; A. Nencka; L. Conant; C. Carlson; C. Anderson; B. Hermann; V. Prabhakaran; J. Binder; B. Meyerand; M. Boly

2.207 Community-Informed Connectomics of the Thalamocortical System in Idiopathic Generalized Epilepsy | Z. Wang; S. Lariviere; Q. Xu; R. Vos de Wael; S. Hong; Z. Wang; B. Zhu; N. Bernasconi; A. Bernasconi; B. Zhang; Z. Zhang; B. Bernhardt

2.208 Distance-Enriched Functional Connectomics in Drug-Resistant Temporal Lobe Epilepsy | S. Lariviere; Y. Wang; R. Vos de Wael; Z. Wang; C. Paquola; A. Bernasconi; N. Bernasconi; Z. Zhang; B. Bernhardt

2.209 Tracking the Evolution of Functional Neuronal Groups During the Transition to a Seizure in a Mouse Model of Dravet Syndrome | S. Muldoon; C. Tran; N. Goldstein; V. Jutton; M. Vaiana; E. Goldberg

2.210 Brainstem Atrophy in Focal Epilepsy Destabilizes Brainstem-Cortex Interactions: A Path Towards SUDEP? | S. Mueller; R. Knowlton; K. Laxer

2.211 WITHDRAWN



2.212 Schizophrenia Is a Later-Onset Manifestation of PCDH19 Girls Clustering Epilepsy | D. Vlaskamp; A. Bassett; J. Sullivan; J. Robblee; L. Sadleir; I. Scheffer; D. Andrade

2.213 Sleep Disturbances in Patients With Psychogenic Non-Epileptic Seizures: Is It All Subjective? | V. Latreille; G. Baslet; M. Pavlova; B. Dworetzky

2.214 Successful Identification and Referral of Patients at Risk for Mood and Behavioral Concerns in the Epilepsy Monitoring Unit Utilizing Quality Improvement Methodologies | J. Twanow; N. Auer; K. Trott; S. Bhatnagar; A. Ganger; W. Parker; J. Hampl; A. Ostendorf

2.215 OSA in Epilepsy: Are There Different Risk Factors? | M. Aguilar Amat Prior; J. Escobar Montalvo; M. Naranjo Castresana; P. Alonso Singer; J. Oliva Navarro; M. Merino Andreu

2.216 Signature of Psychosis: Neuroimaging-Based Brain-Age Gap Estimation in Temporal Lobe Epilepsy With and Without Psychosis | D. Sone; I. Beheshti; N. Maikusa; H. Matsuda

2.217 Prevalence of High-Risk Obstructive Sleep Apnea and Insomnia Ascertained by STOP and Insomnia Severity Index in Adults with Epilepsy | T. Somboon; H. Walia; T. Kinzy; I. Katzan; N. Foldvary-Schaefer

2.218 Impact of Epilepsy Monitoring Unit Admission on Psychological State | A. Roy; A. Sanayei; Y. Goksen; I. Zhang; B. Dworetzky; D. Weisholtz

2.219 Epileptic and Non-Epileptic Seizures: Pediatric Patient Characteristics at Onset | J. Doss

2.220 Quality of Life in Veterans With Epileptic or Psychogenic Nonepileptic Seizures | M. Salinsky; P. Rutecki; K. Parko; D. Storzbach; S. Markward; E. Goy

2.221 WITHDRAWN

2.222 The Effects of Spontaneous Recurrent Seizures on Dentate Gyrus Mediated Learning, Memory, and Synaptic Plasticity | P. West; L. Woods; C. Dowd; R. Phibbs; W. Zimmermann; P. Billingsley; T. Pruess; C. Rueda; G. Saunders; M. Smith; C. Metcalf; K. Wilcox

2.223 A Comparison of Psychological Characteristics of Psychogenic Nonepileptic Seizures and Epilepsy Patients Admitted to an Epilepsy Monitoring Unit | R. Garrett; R. Gerkin; S. Chung; N. Wang; H. Seif-Eddeine; J. Pardini

Antiepileptic Drugs

Animal Studies

2.224 Protective Effects of Padsevonil in Chronic Models of Focal and Generalized Epilepsies With Spontaneous Recurrent Seizures | R. Kaminski; K. Leclercq

2.225 Padsevonil Differs From Brivaracetam and Levetiracetam in Its Interaction With the Synaptic Vesicle 2A (SV2A) Protein | M. Wood; M. Gillard

2.226 No Impact of P-Glycoprotein on the Brain Distribution of Padsevonil | H. Chanteux; H. Chapy; J. Van Asperen; K. Saunders; R. Kaminski; D. Sciberras

2.227 Oxytocin Increases Seizure Resistance in Scn1a Mutant Mice | J. Wong; K. Murnane; A. Escayg

2.228 Intramuscular Versus Intravenous Allopregnanolone Pharmacokinetics and Safety in Dogs for Early Treatment of Status Epilepticus | I. Vuu; L. Coles; I. Leppik; M. Rogawski; D. Zolkowska; C. Wu; E. Patterson; J. Cloyd

2.229 An Assessment of the Anti-Epileptiform Efficacy of Cannabidiols in an In Vitro Model of Mitochondrial Epilepsy | F. Chan; M. Woolley-Roberts; J. Brodie; B. Whalley; M. Cunningham

2.230 A Specific Serotonin Receptor Is Critical in the Ability of Fenfluramine to Prevent Seizure-Induced Respiratory Arrest (S-IRA) in the DBA/1 Mouse Model of SUDEP | C. Faingold; S. Tupal

2.231 Early Intervention With Perampanel Prevents Chronic Epilepsy and Behavioral Abnormalities in the Lithium-Pilocarpine Rat Model of Status Epilepticus (SE) | T. Wu; Y. Osada; Y. Furuya; Y. Ito; K. Fukushima; K. Ido

2.232 Evaluation of Antiepileptic Drugs to Treat Spontaneous Recurrent Seizures Following Nerve Agent Exposure in Mice | B. Barker; H. McCarren; C. Ardinger; P. Bodner; P. Dubée; E. Dunn; M. Eisen; K. Haines; D. Nguyen; A. Santoro; P. McNutt

Clinical Trials

2.233 Cannabidiol Tolerance in Children and Adults With Treatment-Resistant Epilepsy | S. Uliel-Sibony; M. Hausman-Kedem; U. Kramer

2.234 Effect of Perampanel as Add-on Therapy on Seizure Control and Quality of Life in Patients With Brain Tumor-Related Epilepsy: Preliminary Report | M. Maschio; A. Coppola; A. Zarabla; A. Maialetti; V. Villani; V. Belcastro; E. Ferlazzo; S. Balestrini; A. Nozzolillo; T. Koudriatvseva

2.235 Long-Term Safety Experience of Nayzilam™ (USL261; Midazolam Nasal Spray) in Subjects With Seizure Clusters: Safety Results From the Open-Label, Phase 3 Extension of the ARTEMIS-1 Study | T. Meng; D. Sequeira; P. Van Ess; W. Pullman

2.236 Long-Term Efficacy Experience of Nayzilam™ (USL261; Midazolam Nasal Spray) for Outpatient Treatment of Seizure Clusters: Efficacy Results from the Open-Label, Phase 3 Extension of the ARTEMIS-1 Study | D. Sequeira; T. Meng; W. Pullman; P. Van Ess

2.237 Fycompa (Perampanel) Experience in a Tertiary Epilepsy Center | V. Vajjala; D. Treiman

2.238 WITHDRAWN

2.239 Relationship Between Adverse Event Incidence and Eslicarbazepine Acetate (ESL) Dose Across Weight Groups in Clinical Trials of Adjunctive ESL in Children (Aged 4–17 Years) With Focal Seizures | J. Piña-Garza; S. Wolf; P. McGoldrick; T. Grinnell; D. Cantu; Y. Li; M. Vieira; F. Ikedo; D. Blum

2.240 Analysis of Allergic Reactions in Clinical Trials of Eslicarbazepine Acetate in Children (Aged 4–17 Years) With Focal Seizures | T. Resnick; T. Grinnell; D. Cantu; Y. Li; J. Graça; H. Gama; D. Blum

2.241 Analysis of Hepatic and Hypothyroidism-Related Events in Clinical Trials of Adjunctive Eslicarbazepine Acetate in Children (Aged 4–17 Years) With Focal Seizures | J. Wheless; S. Kothare; T. Grinnell; D. Cantu; Y. Li; R. Costa; L. Magalhães; D. Blum


2.242 Analysis of Psychiatric Adverse Events and Suicidality in Clinical Trials of Adjunctive Eslicarbazepine Acetate in Children (Aged 4–17 Years) With Focal Seizures | J. Salpekar; M. Mintz; P. Mintz; T. Grinnell; D. Cantu; Y. Li; M. Vieira; A. Pereira; D. Blum

2.243 Efficacy and Tolerability of Perampanel in Children, Adolescent and Adult With Intractable Epilepsy : A Single-Center Study | C. Yim; J. Byeon; B. Eun

2.244 Clobazam as an Adjunctive Treatment for Infantile Spasms | S. Kim; H. Lee; H. Kang; J. Lee; H. Kim

2.245 Study 311: Safety and Efficacy of Adjunctive Perampanel (PER) in Patients Aged 4 to ?12 Years With Partial-Onset Seizures (POS) With/Without Concomitant Enzyme-Inducing Antiepileptic Drugs (EIAEDs) | M. Milh; R. Flamini; A. Fogarasi; S. Phillips; S. Yoshitomi; A. Patten; T. Takase; L. Ngo

2.246 Population Pharmacokinetics and Exposure–Response Analyses of Adjunctive Perampanel in Pediatric Patients With Epilepsy | O. Majid; L. Reyderman; J. Ferry; Z. Hussein

2.247 Analysis of Hematological and Serum Chemistry Abnormalities in Clinical Trials of Adjunctive Eslicarbazepine Acetate in Children (Aged 4–17 Years) With Focal Seizures | P. Kotagal; T. Loddenkemper; T. Grinnell; D. Cantu; Y. Li; R. Costa; J. Moreira; D. Blum

2.248 Time to Onset of Efficacy in Seizure Reduction With Cenobamate (YKP3089) in Patients With Uncontrolled Partial Seizures From Two Randomized Clinical Trials | M. Kamin; L. Ferrari

2.249 Irritability in Patients Affected by Secondarily Generalized Seizures and Seizure Free After Starting Perampanel Treatment: A Quantitative EEG and Validated Questionnaire Study | C. Liguori; F. Izzi; N. Mercuri; F. Placidi

2.250 Efficacy via Video-EEG Assessment of Pregabalin Adjunctive Therapy in Infants and Young Children With Partial Onset Seizures: A Multinational Controlled Trial | D. Mann; J. Antinew; L. Knapp; M. Almas; J. Liu; J. Scavone; R. Yang; M. Modequillo; I. Makedonska; M. Ortiz; A. Kyrychenko; D. Nordli; V. Farkas; M. Farkas

2.251 Preliminary Evidence of a Predictive Clinical Biomarker in PCDH19-Related Epilepsy: Significant Treatment Effect of Ganaxolone In Biomarker-Positive Patients | J. Sullivan; N. Specchio; M. Chez; G. Pinna; A. Locci; R. Jarrar; K. Ridel; L. Masuoka; M. Gasior; A. Aimetti; A. Poduri

2.252 Adjunctive Perampanel (PER) and Myoclonic and Absence Seizures: Post hoc Analysis of Seizure Days and Seizure-Free days in Study 332 | C. Brandt; R. Wechsler; T. O’Brien; A. Patten; B. Williams; M. Malhotra; L. Ngo; B. Steinhoff

2.253 Transdermal Cannabidiol (CBD) Gel for the Treatment of Focal Epilepsy in Adults | T. O’Brien; S. Berkovic; J. French; J. Messenheimer; M. Bonn-Miller; D. Gutterman

2.254 Study 410 Enrollment Update: Multicenter, Open-Label, Phase IV Study of Perampanel as Monotherapy or First Adjunctive Therapy in Patients Aged =12 Years With Partial-Onset or Primary Generalized Tonic-Clonic (PGTC) Seizures | P. Klein; B. Williams; A. Laurenza; A. Patten; M. Malhotra

2.255 Sustained Seizure-Free Status With Adjunctive Perampanel (PER) for Patients With Secondarily Generalized (SG) Seizures During an Open-Label Extension (OLEx): Study 307 | T. Resnick; A. Patten; M. Malhotra; L. Ngo; B. Williams

2.256 Sustained Seizure-Free Status With Adjunctive Perampanel for Patients With Primary Generalized Tonic-Clonic (PGTC) Seizures During the Open-Label Extension (OLEx) Phase of Study 332 | I. Najm; M. Malhotra; A. Patten; L. Ngo; B. Williams

2.257 Efficacy and Safety of Adjunctive Perampanel (PER) 4 mg/day for the Treatment of Partial-Onset Seizures (POS): Pooled Analysis of Four Randomized Phase III Studies | B. Steinhoff; A. Patten; B. Williams; M. Malhotra

Cohort Studies

2.258 Healthcare Resource Utilization and Cost Before and After Adding Lacosamide as Adjunctive Therapy Among Patients Diagnosed With Epilepsy: A Retrospective U.S. Claims Analysis | D. Labiner, MD; B. Johnson; M. Martin; J. Fishman; C. Lew

2.259 Real-World Use and Clinical Characteristics of Patients Treated with Antiepileptic Drug Combinations With and Without Perampanel in the United States | F. Laliberté; J. Choi; M. Duh; M. Malhotra; V. Barghout; G. Germain; C. O’Connor; D. Lejeune; E. Faught

2.260 MONOZEB Study: Real-World Long-Term Effectiveness and Tolerability With Eslicarbazepine Acetate in Monotherapy | J. Rodriguez-Uranga; V. Villanueva; M. Garcés; K. Hampel; A. Gómez-Ibáñez; P. Bermejo; J. Montoya; M. Toledo; F. López-González; X. Rodriguez-Osorio; P. Giner; J. Ojeda; J. Mauri; J. Ruiz-Giménez; J. Poza; A. Massot-Tarrús; M. Galiano; M. Bonet; D. Tortosa; D. Castro; V. Bertol; P. Esteve; P. Quiroga

2.261 Efficacy and Tolerability of Perampanel Treatment at a Pediatric Epilepsy Center | A. Tanritanir; X. Wang; K. Kapur; F. Mohammadpour Touserkani; T. Loddenkemper

2.262 ESLIRA: A Prospective Behavioral Assessment in Patients with Epilepsy Treated With Eslicarbazepine Acetate | M. Toledo; G. Mazuela; E. Santamarina; M. Quintana; L. Abraira del Fresno; J. Sanchez; J. Salas-Puig

2.263 Characteristics of Adult Patients With Focal Seizure Receiving Eslicarbazepine Acetate Therapy in Routine Clinical Practice: Evidence From a Large US Commercial Claims Database | D. Mehta; A. Lee; J. Simeone; K. Rajagopalan; R. Carroll; B. Nordstrom

2.264 Comparative Efficacy of Antiepileptic Drugs in Community-Based Patients With Refractory Epilepsy Followed With an Online Seizure Diary | N. Poolos; R. Moss

2.265 An Evaluation of Perampanel in People Who Experience Seizures Following Operative Intervention for the Treatment of Epilepsy | K. Ibrahim; I. Stavropoulos; T. Maggie; M. Neale; C. Jory; M. Esposito; R. Shankar; K. Hamandi; F. Rugg-Gunn; R. Elwes; A. Sen

Drug Side Effects

2.266 Effects of Mono Antiepileptic Drug on Haematological and Biochemical Parameters | Y. Yoshimura; K. Hara; M. Akaza; K. Ohta; M. Inaji; Y. Sumi; E. Yanagisawa; T. Maehara

2.267 Predictors of Weight Gain Associated With Perampanel-Treated Epilepsy | K. Jin; N. Nakasato; S. Kaneko

2.268 Identification of Risk Factors for Hyponatremia in Adult Japanese Epilepsy Patients | Y. Yamamoto; Y. Takahashi; K. Imai; Y. Kagawa; Y. Inoue


2.269 Alterations in Sleep Architecture With CBD Use | A. Drake; K. Chapman; J. Bear

2.270 Impact of Anti-Epileptic Drug Polypharmacy Among People Living with Epilepsy | K. Ozenberger; J. Levy; D. Pandey

2.271 Blunted Parathyroid Hormone Response to 25-dihydroxyvitamin D in Patients on Antiepileptic Drugs | M. Cheung; C. LoPinto-Khoury; K. Sivaraaman; R. DeLuccia; R. Ramadoss; J. Pillai; M. Dougherty; D. Sukumar

2.272 Intravenous Lacosamide Use and PR Interval Prolongation in the Critically Ill Population | J. White; I. Vuu; L. Coles; M. Mulder; J. Cloyd

2.273 Fulminant Vigabatrin Toxicity During Combination Therapy With High-Dose ACTH: A Case Series | S. Bhalla; V. Puri; K. Skjei

2.274 Prediction Tools for Psychiatric Adverse Effects Following Levetiracetam Prescription | C. Josephson; J. Engbers; N. Jette; S. Patten; S. Singh; T. Sajobi; D. Marshall; S. Wiebe

2.275 Tolerability of Antiepileptic Drugs in Patients With Newly Diagnosed Epilepsy: A 30-Year Longitudinal Cohort Study | B. Alsfouk; M. Brodie; M. Walters; P. Kwan; Z. Chen

Other

2.276 The Generic Substitution of Antiepileptic Drugs: Further Experience | W. Whitehouse; A. Zahid; M. Moran; J. Simmonds

2.277 PRAX-330, A Novel and Potent Sodium Channel (Nav) Blocker With Greater Selectivity for Persistent Sodium Current and Faster Inhibition Kinetics Compared to Approved Nav Targeting Antiepileptic Drugs (AEDs) | K. Kahlig; M. Chapman; M. Wittmann

2.278 Dynamics of Seizures Duration in Focal Epilepsy Syndromes Under Withdrawal of Antiepileptic Medication | E. Hartl; M. Seethaler; M. Lauseker; S. Noachtar

2.279 Prospective Use of Artisanal Oral Cannabis Extracts in Children With Epilepsy | K. Knupp; L. Helmkamp; K. Chapman; J. Rice

2.280 Does CBD Improve Non-Seizure Outcomes in Pediatric Epilepsy Patients? Qualitative Results From an Expanded Access Program | S. Hagopian; S. Kessler; A. Martinez; J. Minnick; D. Dlugos; E. Marsh

2.281 Refractory Myoclonus in Lance Adams Syndrome Responding to Brivaracetam | R. Chandak; A. Gudlavaletti; K. Medin

2.282 Perampanel (PER) Inhibits All Subtypes of AMPA Receptors Without Affecting NMDA and Kainate Receptors | K. Fukushima; K. Hatanaka; K. Sagane; K. Ido

2.283 Electroclinical Correlate of Adult Patients With Idiopathic Generalized Epilepsy Treated With Brivaracetam | E. Fonseca; M. Toledo; L. Guzmán; M. Quintana; L. Abraira; E. Santamarina; M. Sueiras; J. Salas-Puig

2.284 Prospective Post-Authorization Observational Study of Brivaracetam in the Treatment of Pharmacoresistant Epilepsies | A. Massot-Tarrús; A. Saldaña Díaz; E. Esteban de Antonio; M. Galiano

2.285 False-Positive or False-Negative Results Do Not Exist in the Human Photosensitivity Phase IIa Model | D. Kasteleijn- Nolst Trenite; R. Reed

2.286 Perampanel in Combination With Enzyme-Inducing Antiepileptic Drugs, A Plasma Concentrations/Dose Study | J. Sala; S. Jaraba; J. Miro; R. Juvany; R. Rigo; M. Falip

2.287 Monitoring Plasma Eslicarbazepine Levels in Clinical Practice. A Single Center Study | M. Falip; S. Jaraba; J. Miro; R. Juvany; R. Rigo; J. Sala

2.288 Perampanel Effect on Nocturnal Seizures in a Pharmacoresistant Epilepsy Cohort | D. Reyes; E. Conde Blanco; M. Carreño

2.289 Perception of Effectiveness of Antiepileptic Drugs in Veterans With Drug-Resistant Epilepsy | A. Crossley; H. Chae Suh; S. Dergalust; A. Wilson

2.290 Evaluation of Antiepileptic Drug Discontinuation in the Veteran Population With Focal Onset Epilepsy at the Veterans Affairs Greater Los Angeles Medical Center | L. Chi; H. Chae Suh; A. Crossley; N. Gautam; S. Dergalust

2.291 Therapeutic Response and Adverse Effects of Perampanel (Fycompa) as Adjunctive Antiepileptic Therapy | I. Suchita; S. Rashid; L. Morgan; L. Leary; C. Szabo

2.292 Clobazam in an Adult Clinical Practice - Efficacy for Focal Versus Generalized Epilepsy | M. Osborn; P. Ramey; C. Bedock; B. Abou-Khalil

Non-AED/Non-surgical Treatments

2.293 Evaluating Patient Interest in Mobile Software and Music-Based Interventions for Epilepsy Self-Management | P. Afra; M. Sweney; C. Bruggers; L. Fagatele; F. Alavi; M. Greenwald; K. Nguyen; M. Huntsman; G. Bulaj

2.294 Experiences of Cyclic Progesterone Treatment in Women With Catamenial Epilepsy | J. Kim; W. Kim

2.295 Enhancing Quality of Life Through Physical Activity in Children with Epilepsy: A Randomized Controlled Trial With a Behavioural Counselling Intervention | G. Ronen; D. Brown; D. Pohl; S. Bray; D. Streiner; M. Ferro; N. Mahlberg; S. Hamer; B. Timmons; P. Rosenbaum

2.296 The Effects of Fasting in Ramadan on Seizure Control and Quality of Life in Epilepsy Patients | O. Alghamdi; K. Alqadi; H. Baarmah; S. Bajammal; M. Albalawi; A. Alfadhel; M. Jawhari; A. Abu-jabber; N. Madani; Y. Al-Said; S. Baz; H. Kayyali

2.297 Anticonvulsant Effects of Physical Activity in a Mouse Chronic Corneal Kindling Model | Y. Lee; A. Fernandez; J. Stoll

2.298 Very High Dose Prednisolone Before ACTH for Treatment of Epileptic Spasms | Y. Eliyan; A. Alayari; J. Heesch; R. Rajaraman; S. Hussain

2.299 Serum Pyridoxine Level and Seizure Control in Adult Epilepsy Patients | D. Graf; R. Rodriguez; P. Rai; T. Masel

2.300 Ketogenic Diet Prevents Relapse in Infantile Spasms With Structural and Genetic Etiology | J. Wolak; S. Misra; R. Blackford; W. Lowman; B. Fisher; J. Millichap

2.301 KCNA2 Epileptic Encephalopathy: Clinical Response to Fampridine | P. Martínez-Ulloa; V. Soto Insuga; R. Guerrero López; L. Olivié García; B. Giraldez; G. González; J. Serratosa

2.302 Pilot Feasibility, Safety, and Preliminary Efficacy of High-Dose Vitamin D3 (5,000 IU/day) for Drug-Resistant Epilepsy | C. DeGiorgio; D. Hertling


Surgery

Adult

2.303 Modulation of Electrographic Ictal Patterns Predicts Extent of Seizure Control in Closed-Loop Neurostimulation for Epilepsy | V. Kokkinos; N. Sisterson; T. Wosny; A. Urban; A. Bagic; R. Richardson

2.304 Two-Step Combined Stereo-EEG and Chronic Subdural EEG Recording for Epilepsy Surgery | H. Tanaka; H. Shigeto; S. Ohara; T. Inoue; N. Akamatsu

2.305 Transient Seizure Freedom, Memory Loss, Ataxia, and Visual Symptoms due to Postoperative Electrode-Induced Inflammation After Responsive Neurostimulation System (RNS) Implantation – A Case Report | M. Kellogg; B. Lee

2.306 Improved Seizure Reduction Associated With Novel Robotic Assisted Technique to Implant Responsive Neurostimulation | D. Tran; L. Mnatsakanyan; I. Sen-Gupta; J. Lin; F. Hsu; S. Vadera

2.307 Stereotactic Laser Ablation Is a Safe and Effective Treatment for Epileptogenic Cerebral Cavernous Malformations | J. Willie; J. Malcolm; M. Stern; L. Lowder; S. Neill; B. Cabaniss; D. Drane; R. Gross

2.308 Laser Ablation as a Safe and Effective Treatment for Refractory Temporal Lobe Epilepsy With Incomplete Temporal Lobe Resection | Y. Cheng; P. Li

2.309 Prognostic Value of Presurgical Evaluations for Patients With Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis | H. Lee; H. Jo; D. Seo; S. Hong; Y. Shon

2.310 Assessing Satisfaction With Surgery: Preliminary Evidence of Validity and Reliability of the Epilepsy Surgery Satisfaction Questionnaire (ESSQ) | M. Wang; S. Wahby; T. Sajobi; M. Keezer; D. Nguyen; K. Malmgren; J. Tellez-Zenteno; C. Josephson; F. Girgis; S. Singh; S. Patten; N. Jette; W. Hader; M. Atkinson; M. Lunney; S. Wiebe

2.311 Visual Deficits After Laser Interstitial Thermal Therapy for Mesial Temporal Lobe Epilepsy | C. Donos; K. Tombridge; P. Rollo; J. Johnson; N. Tandon

2.312 Validity and Reliability of a Single-Item, Global Assessment of Satisfaction With Epilepsy Surgery | S. Wahby; M. Wang; T. Sajobi; M. Keezer; D. Nguyen; K. Malmgren; J. Tellez-Zenteno; C. Josephson; F. Girgis; S. Singh; S. Patten; N. Jette; W. Hader; M. Atkinson; M. Lunney; S. Wiebe

2.313 Long-Term Seizure Freedom Following Intracranial Monitoring Without Resection | J. Percy; H. Zaveri; J. Gerrard; L. Hirsch; H. Blumenfeld; D. Spencer; A. Sivaraju

2.314 Postoperative Hygromas in Elderly Patients Undergoing Resective Epilepsy Surgery | A. Maldonado-Naranjo; J. Gonzalez-Martinez; A. Stojic; V. Punia

2.315 Concurrent Resection and RNS System Placement: Three Cases | B. Razavi; E. Mirro; G. Grant; F. Baumer; L. Shuer

Pediatrics

2.316 Anatomical Understanding of Subtotal Hemispherotomy Using Cadaveric Brain, 3D-Simulation Models, and Intraoperative Photographs | T. Uda; R. Umaba; K. Nakajo; Y. Tanoue; H. Uda; N. Kunihiro; Y. Matsusaka; K. Ohata

2.317 Multiple Hippocampal Transections (MHT) in Dominant Hippocampal Epilepsy With an Amygdalar Tumor in a Pediatric Patient | A. Marashly; J. Koop; S. Lew

2.318 Safety and Efficacy of Stereoelectroencephalography in Pediatric Epilepsy Surgery | C. Elliott; K. Narvacan; B. Wheatley; S. Carline; J. Kassiri; D. Sinclair

2.319 Early Outcomes of Stereoelectroencephalography Followed by MR-Guided Laser Interstitial Thermal Therapy: A Paradigm for Minimally Invasive Epilepsy Surgery | I. Fayed; K. Cobourn; S. Sullivan; R. Keating; C. Oluigbo

2.320 VNS Associated Sleep-Disordered Breathing in Pediatrics: Prospective Analysis | C. Carosella; N. Simakajornboon; D. Smith; T. Dye

2.321 A Distinctive Mild Malformation of Cortical Development in Children With Severe Epilepsies | H. Kwon; H. Kang; J. Lee; S. Kim; H. Kim

2.322 Long-Term Outcomes in Pediatric Epilepsy Surgery: A Single Center Experience | H. Ahn; H. Kim; M. Yum; S. Hong; J. Lee; T. Ko

2.323 Seizure Recurrence in Non-Functional Vagal Nerve Stimulation Devices in Pediatrics | R. Villalobos; A. Villalobos; B. Naranjo; E. De leon; J. Garcia-Ramirez; T. Gonzalez

2.324 Impact of Pediatric Epilepsy Surgery on Behavioral and Cognitive Outcomes | T. Kantamneni; B. Lapin; R. Raghupathi; T. Falcone; A. Gupta; P. Kotagal; M. Naduvil; E. Wyllie; L. Jehi; E. Pestana Knight

2.325 Surgical Outcome of Hypothalamic Hamartoma | J. Song; J. Lee; H. Shin; J. Lee; J. Lee

2.326 Inter-Rater Reliability and Timing of Ictal Onset Patterns on Pediatric Subdural Electroencephalogram | A. Alter; T. McDonough; R. Dhamija; G. McKhann; N. Feldstein; A. Mandel; D. McBrian; C. Akman

2.327 Prediction of Postoperative Deficit Using an Improved Diffusion Tensor Imaging Maximum a posteriori Probability Analysis in Pediatric Epilepsy Surgery | J. Jeong; M. Lee; Y. Nakai; H. Motoi; A. Luat; C. Juhasz; S. Sood; E. Asano

2.328 Language Development After Multilobar Surgery of the Posterior Cortex in Infants and Young Children With Refractory Epilepsy | T. Ono; R. Honda; Y. Watanabe; K. Ishida; M. Wada; R. Koshimoto; K. Adachi; S. Baba; K. Toda; H. Baba

2.329 Outcome of Epilepsy Surgery for Genetic Refractory Epilepsy | A. Ghosh; S. Garcia-Tarodo; M. Shah; M. Watkins; M. Funke; G. Von Allmen

2.330 Epilepsy Surgery for Children With Low-Grade Epilepsy-Associated Tumors (LEATs): Factors Associated With Seizure Recurrence and Cognitive Function | H. Choi; A. Ko; S. Kim; S. Kim; E. Park; K. Shim; H. Kang; D. Kim; H. Kim; J. Lee

All Ages

2.331 Epilepsy Surgery Outcomes: One Center’s Experience | O. Danoun; A. Yousuf; S. Glynn; N. Beimer; W. Stacey; D. Harris; D. Minecan; J. Parent; L. Selwa; Y. Wang; R. Shellhaas; N. McNamara; E. Fedak Romanowski; S. Joshi; L. Dang; T. Hoban; O. Sagher; H. Garton; T. Mihaylova


2.332 Good Outcome of Resective Surgery in Lesional and Non-Lesional Focal Epilepsy After Invasive EEG Monitoring | C. Vollmar; J. Thorsteinsdottir; J. Tonn; F. Kreth; A. Peraud; S. Noachtar

2.333 The Evolution of Combined Depth, Strip and Grid (CIEEG) Intracranial Studies | J. Yowtak Guillet; J. Gerrard; H. Zaveri; A. Sivaraju; P. Farooque; D. Spencer

2.334 Patient-Specific 3D-Printed Functional-Anatomic Brain Models: Utility for Patient and Family Education | A. Ostendorf; S. Gedela; A. Long; J. Pindrik; R. Krishnamurthy; J. Jones; A. McAllister; J. Parthasarathy

2.335 Electrocorticography and Surgical Outcomes in Intractable Epilepsy due to Temporal Encephalocele | K. Kanth; G. Cascino; J. Britton; E. So; K. Krecke; R. Witte; J. Van Gompel; L. Wong-Kisiel

2.336 Trends in Epilepsy Surgery at Duke University Medical Center | S. Sinha; J. Allen; M. Luedke

2.337 Outcome and Prognostic Factors for Epilepsy Surgery in Pharmacoresistant Lesional and Non-lesional Epilepsy | P. Yadav; S. Ahmadi; Z. Bozoky; S. Waheed; R. Ward-Mitchell; M. Bensalem-Owen; Z. Mahuwala

2.338 Characteristics and Long-Term Outcomes in Patients Undergoing Resection of the Orbitofrontal Region for Intractable Epilepsy: A 13-Year Single Center Experience | A. Sumida; O. Hope; S. Thompson; M. Thomas; J. Slater; J. Johnson; N. Tandon

2.339 Visual Field Defects After Epilepsy Surgery for Temporal Lobe Epilepsy | H. Hosoyama; R. Hanaya; T. Otsubo; Y. Kashida; M. Sato; S. Maruyama; A. Jingushi; T. Fujimoto; K. Arita; K. Yoshimoto

2.340 Cost Analysis of Subdural Grids and Strips vs. Stereo-Electroencephalography in the Evaluation of Refractory Epilepsy | B. Tong; M. Morales-Morris; J. Johnson; C. Donos; G. Von Allmen; J. Lankford; S. Thompson; G. Kalamangalam; O. Hope; M. Thomas; J. Slater; N. Tandon

2.341 Motor Improvement and Seizure Control After Partial Resection or Disconnection in Destructive Lesions | R. Viale; A. Palmini; E. Paglioli; W. Martins; V. Zarpellon; B. Camargo; R. Soder; R. Paganin; F. Hehn

2.342 Surgical Outcome of Extratemporal Focal Cortical Dysplasia Following Noninvasive Evaluation and Stepwise Intraoperative Electrocorticography | V. Zarpellon; A. Palmini; E. Paglioli; W. Martins; R. Viale; B. Camargo; R. Soder; R. Paganin; R. Mattiello; F. Hehn


Adult

2.343 Long-Term Memory Retrieval in Older Patients With Epilepsy | N. Puri; S. Putta; M. Pavlova; R. Stickgold; R. Sarkis

2.344 Auditory and Visual Naming Performance in Patients With Temporal Lobe Epilepsy | L. Ferguson; O. Hogue; R. Busch

2.345 Utility of Green’s Word Memory Test in Postsurgical Temporal Lobe Epilepsy Patients | A. Reale-Caldwell; R. Mitchell; R. Rum; R. Sever; F. Vale; S. MacIver; S. Benbadis; M. Schoenberg

2.346 Assessment of Long-Term Psychosocial Outcomes in Autoimmune and Infectious Encephalitis | R. Blum; A. Tomlinson; S. Nyamu; N. Jette; A. Yeshokumar

2.347 Communication Abilities in Temporal Lobe Epilepsy Patients. The Right Hemisphere’s Contribution to Social Language Processing | A. Lomlomdjian; V. Terpiluk; R. Prestupa; P. Solis; B. Giagante; S. Oddo; S. Kochen

2.348 Functional Heterogeneity of Anterior and Mid Cingulate. An Electrical Stimulation Study | M. Centeno; M. Garcia; A. Jha; F. Chowdhury; J. Winston; P. Nachev; B. Diehl

2.349 The Role of Neuropsychological Assessment in Epilepsy Surgery: Current Practice Standards | H. McDonald; S. Bowden; W. D’Souza; C. Meade; L. Simpson; S. Vogrin

2.350 Self-Management Practices Associated With the Overall Quality of Life for Adults With Epilepsy | R. Quon; S. Schmidt; N. Streltzov; W. Zhao; R. Roth; L. Schommer; F. Chu; H. Henninger; K. Nagle; A. Andrew; B. Jobst

2.351 Neuropsychological Outcomes of Standard Temporal Lobectomy and Selective Laser Interstitial Thermal Therapy in the Treatment of Mesial Temporal Lobe Epilepsy | K. Tombridge; C. Donos; J. Breier; P. Rollo; J. Johnson; L. Moss; N. Tandon

2.352 Neuropsychological Outcomes Following Repeat Temporal Lobe and Limbic System Resection for Drug-Resistant Epilepsy | A. Atwood; T. Wodushek; M. Brown; C. Domen; A. Abosch; S. Ojemann; C. Drees

2.353 PACES in Epilepsy: Assessing Sustained Impact of Epilepsy Self-Management in a Randomized Controlled Trial | R. Fraser, PhD; E. Johnson, PhD

Pediatrics

2.354 WITHDRAWN

2.355 Longer Febrile Seizure Duration Is Associated With Poorer Auditory Learning EEG Responses in Theta Frequency Band | F. Thébault-Dagher; I. Knoth; M. Lafontaine; F. Deguire; V. Côté; K. Agbogba; F. Barlaam; R. Cook; M. Lagacé; L. Carmant; S. Lippé

2.356 Social Cognition in Childhood Epilepsy with Centrotemporal Spikes | E. Lima; P. Rzezak; M. Montenegro; M. Guerreiro; K. Valente

2.357 Caregiver Perspectives on the Role of Health Care Providers in the Management of Neuropsychological Comorbidities in Their Children with Epilepsy | D. Gaddie; C. Ryan; J. Nguyen; C. Harini; K. Spencer

2.358 Predictors of Healthcare Transition Readiness in Adolescents and Young Adults with Epilepsy | A. Smith; A. Gutierrez-Colina; E. Roemisch; B. Hater; A. Combs; A. Warning; A. Modi

2.359 Support with Legal Guardianship: An Important Transition Service for Pediatric Epilepsy Patients | C. Ryan; C. Vega; K. Boyer

2.360 Barriers to Care for Neuropsychological Comorbidities of Children With Epilepsy: A Qualitative Research Analysis | J. Nguyen; C. Ryan; D. Gaddie; C. Harini; K. Spencer

2.361 Cognition, Academic Services, Psychiatric Disorders and Behavioral Problems in Children with Juvenile Myoclonic Epilepsy | J. Jones; D. Almane; T. McMillan; K. Dabbs; H. David; S. Michael; B. Hermann


Genetics

Human Studies

2.362 Novel Clinically Oriented Gene Panel Web Display: Automated Annotation With Inheritance, Phenotype and More | M. Bailey; N. Miller

2.363 12p13.33 Microdeletion in Korean Child With Epilepsy and Intellectual Disability | J. Han; I. Lee

2.364 A Case of Medical Refractory Epilepsy and Autism With De Novo SLC6A8 Gene Variant | D. Horvat; A. Krokosky; C. Turner; Y. Ma

2.365 The Dense Core Vesicle Protein CADPS in Severe Epilepsy, Intellectual Disability, and Progressive Spasticity | M. Hildebrand; M. Bennett; A. Schneider; A. Macdonald; M. Bahlo; S. Berkovic; I. Scheffer

2.366 Two Different Clinical Faces of PRRT2 Mutation in Korean Pediatric Patients | J. Lee; J. Song; C. Lee; J. Lee

2.367 De Novo Gain-of-Function Variants in CACNA1E Cause a Syndrome of Severe Developmental Impairment, Infantile Spasms, and Profound Hypotonia | K. Helbig; R. Lauerer; C. Myers; J. Bahr; B. Uysal; N. Schwarz; U. Hedrich; C. Study Group; L. Sadleir; I. Scheffer; I. Helbig; H. Lerche; H. Mefford

2.368 Molecular Basis of CLN2 Disease: A Review and Classification of TPP1 Gene Variants Reported Worldwide | N. Miller; E. Gardner; M. Bailey; A. Schulz; M. Aristonera; W. Xin; S. Mole

2.369 Behind the Seizure: A No-Cost Epilepsy Panel for Pediatric Seizure Onset Between 2 and 4 Years | J. Cohen-Pfeffer; N. Miller; M. Bailey; S. Koh; J. Millichap; R. Truty; E. Wirrell; S. Aradhya

2.370 Development of Epilepsy and SUDEP Risk in SSADH Deficiency | M. DiBacco; K. Kapur; M. Brown; G. Sideridis; J. Roullet; M. Gibson; P. Pearl

2.371 WITHDRAWN

2.372 Yield of Whole Exome Sequencing: Experience from an Epilepsy Genetics Program | E. Spinelli; E. Bryant; J. Nowicki; R. Garcia Sosa; S. Misra; P. Tatachar; G. Carvill; A. Berg; L. Laux; J. Millichap

2.373 The 5-HTT Polymorphisms Are Not Related to Depression in Temporal Lobe Epilepsy Caused by Hippocampal Sclerosis | S. Vincentiis; J. Alcantara; P. Rzezak; D. Kerr; W. Gattaz; H. van der Linden; B. Santos; F. Arruda; T. Chaim-Avancini; M. Serpa; F. Fernandes; R. Moreno; G. Busatto Filho; R. Alessi; R. Demarque; K. Valente

2.374 GRIN2C: A Novel Glutamate Receptor Subunit Causes a Broad Epilepsy Phenotypic Spectrum | L. Sadleir; G. de Valles Ibáñez; C. King; M. Coleman; S. Mandelstam; M. Bennett; B. Halliday; S. Myers; H. Yuan; S. Traynelis; S. Rajagopalan; M. Mehaffey; S. Berkovic; S. Robertson; H. Mefford; M. Hildebrand; M. Bahlo; I. Scheffer

2.375 GNB5 Encephalopathy: A Recessive Neonatal or Infantile Developmental and Epileptic Encephalopathy | G. Poke; C. King; M. Germano; C. de Souza; J. Fung; B. Chung; C. Fung; S. Davis; T. Stanley; N. Malerba; A. Muir; H. Mefford; I. Scheffer; G. Merla; L. Sadleir

2.376 Disease-Associated Sites in PCDH19 Are Enriched at Segments Between Cadherin Domains Depleted From the General Population | A. Rochtus; S. Iqbal; E. Pérez-Palma; L. Smith; D. Lal; A. Poduri

2.377 Interpretation of Functional Consequences of Genetic Variants in Epilepsies Using Protein Structures | S. Iqbal; E. Perez-Palma; J. Jespersen; P. May; H. Heyne; K. Lage; A. Palotie; J. Cottrell; F. Wagner; M. Daly; A. Campbell; D. Lal

Health Services

2.378 A ‘Flipped’ Approach to Teaching Epilepsy Monitoring Unit Competencies | K. Bauman; M. Jacobson; S. Zubkov; C. Tsao

2.379 Transitioning Youth With Epilepsy Into Adult Care: A Medical Education | F. Tirol

2.380 Systematic Review of Societal Perspective or QALY Outcome Economic Analyses for Antiepileptic Drug Therapy in Chronic Epilepsy | S. Kindilien; M. Takeda; M. Roberts; Y. Barqawi; M. Borrego

2.381 Awareness of Epilepsy and Its Management in Rural India - A Survey of 9440 Epilepsy Patients | N. Surya; S. Singh

2.382 The Outpatient Epilepsy Monitoring Unit: A New Model for the EMU | K. Batson; A. Sadek

2.383 Self-Management in Epilepsy: Web-Based Seizure Tracking Applications | C. Casassa; E. Rathbun; D. Goldenholz

2.384 Prevalence and Determinants of Seizure Action Plans in a Pediatric Epilepsy Population | M. Chiu; S. Peinhof; M. Borhani; C. DeGuzman; C. Siu; B. Kuzeljevic; D. Schrader; L. Huh; M. Connolly

2.385 Narrative Medicine Themes Involved in Epilepsy Care: A Qualitative Analysis | M. Silver; A. Gedansky; M. Jacobson; C. Tsao; M. Vitez

2.386 Use of a Mobile Lift Device to Reduce Falls in the Epilepsy Monitoring Unit | P. Dorriz; S. Shaw

2.387 Quality of Epilepsy Care in a Medicaid-only Neurology Resident Clinic | G. Waldman; M. Bell

2.388 A Population Health Rural Ambulatory Care (PHRAC) Model for Impacting Refractory Epilepsy and Co-Morbid Mood Disorders | M. Rossi; N. Monica; K. Kelley; Y. Flores; B. Arana; J. Bingham; D. Garibay-Pulido; L. Cendejas-Zaragoza; B. Slack

2.389 The Impact of Specialty Epilepsy Consultation on Management and Outcomes in Veterans | A. Panduranga; E. Boudreau; M. Salinsky

2.390 Multiplex and Multilayered Epilepsy Care Network in Japan | K. Terada; Y. Inoue; T. Nishida; M. Yamano; T. Aoyagi; Y. Tadokoro

2.391 Feasibility of Depression Screening by a 24/7 Epilepsy Helpline | P. Shafer, RN, MN; A. Kanner; T. Buckley; K. Noe; E. Kiriakopoulos; J. Austin; J. Kakacek, MNPM, PhD; S. Owens

2.392 Emergency Department Visits After Receiving Psychogenic Non-Epileptic Events (PNEE) as a Diagnosis | L. Allen; K. Klink; K. Schroeter; C. Carlson

2.393 Consent and Guardianship Documentation, a Transition Quality Improvement Project | I. Villani; C. Ryan; A. Robertson; J. MacClary; C. Gagnon


2.394 Management of Benzodiazepine-Resistant Convulsive Status Epilepticus: Delayed Time to Treatment in a Pediatric Cohort | C. Stredny; M. Gaínza-Lein; S. Carey; S. Lewis; J. Clark; B. Bucciarelli; M. Chiujdea; A. Antonetty; T. Loddenkemper

2.395 Acceptance of Disability in Adults With Epilepsy | M. Ogawa; M. Fujikawa; Y. Kakisaka; T. Ueno; K. Jin; N. Nakasato

2.396 Educational Needs Assessment in Pediatric Epilepsy | S. Murray; S. Labbe; S. Kothare; I. Málaga; G. Kluger; P. Ogden; P. Lazure; A. Arzimanoglou

2.397 Implementation of a Computerized Anti-Epileptic Drug Panel to Reduce Time to Treatment for Status Epilepticus at Grady Memorial Hospital | W. Roche; K. Chester; O. Morgan; T. Harrison; M. Dhakar

2.398 Healthcare Utilization and Cost Outcomes for a Multicenter First Seizure and New Onset Epilepsy Clinic | E. Hudson; E. Fertig; A. Lesko; L. Lucas; E. Baraban; M. Evans; J. Toub

2.399 Hospital Resource Utilization in Epilepsy: Disparities in Rural Versus Urban Care | W. Bensken; G. Norato; O. Khan

Neuropathology of Epilepsy

2.400 Histopathological Features of Hippocampal Sclerosis in Dual Pathology | H. Miyata; S. Sudo; Y. Kubota; H. Nakamoto; R. Honda; K. Toda; T. Ono; M. Itoh; M. Fujii; S. Tanaka; N. Sakamoto; S. Osawa; M. Iwasaki; I. Kitazono; T. Yoshioka; H. Suzuki; T. Hori

2.401 WITHDRAWN

2.402 Medullary Catecholaminergic Neurons in Sudden and Unexpected Death in Epilepsy (SUDEP) | S. Patodia; I. Tan; S. Sisodiya; M. Thom

2.403 Pathology Underlying Drug-Resistant Epilepsy in the Elderly and the Influence of Age of Epilepsy Onset | A. Crudele; J. Bena; A. Stojic; R. Prayson; V. Punia

2.404 Stress-Activated Pathways May Contribute to Alzheimer’s Disease-Like Pathology in Human Drug-Resistant Epilepsy | S. Gourmaud; K. Davis; D. Talos; F. Jensen

2.405 Cognitive Impairment in Drug-Resistant Focal Epilepsy: Could Tau Deposition Play a Role? | K. Smith; M. Blessing; J. Parisi; J. Britton; G. Cascino

Practice Resources

2.406 Caregiver Stress and Benefit: Brief Scales for Caregivers of Children With Epilepsy | M. Jensen; A. Bamer; K. Liljenquist; A. Gammaitoni; C. Aron; B. Galer; D. Amtmann

2.407 Standardization of Ictal Cognitive Assessment in the Epilepsy Monitoring Unit | A. Snowden; V. Gonzalez Montoya

2.408 Treatment Outcomes of Pediatric Patients with Convulsive Status Epilepticus Improved by Protocol-Driven Management at a Tertiary Children’s Hospital | B. Leone; G. Cassel-Choudhury; N. Longani; R. Rivera; C. Katyal; J. Beal

2.409 Improving Family Education Prior to a Paediatric Epilepsy Monitoring Unit Admission | M. Kregel Gratton; A. Hadzic; T. Robinson; A. Andrade; M. Devries-Rizzo

2.410 Impact of Epilepsy Surgery on Healthcare Utilization in Pediatric Patients With Medically Refractory Epilepsy | R. Yardi; R. Pana; B. Lapin; I. Najm; W. Bingaman; J. Gonzalez-Martinez; A. Gupta; L. Jehi

Epidemiology

2.411 Perceived Stress in Individuals with Epilepsy | J. Christensen; A. Prior; Y. Sun; J. Dreier

2.412 Comparison of Psychogenic Nonepileptic Seizures in Singapore With the Worldwide Experience | G. Singh; N. Tan; C. Chang; Y. Tan

2.413 Marijuana Use Among Epilepsy Patients With Legal Recreational Access | A. Kerr; V. Walston; V. Wong; M. Kellogg; L. Ernst

2.414 New Onset Epilepsy in New Onset Seizure Clinic (NOSc) | S. Kim; T. Degrauw; K. Hass; A. Berg; S. Koh

2.415 The Prevalence of Coexisting Epilepsy in Adult Patients With Psychogenic Non-Epileptiform Spells | J. Newman; J. Dutton; R. Fields; J. Croom

2.416 Intervention Targets to Reduce Depression in Hispanic Adults With Epilepsy: The Role of Mindfulness and Rumination | L. Diaz; L. Payano; J. Montesdeoca; D. Friedman; A. Singh; O. Devinsky; T. Spruill

2.417 Depression and Quality of Life in Chinese American Adults with Epilepsy | J. Montesdeoca; J. Li; L. Diaz; D. Friedman; A. Singh; O. Devinsky; T. Spruill

2.418 Daily Stress Is Associated With Poorer Medication Adherence in a Diverse Sample of Adults With Epilepsy | L. Payano; D. Friedman; L. Diaz; J. Montesdeoca; A. Singh; J. Fishman; O. Devinsky; T. Spruill

2.419 Temporal Trends in the Incidence of SUDEP in the United States | E. Cihan; D. Hesdorffer; M. Brandsoy; L. Li; D. Fowler; J. Graham; E. Donner; O. Devinsky; D. Friedman

2.420 Utilization of Brain Imaging in Adult Patients Presenting With Seizure in the Emergency Department | W. Abood; S. Bandyopadhyay

2.421 Perceptions and Barriers to Epilepsy Surgery: An Evaluation in Canada, Mexico and Colombia | J. Tellez-Zenteno; L. Ladino; D. Díaz-Marín; V. Benjumea-Cuartas; I. Martinez Juárez; L. Hernandez; A. Denton

Public Health

2.422 Seizure and Epilepsy Publication in Non-neurology Journals | V. Wong; M. Stevenson; J. Mott; K. Sahaya

2.423 Assessing Quality of Life in Siblings of Children With Severe Epileptic Encephalopathies: A Comparative Analysis of Sibling Self-Reports and Parental Perception of Sibling Experiences | L. Bailey; A. Gammaitoni; B. Galer; L. Schwartz; C. Schad

2.424 Psychosocial Concerns of Growing Up With a Sibling With a Severe Epileptic Encephalopathy: Results From the Sibling Voices Survey Identify Potential Targets for Psychosocial Assessment | C. Schad; L. Bailey; A. Gammaitoni; B. Galer; L. Schwartz


2.425 PWE From Underserved Populations Living in High Crime Neighborhoods Have Higher Seizure Frequency: PAUSE to Learn Your Epilepsy | J. Levy; K. Ozenberger; D. Pandey

2.426 Quality of Life in Patients With Treatment-Resistant Epilepsy: The Roles of Health Literacy, Social Isolation, and the Social Determinants of Health | B. Scrivner; M. Szaflarski; E. Baker; E. Bebin; J. Szaflarski

2.427 Safety-Sensitive Jobs and People With Epilepsy: Can I Drive a Forklift ? Can I Be a Cop? Can I Be a Competitive Swimmer? | E. Garcia; W. Murphy

Case Studies

2.428 Neurogenic Pulmonary Edema as a Risk Factor for Sudden Unexpected Death in Epilepsy: A Systematic Review | R. Martinez; S. Rose; S. Wu; J. Tao

2.429 A Novel Clinical Triad of Epileptic Visual Hallucinations, Nystagmus and Migrainous Headaches with Epileptogenic Zone in the Posterior Cerebral Quadrant. A Novel Case Series and Literature Review | J. Rathore

2.430 Intermittent Idiopathic Atrioventricular Heart Block Masquerading as Seizure | N. Cohen; J. Schreiber

2.431 Infantile Spasms and Hypoglycemia: A Case of a KCNJ11 Gene Mutation | M. Bowling; C. Thompson-Rogers; J. Bhatia; P. Joshi

2.432 Solitary Cerebral Granuloma Mimicking a Primary Neoplasm: Serial MRI and Pathological Findings in a Case of New-Onset Seizures | A. Rafiuddin; A. Becker; H. Chen

2.433 Late Post Hypoxic Myoclonic Epilepsy – Is It Still Lance-Adams Syndrome? | R. Malik; A. Naveed; G. Suarez Cedeno; O. Hope

2.434 Eyelid Myoclonia in a Patient With Juvenile Myoclonic Epilepsy | S. Zahoor; J. Constantinou

2.435 Epilepsy-Associated With Missense Mutation of L1CAM Gene: An Electroclinical Case Report | A. Dabir; J. Magruder; M. Jaynes

2.436 Acute Encephalopathy With Biphasic Seizures and Late Reduced Diffusion Associated With Adenoviral Pneumonia | B. Lee; K. Lee; J. Lee

2.437 Association of Craniosynostosis With Hemimegalencephaly Causing Infantile Spasms | G. Vajapey; V. Shashi; E. Thompson; M. Gunduz; M. Lemmon; M. Mikati

2.438 Add-on Stiripentol Therapy in Children with Dravet Syndrome: A Case Series in China | W. Chen; N. Fu; J. Liang; J. Qin

2.439 Response to Lacosamide Monotherapy in a Patient With Medically Refractory Jeavons Syndrome | I. Zawar; L. Franic; E. Pestana Knight

2.440 Characteristics of Epilepsy After Hematopoietic Stem Cell Transplantation in Children: Case Series | S. Kim; J. Kim; H. Lee; J. Lee; J. Byun; Y. Jung

2.441 Case Series on Autoimmune Epilepsy | M. McConnell

2.442 Epilepsy Surgery in NF-1 | M. McConnell; A. Wabulya; S. Sheikh; L. Ngo; H. Shin

2.443 Use of Single Pulse Electrical Stimulation to Identify the Seizure Onset Zone | D. Lewis; J. Kang

2.444 A Novel Presentation in ATP1A2 Mutation | K. Pawar; T. Myers

2.445 Sleep-Related Hypermotor Epilepsy (SHE) With Confirmed Genetic Diagnostic. Description of a Case Series in a Tertiary Referral Hospital | P. Baena Palomino; B. Vélez Gómez; D. Macías García; P. Martínez Agredano; M. Caballero Martínez; C. Arenas Cabrera

2.446 Novel DOCK7 Pathogenic Variants in Three Siblings With Epileptic Encephalopathy, Cortical Visual Impairment, and Structural Brain Abnormalities | K. Angione; M. Sifuentes Saenz; D. Mirsky; S. Demarest

2.447 A Common Finding in a Rare Condition: Pediatric Case Series of Seizure and EEG Characteristics in Wolf-Hirschhorn Syndrome | S. Engel; S. Bhatia

2.448 GAD 65 Antibody Associated With Focal-Onset Motor Seizure, Dyskinesia and Segmental Myoclonus in a 7-Year-Old Girl: A Case Report | Q. Xu; C. Scramstad; M. Bunge; S. Udow; M. Salman

2.449 Case Report: NMDA Receptor Encephalitis With Persistent Fever as a Presenting Sign | M. Solomon; R. Al-Ramadhani; B. Mitchell; J. Ingram

2.450 Drug-Resistant Gelastic Seizures Successfully Treated With MRI-Guided Laser Interstitial Thermotherapy in Patient with Pallister-Hall Syndrome - Case Report | M. Bilal; N. Mittal; N. Zaher; V. Rajasekaran; R. Richardson; A. Bagic; A. Urban

Late Breaking

2.451 Nocturnal Seizures and Sleep Variability in Children and Young Adults with Dravet Syndrome | E. Golbeck; A. Berg

2.452 Real-time Effects of Interictal Spikes on Hippocampus and Amygdala Functional Connectivity in Unilateral Temporal Lobe Epilepsy: an EEG-fMRI Study | X. Tong; D. An; F. Xiao; D. Lei; R. Niu; W. Li; J. Ren; W. Liu; Y. Tang; L. Zhang; B. Zhou; Q. Gong; D. Zhou

2.453 Pharmacokinetics of Diazepam Buccal Soluble Film in Adult Patients with Epilepsy: Comparison of Bioavailability with Periictal and Interictal Administration | M. Rogawski; H. Gong; K. Liow; S. Aboumatar; P. Klein; M. Gelfand; C. Jung; S. Wargacki; R. Mehta; A. Heller

2.454 Improved Everyday Executive Function With Fenfluramine HCl Oral Solution (Fintepla®): Results From a Phase 3 Study in Children and Young Adults With Dravet Syndrome | K. Bishop; G. Gioia; P. Isquith; A. Gammaitoni; G. Farfel; B. Galer; A. Mistry; M. Lock; G. Morrison

2.455 Missense Epileptic Encephalopathy Mutations in Neuronal KCNQ/Kv7 Channels Occur at Hotspots within Highly Conserved Functional Domains of Kv7.2 and Kv7.3. | J. Zhang; C. Chen; E. Kim; E. Procko; J. Patel; R. Choi; M. Hong; D. Joshi; E. Cooper; E. Bolton; H. Chung

2.456 Common Variant Burden on Epilepsy: Findings from the Epi25k Consortium | A. Smith

2.457 Geographic Barriers to Accessing Epilepsy Surgery | C. Fehr; J. Tellez-Zenteno

2.458 Functionalized ClinPhen: Humanized Animal Models for Detecting Pathogenicity, Interrogating Mechanism of Action, and Enabling Targeted Drug Screening in Clinical Variants | C. Hopkins; K. McCormick; T. Brock; G. He; B. Jones


2.459 CX-8998, A Potent, Selective T-type Calcium Channel Antagonist, Fully Suppresses Seizures in the GAERS Genetic Model of Epilepsy | M. Lee; E. Newbold; S. Papapetropoulos

2.460 Cortical Malformations in Pediatric Epilepsy | L. Subramanian; M. Andrews; A. Bhaduri; M. Paredes; D. Wang; E. Chang; K. Auguste; A. Kriegstein

2.461 Lesion Localization and Treatment Outcome of Patients with Negative Motor Seizures | K. Kim; D. Lee; Y. Choi; K. Cho; H. Kim; Y. Cho; K. Heo

2.462 The Proposed Multimodal Mechanism of Action of Cannabidiol in Epilepsy: Modulation of Intracellular Calcium and Adenosine-Mediated Signaling | K. Nichol; C. Stott; N. Jones; R. Gray; M. Bazelot; B. Whalley

2.463 Levetiracetam may aggravate seizures in patients with focal cortical dysplasia | E. Cvetkovska; I. Kuzmanovski; M. Babunovska; B. Boshkovski; K. Aleksovska; G. Trencevska

2.464 Efficacy and safety of IV brivaracetam as a treatment for increased seizure activity in an Epilepsy Monitoring Unit | J. Szaflarski; A. Sadek; B. Greve; P. Williams; J. Varner; B. Moseley

2.465 Efficacy, Safety and Tolerability of Eslicarbazepine acetate in Post-Stroke Epilepsy: Real-World Evidence from the Euro-Esli Study | J. Chaves; F. Sales; V. Villanueva; R. McMurray; R. Loureiro; H. Fernandes


Monday, December 3


Use alternate entrance to poster session, Hall G, between 8:00 AM – 10:00 AM.

Continental breakfast available.

Basic Mechanisms

Epileptogenesis of Acquired Epilepsies

3.001 Temporal Development of Chronic Epilepsy in the Rat Following Acute Diisopropylfluorophosphate (DFP) Intoxication | M. Guignet; D. Bruun; P. Lein

3.002 Reduced A-Type K+ Current in GABA NTS Neurons in a Murine Model of TLE and SUDEP | I. Derera; B. Smith

3.003 Elucidating the Role of Enhancer of Zeste Homolog 2 (EZH2) in Epilepsy | N. Khan; B. Schoenike; T. Basu; G. Rodriguez; E. Wallace; R. Maganti; R. Dingledine; A. Roopra

3.004 KCNQ M-Type K Channels Are Upregulated After Epileptogenic Seizure and Increased Excitability in T=the Hippocampus | C. Carver; S. Hastings; M. Shapiro

3.005 Unexpected Epileptogenic Effect of TSP1/2 Deletion After Traumatic Brain Injury | H. Shu; F. Gu; I. Parada; D. Prince

3.006 Measuring the Phenotypic Changes of Innate Immune Cells During Viral-Induced Seizure Development | G. Wallis; K. Wilcox; J. Wagner

3.007 Potential Mechanism for Epileptogenesis Mediated by Parvalbumin Cell Loss and Extracellular Glutamate/GABA Imbalance in a Mouse Model of Closed Head Injury | P. MacMullin; H. Lee; N. Hodgeson; J. Qiu; G. Conley; N. Morriss; T. Hensch; R. Mannix; A. Rotenberg

3.008 Glutamine Impacts Seizure Severity in a Model of Mesial Temporal Lobe Epilepsy | E. Chen; R. Dhaher; E. Perez; A. Rapuano; S. Gruenbaum; M. Sandhu; H. Zaveri; T. Eid

3.009 Long-Term Effects of the Acute Treatment of Status Epilepticus in Juvenile Rats | L. Suchomelova; K. Thompson; J. Niquet; C. Wasterlain

3.010 Increased Number of Cardiac Arrhythmias and Long-Term Mortality in Mice Following Status Epilepticus | A. Levine; A. Dao; Y. Lai; S. Larson; A. Anderson

3.011 The Relationship Between Neuronal Extracellular Matrix, Intracellular Cytoskeleton, and Mobile Chloride | K. P. Normoyle; K. Staley

3.012 Toll-Like Receptor 3 Inhibition and Its Effect on Epileptogenesis | O. Shor; F. Benninger

3.013 Anticonvulsant Action of Adenosine A1 Receptor Agonist CCPA After Status Epilepticus in Immature Rats | P. Mares; H. Kubova

3.014 Comorbidities of Early-Onset Temporal Epilepsy: Cognitive, Social, and Emotional Dimensions | A. Mikulecka; P. Mares; H. Kubova

3.015 Reduced Seizure Propensity and Enhanced Function of Hyperpolarization-Activated Cyclic Nucleotide Channels (HCN) in Mice Deficient in Striatal Enriched Protein Phosphatase (STEP) | S. Jang; H. Chung

3.016 Distribution of Spike Within the Thalamocortical Network During Sleep and Wakefulness in Human Focal Epilepsy | D. Pizarro; E. Toth; A. Ilyas; A. Romeo; K. Riley; S. Pati

3.017 Progressive Neuropathological Molecular Mechanisms of Post-Traumatic Epileptogenesis | A. Omole; D. Smith; F. Jensen

Epileptogenesis of Genetic Epilepsies

3.018 Human Stem Cell-Derived Neurons and Cerebral Organoids to Model Pathogenesis in Dravet Syndrome | L. Dang; P. Swaminathan; S. Vaid; A. Tidball; Y. Liu; L. Lopez-Santiago; Y. Yuan; M. Uhler; L. Isom; J. Parent

3.019 Focal Cortical Dysplasia and Genetic Makeup. Review of Our Epilepsy Surgical Cases With 2 New Genetic Mutations Not Previously Reported | M. Hameed; H. Mutboli; R. Alnakali

3.020 Deletion of Tsc2 in Post-Mitotic Excitatory Neurons Leads to Severe Seizures and Premature Death | L. Martinez; W. Lee; D. Sheikh; G. D’Arcangelo; A. Anderson

3.021 Developing a Forward Genetic Screen in iPSC-Derived Neurons to Discover Novel FCD Genes | A. Tidball; T. Glenn; G. Carvill; J. Parent

Hungry?

Nourish your mind with the latest epilepsy scienceand grab some breakfast too!

POSTER BREAKFASTCoffee and Pastries

Monday, December 28 AM – 10 AM

Follow signage for alternate entrance in Hall Gto poster area in Exhibit Hall

The AES Poster Breakfast is sponsored by Sunovion Pharmaceuticals Inc.


3.022 Inhibition of Aldehyde Dehydrogenase Can Re-balance the Imbalanced Synaptic Currents Caused by Slow-Wave Oscillations in an Idiopathic Generalized Epilepsy Model With GABA Receptor A322D Mutatio | C. Zhou; L. Ding; M. Gallagher; R. Macdonald

3.023 Voltage-Gated Sodium Channel ß1 Subunit Processing by BACE1 and γ-Secretase: Potential Roles in Regulating Transcription | A. Bouza; J. Offord; A. Pinsky; J. Hull; L. Isom

3.024 Self-Reinforcing Effects of mTOR Hyperactive Neurons on Dendritic Growth | C. LaSarge; S. Arafa; R. Pun; S. Khademi; S. Danzer

3.025 Excitatory to Inhibitory Transition in GABAergic Currents Guides Circuit Formation of Cortical Interneurons | K. Zavalin; A. Hassan; Z. Khera; A. Lagrange

3.026 Heterozygous Deletion of Scn1a in Adult Mice Confers Sensitivity to Thermally Evoked Seizures | C. Cheah; W. Catterall; J. Oakley

3.027 Modeling Epilepsy Due to DEPDC5 Mutations Using Cortical Neurons Generated From Patient-Derived Induced Pluripotent Stem Cells | L. Kozek; B. Parker; K. Verdier; K. Ess; R. Carson

3.028 Thalamic Hyperexcitability and Atypical Absence Seizures in a Scn1a Model of Dravet Syndrome Are Mediated by Impaired Potassium Current | B. Higashikubo; S. Ritter-Makinson; A. Clemente-Perez; M. Cornet; K. Yamakawa; M. Cilio; B. Delord; J. Paz

Electrophysiology/High-frequency Oscillations

3.029 Synchronized GABA Release Inversely Desensitizes and Diminishes Synaptic but Accentuates Spillover to Extrasynaptic GABA-A Receptors in a Progressive Frequency-Dependent Manner | D. Naylor

3.030 Resolving the Interneuronal Drivers of Functionally and Temporally Diverse Inhibitory Regulation of Dentate Projection Neurons | M. Afrasiabi; V. Santhakumar

3.031 Decreased Ictal Activity in Panx1-Null Mice | P. Obot; L. Velisek; J. Veliskova; E. Scemes

3.032 Altered Synaptic Integration in a Mouse Model of Dravet Syndrome | J. Chancey; M. Howard

3.033 Invasive Recordings of High Gamma Activity in the Human Brain Track Emotional Content | D. Weisholtz; G. Kreiman; E. Stern; D. Silbersweig; T. Butler

3.034 Temporal Dynamics of High-Frequency Oscillations at Slow and Fast Time Scales in Patients With Epilepsy | M. Nunez; K. Charupanit; J. Lin; B. Lopour

3.035 In Search of Biomarkers for the Epileptogenic Zone: A Machine Learning Approach | O. Grinenko; J. Li; J. Mosher; J. Bulacio; J. Gonzalez-Martinez; I. Najm; P. Chauvel; R. Leahy

3.036 Multilayer Epileptogenic Networks for Seizure Localization | H. Shahabi; O. Grinenko; J. Mosher; D. Nair; P. Chauvel; R. Leahy

3.037 Infraslow Activity and HFO-Band Coupling During Seizure Generation | P. Salami; J. Nadalin; M. Kramer; S. Cash

3.038 Evaluation of High-Frequency Oscillations Requires Clinical Context in Patients With Multifocal Epilepsy | W. Stacey; S. Gliske

3.039 Epileptiform and Sleep Spindle Activity in Anterior Nucleus of the Thalamus in Temporal Lobe Epilepsy Patients | D. Fabo; Z. Jordan; B. Hajnal; R. Bodizs; L. Halasz; L. Entz; L. Eross

3.040 Investigation of Circadian Fluctuations in the Rate of High-Frequency Oscillations | S. Gliske; W. Stacey

3.041 Region-Specific Effects of Early-Life Status Epilepticus on the Adult Hippocampal CA3 – Medial Entorhinal Cortex Circuitry In Vitro: Focus on Interictal Spikes and Concurrent High-Frequency Oscillations | C. Lisgaras; C. Psarropoulou

3.042 Unsupervised Clustering of Human Electrocorticography at Seizure Onset | L. Martinet; P. Salami; H. Sun; M. Westover; S. Cash

3.043 Comparison of Electrically Stimulated Seizure Auras With High-Frequency Oscillations in Epilepsy Surgery | S. Billakota; L. Bateman; C. Akman; D. Anbarasan; C. Bazil; M. Bell; H. Choi; P. Kent; D. McBrian; A. Mendiretta; A. Pack; S. Srinivasan; G. McKhann; C. Schevon

Mechanisms of Therapeutic Interventions

3.044 A Novel Combination Therapy for Lowering Mortality Following Organophosphate Paraoxon-Induced Status Epilepticus in Rats | R. DeLorenzo; L. Deshpande; R. Blair; E. Hawkins

3.045 Sodium Cromoglycate Decreases Hippocampal Hyperexcitability and Somatomotor Deficit Subsequent to Severe Traumatic Brain Injury in Rats | L. Rocha; M. Segovia-Oropeza; C. Santiago-Castañeda; S. Orozco-Suarez; L. Concha

3.046 MicroRNA-Mediated Increase in Hippocampal A-Type Currents Is Associated With Reduced Seizure Frequency in a Mouse Model of Epilepsy | D. Tiwari; N. El-Sayad; J. Krzeski; L. Schroeder; S. Danzer; D. Brager; J. Rymer; C. Gross

3.047 Perampanel Prevents Cognitive Impairment, Epileptogenesis and Neuronal Damage in Pilocarpine Rat Model of Status Epilepticus | H. Almesalaty; C. Taghibiglou; F. Moien-Afshari

3.048 Therapeutic Potential of Bifidobacterium infantis on Pilocarpine-Induced Drug-Resistant Epilepsy Rat Model | A. Peng; X. Qiu; W. Lai; W. Li; L. Zhang; X. Zhu; S. He; L. Chen

3.049 Attenuation of Seizure Susceptibility Through Chemo-Genetic Mobilization of Parvalbumin Interneuron Inhibitory Reserve | E. Johnson; S. Gurnani; S. Dhamne; H. Lee; T. Hensch; A. Rotenberg

3.050 Treatment of Drug-Resistant Seizures With Chloride Extrusion Enhancer CLP257 | V. Dzhala; K. Staley

3.051 Ketone Body ß-hydroxybutyrate Prevents Seizures by Activating M-Channels | R. Manville; G. Abbott

3.052 Cannabidiol (CBD) Exerts Antiepileptic Properties by Targeting the LPI-GPR55 Lipid Signaling System Potentiated by Seizures | E. Rosenberg; M. Bazelot; A. Salah; S. Chamberland; E. Nebet; B. Whalley; O. Devinsky; R. Tsien

3.053 Pharmacodynamic Dependence of Retigabine on Kcnq2 Expression in PV+ Interneurons | S. Park; C. Dunbar; Y. Tarkunde; A. Akbar; R. Marks; M. Lee; H. Soh; E. Cooper; A. Tzingounis; A. Maheshwari


3.054 EEG and Cardiac Correlates in Drug-Resistant Temporal Lobe Epilepsy | E. Melo; R. Pereira; J. Fiel; R. Navegantes; F. Gomes; B. Gomes; A. Pereira

3.055 Non-Pharmacological Manipulations of Sleep to Alleviate Epilepsy Phenotypes in a Mouse Model of Dravet Syndrome | R. Dalvi; A. Bard; H. de La Iglesia; F. Kalume

Models

3.056 Cognition-Related Behavior of Coriaria Lactone-Induced Epilepsy Model | X. Qiu; A. Peng; W. Lai; L. Zhang; X. Zhu; S. He; W. Li; L. Chen

3.057 Enhanced Seizure Susceptibility in a Mouse Model of Neurofibromatosis Type 1 | G. Rizwan; H. Song; J. Liu; L. Zhang; A. Reid

3.058 SCN8A Epileptic Encephalopathy Mice Exhibit Cardiac Arrhythmias and Altered Autonomic Tone In Vivo | C. Frasier; J. Simpson; L. Isom

3.059 Age-Specific Effects of Inflammation on the Expression of Cytokines, Seizures and Breathing Responses in a Rodent Model of Febrile Seizures Induced by Exposure to Heated Dry Air | K. Barrett; M. Scantlebury

3.060 Differences in the Expression of miR-155 and miR-146a During the Early Inflammatory Response After Status Epilepticus in Male and Female Kainic Acid Mouse Models | K. Peariso; R. Lacher; D. Tiwari; C. Gross

3.061 Conditional Activation of a Severe Patient Mutation Reveals Major Role of Forebrain Excitatory Neurons in SCN8A Encephalopathy | J. Wagnon; R. Bunton-Stasyshyn; A. Faulkner; E. Wengert; P. Wagley; Y. Yuan; K. Bhatia; J. Jones; L. Isom; J. Parent; H. Goodkin; M. Patel; M. Meisler

3.062 Focal Brain Glutamine Synthetase Inhibition Leads to Epilepsy With Bilateral Changes in Glutamate, GABA and Seizure Expression | R. Dhaher; S. Gruenbaum; M. Sandhu; H. Zaveri; T. Eid

3.063 Rhythmic Patterns of Seizures and GABA in a Model of Temporal Lobe Epilepsy | M. Sandhu; S. Gruenbaum; R. Dhaher; H. Zaveri; K. Deshpande; T. Eid

3.064 Abnormal Tryptophan Metabolism Can Accelerate the Pathology of Epilepsy via Astrocyte Functional Failure | S. Hashimoto; J. Maeda; H. Takuwa; Y. Takado; M. Shimojo; M. Takahashi; T. Urushihata; K. Sampei; T. Minamihisamatsu; M. Inaji; K. Kumata; M. Zhang; T. Suhara; T. Maehara; M. Higuchi

3.065 Accelerometry and EEG in the Evaluation of a Rat Model of Epilepsy | J. Leiphart; N. Peixoto

Other

3.066 Seizure Activity in Cultured Hippocampal Neurons Alters Dendritic Spine Maturation in a Developmentally Dependent Manner | H. Hussein; M. Swensen; D. Exler; J. Lippman-Bell

3.067 Astrocyte and Neuronal Pannexin1 Differently Affect Seizure Progression | E. Scemes; J. Veliskova

3.068 Establishing the Mechanism of Gastrointestinal and Enteric Nervous System Dysfunction in a Mouse Model of Dravet Syndrome | V. Beck; L. Isom

3.069 Optical Mapping of Epileptic Foci in Awake Mice Using a Novel Method Combining Air-Lifted Platform and a Silicone-Based Cranial Window | M. Zhao; H. Ma; R. Alleva; R. Radwanski; N. Nishimura; C. Schaffer; T. Schwartz

3.070 Secondary Bilateral Synchrony in the Setting of Partial Agenesis of the Corpus Callosum: An Anatomical Study | A. Patel; C. Malpe; P. Shah

Translational Research

Human Studies

3.071 Temporal Trends and Predictors of Thalamic Recruitment in Human Focal Epilepsy | E. Toth; D. Pizarro; I. Vlachos; A. Ilyas; A. Romeo; K. Riley; S. Pati

3.072 Common Exclusionary Criteria Eliminate Two-Thirds of EMU Patients From Study Participation | N. Connolly; M. Berg; O. Selioutski

3.073 Direct Electrical Amygdala Stimulation Enhances Declarative Memory in Epilepsy Patients | C. Inman; J. Manns; K. Bijanki; D. Drane; R. Fasano; D. Bass; R. Gross; S. Hamann; J. Willie

3.074 Exercise Effects on Aerobic Fitness, Memory and Brain Network Connectivity in People With Epilepsy | J. Allendorfer; G. Brokamp; R. Nenert; S. Tuggle; J. Szaflarski; L. Ver Hoef; R. Martin; C. Morgan; M. Bamman

3.075 Neoangiogenesis and Blood-Brain Barrier Dysfunction in Human TSC Brain Lesions | K. Sansalone; P. Dilsiz; H. Weiner; O. Devinsky; D. Talos

3.076 Is Seizure Risk Forecasting Possible Using Patient Reported Seizure Diaries Without EEG or Biosensor Data? | D. Goldenholz; R. Moss; S. Herman

3.077 Sleep-Dependent Memory Consolidation Impairment in People With Epilepsy | F. Khadjevand; T. Pal Attia; L. Miller; V. Kremen; G. Ramazanian; J. Cimbalnik; E. St Louis; G. Worrell

Devices, Technologies, Stem Cells

3.078 Clinical Evaluation of the Embrace Smartwatch Detection Capability of Generalized Tonic-Clonic Seizures Recorded at the Ankles | C. Caborni; G. Regalia; F. Onorati; R. Picard

3.079 Toxicological Evaluation of Convulsant and Anticonvulsant Drugs in Human iPSC-Derived Cortical Neuronal Networks Using an MEA System | A. Odawara; N. Matsuda; Y. Ishibashi; R. Yokoi; R. Arant; I. Suzuki

3.080 Automatic Spike Detection: Towards Fast and Reliable Simultaneous EEG-Functional MRI Analysis of Epilepsy | A. Omidvarnia; M. Kowalczyk; M. Pedersen; G. Jackson

3.081 Seizure Forecasting From External Factors | D. Payne; P. Karoly; K. Dell; L. Kuhlmann; M. Cook; D. Freestone; D. Grayden

3.082 Chemogenetic Activation of Inhibitory DREADDs With Clozapine and Clozapine-N-Oxide Results in Potent Suppression of Hippocampal Seizure Activity in a Mouse Model for Temporal Lobe Epilepsy | J. Desloovere; M. Goossens; C. Van den Haute; V. Baekelandt; E. Carrette; K. Vonck; W. Wadman; A. Meurs; P. Boon; R. Raedt


3.083 Dravet Syndrome Patient Variant SCN1B p.R89C Results in Increased Sodium Current and Hyperexcitability in Human iPSC-Derived Excitatory Cortical Neurons | L. Lopez-Santiago; Y. Yuan; L. Dang; P. Swaminathan; K. Šterbová; S. Weckhuysen; P. DeJonghe; J. Parent; L. Isom

3.084 Predicting Seizure Risk from Interictal Epileptiform Activity | T. Proix; W. Trucculo; V. Rao; M. Baud

3.085 Automated Calculation of Tonic and Clonic Phase Lengths in GTC Seizures From Single-Channel EMG | D. Cardenas; J. Halford; S. Voyles; L. Whitmire; J. Cavazos

3.086 Transcranial Focal Electrical Stimulation (TFS) via Tripolar Concentric Ring Electrodes (TCREs) Safety in Humans | W. Besio; L. McCane; P. Steele; J. Mercier; D. McFarland

Biomarkers

3.087 Proinflammatory Cytokines in Blood From Children With Seizures: Preliminary Results of a Cross-Sectional Study | L. Bartolini; M. Moran; E. Leibovitch; B. Thomas; A. Dick; E. Wells; W. Suslovic; A. Bumbut; J. Chamberlain; W. Gaillard; S. Jacobson

3.088 Inter-ictal Hypercapnic Ventilatory Response Correlates With Severity of Peri-ictal Hypoventilation | R. Sainju; D. Dragon; H. Winnike; M. Granner; B. Gehlbach; G. Richerson

3.089 Telomere Length Is Reduced in Rats With Chronic Temporal Lobe Epilepsy, and This Is Mitigated by Treatment With the Antiepileptogenic Drug Sodium Selenate | P. Casillas-Espinosa; R. Brady; J. Lee; E. Braine; T. O’Brien; R. Mychasiuk; S. Shultz

3.090 Simultaneous Quantification of Alpha-Aminoadipic Semialdehyde, Piperideine-6-Carboxylate, Pipecolic Acid and Alpha-Aminoadipic Acid in Pyridoxine-Dependent Epilepsy | Z. Yang; J. Xue; P. Gong; J. Wang; M. Wu; W. Yang; S. Jiang; Y. Wu; Y. Jiang; Y. Zhang; T. Yuzyuk; H. Li

3.091 Spatial Arrangement of HFOs Correlates with Interictal Spikes on Scalp EEG in Pediatric Epilepsy | S. Sumsky; T. Somma; S. Santaniello; M. Schomer

3.092 Electrographic Events Recorded by a Responsive Neurostimulator May Provide an Objective Assessment of Clinical Seizure Burden | D. Spencer; M. Quigg; N. Fountain; B. Jarosiewicz; T. Skarpaas; M. Morrell

3.093 Etiology Is the Key Determinant of Neuroinflammation in Epilepsy: The Prominent Elevation of Cerebrospinal Fluid Cytokines and Chemokines in FIRES and Febrile Status Epilepticus | K. Kothur; S. Bandodkar; L. Wienholt; S. Chu; A. Pope; D. Gill; R. Dale

3.094 Predictive Blood Test for Psychogenic Nonepileptic Seizures: Post hoc Assessment of Plasma Biomarkers and Risk Factors | J. Gledhill; E. Brand; R. St.Clair; T. Wallach; J. Pollard; P. Crino

3.095 Photoplethysmography: A Measure for the Function of the Autonomic Nervous System During Focal Impaired Awareness Seizures | B. Bucciarelli; R. El Atrache; E. Tamilia; S. Hammond; F. Mohammadpour Touserkani; C. Papadelis; K. Kapur; M. Bendsen-Jensen; M. Tsuboyama; R. Sarkis; T. Loddenkemper

3.096 miRNA and Cytokine Profiles in Cryptogenic, Focal Epilepsy: A Pilot Study | T. Veldman; V. Venkat; R. Radtke; S. Sinha

3.097 Electrographic Findings During Acute Illness May Serve as Prognostic Biomarker for Epilepsy Development: A Case-Control Study | V. Punia; Z. Fitzgerald; X. Zhang; H. Huynh; S. Hantus

Models

3.098 Swine Model for Validation of a Fully Integrated Closed-Loop Neuromodulation SoC With Wireless Power and Bidirectional Data Telemetry for Real-Time Seizure Control | Y. Hsin; C. Chen; F. Shih; S. Peng

3.099 Loss of an Alzheimer’s Disease-Associated Gene, Presenilin 2, Age Dependently Increases Susceptibility to Chronic Seizures | M. Beckman; K. Knox; Z. Koneval; C. Smith; H. White; S. Jayadev; M. Barker-Haliski

3.100 Development and Pharmacological Characterization of a Mouse Model of Acute Repetitive Seizures | K. Knox; H. White; M. Barker-Haliski

3.101 A Dynamical Systems Approach for Seizure Propagation: Towards a Model-Based Design for Control via Brain Stimulation | A. Ashourvan; S. Pequito; A. Khambhati; F. Mikhail; S. Baldassano; K. Davis; T. Lucas; J. Vettel; B. Litt; G. Pappas; D. Bassett

3.102 Screening of Antiseizure Therapies Using an Automated Feeding System to Deliver Drug-in-Food to Rats With Kainic-Acid Induced Epilepsy | K. Thomson; C. Metcalf; T. Newell; K. Wilcox

3.103 Genetic Background in Rats Influences Gene Expression in Response to TBI | R. Kotloski; P. Rutecki; T. Sutula

3.104 Seizures in Captive Nonhuman Primates | C. Szabo; L. Croll; M. De La Garza; N. Abu-Madi; O. Devinsky

3.105 MEK/ERK Inhibition Suppresses Epilepsy in Mouse Models of Focal Cortical Dysplasia and Tuberous Sclerosis Complex | L. Nguyen; S. Roberds; S. Leiser; D. Brunner; M. Wong; A. Bordey

3.106 Assessment of Antiseizure and Neuroprotective Effects of Novel Compounds in a Delayed-Treatment Rat Model of Organophosphate (OP) Exposure | J. Spampanato; M. Smolik; F. Dudek

3.107 Low-Grade Inflammation in the Epileptic Hippocampus Contrasts With Explosive Inflammation Occurring in the Acute Phase Following Epileptogenic Brain Insults | N. Gasmi; A. Belmeguenaï; M. Ogier; B. Georges; S. Bouvard; J. Bodennec; M. Guénot; S. Rheims; L. Bezin

3.108 Acute Septal Stimulation Improves Behavioral Performance and Seizure Threshold in Pilocarpine-Treated Rats | K. Ondek; A. Izadi; A. Schedlbauer; I. Keselman; K. Shahlaie; G. Gurkoff

3.109 Stimulation of the Medial Septal Nucleus Reduces Interictal Spikes, Entrains Oscillations and Improves Object Learning in Epileptic Rats | A. Izadi; K. Ondek; A. Schedlbauer; E. Hsu; G. Disse; K. Shahlaie; G. Gurkoff

3.110 Identifying the Contributions of Contusion and/or Inertial Injury to Epileptogenesis in a Large Animal TBI Model Using a Wireless Monitoring Unit | A. Ulyanova; C. Adam; C. Cottone; B. Litt; D. Smith; D. Cullen; H. Chen; V. Johnson; J. Wolf


3.111 Defining a Murine Model of Polyhydramnios-Megalencephaly and Symptomatic Epilepsy | B. Allan; U. Moon; M. Baybis; S. Kim; P. Crino; P. Iffland

3.112 Integration of Structural and Electrophysiology Data Allows for Inference of Patient-Specific Models of Seizure Propagation | M. Woodman; V. Jirsa

3.113 WITHDRAWN

3.114 Probing the Perils of Sodium Channel Anticonvulsants in Dravet Syndrome With Multiscale Models | A. Knox; T. Bugnon; W. Mayner; G. Tononi

Neurophysiology


3.115 Diverse Mechanisms for Ictal Loss of Consciousness: A Comparison of Intracranial Recordings During Complex Partial and Secondarily Generalized Seizures | M. Boly; E. Juan; T. Bugnon; G. Findlay; R. Verhagen; A. Mensen; C. Schevon; O. Devinsky; R. Maganti; H. Blumenfeld; G. Tononi

3.116 The Utility and Yield of Long-Term Video Ambulatory EEG | S. Jamal Omidi; S. Amina; M. Devereaux; G. Fernandez-BacaVaca; N. GarciaLosarcos; J. Hampson; N. Lacuey; H. Luders; S. Lhatoo

3.117 Spontaneous Seizure-Associated Spreading Depolarization in a Chronic Rodent Model of Temporal Lobe Epilepsy | F. Bahari; C. Curay; J. Liu; J. Kimbugwe; S. Schiff; K. Alloway; B. Gluckman

3.118 Quantitative Pupil Measurements In Epileptic Seizures and Non-Epileptic Events – A Step Towards SUDEP Pathophysiologic Mechanisms | S. Yerram; D. Lardizabal; L. Liu; S. Surimohanram; S. Whitton

3.119 Postictal Generalized EEG Suppression (PGES) in a Prospective, Multicenter Trial of Subjects With Suspected Generalized Tonic-Clonic (GTC) Seizures | K. Karkar; D. Cardenas; S. Voyles; L. Whitmire; J. Cavazos

3.120 Optical Flow Estimation Improves Automated Seizure Detection in Neonatal EEG | J. Martin; P. Gabriel; M. Nespeca; J. Gold; R. Haas; S. Davis; D. Gonda; C. Sharpe; S. Wang

3.121 Invasive EEG in Presurgical Monitoring – Association of Electrophysiological Parameters With Localisation of Seizure Focus, Histopathology and Postoperative Outcome | M. Holtkamp; M. Steinbrenner; D. Steinbart

3.122 Cinematic Projection of Ictal Activity on Three-Dimensional Brain Surface Renderings as an Adjunct for Seizure Localization | J. Kleen; M. Baud; B. Spiedel; S. Ammanuel; L. Hamilton; E. Chang; R. Knowlton

3.123 Impact of the Video-EEG Unit in a High-Complexity Public Hospital | S. Oddo; B. Giagante; L. Dalessio; M. Fernandez Lima; J. Princich; P. Solis; P. Seoane; S. Kochen

3.124 Localization Value of Ictal Turning Prone | A. Arain; A. Umar; P. Rawal; N. Azar; M. Obideen; P. Singh; M. Al-Kaylani; B. Abou-Khalil

ICU EEG

3.125 Electrographic Predictors of Electrographic Seizures and Electrographic Status Epilepticus in Patients With Bilateral Independent Periodic Discharges: A Retrospective Multi-Center Study | G. Osman; R. Rahangdale; A. Wallace; J. Britton; E. Gilmore; H. Haider; S. Hantus; A. Herlopian; S. Hocker; J. Lee; B. Legros; M. Mendoza; V. Punia; N. Rampal; L. Schultz; J. Szaflarski; M. Westover; L. Hirsch; N. Gaspard

3.126 Extreme Delta Brush Pattern in Hashimoto’s Encephalitis: A Case Report | E. Way; L. Morton

3.127 Early Predictors of Electrographic Seizures in the Pediatric Intensive Care Unit | M. DiBacco; R. Hodgeman; A. Sansevere

3.128 Stepwise Prognostication Using Electroencephalography Monitoring Findings During Pediatric Critical Illness Supported by Extracorporeal Membrane Oxygenation | A. Sansevere; M. DiBacco; M. Libenson; T. Loddenkemper; P. Pearl; R. Tasker

3.129 Valacyclovir-Induced Cortical Myoclonus | Y. Makke; J. Britton

Other Clinical EEG

3.130 A Quantification of the Cost of HD EEG in Technologist-Minutes | J. Conway-Kinstler; J. Britton; B. Lundstrom; L. Wong-Kisiel; E. So; G. Worrell; B. Brinkmann; K. Daniel

3.131 Methohexital-Induced Lateralized Periodic Discharges During the Wada Test | O. Danoun; N. Beimer; H. Buchtel; S. Glynn; D. Harris

3.132 Hippocampal Source of 14- and 6-Second Positive Spikes–Simultaneous Scalp and Stereo-EEG Recordings | A. Urban; V. Kokkinos; C. Plummer; N. Zaher; A. Antony; J. Pan; R. Richardson; A. Bagic

3.133 High-Density Electroencephalogram (HD-EEG) Complements the Presurgical Workup Routine for Focal Epilepsy Patients | Y. Song; K. Bujarski; G. Thomas; E. Kobylarz; J. Aronson; B. Jobst

3.134 Clinical Neurological Features and Electrographic Patterns of Patients With Relapsed or Refractory Large B-Cell Lymphoma Treated with Axicabtagene Ciloleucel at Memorial Sloan Kettering Cancer Center (MSKCC) | A. Sequeira; X. Chen; E. Avila; E. Mead; C. Sauter; M. Palomba; P. Dahi; C. Batlevi; G. Shah; H. Chan; S. Giralt; M. Perales; B. Santomasso

3.135 Comparison of Seizure Onset Patterns With Stereotactic EEG (sEEG) and Chronic Electroencephalography (Ecog) | E. Valenti; M. Young; S. Vadera; J. Lin; L. Mnatsakanyan

3.136 EEG Features of Medically Refractory Genetic Generalized Epilepsy Syndromes | B. Kamitaki; H. Choi

3.137 The Utility of Intracranial Electroencephalography During Non-Awake Craniotomy to Predict Tumor-Related Epilepsy | T. Wychowski; J. Fessler; G. Worrell; B. Brinkmann; K. Walter; N. Mohile; G. Birbeck

3.138 Cortical Spreading Depolarization and Depression Can Be Detected in Patients With Chronic Epilepsy Undergoing sEEG Monitoring | M. Pain; D. Camara; J. Young; S. Ghatan; F. Panov

3.139 Localization of Seizure-Induced Arousal (Hypnopompic Seizures) With Stereo EEG | H. Ladha; R. Jamy; S. Pati


MEG

3.140 Identification of Magnetic Ictal Potentials in Epilepsia Partialis Continua Using Jerk-Locked Back Averaging | M. Quach

3.141 Mapping Critical Hubs of Receptive and Expressive Language in MEG; A Validation Against fMRI | V. Youssofzadeh; F. Salami; A. Babajani

3.142 WITHDRAWN

3.143 Fusion EEG-MEG Source Localizations Correlated With Hemodynamic Responses and Postsurgical Outcomes in Focal Epilepsy | C. Abdallah; R. Chowdhury; G. Pellegrino; T. Hedrich; M. Heers; J. Gotman; E. Kobayashi; C. Grova

3.144 Advanced dSPM in Localizing Epileptogenic Zone in MRI-Negative Epilepsy | M. Nakajima; S. Baba; H. Otsubo

Brain Stimulation

3.145 Dual Target Amygdalohippocampal-Thalamic Low Frequency Responsive Neurostimulation Is More Effective Than Amygdalohippocampal High Frequency Responsive Stimulation in Temporal Lobe Epilepsy | A. Alwaki; K. Bullinger; R. Fasano; A. Rodrigues-Ruiz; I. Karakis; L. Edwards; J. Willie

3.146 Seizure Outcomes in Responsive Neurostimulator (RNS) Therapy Comparing Strip Electrodes to Depth Electrodes | D. McDermott; M. Brown; S. Sillau; S. Schwarz; A. Abosch; S. Ojemann; C. Drees

3.147 Interictal Epileptiform Activity Predicts Poor Memory Performance in RNS Patients | S. Meisenhelter; B. Jobst

3.148 Corpus Callosum Low-Frequency Stimulation Suppresses Seizures in an Acute Rat Model of Focal Cortical Epilepsy | N. Couturier; D. Durand

3.149 Seizure Induction by Direct Cortical Stimulation Predicts Postsurgical Outcome: A Two-Center S-EEG Study Combined With 3D MRI Analysis | B. Frauscher; N. von Ellenrieder; P. Kahane; A. Hincapie; A. Eisenberg; H. Khoo; J. Hall; A. Job; D. Hoffmann; L. Minotti; J. Gotman; F. Dubeau; C. Cuello-Oderiz

3.150 Patterned Direct Intracranial Electrical Stimulation in the Human Brain Causes Frequency-Specific Effects | S. Bickel; J. Herrero; M. Mercier; E. Yeagle; S. Khuvis; P. Lakatos; F. Lado; A. Mehta

3.151 Real-Time Detection of After-Discharges Improves Electrical Brain Stimulation Mapping | C. Kapeller; J. Grünwald; K. Kamada; C. Guger

3.152 Accelerated Corticospinal Tract Maturation, as Detected by Neuronavigated Transcranial Magnetic Stimulation (nTMS), Corresponds to Preserved IQ in Girls, but Not in Boys, With Focal Epilepsy | H. Kaye; C. Vega; H. Purtell; A. Jannati; M. McNally; K. Kapur; A. Pascual-Leone; A. Rotenberg

3.153 Thalamic Detection of Focal Onset Seizures Using the NeuroPace RNS System | A. Joshi; C. Halpern; K. Graber

3.154 Short-Term Neurostimulation Trials During Invasive Monitoring of Epilepsy Patients | N. Gregg; A. Fine; I. Lavrov; K. Nickels; E. Payne; B. Lundstrom

Animal Studies

3.155 Prevalence of Electrographic Spikes in Wild Type Mice | H. Purtell; S. Dhamne; S. Gurnani; E. Bainbridge; M. Hameed; M. Sahin; A. Rotenberg

3.156 Sex Differences Underlying Risk for Sudden Unexpected Death in Epilepsy (SUDEP) | P. Kumar; N. Gautier; V. Mishra; S. Villalba; E. Glasscock

3.157 Disordered Breathing and Premature Death in a Mouse Model of Dravet Syndrome | F. Kuo; D. Mulkey

3.158 Electrophysiological and Behavioural Alterations Associated With Amygdala Kindling in Rats: The Role of the Endocannabinoid System | R. Colangeli; M. Morena; Q. Pittman; M. Hill; G. Teskey

3.159 Characterization of Heart Rate Variability and ECG Rhythm Alterations in the Pilocarpine Rat Model of Acquired Temporal Lobe Epilepsy | H. Grabenstatter; D. Barth

3.160 Excessive Silencing of Orexin Neurons by Protons in a Mouse Model of Epilepsy and SUDEP | T. Warren; T. Simeone; K. Simeone

3.161 Acute Non-Convulsive Status Epilepticus After Experimental Traumatic Brain Injury Induced With Lateral Fluid-Percussion in Rats | P. Adrade de Abreu; I. Banuelos; N. Lapinlampi; T. Paananen; R. Ciszek; X. Ndode-Ekane; A. Pitkänen

3.162 Thalamic Synchrony and Its Interruption During Absence Seizures | P. Fogerson; J. Huguenard


3.163 Ten-Year Study on the Structural and Clinical Profile of Private Video-Electroencephalography Service in São Paulo-SP | A. Estevo; S. Rodrigues; E. Garzon; L. Inuzuka Nakaharada

3.164 Spectral Coherence EEG Analysis in Sleep-Related Hypermotor Epilepsy | M. Puligheddu; G. Busonera; M. Cogoni; R. Ferri; G. Milioli; L. Parrino; F. Marrosu; G. Zanetti

3.165 Phase Shift Over Subdural Leads Permits Real Time Localization of the Seizure Source During the Interictal-Ictal Transition | J. Diamond; S. Inati; K. Zaghloul

3.166 A Novel Sonification Method Reveals Spectral and Spatial Features of Epileptiform EEG Activity | G. Leslie; V. Thadani; B. Jobst

3.167 The Attempt to Purify Electroencephalogram Data Using Empirical Mode Decomposition (EMD) Reconstruction Method | Y. Maruta; T. Inoue; H. Imoto; S. Nomura; M. Fujii; M. Suzuki

3.168 Machine Learning-Based Epileptic EEG Identification System: A Multicenter Study | R. Rathakrishnan; J. Thomas; J. Jin; S. Cash; M. Westover; J. Dauwels

3.169 Prevalence of Interictal Scalp EEG High-Frequency Oscillations in Pediatric Epilepsy Monitoring Unit | H. Nariai; D. Cao; D. Bernardo; R. Sankar; S. Hussain; J. Wu

3.170 Cortical Regions With Ongoing Epileptic High-Frequency Oscillations Display Normal Physiological Responses During Cognitive Tasks | S. Liu; J. Parvizi


3.171 Effective Connectivity Changes Reveal Seizure Onset Zone in Focal Cortical Dysplasia | R. Janca; P. Jezdik; M. Tomasek; V. Komarek; P. Krsek; P. Marusic; P. Jiruska

3.172 High-Frequency Signal Abnormalities in Long-Term Scalp EEG Are Specific Electrophysiological Signatures of the Pediatric Epileptic Brain | C. Stamoulis; J. Connolly; F. Duffy; P. Pearl

Clinical Epilepsy


3.173 A Single-Center Experience of NORSE Over a 10-Year Period | M. Rezayee; M. Nguyen; C. Murchison; M. Kellogg

3.174 Automatic Epileptic Seizure Type Classification Using Deep Neural Networks | I. Kiral-Kornek; S. Roy; S. Harrer

3.175 A Multi-Disciplinary Clinic for Patients With SCN8A -Related Epilepsy | J. Schreiber; A. Bumbut; L. Ball; R. Thewamit; C. Black; E. Boutzoukas; E. Fanto; M. Berl; W. Gaillard

3.176 The Epilepsy Phenotype of NPRL3 Mutation Heterozygotes in the Old Order Mennonite Population of North America | K. Cobb-Pitstick; V. Carson

3.177 Genetic Etiologies of Early-Onset Epileptic Encephalopathy With Burst Suppression Identified by Whole Exome Sequencing | D. Takacs; K. Houck; E. Seto; A. Anderson; R. Coorg

3.178 A Case Series of Medication Refractory Recurrent Absence Status Epilepticus of Later Life | C. Correll; A. Novroski

3.179 Cost and Health Services Trajectories After Treatment for Infantile Spasms | M. Zhang; Z. Grinspan; A. Patel; R. Shellhaas; K. Knupp

3.180 Lennox-Gastaut Syndrome: Characteristics and Major Caregiver Concerns (LGS) | T. Dixon-Salazar; M. Huntley; C. SanInocencio

3.181 Coexistence of Temporal Lobe and Idiopathic Photosensitive Epilepsies | D. Kinay; G. Engin; D. Coskun; S. Ustun ozek

3.182 Comorbidities of Rare Epilepsies: Results From the Rare Epilepsy Network (REN) | B. Fureman; N. Ho; B. Kroner; K. Farrell; D. Hesdorffer

Clinical Diagnosis

3.183 Application of Salzburg Criteria in an Argentinean Center in Patients with Non-Convulsive Status Epilepticus | D. Consalvo; E. Garino; N. Bein; A. Piedrabuena; D. Ballesteros; R. Leiguarda

3.184 Electrographic Status Epilepticus as a Presentation of a Patient With Hemiplegic Migraine | M. Alkhaldi; R. Martins; F. Almayman; G. Fernandez-Baca Vaca; M. Banks

3.185 Clinical Characteristics of Pediatric Brain Tumor-Related Epilepsy | A. Schupper; P. Upadhyayula; J. Martin; J. Crawford; K. Daniel; S. Wang

3.186 Genetic Features Influencing Seizure at Presentation and Survival in Brain Tumors | V. Wasade; L. Schultz; G. Osman; A. Gaddam; D. Dharaiya; N. Pellumbi; T. Walbert; J. Snyder; M. Spanaki-Varelas

3.187 Towards an Early Diagnosis of Psychogenic Nonepileptic Seizures With an Objectively Validated, Standardized Clinical History | W. Kerr; A. Chau; E. Janio; C. Braesch; J. Le; J. Hori; A. Patel; N. Gallardo; J. Bauirjan; E. Hwang; E. Davis; A. Buchard; D. Torres-Barba; S. D’Ambrosio; M. Al Banna; A. Cho; J. Engel; M. Cohen; J. Stern

3.188 Expert Opinion: A New Diagnostic Algorithm for Lennox-Gastaut Syndrome (LGS) in Adult Patients | S. Chung; S. Aboumatar; D. Burdette; R. Kuzniecky; G. Montouris; W. Rosenfeld; S. Kothare

3.189 Nonconvulsive Status Epilepticus Associated with Leptomeningeal Carcinomatosis | J. Kim; S. Kim

3.190 Making the Diagnosis | M. Holmes; S. Cristofaro; J. French; D. Lowenstein; R. Kuzniecky; K. Thio; O. HEP Investigators

3.191 Orgasm-Induced Seizures in Temporal Epilepsy With Auras of Musical Hallucinations: Case Report and Literature Review | W. Fu; L. Yang; L. Zhao; J. Wu

3.192 How Reliable Is “Head Shaking Sign” to Diagnose Psychogenic Nonepileptic Seizures? | E. Minato; H. Mun Au Yong; U. Seneviratne

3.193 Anatomo-Electroclinical Features of Perisylvian Epilepsy: An Evaluation in 26 Patients | X. Wang; W. Hu; C. Zhang; L. Ai; X. Shao; K. Zhang; Y. Ma; J. Zhang

3.194 Autonomic Dysfunction in Patients With Chronic Epilepsy | T. Subramaniam; O. Ajijola; M. Rosenberg; J. Alexander; G. Mathern

3.195 A Systematic Review of Reduced Electrode EEG for Seizure Detection | K. Gururangan; B. Razavi; R. Popat

3.196 Benign Rolandic Epilepsy Mimics: A Case Series and the Role of Prolonged Video-EEG | A. Alanezi; A. Andrade

3.197 Clinical Factors Associated With the Use of Infusion Therapy in Pediatric Status Epilepticus: A Case Control Study (the pSERG Consortium) | R. Arya; K. Peariso; T. Glauser; N. Abend; M. Amengual Gual; A. Anderson; J. Brenton; J. Carpenter; J. Clark; R. Farias Moeller; W. Gaillard; M. Gaínza-Lein; J. Goldstein; H. Goodkin; K. Kapur; S. Kelley; E. Kossoff; Y. Lai; T. Loddenkemper; M. Mikati; L. Morgan; E. Novotny; A. Ostendorf; E. Payne; J. Piantino; J. Riviello, Jr; I. Sánchez Fernández; K. Sannagowdara; C. Stafstrom; R. Tasker; D. Tchapyjnikov; A. Topjian; A. Vasquez; M. Wainwright. A. Wilfong; K. Williams; K. Chapman

3.198 Aids in the Diagnosis of Autoimmune Encephalitis and Encephalopathy | S. VanHaerents

Clinical Treatments

3.199 Retrospective Comparison of Seizure Outcomes in Patients with Focal Epilepsy Treated With Responsive Neurostimulation or Vagus Nerve Stimulation | K. Kim; M. Holmes; A. Silverberg; W. Doyle; D. Friedman

3.200 Laser Interstitial Thermal Therapy in Adult Patients With Hypothalamic Hamartoma and Long-Standing Gelastic Seizures | N. Mittal; M. Bilal; N. Zaher; V. Rajasekaran; A. Bagic; R. Richardson; A. Urban


3.201 Expert Opinion: A New Treatment Algorithm for Lennox-Gastaut Syndrome (LGS) in Adult Patients | S. Kothare; S. Aboumatar; D. Burdette; R. Kuzniecky; G. Montouris; W. Rosenfeld; S. Chung

3.202 What Defines “Clinical Meaningful Changes in Seizure Frequency?” Analysis of Data From a Phase 3 Clinical Trial of ZX008 in Dravet Syndrome | R. Nabbout; J. Sullivan; D. Dlugos; G. Farfel; B. Galer; G. Morrison; D. Haney; M. Lock; A. Gammaitoni

3.203 High-Dose Midazolam Plus Ketamine in Refractory Status Epilepticus | A. Pickard; H. Chan; A. Patel; Y. Au; C. Skidmore; F. Rincon; M. Vibbert; M. Sperling; A. Fernandez

3.204 Two Extreme Faces of Newborn Status Epilepticus and Epileptic Encephalopathy | S. Ahmad; Y. Ng

3.205 Clinical Experience With Briviact in Refractory Epilepsy | E. Conde Blanco; I. Manzanares Téllez; F. Gil-López; A. Donaire; M. Carreño

3.206 When to Terminate Medications in Patients With Epilepsy With Continuous Spikes and Waves During Slow-Wave Sleep? | H. Ikeda; K. Imai; H. Ikeda; H. Shigematsu; Y. Inoue

3.207 Compliance With the Quality Measure for Epileptic Spasms | J. Mytinger

3.208 Verbal Deficits After Left SMA Resection in Epilepsy Surgery | D. Ni; X. Wang; C. Liu; C. Xu; L. Qiao; T. Yu

3.209 Cannabidiol (Epidiolex) in Children with Refractory Absence Seizures | J. Conry; J. Schreiber; A. Kao; A. Pasupuleti; T. Vu; T. Zelleke

3.210 First Year Experience With Patients in the Post-Acute Symptomatic Seizure (PASS) Clinic | S. Hantus; J. Fesler; V. Punia

3.211 A First in Human Phase 1 Study to Assess the Safety, Tolerability and Pharmacokinetics of a Novel NaV1.6 Selective Small Molecule Sodium Channel Blocker (XEN901) in Healthy Subjects | R. Namdari; L. Buchy; J. Cadieux; H. Kato; L. Legkaia; P. Goldberg; G. Beatch; J. Johnson; S. Pimstone; R. Sherrington; C. Cohen; J. Empfield; E. Aycardi

3.212 Epilepsy Management in Pediatric Brain Tumor Patients | P. Upadhyayula; A. Schupper; J. Martin; J. Crawford; K. Daniel; S. Wang

3.213 Which Is the Drug of Choice for Elderly Onset Epilepsy? | H. Ikeda; T. Hiyoshi; H. Ikeda; T. Nishida; T. Matsudaira; Y. Inoue

3.214 Brivaracetam: Real-Life Experience in Wales | C. Lawthom; J. Anderson; K. John; J. Edwards; R. Morcom; J. Ham; R. Powell

3.215 Use of Vigabatrin in Super-Refractory Status Epilepticus – An Update | M. Poongkunran; V. Sabharwal; F. Khan; L. Ades; N. Billeaud; C. Maciel; U. Menon; R. Ramsay

3.216 Role of Eslicarbazepine in Seizure Control: A Retrospective Review of Patients at Ochsner Epilepsy Center | L. Ades; R. Abraham; U. Menon; R. Ramsay

3.217 Antiepileptic Drug Prescribing Trends in EMU Patients Diagnosed With Psychogenic Nonepileptic Seizures | M. Kentris; K. Haas

3.218 The Use of Steroids for the Treatment of Epilepsia Partialis Continua | G. Ansoanuur; Y. Rodriguez; S. Smart

Prognosis

3.219 Quality of Life in Children With Epilepsy | R. Albaradie; S. Bashir; A. Mir

3.220 Prognostication Following Cardiopulmonary Resuscitation: Beyond the Binary Classification of N20 Evoked Potentials | R. Alkawadri; Q. Yan; A. KacarBayram

3.221 Risk Factors for Early Mortality in SCN8A-Related Epilepsy | E. Gardella; K. Johannesen; K. Howell; D. Smith; I. Helbig; I. Scheffer; G. Rubboli; R. Møller

3.222 Refractory Status Epilepticus in the Elderly: New-Onset Versus Those With Epilepsy | M. Kakara; M. Nasseri; A. Mahulikar; M. Sadeghi; M. Ravishankar; S. Khan; M. Basha; D. Zutshi; K. Suchdev; S. Mittal; W. Mohamed; R. Marawar

3.223 Multidimensional Bayesian Network Classifiers for Individualized Prediction of Temporal Lobe Epilepsy Surgical Outcomes | Y. Tan; K. González Otárula; M. Benjumeda; D. Chandramohan; E. Chang; J. Hall; C. Bielza; P. Larranaga; E. Kobayashi; R. Knowlton

3.224 Outcomes of Refractory Febrile Status Epilepticus | K. Labiner; K. Husari; R. Huang; R. Said

3.225 Current Status and Challenges in Transition of Children With Epilepsy to Adult Care | Y. Yi; J. Kang

3.226 Predictors of Refractory Seizures in a Large Tertiary Cohort with 1,177 Patients | M. Morita-Sherman; C. Yasuda; M. Alvim; A. Gomes; L. Ribeiro; A. Pinheiro; F. Cendes

3.227 Identification of Risk Factors for Development of Epilepsy Post-Stroke | J. Manske; M. Smith; R. O’Dwyer

Women

3.228 The Role of De Novo Mutations in Antiepileptic Drug-Associated Birth Defects | P. Perucca; A. Anderson; D. Jazayeri; A. Hitchcock; J. Graham; M. Todaro; T. Tomson; D. Battino; E. Perucca; M. Martinez Ferri; A. Rochtus; L. Lagae; E. Campbell; B. Koeleman; S. Berkovic; P. Kwan; D. Goldstein; S. Petrovski; J. Craig; F. Vajda; T. O’Brien; T. O’Brien; T. O’Brien

3.229 Changes in Seizure Rates During Pregnancy: Results from the MONEAD Study | P. Pennell; K. Meador; R. May; J. French; E. Gerard; L. Kalayjian; E. Gedzelman; P. Penovich; J. Cavitt; S. Hwang; A. Pack; M. Sam

3.230 Changes in Lamotrigine and Levetiracetam Serum Concentrations Throughout Individual Weeks in Pregnancy | M. Makelky; J. Bainbridge; A. Shrestha

3.231 Adverse Fetal Outcomes in the MONEAD Study | K. Meador; P. Pennell; R. May; R. Finnell; L. Van Marter; T. McElrath; E. Gerard; L. Kalayjian; E. Gedzelman; P. Penovich; J. Cavitt; J. French; S. Hwang; A. Pack; M. Sam

3.232 Total Daily Dosage of Antiepileptic Drugs of Women With Epilepsy With Subsequent Pregnancies | A. Sanchez; S. Mintzer; L. Higdon; M. Nei

3.233 Increasing Contraception Counseling by Epileptologists: An Educational and Clinical Intervention | R. Bhatia; A. Espinera; E. Bachman; I. Bellinski; K. Gonzalez Otarula; E. Gerard


3.234 Termination of Pregnancy in Women With Epilepsy | L. Goldstein; F. Benninger

3.235 Epilepsy Connectome Project (ECP) - Gender Differences in Temporal Lobe Epilepsy | O. Nwoke; C. Forseth; J. Mathis; V. Nair; G. Hwang; N. Tellapragada; C. Rivera-Bonet; C. Cook; G. Zhao; L. Conant; E. DeYoe; M. Rozman; D. Almane; A. Nencka; A. Struck; R. Birn; R. Maganti; C. Humphries; M. Raghavan; C. Ustine; B. Ward; B. Hermann; B. Meyerand; J. Binder; V. Prabhakaran; E. Felton

3.236 Variations in Seizure Frequency During Pregnancy and Postpartum by Epilepsy Type | P. Voinescu; S. Allien; A. Ehlert; L. Chen; E. Ansari; P. Pennell

Neuroimaging

Structural Imaging

3.237 Automatic Detection of Focal Cortical Dysplasia Using Deep Learning: A Multicentre Validation Study | R. Gill; S. Hong; F. Fadaie; B. Caldairou; H. Lee; B. Bernhardt; J. Hall; M. Veilleux; F. Dubeau; E. Kobayashi; B. Frauscher; R. Dudley; L. Carmant; A. Lortie; A. Weil; D. Nguyen; C. Barba; A. Brandt; V. Coelho; L. d’Incerti; M. Lenge; M. Semmelroch; F. Bartolomei; M. Guye; F. Deleo; A. Schulze-Bonhage; F. Cendes; R. Guerrini; G. Jackson; N. Bernasconi; A. Bernasconi

3.238 Imaging Hippocampal Internal Architecture at 3T and 7T Using High-Resolution Multiple Image CoRegistration and Averaging (HR-MICRA) | L. Ver Hoef; G. Selladurai; T. Denney

3.239 A Method for Visualizing the Centromedian Nucleus of the Thalamus for Deep Brain Stimulation in Lennox-Gastaut Syndrome | A. Warren; L. Dalic; W. Thevathasan; K. Bulluss; A. Roten; J. Archer

3.240 Examination of Cognition and Brain Volumetric Variables in Newly Diagnosed Focal Epilepsy | M. Calvillo; C. Morrison; K. Meador; J. French; R. Kuzniecky; H. Pardoe; O. HEP Investigators

3.241 MRI Abnormalities of Type II Focal Cortical Dysplasia Are Recognized Mostly in the Bottom Part of Dysplastic Sulcus: A Quantitative Study | Z. Liu; W. Hu; X. Wang; B. Zhao; C. Zhang; L. Liu; X. Shao; K. Zhang; Y. Ma; J. Zhang

3.242 Surface-Based Local Feature Analysis to Aid Visualization of Epileptogenic Lesions | K. Snyder; S. Inati; W. Theodore; K. Zaghloul; S. Inati

3.243 Neuroanatomical Abnormalities in Newly Diagnosed Focal Epilepsy: MRI Findings From Baseline Imaging in the Human Epilepsy Project | H. Pardoe; R. Kuzniecky; O. HEP Investigators

3.244 Regional Cortical Thickness Varies With Seizure Frequency in Patients With Generalized Tonic-Clonic Seizures | J. Ogren; R. Tripathi; P. Macey; R. Kumar; D. Eliashiv, M.D.; J. Stern; L. Allen; B. Diehl; J. Engel; M. Rani; S. Lhatoo; R. Harper

3.245 The Impact of Multimodal 7T MRI in Presurgical Evaluation of Patients With Severe Epilepsy | G. Opheim; M. Ganz-Benjaminsen; U. Lindberg; M. Vestergaard; H. Simonsen; A. Leffers; C. Goebel Madsen; H. Wiberg Larsson; O. Paulson; L. Pinborg

3.246 Volumetric Measurements of Hippocampal Formations: Is It Time to Replace the Manual by an Automated Method? | C. Millan; A. Saporta; R. Ribot; T. Stoub; A. Kanner

3.247 Cortical Thickness in Childhood Left Focal Epilepsy: Thinning Beyond the Seizure Focus | E. Boutzoukas; J. Crutcher; E. Somoza; L. Sepeta; X. You; G. Wallace; W. Gaillard; M. Berl

3.248 Mesial Temporal Lobe Epilepsy as Measured by Magnetic Resonance Elastography (MRE); Hippocampal Tissue Stiffness and Relational Memory Deficits | C. Johnson; H. Schwarb; B. Sutton; T. Wszalek; G. Huesmann

Functional Imaging

3.249 Disrupted Basal Ganglia Pathways in Temporal Lobe Epilepsy With Focal to Bilateral Seizures | X. He; G. Chaitanya; B. Asma; E. Eline; N. Sideman; H. Saidi; N. Kim; A. Sharan; J. Tracy; M. Sperling

3.250 Machine Learning Prediction of Surgical Cognitive Outcome Using Multimodal Network MRI | K. Osipowicz; X. He; M. Sperling; A. Sharan; J. Tracy

3.251 Evaluation of MRI Arterial Spin Labeling and Susceptibility-Weighted Imaging in Postictal Todd’s Paresis; Hypoperfusion or Hyperperfusion? | S. Baba; C. Somagawa; Y. Morofuji; Y. Tateishi; T. Matsuo

3.252 Functional MRI and Structural Connectome Mapping Analysis of Language Networks in Japanese-English Bilinguals | K. Kawamura; H. Sugano; T. Mitsuhashi; M. Nakajima; Y. Iimura; H. Suzuki; H. Arai; K. Asano; T. Tanaka

3.253 Connectome-Based Biotyping of Focal Cortical Dysplasia Type II | S. Hong; H. Lee; R. Gill; B. Bernhardt; N. Bernasconi; A. Bernasconi

3.254 Awake fMRI in a Rat Model of Absence Epilepsy: Similarity to Human Absence Hemodynamics | Z. Kratochvil; C. McCafferty; P. Herman; J. Ryu; B. Sanganahalli; B. Gruenbaum; P. Antwi; W. Islam; E. Johnson; P. Vitkovskiy; I. Freedman; A. Kundishora; A. Depaulis; F. Hyder; H. Blumenfeld

3.255 Investigating the Contribution of Insular Cortex to Speech Production With Stereo-EEG Recordings in Epileptic Patients | O. Woolnough; K. Forseth; N. Tandon

3.256 Predicting Postoperative Language Outcome Using DWI, fMRI, and MEG | A. Babajani; C. Holder; A. Siddiqui; A. Choudhri

3.257 Implications of White Matter Changes in MTLE-HS Syndrome: Is MTLE-HS a Progressive Disease? | A. Radhakrishnan; A. Chandran

3.258 Individual Hippocampal Activation During Verbal Memory fMRI in Children with Focal Epilepsy | S. Leigh; M. Berl; X. You; M. Wilke; S. Inati; V. Roopchansingh; E. Fanto; E. Boutzoukas; S. Bookheimer; N. Suthana; W. Theodore; W. Gaillard


3.259 Sleep and Behaviour in Jamaican Children With Epilepsy: A Case-Control Study | L. Graham; R. Melbourne-Chambers; M. Gossell-Williams; J. Tapper


3.260 Suicidality in Patients With Newly Diagnosed Focal Epilepsy: A Relatively Frequent Comorbidity | A. Kanner; C. Millan; D. Hesdorffer; M. Winawer; S. Nadkarni; J. Barry; H. Altalib; O. Hope; T. O’Brien; M. Sperling; J. French

3.261 Psychiatric Symptoms Comorbid in Patients With Epilepsy and Their Impact on Quality of Life: Epilepsy and VideoEEG Unit, CMDLT, Caracas,Venezuela | A. Daza-Restrepo; A. Soto; G. Contreras Caicedo; H. Scholtz

3.262 The Correlation Between Sleep and Quality of Life in Epilepsy | A. Pentagna; S. Terrin; B. Santos; S. Vincentiis; K. Valente

3.263 Putting Depression on the Map: A Quality Improvement Project for Epilepsy Patients | D. Mao; A. Choi; K. Mortati; G. Chari

3.264 Do Psychotropic Drugs Impact Seizure Frequency in Epilepsy Monitoring Unit Patients? | M. Kolikonda; R. Yeruva; B. Unroe; C. Ziegler; M. Bilal; B. Chapman

3.265 WITHDRAWN

3.266 Insights on Art Therapy With Epilepsy Patients | T. Shella; E. Pestana Knight

3.267 Polysomnographic Findings in Children With Juvenile Myoclonic Epilepsy | P. Jorrat; M. Mazzola; A. Schteinschnaider

3.268 Migraine and Psychiatric Comorbidities in Patients With Epilepsy | M. Minen; S. India; J. French; A. Kanner; J. Barry; H. Altalib; D. Hesdorffer; M. Winawer; T. O’Brien; O. Hope; S. Nadkarni; M. Sperling; O. HEP Investigators

3.269 Obstructive Sleep Apnea Risk in Adults With Localization-Related Versus Generalized Epilepsy | R. Mani; S. Wong; M. Krishnagiri; A. Cilly; K. Sivaraaman; S. Rishty; M. Scharf

3.270 Demographics and Clinical Aspects of SUDEP in Bexar County, Texas: Preliminary Evaluation of Cases Identified 2011-2016 | S. Ellis; D. Molina; C. Szabo

3.271 Identifying Common Characteristics in Veterans With Psychogenic Nonepileptic Spells to Foster More Rapid Diagnosis to Minimize Morbidity and Delays in Appropriate Treatment | L. Smith; K. Ono

Antiepileptic Drugs

Animal Studies

3.272 The Effect of Decanoic Acid in the Multiple Hit Rat Model of Infantile Spasms due to Structural Lesion | A. Katsarou; W. Mowrey; Q. Li; W. Liu; S. Moshé; R. Williams; A. Galanopoulou

3.273 Repeat Dosing of Novel Selective Inhibitors of NaV1.6 Enhances Efficacy in the Mouse Maximal Electroshock Model | J. Johnson; P. Karimi Tari; C. Dube; M. Waldbrook; S. Goodchild; N. Shuart; S. Lin; T. Focken; C. Dehnhardt; M. Grimwood; K. Burford; A. Hasan; R. Winquist; C. Cohen; J. Empfield

3.274 Antiseizure Drug Response of Outbred Versus Inbred Mice in Pharmacoresistant Acute and Chronic Seizure Models | Z. Koneval; K. Knox; D. Zierath; H. White; M. Barker-Haliski

3.275 Effects of the Soluble Epoxide Hydrolase Inhibitor TPPU and the Calcium Plateau Inhibitor Dantrolene on Tetramethylenedisulfotetramine-Induced Status Epilepticus in Mice | D. Zolkowska; C. Flamm; T. Alcala-Arcos; M. Rogawski

3.276 The Novel Sodium Channel Blocker PRAX-330 Has a Broad Anticonvulsant Profile and Is Well Tolerated in Mice | M. Wittmann; T. Evron

3.277 Perampanel, a Glutamatergic Antagonist, Exhibits an Anti-Epileptogenic Effect in Lithium-Pilocarpine Model of Mesial Temporal Lobe Epilepsy in Adult Rats. A Video Monitoring and MicroPET-FDG Study | B. Girard; F. Maskali; A. Clement; A. Cullier; P. Marie; E. Raffo

3.278 Comparison of Long-Term Behavioral Outcomes After Neonatal Phenobarbital or Levetiracetam in Rats | S. Kaushal; G. Danko; P. Forcelli

3.279 Antiepileptic Effect or Anti-Neuroinflammatory Effect of Red Ginseng in the Intrahippocampal Kainic Acid Model of Temporal Lobe Epilepsy | S. Kim; H. Lee; J. Kim; T. Kim; Y. Jung

3.280 Real-Time Detection of Glutamate Dynamics in Normal and Impaired Brain Cells With Novel Microelectrode | T. Murray; C. Tan; J. Scoggin; N. Nguyen; U. Kansakar; S. Siddiqui; P. Arumugam; M. DeCoster

Clinical Trials

3.281 Phase I/II Trial of Cannabidivarin (CBDV) for the Treatment of Epilepsy in Females with Rett Syndrome | J. Lawson; L. Truong; D. Gill; G. Subramanian; C. Cowell; J. Martin; C. Ellaway

3.282 A First in Human Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Pharmacodynamics of a Novel Small Molecule KV7.2/7.3 Positive Allosteric Modulator (XEN1101) in Healthy Subjects | E. Aycardi; R. Namdari; J. Cadieux; H. Kato; C. Leung; P. Goldberg; S. Pimstone; R. Sherrington; C. Cohen; J. Empfield; C. Crean; G. Beatch

3.283 Long-Term, Durable Seizure Frequency Reduction in Individuals with CDKL5 Deficiency Disorder (CDD) Treated with Ganaxolone | N. Specchio; L. Masuoka; A. Aimetti; M. Chez

3.284 Perampanel in Real-World Clinical Care of Patients With Epilepsy: Retrospective Phase IV Study 506 – Second Interim Analysis | R. Wechsler; J. Wheless; M. Lancman; S. Aboumatar; A. Patten; B. Williams; M. Malhotra

3.285 Retrospective, Phase IV Study of Perampanel in Real-World Clinical Care of Patients With Epilepsy: Analysis of Adolescent Subgroup (Aged 12 to <18 Years) | E. Segal; J. Wheless; K. Moretz; P. Penovich; A. Patten; B. Williams; M. Malhotra

3.286 Study 506: Retrospective, Phase IV Study of Perampanel in Real-World Clinical Care of Patients With Epilepsy: Analysis of a Pediatric Subgroup (Aged <12 Years) | K. Moretz; J. Wheless; E. Segal; M. Lancman; A. Patten; B. Williams; M. Malhotra

3.287 Study 311: Safety and Efficacy of Adjunctive Perampanel in Younger (Aged 4 to <7 Years) and Older (7 to <12 Years) Pediatric Patients With Partial-Onset Seizures (POS) or Primary Generalized Tonic-Clonic Seizures (PGTCS) | A. Fogarasi; R. Flamini; M. Milh; S. Phillips; S. Yoshitomi; A. Patten; T. Takase; L. Ngo

3.288 Safety and Tolerability of GWP42006 (CBDV) in Subjects With Drug Resistant Epilepsy and Autism | G. Barnes; J. Sullivan; L. Sears; X. Qiu; K. VanLandingham; V. Knappertz; G. Guy


3.289 Study 311: Safety and Efficacy of Adjunctive Perampanel in Pediatric Patients (Aged 4 to ?12 Years) With Partial-Onset Seizures (POS) or Primary Generalized Tonic-Clonic Seizures (PGTCS) | R. Flamini; A. Fogarasi; M. Milh; S. Phillips; S. Yoshitomi; L. Ngo; A. Patten; T. Takase; A. Laurenza

3.290 Dravet Syndrome: An Open Label Trial of a CBD/THC Cannabis Oil for Drug-Resistant Epilepsy | B. Mccoy; L. Wang; M. Zak; N. Kabir; S. Almehmadi; K. Al-hadid; K. Sinopoli; C. Snead

3.291 Phase II, Open-Label Pharmacokinetic (PK) Study of Perampanel Oral Suspension as Adjunctive Therapy in Pediatric Patients (Aged =1 to <24 Months) With Epilepsy: Study 238 Design and Preliminary Safety Data | B. Renfroe; G. Rozentals; J. Aluri; Y. Umetsu; Y. Ma; A. Laurenza; L. Ngo

3.292 A Phase I Sub-Study Utilizing Transcranial Magnetic Stimulation to Assess the Pharmacodynamic Effects of a Novel Potassium Channel Opener (XEN1101) on Human Cortical Excitability | G. Beatch; P. Rossini; E. Abela; K. Posadas; L. Green; N. Yogo; P. Goldberg; M. Richardson; S. Pimstone; R. Sherrington; I. Premoli

3.293 Withdrawal Seizures Seen When Converting From Carbamazepine to Alternate Monotherapy AED Treatment Was Not Observed When Converted to Eslicarbazepine Acetate | R. Ramsay; T. Grinnell; U. Menon; D. Blum; A. Jung

3.294 Long-Term Safety of Pharmaceutical Cannabidiol Oral Solution as Adjunctive Treatment for Pediatric Patients With Treatment-Resistant Epilepsy | M. Cilio; J. Wheless; D. Dlugos; N. Parikh; I. Miller

3.295 Pharmacokinetics of Clobazam and N-desmethylclobazam Following Administration of Clobazam Oral Soluble Film | A. Heller; S. Wargacki; C. Jung; D. Wyatt; A. Schobel

Cohort Studies

3.296 Treatment of Refractory Epileptic Spasms with Felbamate | B. Asilnejad; J. Heesch; M. Ji; Y. Eliyan; R. Rajaraman; S. Hussain

3.297 Treatment of Refractory Infantile Spasms With Zonisamide: The UCLA Experience | M. Navarro; J. Heesch; M. Ji; A. Labib; B. Asilnejad; R. Rajaraman; S. Hussain

3.298 Comparison of Intranasal Midazolam Versus Intravenous Lorazepam for Seizure Rescue in the Adult Epilepsy Monitoring Unit | K. Owusu; M. Dhakar; D. McKimmy; C. Bautista; C. Maciel; L. Hirsch; P. Farooque

3.299 Highly Significant Seizure Reduction to Perampanel in Patients With Known or Suspected Cortical Malformation/Dysplasia | J. Carpenter-Thompson; M. Whiting; G. Huesmann

3.300 Empiric Lamotrigine Dosing Strategies During Pregnancy: A Simulation Study | A. Karanam; J. French; P. Pennell; C. Harden; A. Birnbaum

3.301 Perampanel Seems to Improve Sleep Architecture in Patients With Focal Onset Epilepsy | R. Rocamora; I. Alvarez; B. Chavarria; M. Ley; A. Principe

3.302 Long-Term Persistence of CBD Use: Retention Rate Analysis From Expanded Access Programs in Pennsylvania | S. Kessler; A. Martinez; Y. Segawa; J. Gottoff; L. Davis; S. Hagopian; D. Dlugos; E. Marsh

3.303 Perampanel Treatment in Refractory Status Epilepticus in a Neurological Intensive Care Unit | C. Ho; M. Tsai

Other

3.304 Pharmacokinetics and Safety of Cenobamate in Non-Epileptic Special Populations: Effect in Hepatically Impaired and Elderly Subjects | K. Glenn; L. Vernillet; M. Kamin

3.305 Mobile Health and Motivational Interviewing to Improve Medication Adherence in Adults With Epilepsy: A Pilot Study | D. Friedman; L. Diaz; J. Montesdeoca; L. Peyano; A. Singh; J. Fishman; O. Devinsky; T. Spruill

3.306 Effects of Cenobamate on GABA-A Receptor Modulation | R. Sharma; W. Song; M. Nakamura; C. Neupane; H. Shin; S. Melnick; K. Glenn; I. Jang; M. Kim; J. Park

3.307 Pharmacodynamic and Pharmacokinetic Interactions Between Cenobamate and Alcohol in Healthy Subjects | L. Vernillet; K. Glenn; M. Kamin

3.308 Effectiveness, Safety and Tolerability of Eslicarbazepine Acetate in Elderly Patients (=60 Years) Treated in European Clinical Practice | V. Villanueva; P. Santágueda; R. McMurray

3.309 Withdrawal to Eslicarbazepine Acetate Monotherapy From Adjunctive Therapy in European Clinical Practice | R. McMurray; M. Holtkamp; P. Santágueda; V. Villanueva

3.310 Safety and Tolerability of Eslicarbazepine Acetate in Patients With Psychiatric Comorbidities and Intellectual Disability: Real-World Evidence From the Euro-Esli Study | C. Doherty; R. McMurray; P. Santágueda; V. Villanueva

3.311 Levetiracetam as Monotherapy for Juvenile Absence Epilepsy: A Two Case Study | A. Chang; A. Venkat

3.312 Eslicarbazepine Acetate Monotherapy in Elderly Patients: Real-Life Long-Term Experience | J. Montoya; M. Díaz; D. Cerveró

3.313 Clinical Experience of Patients With Juvenile Myoclonic Epilepsy in Adjuvant Treatment With Permapanel: Electroclinical Analysis | M. Díaz; J. Montoya; D. Cerveró

3.314 Outcome of Children With Repeated Seizures and Status Epilepticus: Effect of Clinical Variables and Treatment | C. Ladeia-Frota; M. Barbosa Aidar; L. Caboclo

3.315 Significant Improvement of Myoclonus in Lance-Adams Syndrome With Add-on Perampanel in Two Cases | A. Biraben; A. Nica; C. Rummens; R. Allibert

3.316 Efficacy and Tolerability of Perampanel Monotherapy in Focal and Generalized Tonic-Clonic Seizures in Clinical Practice. Preliminary Results From a Multicenter Spanish Study | R. Toledano; F. Ayuga Loro; B. Parejo; I. García-Morales; J. Ojeda; J. Zurita; E. Santamarina; B. Mercedes; J. Rodriguez-Uranga; M. Aguilar; J. Mauri; R. Saiz; D. Sopelana; N. Garcia-Barragán

3.317 Delayed Neuronal Death in the Developing Hippocampus After Trauma and Seizures | T. Balena; N. Rahmati; K. P. Lillis; K. Staley


3.318 Clobazam Add-on Treatment of Refractory Focal Epilepsy in Adults. A Prospective Study | I. Tyrlikova; D. Gorelik; S. Kamberi; L. Goldman; A. Barber; M. Tyrlik; P. Klein

Surgery

Adult

3.319 Amygdala Is Not an Actual Epileptic Focus in Temporal Lobe Epilepsy Associated With Amygdala Enlargement | H. Suzuki; H. Sugano; M. Nakajima; T. Higo; Y. Iimura; T. Mitsuhashi

3.320 Outcome of Epilepsy Patients Unsuitable for Resective Surgery Following Invasive Monitoring | D. Eddelman; K. Keppetipola; F. Lynn; R. O’Dwyer; R. Byrne; S. Sani

3.321 Mesial Volume Changes Associated With Seizure Remission After Open- or Radiosurgery for Mesial Temporal Lobe Epilepsy: Findings of the ROSE Trial | M. Quigg; S. Mueller; N. Barbaro; M. Ward; E. Chang; D. Broshek; J. Langfitt; G. Yan; K. Laxer; A. Cole; P. Sneed; C. Hess; W. Yu; M. Tripathi; C. Heck; J. Miller; P. Garcia; N. Fountain; A. McEvoy; V. Salanova; R. Knowlton; A. Bagic; S. Kapoor; T. Henry; G. McKhann; A. Palade; M. Reuber; E. Tecoma

3.322 Aura as a Predictor of Outcome Following Epilepsy Surgery | S. Grossman; J. French; P. Dugan

3.323 Long-Term Outcomes in Patients With Intractable Mesial Temporal Lobe Epilepsy Who Undergo Laser Ablation | A. Patel; S. Dawit; M. George; R. Zimmerman; A. Crepeau

3.324 A Novel Parietal Approach for Deep Brain Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy | Y. Wang; S. Grewal; E. Middlebrooks; G. Worrell; M. Stead; B. Lundstrom; J. Britton; W. Min-Hsien; J. Van Gompel

3.325 The Use Telemedicine for Patients Undergoing Epilepsy Surgery Evaluation: A Pilot Patient | D. Reider-Demer DNP; D. Eliashiv, M.D.; S. Benard, M.D., M.P.H.; V. Shah; C. Elder

3.326 Stereotactic Laser Ablation for Neocortical Epilepsy | P. Koch; S. Ramesha; D. Graf; B. Cabaniss; R. Gross; J. Willie

3.327 Brain-Responsive Neurostimulation Guided by Stereo-EEG | L. Feldman; B. Krishnan; A. Alexopoulos; M. Mackow; K. Taylor; J. Bulacio; P. Chauvel; I. Najm; W. Bingaman; J. Gonzalez-Martinez; D. Nair

3.328 Postoperative Long-Term Changes of Hippocampal Volume in Temporal Lobe Epilepsy Patients With Hippocampal Sclerosis | K. Iida; K. Kagawa; M. Katagiri; G. Seyama; A. Okamura; J. Katayama; A. Hashizume; K. Kurisu; H. Otsubo

3.329 Quality of Life, Psychiatric Symptoms and Stigma Perception in Epileptic Patients: The Effect of Epilepsy Surgery | F. Deleo; R. Quintas; C. Pastori; G. Didato; M. de Curtis; G. Tringali; F. Villani

Pediatrics

3.330 An Interesting Case of a Low-Grade Glioma Masquerading as Generalized Epilepsy | N. Agarwal MBBS; W. Zhang; M. Kebriaei MD

3.331 Hypothalamic Hamartoma and MRI-Guided Stereotactic Laser Ablation | S. Verma; I. Ali; D. Clarke; S. Lam; A. Anderson; L. Martinez; D. Curry

3.332 Additional Stimulation Cycles in Children with Lennox-Gastaut Submitted to Cardiac-Based Closed-Loop Vagus Nerve Stimulation | C. Cukiert; A. Cukiert; J. Burattini; P. Mariani

3.333 Responsive Neuro Stimulator (RNS) for Children With Medically Intractable Epilepsy Where Resective Surgery Cannot Be Done | S. Gedela; S. Gedela; P. Glynn; J. Leonard

3.334 Robotic-Assisted Stereotactic Electroencephalography (SEEG) in Pediatric Epilepsy: Institutional Experience | O. Lobanov; M. Bertrand; J. Griffith; R. Guerriero; C. Gurnett; S. Jain; M. Morrissey; R. Ryther; A. Shamsuzzaman; K. Thio; J. Weisenberg; M. Wong; J. Zempel; M. Smyth; S. Tomko

3.335 Visualizing the Seizure Onset Zone with Granger Causality: Use with Stereotactic Electroencephalography (sEEG) to Enhance Intraoperative Decision-Making | J. Madsen; E. Park; S. Stone; S. Barrit; M. Hameed; J. Bolton; C. Harini; M. Libenson; P. Pearl

3.336 Frontal Sparing Surgery in Sturge-Weber Syndrome | S. Mathur; A. Pinto; J. Madsen; M. Takeoka

3.337 WITHDRAWN

3.338 Surgical Outcomes of Intraoperative MRI-Guided Resection of Focal Cortical Dysplasia in Comparison With Conventional Technique in Children With Intractable Epilepsy | A. Maksikharin; K. Havens; C. Oluigbo; T. Vu; J. Conry; J. Murnick; W. Gaillard; D. Depositario-Cabacar

3.339 Lateral Versus Parasagittal Hemispherotomy: A Direct Comparison in the First Multicenter Italian Cohort | L. De Palma; F. Gozzo; C. Barba; N. Pietrafusa; A. De Benedictis; G. Carfi-Pavia; L. Tassi; V. Pelliccia; M. Cossu; C. Rossi-Espagnet; S. Rizzi; F. Giordano; C. Marras; F. Vigevano; R. Guerrini; G. Lo Russo; N. Specchio

3.340 Long-Term Outcomes of Epilepsy Surgery in Cortical Dysplasia With Postoperative Seizure Recurrence | P. Javarayee; K. Holland-Bouley; H. Greiner; F. Mangano; P. Horn; R. Arya

3.341 Sociodemographic Profile of Cortical Dysplasia Patients Undergoing Epilepsy Surgery | H. Jackson; N. Gadgil; K. Wagner; K. Chiou; C. Cronkite; D. Clarke; J. Riviello; D. Curry; I. Pan; S. Lam

3.342 Granger Causality Analysis Using Short Segments of Electrocorticography Data Recorded During One-Stage Epilepsy Surgeries | E. Park; S. Barrit; C. Harini; M. Takeoka; C. Achkar; J. Bolton; J. Peters; A. Bergin; P. Pearl; J. Madsen

3.343 Rapid Improvement of Encephalopathy and EEG in Children With Lennox-Gastaut Syndrome and Generalized Epilepsy After Focal Resection | A. Katyayan; M. Takeoka

All Ages

3.344 Novel Scale to Predict Seizure Freedom Following Stereoelectroencephalography | A. Chan; J. Mullin; F. Hsu; S. Vadera

3.345 Seizure-Spread and Surgical Failure in Epilepsy: Insight From a Single-Surgeon Cohort | J. Andrews; A. Gummadavelli; P. Farooque; J. Bonito; C. Arencibia; H. Blumenfeld; D. Spencer


3.346 Intraoperative Rotation Technique With Sugita Head Frame Is Useful for the Easier Gravity Control in Callosotomy | I. Takumi; M. Noha; J. Kadekawa; K. Hironaka; T. Matsumori; K. Oshio; A. Morita; E. Watanage; K. Sugai; H. Yamamoto; Y. Tanaka

3.347 Consensus Polling in Epilepsy Surgery Conference – Does It Improve the Surgical Discussion? | W. Bird; K. Chapman; C. Joshi

3.348 Extracranial to Intracranial Bypass in Down Syndrome Related Moyamoya and Improved Seizure Controls | M. Doherty; S. Monteith; S. Garson; N. Warner; B. Keogh; R. Gwinn

3.349 Neuronavigation-Guided Frameless Stereoelectroencephalography (SEEG) | A. Fujimoto; N. Kuroad; T. Okanishi; H. Enoki

3.350 Super-Selective Posterior Cerebral Artery Propofol Test: Presurgical Assessment of Hippocampal Functions | S. Osawa; M. Iwasaki; K. Suzuki; K. Niizuma; K. Jin; Y. Matsumoto; N. Nakasato; T. Tominaga

3.351 Stereoelectroencephalography and Subdural Recordings Lead to Similar Rates of Resective Epilepsy Surgery and Postoperative Seizure Freedom: A Meta-Analysis | T. Abel; H. Yan; M. Anderson; N. Alotaibi; J. Rutka; G. Ibrahim

3.352 Late Follow-up of Adults and Children Who Have Undergone Vagus Nerve Stimulation for Intractable Epilepsy Over a Decade Ago | H. Hasegawa; D. Dutta; J. Ellenbogen; N. Kalyal; E. Hughes; D. McCormick; A. Valentin; M. Richardson; L. Nashef; S. Goyal; N. Mullatti; Z. Agirre-Arrizubieta; F. Brunnhuber; R. Elwes; I. Malik; R. Selway

3.353 The Prevention and Treatment of Temporal Lobe Epilepsy Operative Complications | F. Zhai; J. Zhou

3.354 Optimising Trajectories in Computer-Assisted Planning for Cranial Laser Interstitial Thermal Therapy: A Machine Learning Approach | K. Li; V. Vakharia; R. Sparks; L. França; A. Granados; A. McEvoy; A. Miserocchi; S. Ourselin; J. Duncan

Dietary

3.355 Pediatric Lipid Panels in Children Treated with Prolonged Ketogenic and Modified Atkins Diet Therapy | C. Stillman; S. Criteser; S. Graber

3.356 Effects of Modified Atkins Diet on Thyroid Function in Adults with Drug-Resistant Epilepsy | E. Molteberg; M. Kverneland; P. Thorsby; K. Nakken; K. Selmer; P. Iversen; E. Taubøll

3.357 Does Dietary Fat Composition Predict Short-Term Elevations in Lipid Levels in Adults on a Modified Atkins Diet? | T. McDonald; B. Henry-Barron; D. Vizthum; M. Cervenka

3.358 Profiling of Brain Inflammatory Mediators Following Ketogenic Diet Treatment in Epileptic <em>Kcna1</em>-null Mice | Y. Ahn; B. Villa; B. Ahn; D. Senger; J. Rho

3.359 Evaluation of the Potential Anti-Seizure Effects of the Ketogenic Diet in Chronically Epileptic Rats | C. Metcalf; K. Thomson; J. Huff; T. Newell; K. Wilcox

3.360 Phoenix Children’s Hospital’s Experience With the Implementation of Safety Features for Ketogenic Diet Patients by Utilizing the Electronic Health Record | R. Jarrar; J. Fox; L. Vanatta; V. Vaidya

3.361 The Ketogenic Diet Alters the Gut Microbiome in the Triple-Hit Rodent Model of Infantile Spasms | C. Mu; A. Choudhary; B. Charkhad; K. Barrett; J. Shearer; J. Rho; M. Scantlebury

3.362 Ketogenic Diet Initiation in Zambia – Challenges and Successes | S. Tarrant; K. Nkole; N. Kawatu; C. Kanyinji; T. Njobvu; O. Ciccone; A. Patel; A. Bergin

3.363 Prevalence of Neutropenia in Children Treated With a Ketogenic Diet | H. Lowe; E. Ferrara; A. Keller; R. Whitney; M. Zak; C. Liu; J. Kobayashi; V. Chan; E. Donner

3.364 Low Ratio Classic Ketogenic Diet Provides Good Seizure Outcome at 2 Years | R. RamachandranNair; Z. Chen

3.365 Are Urine Ketones a Reliable Biomarker for Seizure Reduction in Adults With Epilepsy on a Modified Atkins Diet? | M. Lwin; K. Carson; M. Cervenka

3.366 WITHDRAWN

3.367 The Ketogenic Diet Affects Serotonin Levels in the Mouse Brain | F. Teran; Y. Kim; G. Richerson

3.368 An Old Anti-Epileptic Therapy Meets an Ancient Morbidity: The Ketogenic Diet and Scurvy | I. Hughes; G. Weinberg; D. Weber; M. Cullimore; L. Habben

3.369 Correlation Between Blood Ketone Level Beta-hydroxybutyrate (BHB) and Seizure Frequency in Children With Epilepsy Treated With the Classic Ketogenic Diet | B. Fisher; J. Wolak; R. Blackford; W. Lowman; E. Golbeck; A. Berg

3.370 Safety and Efficacy of Outpatient Initiation of Ketogenic Diet Therapy in Infants | C. Wheeler; L. Vanatta; A. Wilfong; R. Jarrar

3.371 Barriers to Implementation of Dietary Therapy for Pediatric Epilepsy in Ethiopia | E. Fedak Romanowski; A. Yeshidinber

3.372 The Impact of Psychosocial Factors on Ketogenic Diet Maintenance for Pediatric Epilepsy Management | R. Fraser; J. Lockrow; E. Novotny; R. Saneto


Adult

3.373 Optimal Cut-Off Score for Diagnosing Major Depressive Disorder With the Neurological Depression Disorder Inventory for Epilepsy (NDDI-E): A Meta-Anlaysis | D. Kim; Y. Kim; T. Yang; J. Kang; O. Kwon

3.374 Cognitive Impairments in Patients Diagnosed With Psychogenic Nonepileptic Seizures (PNES): What Role Do Psychiatric Comorbidities Play? | L. Myers; K. Perrine; R. Trobliger; K. Bortnik; M. Lancman

3.375 Preoperative Evaluation of Speech and Memory Dominance by Intracarotid Wada Test With Propofol | T. Kunieda; T. Aki; T. Shinohara; S. Ozaki; M. Nishikawa; S. Suehiro; S. Matsumoto; A. Inoue; M. Tagawa; S. Shigekawa; S. Matsui; H. Watanabe

3.376 Improvement of Remote Cognitive Functions After Successful Temporal Lobe Epilepsy Surgery | M. Lutz; T. Mayer

3.377 Characterization of Subjective Seizure Semiology in Patients With Psychogenic Nonepileptic Seizures: A Mixed Methods Approach | A. Kairys; M. Watson; R. Libbon; L. Strom


3.378 Decision Making Under Risk and Ambiguity in Juvenile Myoclonic Epilepsy | M. Paiva; E. Lima; P. Rzezak; M. Mendoza; K. Valente

3.379 Importance of Different Quality-of-Life Themes in Hispanics With Intractable Epilepsy | S. Shaw; S. Juengst; M. Armacost; M. Vega; J. Smith

3.380 The Impact of Clinical Epilepsy Variables in Memory Functions in Patients With Temporal Lobe Epilepsy Related to Hippocampal Sclerosis Throughout Life – From Childhood to Late Adulthood | P. Rzezak; E. Lima; A. Gargaro; E. Coimbra; S. Vincentiis; T. Velasco; J. Leite; K. Valente

3.381 Performance of Patients With Temporal Lobe Epilepsy in Test of Executive Function | P. Marques; L. Muller; M. Mader-Joaquim; V. Terra; L. de Paola; C. Silvado

3.382 Low-Frequency Accelerated TMS in Patients With Depression and Focal Epilepsy | B. Krzysztof; Y. Song; N. Streltzov; H. Yang; L. Schommer; J. Knight; P. Holtzheimer

3.383 Hippocampal Stimulation Does Not Disrupt Naming or Memory | M. Hamberger; A. Mehta; P. Mégevand; D. Groppe; G. McKhann; C. Schevon

Pediatrics

3.384 Theory of Mind and Social Competence in Children With Genetic Generalised Epilepsy (GGE): Cognitive and Epilepsy Correlates | E. Stewart; C. Catroppa; D. Gill; R. Webster; J. Lawson; A. Mandalis; M. Sabaz; B. Barton; S. Lah

3.385 Have You Seen This Person Before? Face Recognition in Children Undergoing Temporal Lobe Resections for Treatment of Epilepsy | M. Smith

3.386 Impact of Treatment With Epidiolex® (Cannabidiol) on the Cognitive Functioning of Pediatric Patients With Treatment-Resistant Epilepsy | K. Bortnik; R. Trobliger; K. Boreale; R. Zeng; M. Lancman; E. Segal

3.387 Changes in Definition Naming for Common and Proper Nouns After Left Anterior Temporal Lobectomy | S. Swanson; L. Conant; M. Rozman; M. Raghavan; W. Mueller; L. Allen; W. Gross; C. Anderson; C. Carlson; C. Humphries; L. Schwartz; R. Busch; M. Lowe; J. Langfitt; M. Tivarus; D. Drane; D. Loring; M. Jacobs; V. Morgan; J. Szaflarski; L. Bonilha; J. Binder

3.388 Observations in Pediatric Patients Comparing Pre- and Post-Stereotactic MRI-Guided Laser Ablation Neuropsychological Testing | J. Alford; P. Malay; M. Chez

3.389 Impact of Treatment With Epidiolex® (Cannabidiol) on the Behavior of Pediatric Patients With Treatment-Resistant Epilepsy | R. Trobliger; K. Bortnik; K. Boreale; R. Zeng; M. Lancman; E. Segal

3.390 Care-Related Quality of Life in Caregivers of Children with Drug-Resistant Epilepsy | E. Widjaja; P. Jain; J. Subendran; M. Smith

3.391 Long-Term Quality of Life Trajectories Among Individuals Diagnosed With Epilepsy in Childhood | K. Puka; M. Ferro; C. Camfield; S. Levin; M. Smith; S. Wiebe; G. Zou; K. Speechley

Genetics

Human Studies

3.392 The Genetic Landscape of the Developmental and Epileptic Encephalopathies | A. Muir; C. Myers; M. Mehaffey; A. Buttar; K. Boysen; G. Hollingsworth; C. King; A. Schneider; A. Chowdhary; A. Rosen; M. Sud; N. Weed; U. Center for Mendelian Genomics; L. Sadleir; I. Scheffer; H. Mefford

3.393 Genetic Etiology and Prediction of the Pharmacotherapy Response Status in Epilepsy | C. Leu; A. Avbersek; D. Speed; A. Ingason; S. Peter; R. Krause; M. McCormack; N. Delanty; G. Cavalleri; J. Craig; C. Depondt; M. Johnson; B. Koeleman; H. Lerche; T. Marson; T. O’Brien; J. Sander; G. Sills; P. Striano; F. Zara; S. Sisodiya; E. Consortium

3.394 Improved Access to Diagnostic Testing With Dedicated Epilepsy Genetics Clinic | J. Nowicki; E. Bryant; J. Millichap; A. Murad

3.395 Epilepsy Masquerades: Alternating Hemiplegia of Childhood With a Novel Mutation in the ATP1A3 Gene -- A Case Report With Literature Review | P. Tatachar; A. De La Torre Ribadeneira; P. Lewis de-los Angeles

3.396 A Novel Genetic Variant in the NDUFV1 Gene Presenting in Siblings With Mitochondrial Complex I Deficiency | P. Motika; W. Wiszniewski

3.397 Age at Genetic Diagnosis for Patients With Infantile-Onset Epilepsies: Analysis of 2833 Individuals Reveals a Delay in the Utilization of Genetic Testing for Many Patients | E. Butler; G. Richard; A. Lindy; D. McKnight

3.398 Restless Genital Syndrome Associated With a Mutation in the SCN4A Gene | S. Ogden; A. Mello; R. Morse; J. Filiano

3.399 The Phenotypic Spectrum of NEXMIF Encephalopathy | H. Stamberger; D. Vlaskamp; A. Muir; G. Hollingsworth; C. Myers; A. Schneider; G. Wallace; R. Leventer; R. Shalev; A. Cairns; R. Dale; D. Gill; S. Berkovic; C. Patel; H. Mefford; I. Scheffer

3.400 Investigation of Long Interspersed Element-1 Retrotransposon Gene Disruptions in the Etiology of Idiopathic Temporal Lobe Epilepsy | G. Doyle; R. Buono; R. Crist; B. Reiner; G. Arauco-Shapiro; R. Levinson; L. Shah; W. Berrettini; T. Ferraro

3.401 Exome Sequencing of a Pediatric Refractory Status Epilepticus Cohort (the pSERG Cohort) | E. Heinzen; J. Clark; A. Vimla; M. Amengual Gual; R. Arya; J. Carpenter; K. Chapman; W. Gaillard; M. Gaínza-Lein; T. Glauser; J. Goldstein; M. Jackson; K. Kapur; T. McDonough; M. Mikati; K. Peariso; I. Sánchez Fernández; K. Stanley; R. Tasker; D. Tchapyjnikov; A. Vasquez; M. Wainwright; A. Wilfong; K. Williams; D. Goldstein; T. Loddenkemper

3.402 Whole Exome Sequencing (WES) in 21 Patients With Infantile Spasms | T. Benke; E. Geiger; H. Yu; K. Eschbach; T. Shaikh; S. Demarest

3.403 Reanalysis of Whole Exome Data by the Epilepsy Genetics Initiative | L. Bier; E. Genetics Initiative

3.404 Phenotypic Characterization of CDKL5 Deficiency Syndrome | S. Demarest; H. Olson; S. Parikh; E. Pestana Knight; T. Benke


3.405 Aberrant Inclusion of an SCN1A Poison Exon Causes Dravet Syndrome and Related Disorders | G. Carvill; K. Engel; J. Cochran; G. Barsh; J. Roovers; H. Stamberger; A. Schneider; G. Hollingsworth; S. Weckhuysen; S. Berkovic; P. DeJonghe; I. Scheffer; R. Myers; G. Cooper; H. Mefford

3.406 Cardiac Arrhythmia- and Epilepsy-Related Genetic Variants in Sudden Unexpected Death in Epilepsy | A. Keller; A. Williams; R. Whitney; K. Cunningham; R. Hamilton; M. Pollanen; E. Donner

Health Services

3.407 Implementation of an Inpatient Alert Protocol Reduces Time to Administration of Second-Line Antiseizure Medications for Status Epilepticus | M. Villamar; J. Clay; K. Dolbec; A. Cook; C. Ke; Y. Xu; R. Ward-Mitchell; L. Goldstein; M. Bensalem-Owen

3.408 The Development of a Simulation-Based Mastery Learning Curriculum to Improve the Identification and Management of Status Epilepticus | Y. Mikhaeil-Demo; J. Barsuk; J. Templer; S. VanHaerents; I. Bellinski; D. Bega; D. Salzman; E. Gerard

3.409 Resident Use of EEG Cap System on Call: Feasibility and Resident Perception | P. Kyriakopoulos; J. Ding; J. Carpentier; T. Fantaneanu

3.410 Seizure-Related ED Utilization and Hospitalization in a Large Metropolitan and Suburban Hospital Network | F. Lado; S. Pacia; D. Chong; S. Hwang; S. Stevens; C. Malpe; A. Fu; S. Bickel; R. Kuzniecky

3.411 Risk Factors Predicting 90-day Readmission for Individuals With Epilepsy in an Urban Safety Net Hospital System | F. Lado; S. Ethan; X. Xue; D. Wang; D. Kaufman

3.412 Epilepsy Physicians’ Perceptions of Transition and Transfer of Epilepsy Care From the Pediatric to the Adult Health Care Setting | H. Pieters; M. Watson; C. Baca

3.413 Factors Associated With Pediatric to Adult Transition Care Gaps for Youth With Epilepsy and Chronic Medical Conditions | C. Baca; F. Barry; A. Kuo

3.414 Thirty-Day Readmissions After Status Epilepticus in the United States: Insights From the Nationwide Readmissions Database | M. Dhakar; D. Thurman; E. Faught

3.415 Pharmacist’s Role in a Pediatric Outpatient Neurology Clinic: The IMP(H)ACT Study | L. Genevieve; H. Christian

3.416 Epilepsy Neuromodulation Clinic-A Hub for Science and Service Complemented by Regional Spokes | R. Jamy; H. Ladha; S. Pati

3.417 ESLi-Trans: Epilepsy-Specific Guidelines for Transition | T. Mayer; S. Butovas; K. Gilling

3.418 A Childhood Epilepsy Screening, Diagnosis and Management Education Program for Community Health Extension Workers in Northern Nigeria | E. Trevathan; A. Abdullahi; M. Aliyu; A. Salihu; U. Sabo; H. Adamu; Z. Iliyasu

3.419 Infantile Spasms: Improving Care Across the Continuum | L. Cochran; E. Romano

3.420 Patient Satisfaction With Telemedicine Visits for Pediatric Epilepsy Care | S. Nuss; C. Camayd-Muñoz; R. Jonas; L. Douglass

3.421 ‘Treatment Gap’ in People With Newly Diagnosed Epilepsy: Does It Exist in High-Income Countries? | Z. Chen; S. Sharma; M. Rychkova; J. Dunne; J. Lee; N. Lawn; P. Kwan

3.422 Poorer Epilepsy Self-Management Skills Are Present in Those Who Most Need Good Seizure Control: PAUSE to Learn Your Epilepsy | D. Pandey; K. Ozenberger; J. Levy; M. Habibi; W. Song; P. Shafer, RN, MN; A. Serafini; J. Loeb

3.423 Improvement in Epilepsy Self-Management Practice and Behaviors Following 12 weeks of Personalized Epilepsy Self-Management Education: Preliminary Results from PAUSE to Learn Your Epilepsy | D. Pandey; K. Ozenberger; J. Levy; A. Serafini; M. Habibi; W. Song; P. Shafer, RN, MN; J. Loeb

3.424 Patient Preferences for Novel Methods of Epilepsy-Related Education Delivery | W. Miller

3.425 Mid-Level Providers’ Contribution to Epilepsy Monitoring Unit | H. Shin; S. Sheikh; D. Miyani; L. Ngo; J. Kern; H. Ritchie; J. Kwon; A. Hinn; B. Vaughn; A. Wabulya

Epidemiology

3.426 24-hour Distribution of the Onset of Pediatric Refractory Status Epilepticus (the pSERG Cohort) | J. Clark; I. Sánchez Fernández; N. Abend; M. Amengual Gual; A. Anderson; R. Arya; J. Brenton; J. Carpenter; K. Chapman; R. Farias Moeller; W. Gaillard; M. Gaínza-Lein; T. Glauser; J. Goldstein; H. Goodkin; K. Hecox; M. Jackson; K. Kapur; S. Kelley; E. Kossoff; Y. Lai; T. McDonough; M. Mikati; L. Morgan; E. Novotny; A. Ostendorf; E. Payne; K. Peariso; J. Piantino; J. Riviello; K. Sannagowdara; C. Stafstrom; R. Tasker; D. Tchapyjnikov. A. Topjian; A. Vasquez; M. Wainwright; A. Wilfong; K. Williams; T. Loddenkemper

3.427 Incidence and Prevention of Venous Thromboembolism in Patients Admitted to a Level 4 Epilepsy Monitoring Unit | E. Okazaki; S. Swinford; K. Noe

3.428 Psychogenic Non-Epileptic Seizures (PNES) – Inpatient Trends and Psychiatric Comorbidities | U. Patel; R. Sankaraneni; S. Singh

3.429 The Incidence of Sudden Unexpected Death in Epilepsy in an Unselected Nationwide Population of Patients With Epilepsy Younger Than 50 years in Denmark | M. Kløvgaard; T. Lynge; I. Tsiropoulos; P. Uldall; B. Winkel; P. Ryvlin; J. Tfelt-Hansen; A. Sabers

3.430 The Effect of Exposure of Civil Population to Military Stress on Disease Course of Patients With Epilepsy: The Lesson Learned in the Last Operation in Gaza | S. Appel; A. Gelfand; G. Kotlyar; R. Milo

3.431 WITHDRAWN

3.432 Exploring the Link Between Dementia and Epilepsy in the Framingham Heart Study | M. Stefanidou; J. Himali; A. Beiser; A. O’Donnell; O. Devinsky; S. Seshadri; D. Friedman

3.433 Hyperlipidemia in Patients Newly Treated With Enzyme-Inducing or Non-Inducing Anticonvulsants: A Population Study | S. Mintzer; S. Hegarty; V. Maio; S. Keith

3.434 Prescription of Antiepileptic Drugs in Stroke Patients Presenting for Inpatient Rehabilitation | S. Tallavajhula; H. Pham; M. Ayers; D. Pandya; M. Jones


Case Studies

3.435 Successful Treatment of Refractory NMDA Antibody Encephalitis With Intrathecal Rituximab | M. Casares; H. Skinner; E. D.Gireesh; C. Wombles; J. Schweitzer; P. Gwyn; H. Newton; S. Makar; K. Lee; M. Westerveld

3.436 Homozygous SCN1B Mutation Presenting as Early-Onset Developmental and Epileptic Encephalopathy and Not Dravet Syndrome: A Case Report | C. Sculier; D. Lederer; S. Mary; B. Ceulemans; P. Van Bogaert; L. Danvoye; A. Aeby

3.437 Ketogenic Diet in Diabetes Mellitus Type I | A. Michon; A. Shaw; L. Meagher; S. Miceli; C. Wolford; D. Arndt

3.438 Mosaic Turner Syndrome With Bitemporal Lobe Epilepsy Presenting in a Neonate | L. Lasky; A. Jewell; S. Khalil

3.439 Effect of Regular Cannabis Consumption on Epileptiform Activity Detected by the Responsive Neurostimulation® (RNS®) Device | A. Ismail; C. Lin; L. Edwards; W. Muhlhofer

3.440 Unprecedented Manifestation of Multisensory Hallucinations in Epilepsy | M. Rosenberg; H. Ramos Salinas; H. Bhandari

3.441 Reduction in Drop Attacks With Rufinamide (Banzel) in a Patient with Angleman Syndrome | G. Huesmann; E. Marr; R. Murphy

3.442 Peri-ictal Respiratory Depression Leading to Sudden Unexpected Death in Epilepsy: A Report of Two Cases | S. Rose; R. Martinez; N. Issa; S. Wu; X. Liu; T. Sun; J. Tao

3.443 A Novel Nonsense Mutation in the Pumilio-2 Gene Associated With Early Myoclonic Encephalopathy | D. Nadkarni; J. Matsumoto

3.444 WITHDRAWN

3.445 WITHDRAWN

3.446 Novel Phenotype of Paroxysmal Spells due to KCNMA1 De Novo Gene Mutation Mimicking Epilepsy and Responding to Stimulant Therapy | R. Gibson; M. McDonald; W. Galentine; M. Gunduz; M. Mikati

3.447 Multi-Drug Regimen including Anakinra, Cannabidiol, Ketogenic Diet in the Management of Refractory Seizures in a Patient With FIRES | S. Rath; J. Madan Cohen

3.448 Musicogenic Epilepsy in a Patient With Limbic Encephalitis, Stiff Person Syndrome, and Possible Myasthenia Gravis: A Case Report | E. Kaye; N. Song; V. Thadani

3.449 Refractory Myoclonic and Generalized Tonic-Clonic Seizures in Post-Liver Transplant Patients and the Possible Role of Vitamin B6 Supplementation | H. Cheung; A. Ferdinand; M. Fields

3.450 Observations in Anti-NMDA Receptor Encephalitis: Possible Ictal Nature of the Extreme Delta Brush Pattern and Potential Role for Perampanel | H. Shaker; D. Burdette; M. Haykal

Late Breaking

3.451 Non-lesional Mesial Temporal Lobe Epilepsy Requires Bilateral Invasive Evaluation | G. Perven; I. Podkorytova; B. Lega; M. Agostini; R. Hays

3.452 The Effect of Cannabidiol on Childhood-Onset Epilepsy with GRIN2A Mutation: A Case Study | A. Alfarano; A. Patel

3.453 Long-Term Cardiovascular Safety of Fenfluramine HCl (Fintepla®) in the Treatment of Dravet Syndrome: Interim Analysis of an Open-Label Safety Extension Study | W. Lai; M. Pringsheim; G. Farfel; B. Galer; G. Morrison; A. Gammaitoni; M. Lock; A. Agarwal

3.454 Cannabidiol as an Adjunct Treatment for Children with Febrile Infection-Related Epilepsy Syndrome (FIRES) Reduces Seizure Frequency and Dependence on Multiple Anti-Epileptic Drugs. | M. Myette

3.455 Clinical Decision Support to Promote SUDEP Discussions | S. Downs; J. Buchhalter; A. Patel; A. Miller; A. Clark; M. Holmay; T. Story

3.456 Early Epilepsy Surgery in Tuberous Sclerosis Complex: Preliminary Results on Safety, Efficacy and Neurodevelopmental Outcomes | J. Peters; L. Grayson; D. Krueger; M. Sahin; J. Wu; H. Northrup; G. Cutter; T. McPherson; S. O’Kelley; J. Krefting; T. Study Group; E. Bebin

3.457 Assessing the Efficacy of Ketogenic Diets for Adult Epilepsy Control in a Canadian Population: A Retrospective Chart Review | B. Chen; C. Anor; D. MacGarvie; E. Bercovici

3.458 Dual-center, Dual-platform MicroRNA Profiling Identifies Potential Plasma Biomarkers of Adult Temporal Lobe Epilepsy | H. El-Naggar; R. Raoof; S. Bauer; E. Spain; C. Mooney; N. Delanty; H. Hamer; F. Rosenow; D. Henshall

3.459 Automated Multimodal Epileptic Seizure Detection Using EEG and ECG | K. Vandecasteele; T. De Cooman; Y. Gu; S. Vandeput; E. Cleeren; K. Claes; J. Dan; W. Van Paesschen; S. Van Huffel; B. Hunyadi

3.460 In-Vitro Hippocampal Inhibitory Neuronal activity of SCN1A KO Mice and a Potential Alternative Treatment Path | K. Moreira; Y. Tanaka; S. Hirose

3.461 Fenfluramine (Fintepla®) Reduces Convulsive Seizure Frequency in Dravet Syndrome Patients Receiving an Antiepileptic Drug Treatment Regimen Containing Stiripentol: A Phase 3, Randomized, Placebo-Controlled Clinical Trial | R. Nabbout; S. Auvin; S. Zuberi; N. Villeneuve; A. Gil-Nagel; R. Sanchez-Carpintero; U. Stephani; L. Laux; E. Wirrell; K. Knupp; C. Chiron; G. Farfel; B. Galer; G. Morrison; M. Lock; A. Gammaitoni; A. Mistry

3.462 The Established Status Epilepticus Treatment Trial (ESETT): A PK Simulation Study to Assess Feasibility of a Sparse Sampling Approach to Estimate PHT, VPA, and LEV Exposures in Children | A. Sathe; V. Ivaturi; R. Brundage; J. Chamberlain; J. Cloyd; H. Cock; J. Elm; N. Fountain; J. Kapur; D. Lowenstein; S. Shinnar; R. Silbergleit; H. Tillman; L. Coles

3.463 Fenfluramine HCl (Fintepla®) Provides Long-Term Clinically Meaningful Reduction in Seizure Frequency: Results of an Open-Label Extension Study | L. Lagae; J. Sullivan; R. Nabbout; M. Pringsheim; G. Farfel; B. Galer; G. Morrison; M. Lock; A. Gammaitoni; A. Mistry

3.464 FMRI Response to a Novel Cognitive Rehabilitation Program for Epilepsy | T. Gaston; A. Fahey; S. Nair; J. Allendorfer; R. Martin; J. Beattie; J. Szaflarski

3.465 Neuromagnetic Dynamics of Working Memory in Temporal Lobe Epilepsy and in Healthy Controls | B. Albritton; S. Nair; D. Pizarro; J. Killen; S. Pati; R. Martin; J. Szaflarski; I. Mohamed; T. Gawne


3.466 Home based Continuous Tele-EEG in Veterans: Effectiveness and Cost Savings of EEG monitoring delivered through a VA Tele-EEG Network | D. McCarthy; A. Saxena; R. Sauseville; G. Head; C. Riley

3.467 Validation of a Dry-electrode EEG Recording System: Results of a Multireader Blinded Comparison to Standard EEG. | K. Zarroli; H. Alexander; D. Bauer; S. Tanabe; C. Hucek; M. Quigg

3.468 The Usability of Diazepam Buccal Soluble Film as an Oral Treatment in Adult Patients with Epilepsy | C. Jung; J. Dubow; H. Gong; K. Liow; S. Aboumatar; P. Klein; M. Gelfand; S. Wargacki; R. Mehta; M. Rogawski; A. Heller

3.469 Cannabinoid Knowledge and Attitudes among US Healthcare Providers | M. Szaflarski; P. McGoldrick; L. Currens; D. Blodgett; H. Land; J. Szaflarski; E. Segal

3.470 Measuring the Response of Epileptic Tissue to Cognitive Tasks: Event Related Potentials in Hippocampal Seizure Onset Zone | I. Balzekas; K. Saboo; F. Khadjevand; B. Berry; L. Miller; B. Brinkmann; M. Stead; J. Van Gompel; V. Kremen; M. Kucewicz; R. Iyer; G. Worrell

3.471 Surgical Outcome Prediction Algorithm in Drug Resistant Epilepsy: MEG Source Connectivity with Stereotactic-EEG Virtual Sensors | H. Fujiwara; J. Tenney; D. Kadis


AUTHOR INDEX

A

Abbasi, S 1.058

Abbott, G W. 1.069, 1.047, 3.051

Abdallah, C 3.143

Abdel-mannan, O 1.238

Abdelmoity, A 1.149, 1.224

Abdullahi, A T. 3.418

Abe, T 1.223

Abel, T J. 1.132, 3.351

Abela, E 3.292

Abend, N 1.231, 1.232, 3.426, 1.235, 3.197

Abood, W 2.420

Abosch, A 1.165, 3.146, 2.352

Abou Jaoude, M 1.173

Abou Khaled, K 1.171

Abou Nader, C 1.171

Aboubakr, O 1.002

Abou-Khalil, B 1.258, 1.259, 3.124, 2.292

Aboumatar, S 3.188, 3.201, 3.284, 2.453, 3.468

Abraham, R 1.416, 3.216

Abrahams, B 1.286

Abraira, L 2.114, 2.141, 2.283

Abraira del Fresno, L 2.262

Abu-jabber, A 2.296

Abukhalid, M 1.319

Abu-Madi, N 3.104

Acharya, J 2.117

Acharya, V J. 2.117

Achkar, C 3.342

Acosta, M T. 1.407

Acton, B 1.462

Adachi, K 2.328

Adam, C D. 3.110

Adams, J 1.271, 1.272

Adams, S 1.139

Adamski, T 1.086

Adamu, H 3.418

Addo-Osafo, K 2.082

Addy, R 1.433

Adelson, P 2.022

Ades, L 3.215

Ades, L M. 3.216

Adler, S 1.250, 1.251

Adoor, G 1.435

Adrade de Abreu, P 1.096, 1.097, 1.098, 1.099, 3.161

Aeby, A 1.208

Aeby, A 1.208, 3.436

Afacan, O 2.180

Afra, P 2.293

Afrasiabi, M 3.030

Agarwal, A 3.453

Agarwal, N 1.362

Agarwal, N 3.330

Agarwal, P 1.434

Agarwal, R 1.132

Agarwal, S 2.019

Agbogba, K 2.355

Agirre-Arrizubieta, Z 3.352

Agostini, M 3.451

Agoston, D 1.099

Aguglia, U 2.013

Aguilar, M 3.316

Aguilar Amat Prior, M 2.215

Ahmad, S 3.204

Ahmadi, S 2.337

Ahn, B 3.358

Ahn, H 2.322

Ahn, Y 1.316, 3.358

Ahonen, S 1.458

Ai, L 3.193

Aimetti, A 2.251, 3.283

Aimiuwu, O 1.116

Ajijola, O 3.194

Ajinkya, S 1.146

Akamatsu, N 2.304

Akaza, M 2.266

Akbar, A 3.053

Akbari, R 1.062

Aki, T 3.375

Akiyama, T 2.030

Akiyama, Y 1.163

Akkineni, K 1.448

Akman, C I. 1.203, 2.326, 1.392, 3.043

Al Banna, M 3.187

Al Hail, H 1.429

Al Hail, H 1.214

Al Thobaity, I 2.115

Alam, U 2.140

Alanezi, A 3.196

Alarcón, G 1.429, 1.214, 2.118, 2.070

Alavi, F 2.293

Alayari, A 2.298

Albalawi, M 2.296

Albaradie, R S. 3.219

Albert, D 1.273

Albritton, B 3.465

AlBunni, H 2.001

Alcala-Arcos, T 3.275

Alcantara, J 2.373

Alcantara-Gonzalez, D 1.465

Alcauter, J 1.003

Alcorn, J 1.462

Aldana, B I. 1.028

Aldhalaan, H 1.319

Aldosari, M M. 1.158, 2.054

Aldosari, M M. 2.055

Aldrich, C 1.284

Aleksonis, H 1.386

Aleksovska, K 2.463

Alessi, R 2.373

Alexander, H 3.467

Alexander, H 1.438

Alexander, J 3.194

Alexandra, K 1.347

Alexopoulos, A 1.158, 1.185, 2.054, 3.327, 2.172, 2.055, 2.179, 2.127

Alfadhel, A 2.296

Alfarano, A S. 3.452

Alford, J 3.388

Alghamdi, O 2.296

Al-hadid, K 3.290

Alharthi, S 1.319

Alhilani, M 2.058

Alhourani, A 1.015

Alhussein, H 1.214, 2.118

Ali, I 1.097, 1.098, 1.099, 1.101, 1.288

Ali, I 1.096, 1.118

Ali, I 3.331

Ali, M 1.429, 1.214, 2.118

Ali, Y 1.429, 1.214

Aliyu, M 3.418

Alkawadri, R 2.059, 2.116, 2.060, 3.220

Al-Kaylani, M 3.124

Alkhaldi, M 3.184

Allan, B 1.129, 3.111

Allen, A S. 1.392

Allen, B N. 1.427

Allen, J 2.336

Allen, L S. 2.392, 1.256, 3.387

Allen, L 2.170, 2.204, 3.244

Allen, N 1.396

Allendorfer, J B. 3.074



Alleva, R 3.069

Allibert, R 3.315

Allien, S 3.236

Alloway, K 3.117

Almane, D 2.206, 2.361, 3.235

Almansa Castillo, R 2.149

Almas, M 2.250

Almayman, F 3.184

Almehmadi, S 3.290

Almesalaty, H 3.047

Almuhaizea, M 1.319

Alnakali, R 3.019

Alonso Singer, P 2.215

Alotaibi, N 3.351

Alothaimeen, H 1.319

Alqadi, K 2.296

Alqadi, K 2.008, 2.009

Alrabi, A 2.118

Al-Ramadhani, R 2.449

Al-Said, Y 2.296, 2.008, 2.009

Alsfouk, B 2.275

Alsowat, D 2.154

Alsulami, A 1.319

Altalib, H 1.277, 3.260, 3.268

Alter, A S. 2.326

Aluri, J 3.291

Alvarez, I 3.301

Alvarez de la Rosa, D 1.174

Alvim, M K. 3.226

Alwaki, A 3.145

Alwaki, A 1.338

Alyamani, S 1.319

Amengual Gual, M 1.231, 1.232, 3.426, 1.235, 3.401, 3.197

Amin, U 1.150

Amina, S 3.116

Ammanuel, S 3.122

Ammanuel, S 1.111

Amtmann, D 2.406

An, D 2.171, 2.452

An, S 1.325

Anbarasan, D 3.043

Andersen Becser, N 2.138

Anderson, A 3.228

Anderson, A 2.080, 1.231, 1.232, 3.426, 1.235, 3.331, 3.020, 3.177, 3.010, 3.197


Anderson, C T. 3.387

Anderson, C T. 1.256, 2.206

Anderson, J 3.214

Anderson, M 3.351

Anderson, T 1.107

Andrade, A 2.409, 3.196

Andrade, D M. 2.212

Andrade de Abreu, P 1.101

Andresen, J 1.103

Andrew, A 1.312, 2.350

Andrews, I 1.201

Andrews, J 2.145

Andrews, J P. 3.345

Andrews, M 2.460

Angelini, B 2.025

Angione, K 2.446

Anibaldi, G 1.306

Anink, J J. 1.003

Ann Shenkman, E 2.110

Anor, C 3.457

Ansari, E 3.236

Ansoanuur, G 3.218

Antaya, T C. 1.427

Antinew, J 2.250

Antonetty, A 2.394, 1.439, 1.411

Antony, A 2.178, 3.132

Antwi, P 1.074, 1.062, 3.254

Anumonwo, C 1.051

Anwar, T 2.163

Aoyagi, T 2.390

Appavu, B 2.022

Appel, S 3.430

Appendino, J 1.237, 1.384

Aradhya, S 2.369

Arafa, S 3.024

Arai, H 1.040, 2.088, 2.095, 3.252

Arai, Y 1.442

Arain, A M. 3.124

Araki, Y 1.135

Araki, Y 1.111

Arana, B 2.388

Arant, R 3.079, 1.067

Aranzábal Alustiza, I 1.307

Arauco-Shapiro, G 3.400

Araujo, T K. 1.398

Arbune, A 2.094, 2.061, 2.078

Archer, J 1.263, 2.036, 3.239

Archer, R 1.423

Arcos Sanchez, C 1.307

Arcot Desai, S 2.048, 2.050

Ardinger, C 2.232

Arenas Cabrera, C 2.445, 1.453

Arencibia, C 3.345, 1.074

Aristonera, M 2.368

Arita, K 2.339

Arivazhagan, A 1.161

Armacost, M 3.379

Armas-Capote, N 1.174

Armour, E 1.203

Armstrong, M 1.022

Arndt, D 3.437

Arnold, S T. 1.388

Arntsen, V 1.154

Aron, C 2.406

Aronica, E 1.003

Aronson, J P. 3.133

Arroyo, S 1.173

Arruda, F 1.209, 2.373

Arumugam, P 3.280

Arya, R 1.231, 1.232, 3.426, 1.235, 3.340, 3.401, 3.197

Arzimanoglou, A 2.396

Asadi-Pooya, A 1.429, 2.118

Asano, E 1.132, 1.138, 2.002, 2.327

Asano, K 3.252

Asgharnejad, M 1.301

Asheeb, A 1.161

Ashizawa, T 2.112

Ashourvan, A 3.101

Asilnejad, B 3.296, 3.297

Aslam, H 1.448

Asma, B 3.249

Assirati, J 1.248

Atac, E 1.074

Atkinson, M J. 2.310, 2.312

Atteyah, D 2.008, 2.009

Atwood, A 2.352

Au, Y 3.203

Auer, N 2.214

Auguste, K 2.460

Aung, T 1.158, 1.185, 2.054, 2.055

Aung, T 2.172

Austin, J 2.391, 1.195

Auvin, S 3.461

Avati, A 1.435

Avbersek, A 3.393

Avbersek, A 1.289

Avidan, M 2.042

Avila, E K. 3.134

Ávila, C 1.464

Awati, A 1.435

Aycardi, E 3.282, 3.211

Aydin, Ü 1.160

Ayers, M 3.434

Ayub, N 2.158

Ayuga Loro, F 1.162, 3.316, 2.149

Ayuga Loro, F 1.307

Ayyad, A 1.429

Azar, N J. 3.124

Aznarez, I 1.051

B

B Forrest, C 2.110

Baarmah, H 2.296

Baba, H 2.328, 1.350

Baba, S 1.442

Baba, S 2.328, 3.251, 3.144

Babajani, A 3.141, 3.256

Babilliot, L 1.091

Babtain, F 2.008, 2.009

Babunovska, M 2.463

Baca, C 3.412, 3.413

Bachman, E 3.233

Badachi, S 1.435

Badalamenti, V 1.292, 1.293

Baekelandt, V 3.082

Baena Palomino, P 2.445

Bagic, A 3.321, 2.303, 2.178, 2.450, 3.132, 3.200

Bahari, F 3.117

Bahlo, M 2.365, 2.374, 1.451

Bahr, J 2.367

Baig, N 2.115

Bailey, K 2.101

Bailey, L D. 2.423, 2.424

Bailey, M 2.362, 2.368, 2.369

Bainbridge, E 3.155

Bainbridge, J 3.230

Baird-Daniel, E 2.085

Bajammal, S 2.296, 2.008, 2.009

Bajenaru, O 2.061

Baker, E 2.426

Balachandra, A 1.372

Baldassano, S 1.086, 3.101

Baldeweg, T 1.250, 1.251

Balena, T 3.317

Balestrini, S 1.022, 2.170, 2.234

Ball, L 3.175

Ballesteros, D 3.183

Balubaid, W 2.008, 2.009

Balzekas, I 3.470

Bamer, A 2.406

Bamman, M M. 3.074

Bandodkar, S 3.093

Bandyopadhyay, S 2.420

Baner, N 1.305

Bank, A M. 1.304

Banks, M 3.184

Bankstahl, J 1.282

Bankstahl, M 1.282

Bansal, L 1.149, 1.224

Banuelos, I 3.161

Banz, B 1.074

Baptist, A 1.435

Baraban, E 2.398

Barba, C 2.188

Barba, C 3.339, 3.237

Barbaro, N 3.321, 1.195, 1.340

Barber, A 3.318

Barborica, A 2.094, 2.061, 2.078

Barbosa Aidar, M 3.314

Bard, A 3.055

Barghout, V 2.259

Barker, B 2.232

Barker, B S. 1.050

Barker, G J. 1.246

Barker-Haliski, M 3.099, 3.274, 3.100

Barlaam, F 2.355

Barnard, BS, S 1.422

Barnes, A 1.409

Barnes, G 3.288

Barot, N 1.345

Barqawi, Y 2.380

Barrett, K 3.361, 1.119, 3.059

Barrington, B 2.105

Barrit, S 1.368, 3.342

Barrit, S 3.335

Barry, F 3.413

Barry, J 3.260, 2.124, 3.268

Barsh, G 3.405

Barsuk, J 3.408

Barth, D 3.159

Barth, D S. 1.064


Bartley, M 1.215

Bartolini, L 3.087

Bartolomei, F 3.237

Barton, B 3.384

Baruah, S 1.363

Bascuñana, P 1.282

Basha, M 3.222

Bashir, S 3.219

Baslet, G 1.277, 1.279, 2.213

Basma, N 1.437, 2.108, 2.109, 1.412

Bass, D 3.073

Bassett, A S. 2.212

Bassett, D 3.101

Basu, T 3.003

Bateman, L M. 1.037, 3.043

Baten, A 2.128

Batlevi, C 3.134

Batson, K 2.382

Battino, D 3.228

Baud, M R. 2.084, 3.084, 2.052, 3.122

Bauer, D 3.467

Bauer, P M. 1.256

Bauer, S 3.458

Baugh, E 1.392

Bauirjan, J 3.187

Bauman, K 2.378

Baumer, F M. 2.072, 2.315

Baumgartner, J 1.367, 2.181, 1.337

Bautista, C 3.298

Baybis, M 1.129, 3.111

Baydin, S 1.366

Baz, S 2.296

Bazelot, M 3.052, 1.463, 2.462

Bazil, C 3.043

Beňová, B 1.170

Beal, J 2.408

Bear, J J. 2.269

Beatch, G 3.282, 3.211

Beatch, G N. 3.292

Beattie, J F. 3.464

Beaulieu, C 2.167, 2.173

Bebin, E 1.383, 2.426, 1.468, 3.456

Beck, V C. 3.068

Becker, A M. 2.432

Becker, D 1.447

Beckman, M 3.099

Becu, C 1.205

Bedock, C 2.292

Bega, D 3.408

Begley, PhD, C 1.433

Beheshti, I 2.216

Beimer, N 2.331, 3.131, 1.419

Bein, N 3.183

Beiser, A 3.432

Bektas, H 1.216

Belcastro, V 2.234

Belisle, A 1.427

Bell, M 1.458

Bell, M 2.387, 3.043

Bellinski, I 3.408, 3.233

Bello-Espinosa, L E. 1.237, 1.384

Belmeguenaï, A 3.107

Bena, J 2.403

Benard, M.D., M.P.H., S 1.186

Benard, M.D., M.P.H., S 3.325

Benbadis, S 1.147, 1.133, 1.150, 2.345

Bendsen-Jensen, M 1.095, 2.047, 3.095

Benfield, J 1.107

Beniczky, S 1.153, 2.035

Beniczky, S 2.014

Benjamin, C 2.060

Benjamin, R 1.194

Benjumea-Cuartas, V 1.278, 2.421

Benjumeda, M 3.223

Benke, T 3.402, 3.404

Ben-Menachem, E 1.453

Ben-Menachem, E 1.291

Bennett, M F. 2.365, 2.374

Benninger, F 3.012

Benninger, F 3.234

Bensalem-Owen, M 3.407, 2.337

Benscoter, M 1.088

Bensken, W 2.399

Benson, K 1.396

Bentley, N 1.226

Benwait, J 1.411

Bercovici, E 3.457

Berdichevsky, Y 1.010

Berg, A 3.369

Berg, A T. 2.372, 1.200, 1.309, 2.126, 1.412, 2.414, 1.415, 2.451

Berg, M 1.330, 3.072

Bergin, A M. 1.392, 3.362

Bergin, A M. 3.342

Bergin, D 1.282

Berkovic, S F. 2.253

Berkovic, S F. 3.228, 1.139, 2.365, 1.263, 2.374, 2.193, 2.156, 3.399, 3.405, 1.451

Berl, M 3.258

Berl, M M. 2.205, 1.406, 3.175, 1.352, 3.247

Bermejo, P 2.260

Bermudez, C 2.100

Bernal, B 1.354

Bernard, C 2.084

Bernardo, D 2.098, 3.169

Bernasconi, A 1.246, 1.257, 2.182, 2.190, 2.207, 2.208,3.237, 3.253

Bernasconi, N 1.246, 1.257, 2.182, 2.190, 2.207, 2.208, 3.237, 3.253

Bernhardt, B 1.246, 1.257, 2.190, 2.208, 2.182, 3.237, 3.253

Bernhardt, B 2.207

Bernstein, H 1.070

Berrettini, W H. 3.400

Berry, B 3.470

Berry, K 1.437

Bertol, V 2.260

Bertol Alegre, V 1.307

Bertrand, M 3.334

Besio, W 3.086

Bessone, S 1.456

Betjemann, J P. 1.460

Bettencourt, A 1.079

Bezin, L 3.107

Bhaduri, A 2.460

Bhalla, S 2.273

Bhandari, H 3.440

Bharath, R D. 1.161, 2.057

Bhargava, G K. 1.161, 2.057

Bhaskar, A 1.161

Bhatia, J 2.431

Bhatia, K 3.061

Bhatia, R 3.233

Bhatia, S 1.092, 2.196, 2.447

Bhatnagar, S 2.214

Bhatt, S K. 1.202

Bickel, S 3.410, 3.150

Bidwell, J 1.089

Bielza, C 3.223

Bien, C G. 1.211

Bier, L 3.403

Bijanki, K 3.073, 2.074

Bilal, M 3.264

Bilal, M F. 2.450, 3.200

Billakota, S 3.043

Billeaud, N 3.215

Billingsley, P 2.222

Billioux, B 1.081

Bin Ka’b Ali, O 1.160

Binder, D K. 1.112

Binder, J R. 1.256, 3.387, 2.206, 3.235

Binder, M 1.061

Bingaman, W 3.327, 1.365, 2.410, 1.369, 1.335

Bingham, J 2.388

Biraben, A J. 3.315, 2.096

Birbeck, G L. 3.137

Bird, W 3.347

Birn, R 2.206, 3.235

Birnbaum, A K. 3.300

Birnbaum, D 2.112

Bishop, K I. 2.454

Biton, V 1.291

Black, C 2.205

Black, C 3.175, 1.352

Blackford, R 2.300, 3.369

Blair, R 1.056, 3.044

Blakey, G 1.300

Blank, L 1.423

Bleasel, A 1.215

Blessing, M M. 2.405

Blixen, C 2.122

Blodgett, D 3.469

Blond, B 1.370

Blum, D 2.239, 2.240, 2.241, 2.242, 2.247, 3.293

Blum, R A. 1.404, 2.346

Blumcke, I 1.253

Blumenfeld, H 3.345, 1.074, 1.264, 1.062, 1.175, 1.176, 1.277, 3.115, 2.024, 2.313, 3.254

Bodden, C 1.183

Bodennec, J 3.107

Bodizs, R 3.039

Bodner, P 2.232

Boggs, J 2.140

Bolden, D 1.357

Boleixa, D 1.079

Bolton, E 2.455

Bolton, J 1.041, 3.335, 3.342, 1.359


Boly, M 1.134, 1.450, 2.206, 2.024

Boly, M 3.115

Bonet, M 2.260

Bonet Valls, M 1.307

Bonilha, L 1.092, 1.256, 3.387, 1.343

Bonito, J 3.345, 1.194

Bonn-Miller, M 2.253

Bookheimer, S 3.258

Boon, P 3.082

Boon, P 1.289

Boop, F 2.062

Boop, F 2.077

Bordey, A 3.105

Boreale, K 3.386, 3.389

Borggraefe, I 2.011

Borghs, S 1.292

Borhani, M 2.384

Borkowska, J 2.135

Born, H A. 2.080

Boro, A 2.004

Borrego, M 2.380

Bortnik, K 3.386, 3.389, 3.374

Borzi, G 2.184

Boshkovski, B 2.463

Botterill, J 1.070, 1.465

Boudreau, E 2.389

Boutzoukas, E 3.247

Boutzoukas, E 3.175

Boutzoukas, E 3.258

Bouvard, S 3.107

Bouza, A 3.023

Bowden, S 2.197, 2.349

Bowling, M 2.431

Boyce, D 2.110

Boyer, K 2.359

Boysen, K 1.201, 3.392

Bozarth, X 1.125

Bozoky, Z 2.337

Bozorg, A 1.323, 1.324, 1.290

Braatz, V 2.151

Brady, R D. 1.097, 1.099, 1.122, 3.089, 1.288

Brady, R D. 1.118

Braesch, C 3.187

Brager, D 3.046

Bragin, A 1.032, 1.011

Braine, E 3.089

Branca, D 2.013

Branch, C A. 1.097

Brand, E 3.094

Brandsoy, M 2.419

Brandt, A 1.182, 3.237

Brandt, C 1.407

Brandt, C 1.289, 2.252

Braun, K 2.044

Bray, S 2.295

Breier, J 2.351

Brennum, J 2.014

Brenton, J 1.231, 1.232, 3.426, 1.235, 3.197

Breslow, R 1.315

Bridoux, B 1.308

Brigham, D 2.039

Brinkmann, B H. 1.035, 1.254, 1.086, 1.267, 3.130, 1.347, 3.137, 3.470

Britton, J W. 1.142, 3.324, 1.035, 1.254, 3.130, 2.335, 3.125, 3.129, 2.405

Brock, M 1.291

Brock, T 2.458

Brodie, J S. 2.229

Brodie, M 2.162, 2.275

Brodtkorb, E 1.154

Brokamp, G A. 3.074

Brooks, B 1.384

Broshek, D 3.321, 1.340

Brown, D 2.022

Brown, D 2.295

Brown, K 1.022

Brown, M 2.370

Brown, M 1.165, 1.336, 3.146, 2.352

Brown, T 1.347

Browning, K 1.424

Bruce, R 1.196

Bruder, J 1.094

Bruggers, C 2.293

Brundage, R 3.462

Brunklaus, A 1.201, 1.402

Brunklaus, A 1.299, 1.397

Brunner, D 3.105

Brunner, P 2.069

Brunnhuber, F 3.352

Bruun, D A. 3.001

Bryant, E 2.126, 3.394

Bryant, E M. 2.372, 1.309

Bucciarelli, B 2.394, 3.095

Buchanan, K 2.145

Buchard, A 3.187

Buchfelder, M 1.339

Buchhalter, J 1.412, 3.455

Buchtel, H 3.131

Buchy, L 3.211

Buckley, T 2.391, 1.405

Bugnon, T 1.450, 3.115, 3.114

Bujarski, K 1.312

Bujarski, K A. 3.133

Bulacio, J 3.327, 1.365, 1.369, 3.035

Bulacio, J 1.185

Bulaj, G 2.293

Bullinger, K 1.338, 3.145, 1.341

Bulluss, K 2.036, 3.239

Bumbut, A 3.087, 1.406, 1.407, 3.175

Bunge, M 2.448

Bunton-Stasyshyn, R K. 3.061

Buono, R J. 3.400

Burattini, J 1.360, 3.332

Burbano, L 1.466

Burbidge, A 1.436

Burch, M 1.273

Burdette, D 3.188, 3.201, 3.450

Burford, K 1.287, 3.273

Burger, K M. 2.019

Burgess, R C. 1.158, 1.185, 2.054, 2.055

Burgess, R 1.201

Burke, C 1.201

Burke, J F. 1.460

Burman, J 1.430

Burneo, J 1.084

Burneo, J G. 1.427

Burnsed, J 1.172

Burris, N 1.440

Burrows, B 2.022

Busatto Filho, G 2.373

Busch, R M. 1.256, 3.387, 2.344

Bushman, J 2.180

Busonera, G 3.164

Butler, E 1.403

Butler, E 3.397

Butler, T 3.033

Butovas, S 3.417

Buttar, A 3.392

Bye, A 1.395

Byeon, J 1.115, 2.243

Byrne, R 3.320

Byun, J 2.440

C

Côté, V 2.355

Caballero Martínez, M 2.445

Cabaniss, B 3.326, 1.169, 2.307

Cabeza, C 1.310

Cabeza Alvarez, C 2.149

Caboclo, L 3.314

Caborni, C 1.377, 1.091, 3.078

Cabral, N 2.151

Caciagli, L 2.166

Cadieux, J 3.282, 3.211

Caffrey, K 1.414

Caffrey, K A. 1.276

Cagnetti, C 1.306

Cai, Z 1.266

Cairns, A 3.399

Calabrese, T 1.420

Caldairou, B 1.246, 2.182, 3.237

Calhoun, J 1.024

Caligiuri, M 2.188

Calle-López, Y 1.278

Calvillo, M 3.240

Camara, D 3.138

Camargo, B 2.341, 2.342

Camarillo-Rodriguez, L 1.033

Camayd-Muñoz, C 3.420

Cambrodí, R 2.141

Camfield, C 1.243, 3.391

Camfield, P 1.243

Camp, C 1.025

Campbell, A J. 2.377

Campbell, E 3.228

Campos, D 1.310

Cances, C 1.295

Canevini, M P. 1.022

Canoll, P 1.392

Cantu, D 2.239, 2.240, 2.241, 2.242, 2.247

Cantu, D 1.018

Cao, D 3.169

Cappanera, S 1.306

Carbone, L 1.419

Cardenas, D 3.119, 3.085

Cardin, J 1.175, 1.176


Carey, S 2.394

Carfi-Pavia, G 3.339

Carino, J 2.010

Carline, S 2.318

Carlotti, C 1.248

Carlson, C 2.392, 1.256, 3.387, 2.206

Carlson, S 1.045

Carmant, L 2.355, 3.237

Carney, P 2.156

Carosella, C 2.320

Carpenter, J L. 1.231, 1.232, 3.426, 1.235, 3.401, 3.197

Carpenter-Thompson, J 3.299

Carpentier, J 3.409

Carrazana, E 1.302, 2.005

Carreño, M 3.205, 2.288

Carrette, E 3.082

Carrington, B 2.112

Carroll, R 2.263

Carson, K 3.365

Carson, R 3.027

Carson, V 3.176

Carter, B 1.280

Carvalho, C 1.079

Carvalho, K 1.333

Carvalho, S 1.080

Carver, C M. 3.004

Carvill, G L. 2.372, 3.021, 3.405

Casadevall, T 1.307

Casale, M J. 1.313

Casares, M 3.435

Casassa, C M. 2.383

Casciato, S 2.123

Cascino, G D. 2.335, 2.405

Cash, S 1.173, 2.092, 2.025, 1.128, 3.037, 3.168, 3.042

Casillas-Espinosa, P M. 1.108, 1.096, 1.122, 1.118, 1.288

Casillas-Espinosa, P M. 1.097, 1.098, 1.101, 3.089

Cassel-Choudhury, G 2.408

Cassidy, K 1.218

Castillo, D 1.271, 1.272

Castillo, E 2.181

Castrillón-Velilla, D 1.278

Castro, D 2.260

Catroppa, C 3.384

Catterall, W A. 3.026

Cavalleri, G 1.396, 1.398, 3.393

Cavalli, A 2.188

Cavazos, J 3.119, 3.085

Cavitt, J 3.229, 3.231

Cen, Z 2.112

Cendejas-Zaragoza, L 2.388, 2.063, 1.130

Cendes, F 3.237, 3.226

Cendes, F 1.335

Centeno, M 2.348

Centeno, M 2.166

Center for Mendelian Genomics, U 3.392

Cervenka, M 3.357, 3.365

Cerveró, D 3.312, 3.313

Cesaroni, E 1.306

Ceulemans, B 3.436

Chae Suh, H 2.289, 2.290

Chaim-Avancini, T 2.373

Chaitanya, G 3.249

Chakraverty, K 2.038

Chalia, M 2.117

Chamberlain, J 3.087, 3.462

Chamberland, S 3.052

Chambers-Blair, J 1.440

Chan, A 3.344

Chan, E 1.439

Chan, F 2.229, 1.052

Chan, F 1.028

Chan, H 3.134

Chan, H 3.203

Chan, V 3.363, 2.154

Chancey, J H. 3.032

Chandak, R B. 2.281

Chandra, S 1.348

Chandramohan, D 3.223

Chandran, A 3.257

Chandrasekharan, P K. 2.016

Chang, A 3.311

Chang, C 2.412

Chang, E 3.321, 1.340, 2.460

Chang, E F. 3.122, 2.073, 3.223

Chang, J 1.334

Chang, J 2.153

Chang, S 1.086

Chang, T 2.163

Chanteux, H 2.226

Chapman, B 3.264

Chapman, K 3.347, 1.231, 1.232, 3.426, 1.235, 2.269, 2.279, 3.401, 3.197

Chapman, M 2.277

Chapy, H 2.226

Chari, G 3.263

Charkhad, B 3.361, 1.119

Charupanit, K 3.034

Chaturvedi, S 1.112

Chau, A 3.187

Chaudhari, R M. 1.348

Chauhan, B 2.023

Chauvel, P 3.327, 1.369, 3.035, 3.036

Chavarria, B 3.301

Chaves, J 1.079, 2.465

Chayasirisobhon, S 2.147

Cheah, C S. 3.026

Checketts, D 1.296, 1.299, 1.470

Chedrawi, A 1.319

Chen, B 3.457

Chen, C 3.098

Chen, C 1.051

Chen, C 2.127

Chen, C 2.455

Chen, E 3.008

Chen, H 3.110

Chen, H 2.432

Chen, L 3.048, 1.012, 3.056

Chen, L 3.236

Chen, M 1.264

Chen, P 1.371, 1.218

Chen, P 2.181

Chen, S 1.148

Chen, W 2.438

Chen, X 3.134

Chen, Y 2.183

Chen, Z 3.364

Chen, Z 1.139, 2.010, 2.162, 2.275

Chen, Z 3.421

Cheng, G 1.067

Cheng, L 1.034

Cheng, Y F. 2.308

Cherubini, A 2.188

Chester, K 2.397

Cheung, H 3.449

Cheung, M 2.271

Chez, M G. 3.388, 2.031, 2.251, 3.283

Chi, C 1.027, 1.029

Chi, L S. 2.290

Chiang, S 1.192, 1.212, 2.158

Chiclana, G 1.206

Chilukuri, R 2.003

Chin, R 1.298

Chinappen, D 2.012

Ching, M 1.233

Ching, S 2.021

Chiou, K 3.341

Chiron, C 3.461

Chitnis, S 1.204

Chiu, M 2.384

Chiujdea, M 2.394, 1.439, 1.411

Chmielewski, D 2.135

Cho, A 3.187

Cho, F S. 1.003

Cho, I 1.049

Cho, K 2.461

Cho, Y 2.461

Choi, A 3.263

Choi, E 1.327

Choi, H 2.330

Choi, H 1.304, 3.043, 3.136

Choi, J 2.259, 1.196, 2.152

Choi, J 1.389

Choi, R 2.455

Choi, Y 1.049, 2.461

Chong, D 3.410

Chong, PhD, J 1.433

Chopade, P 1.146

Choudhary, A 3.361, 1.119

Choudhri, A 1.164, 3.256

Choudhury, K 1.021

Chouinard, T 1.086

Chourasia, N 1.205

Chowdhary, A 3.392

Chowdhury, F 2.168

Chowdhury, F 2.348

Chowdhury, R 3.143

Christensen, J 2.411

Christian, C 1.179

Christian, H 3.415

Christiansen, A 1.051

Chrusciel, D 2.146

Chu, C J. 1.255, 2.092, 2.012, 1.102

Chu, F 2.350

Chu, S 3.093

Chuang, D 2.165

Chuang, D 2.164

Chung, B 2.375


Chung, H 3.015, 2.455

Chung, H 2.133

Chung, S S. 1.294, 2.150, 2.223, 3.188, 3.201

Cianci, V 2.013

Ciccone, O 3.362

Cihan, E 2.419

Cilio, M R. 1.203, 1.022, 3.028, 3.294

Cilly, A 3.269

Cimbalnik, J 3.077

Cimbalnik, J 1.035, 1.086

Ciszek, R 1.098, 3.161

Ciszek’s, R 1.101

Ciurea, J 2.094, 2.061, 2.078

Claassen, J 2.019

Claes, K 3.459

Clark, A A. 3.455

Clark, C 1.326

Clark, J 2.394, 1.231, 1.232, 3.426, 1.235, 3.401, 3.197

Clark, S 1.419

Clarke, D F. 3.331

Clarke, D F. 3.341

Clay, J L. 3.407

Cleeren, E 3.459

Clement, A 3.277

Clemente-Perez, A 3.028

Cleveland, J 1.292

Cloyd, J 2.228, 2.272, 3.462

Cloyd, J 1.288

Cobb-Pitstick, K 3.176

Cobourn, K 2.319

Cochran, J 3.405

Cochran, L 3.419

Cock, H 3.462

Coelho, V 3.237

Cogoni, M 3.164

Cohen, C J. 1.285, 1.287, 3.273, 3.282, 3.211

Cohen, M 3.187

Cohen, N T. 2.430

Cohen-Pfeffer, J 2.369

Coimbra, E 3.380

Colangeli, R 3.158

Cole, A 3.321, 1.340

Coleman, M 2.374

Colen, C 2.040

Coles, L 2.228, 1.288, 2.272, 3.462

Colon-Zimmermann, K 1.371

Colon-Zimmermann, K 1.218

Combs, A 1.382

Combs, A 2.358

Comerford, E 1.396

Comrie, M 1.113

Conant, L L. 1.256, 3.387, 2.206, 3.235

Concepcion, F A. 1.008

Concha, L 3.045, 2.185

Conde Blanco, E 3.205, 2.288

Conley, G 3.007

Conner, K 2.140

Connolly, E 2.019

Connolly, J 3.172

Connolly, M 2.384

Connolly, N L. 3.072

Conrad, E J. 1.443

Conrad, E 1.190

Conry, J 3.338, 3.209

Consalvo, D E. 3.183

Consortium, E 3.393

Consortium, M 1.250

Constantinou, J E. 2.434

Contreras Caicedo, G 3.261

Conway-Kinstler, J 3.130

Cook, A M. 3.407

Cook, C 3.235

Cook, M 1.321

Cook, M J. 1.068, 1.139, 1.075, 3.081

Cook, R 2.355

Cook, R 2.121

Cooke, D 2.145

Cooney, C 1.405

Cooper, E 3.053, 2.455

Cooper, G 3.405

Coorg, R 2.155, 3.177

Coppola, A 2.234

Corbett, B A. 1.428

Corbridge, R 1.396

Corley, S 1.462

Cornet, M 1.203, 3.028

Correa, D 1.417

Correia-de-Sá, P 1.079

Correll, C 3.178

Coryell, J 1.381

Coskun, D 3.181

Cossu, M 3.339

Costa, P 1.079

Costa, R 2.241, 2.247

Costello, D 3.431, 1.396

Cottone, C 3.110

Cottrell, J R. 2.377

Couch, C 2.019

Coutin-Churchman, M.D., Ph.D., P 1.186

Couturier, N H. 3.148

Cowell, C 3.281

Cowley, M 1.395

Craig, J 3.228, 3.393

Crane, K 2.086

Crawford, J 3.185, 3.212

Crean, C 3.282

Crepeau, A 3.323, 1.145

Crino, P B. 1.392, 3.094, 1.129, 3.111

Crist, R C. 3.400

Cristofaro, S 3.190

Critchley, D 1.297, 1.453

Criteser, S 3.355

Crockett, J 1.297, 1.453

Croll, L 3.104

Crone, N 1.168

Cronkite, C A. 3.341

Croom, J 2.415

Cross, J 1.295, 1.250, 1.251

Crossley, A M. 2.289, 2.290

Crowe, C M. 1.086

Crowley, M 1.074

Crowther, L J. 2.069

Crudele, A 2.403

Crutcher, J 3.247

Cuello-Oderiz, C 1.042, 3.149

Cukiert, A 1.360, 3.332

Cukiert, C 1.360, 3.332

Cullen, D 3.110

Cullier, A 3.277

Cullimore, M 3.368

Cullum, M 1.271, 1.272

Cunningham, K 3.406

Cunningham, M O. 2.229, 1.052, 1.028

Curay, C 3.117

Currens, L 3.469

Currens, L 1.444

Curry, D J. 3.331, 2.066, 3.341

Cutter, G 1.383, 3.456

Cvetkovska, E 2.463

Czech, M 1.246

D

D Souza, D 1.435

D. Kocsis, J 1.044

D.Gireesh, E 3.435, 1.367, 2.181

D.Perkins, J 1.429

Dávila-González, P 1.307

Dümpelmann, M 1.182, 1.094, 2.007

Díaz, M 3.312, 3.313

Díaz Peregrino, R 1.225

Díaz-Marín, D 2.421

Dabbagh, O 1.319

Dabbs, K 2.206, 2.361

Dabir, A 2.435

D’Agostino, T 2.013

Dahi, P 3.134

Dahle, E 1.117

Dai, J 2.015

Dalby, K 1.466

Dale, R C. 3.093

Dale, R C. 3.399

Dalessio, L 3.123

Dalic, L 3.239

Dalic, L J. 2.036

Dalvi, R 3.055

Daly, M 2.377, 1.393

D’Ambrosio, S 3.187

Damiano, J 1.451

Dan, J 3.459

Daneasa, A 2.094, 2.061

Dang, L T. 3.018, 3.083, 2.331

Daniel, K 1.254, 3.130, 1.347, 3.185, 3.212

Danko, G 3.278

Danoun, O 2.331, 3.131

Danvoye, L 3.436

Danzer, S C. 3.046, 3.024

Dao, A 3.010

D’Arcangelo, G 3.020

Darra, F 1.022

Das, D A. 1.202

Das, S 1.033

Dash, D 1.348

Dash, G 2.023


Dauwels, J 3.168

Davachi, L 1.379

Davey, M J. 1.233

David, H 2.361

Davis, E 3.187

Davis, K A. 1.033, 1.190, 2.404, 3.101

Davis, L 3.302

Davis, S 3.120

Davis, S 2.375

Davis Perkins, J 1.214

Dawit, S 1.202, 3.323, 1.217

Daza-Restrepo, A 1.278, 3.261

De Backer, M 1.291

De Benedictis, A 3.339

de Boer, G 1.285

De Bruyn, S 1.289

De Cooman, T 3.459

de Curtis, M 3.329

De La Garza, M 3.104

De La Hoz, C 1.114

de La Iglesia, H 3.055

De La Torre Ribadeneira, A 3.395

De leon, E 2.323

De Palma, L 3.339

de Paola, L 3.381

de Souza, C 2.375

De Tiège, X 1.208

de Tisi, J 2.184

de Valles Ibáñez, G 2.374

De Vol, E 1.319

Deconinck, N 1.208

DeCoster, M 3.280

DeGiorgio, C 2.302, 2.131

Degrauw, T 2.414

Deguire, F 2.355

DeGuzman, C 2.384

Dehnhardt, C 1.285, 1.287, 3.273

DeJonghe, P 3.083, 3.405

Delaney, S 2.106

Delanty, N 1.396, 1.398, 2.106, 3.458

Delanty, N 3.393

Deleo, F 3.329, 1.306, 3.237

Deleu, D 1.429, 1.214, 2.118

Dell, K 3.081

Della Costanza, M 2.168

Delord, B 3.028

DeLorenzo, R 1.056, 3.044

DeLuccia, R 2.271

Demarest, S 2.446, 3.402, 3.404

Demarque, R 2.373

Deneen, B 1.180

Deneubourg, C 1.063

Denison, T 1.086

Denney, D 1.271, 1.272

Denney, T 3.238

Dentel, B 1.020

Denton, A 2.421

Depaulis, A 1.062, 3.254

Depondt, C 1.308, 3.393

Depositario-Cabacar, D 2.196, 3.338, 1.346

Derera, I 3.002

Dergalust, S 2.289, 2.290

Deschamps, K 1.384

Deshmane, A 1.253

Deshpande, K 3.063

Deshpande, L 1.056, 3.044

Desloovere, J 3.082

Desmond, P M. 2.198

Detyniecki, K 1.194

Devereaux, M 3.116

Devinsky, O 1.425, 1.103, 1.299, 3.305, 1.379, 1.100, 3.432, 3.115, 3.052, 2.416, 2.417, 2.418, 2.419

Devinsky, O 3.104

Devinsky, O 1.295, 1.187, 1.038, 2.071, 3.075

Devries-Rizzo, M 2.409

Dewar, S 2.067

Dexter, M 1.215

DeYoe, E 2.206, 3.235

Dhaher, R 3.062, 3.063, 3.008

Dhakar, M 2.397, 2.027

Dhakar, M B. 3.298

Dhakar, M B. 3.414

Dhamija, R 2.326

Dhamne, S C. 3.049, 3.155, 2.068

Dhamoon, M 1.434

Dharaiya, D 3.186

Dharan, A 2.197

Dhir, A 1.281

Diamond, J 3.165

Diamond, K 1.375

Diaz, L 3.305, 2.416, 2.417, 2.418

DiBacco, M 2.370, 3.127, 3.128

Dibue-Adjei, M 1.457

Dick, A 3.087

Dickens, D 1.362

Dickey, A 1.169

Didato, G 3.329

Diehl, B 2.168, 2.170, 2.204, 2.348, 3.244

Dilley, C 1.325, 1.326

Dilsiz, P 1.038, 3.075

Dimova, S 1.290, 1.294

Din, F 2.030

d’Incerti, L 3.237

Dindot, S V. 2.080

Ding, D 2.132

Ding, J 3.409

Ding, K 1.271

Ding, K 1.272

Ding, L 3.022

Ding, M 2.179, 2.127

Dinger, M 1.395

Dingledine, R 3.003

Diosy, D 1.084

Dirodi, M 1.043

Disse, G 3.109

Diwan, A G. 1.137

Dixon-Salazar, T 3.180

Dlugos, D 2.109, 2.280, 3.202, 3.294, 3.302

Do, H 1.451

Dobrovic, A 1.451

Dobyns, W 1.125

Doerfler, A 1.339

Doescher, J 1.362

Doherty, C 3.310, 1.396, 1.398

Doherty, M 1.167, 3.348

Dolbec, K S. 3.407

Dolce, A 1.230

Dolim, S 2.005

Domańska-Pakieła, D 2.135

Domen, C 2.352

Donaire, A 3.205

Donmez, M 1.032

Donner, E 3.363, 2.154, 2.419, 3.406

Donos, C 2.311

Donos, C 2.351, 2.340

Donos, C 2.094, 2.061, 2.078

Dony, R 1.113

Dorn, T 1.022

Dorriz, P J. 2.386

Doshi, M 2.107

Doss, J 2.219

Doss, R C. 1.276

Dougherty, D 1.128

Dougherty, M 2.271

Dougherty, M 1.143

Douglass, L 3.420

Dowd, C 2.222

Downs, S M. 3.455

Doyle, A 1.271, 1.272

Doyle, G A. 3.400

Doyle, K 2.019

Doyle, W 1.038, 2.071

Doyle, W K. 1.379, 1.392, 3.199

Dragon, D N. 3.088

Drake, A 2.269

Drane, D L. 1.373, 1.256, 3.387, 2.307, 3.073, 1.341, 1.343

Drazkowski, J F. 1.202

Drees, C 1.165, 1.336, 3.146, 2.352

Drees, C 1.447

Dreier, J 2.411

Drew, A 1.395

Drummond-Main, C 1.316

D’Souza, W 2.349

D’Souza, W 1.321, 1.139

D’Souza, W 2.197

Dubée, P 2.232

Dube, C 1.285, 1.287, 3.273

Dubeau, F 1.260, 1.160, 1.077, 1.042, 2.043, 2.201, 3.237, 3.149

Duble, S 2.057

Dubow, E 2.129

Dubow, J 3.468

Duckrow, R 2.024

Dudek, F 1.064, 3.106

Dudley, R 3.237

Duffy, F 3.172

Dugan, P 3.322, 1.379, 1.392, 2.071

Duh, M 2.259

Duke, J 1.327

Dulla, C 1.018

Dunbar, C 3.053

Duncan, D 1.097

Duncan, J S. 1.246, 1.249, 2.166, 2.168, 3.354, 2.175, 2.184

Dunn, E 2.232

Dunne, J 3.421


Durand, D M. 3.148

Durch, P 1.311

Durica, S 2.146

During, M 1.286

Dutta, D 3.352

Dutton, J 2.415

Dwivedi, R 1.348

Dworetzky, B 1.330, 1.277, 1.279, 2.213, 2.218

Dye, T 2.320

Dzhala, V 3.050

E

Ebrahim, S 1.173

Eckenweiler, M 2.102

Eddelman, D B. 3.320

Eden, S C. 2.105

Edsall, D 1.381

Edun, I 1.195

Edwards, J 3.214

Edwards, J C. 1.092

Edwards, L 3.145

Edwards, L 3.439

Edwards, S 1.117

Egger, K 2.134

Ehlert, A 2.028, 3.236

Eid, T 3.062, 3.063, 3.008

Einon, M 1.391

Einstadter, D 1.218

Eisen, M 2.232

Eisenberg, A 3.149

Eisenschenk, S 1.431

El Atrache, R 2.001, 1.095, 1.100, 2.047, 3.095

Elahian, B 1.168

Elbermawy, A 1.224

Elder, C 3.325

Eliashiv, M.D., D 1.191, 1.186, 3.325, 2.067, 3.244

Eline, E 3.249

Eliseyev, A 2.019

Eliyan, Y 2.298, 3.296

Ellaway, C 3.281

Ellenbogen, J 3.352

Elliott, C 2.318

Elliott, K S. 1.402

Ellis, C 1.233

Ellis, S 3.270

Elm, J 3.462

Elmoufti, S 1.293, 1.294

El-Naggar, H 3.458

El-Sayad, N 3.046

Elsheikh, L 1.214

Elsheikh, L 1.429, 2.118

Elshoff, J 1.292, 1.293

Elwes, R 3.352, 2.265, 2.070

Emami, A 1.082

Emerson, D 1.018

Emerton, B C. 1.255

Emery, E 2.205

Empfield, J 1.285, 1.287, 3.273, 3.282, 3.211

Enatsu, R 1.163

Enciso, L 1.273

Engbers, J D. 2.274

Engel, J 1.011, 3.187, 3.244

Engel, K 3.405

Engel, S G. 2.447

Engel, Jr., M.D., Ph.D., J 1.032, 1.191, 1.186, 2.187

Engin, G 3.181

Englot, D 1.259

Englot, D J. 1.258, 1.252, 2.091

Enoki, H 1.442, 3.349

Enoki, H 2.169

Entz, L 3.039

Eom, S 1.387

EpiBioS4Rx, 1.417

Eplin, E 1.273

Epp, J 2.082

Ernst, L 2.413

Eross, L 3.039

Ersahin, D 1.264

Escayg, A 2.227

Eschbach, K 3.402

Escobar Montalvo, J 2.215

Eskandar, E 1.128

Espinera, A 3.233

Espinosa, MD, MPH, FAAN, P 1.422

Esposito, M 2.265

Ess, K 3.027

Esteban de Antonio, E 2.284

Esterlitz, J 1.195

Esteve, P 2.260, 1.307

Estevo, A 3.163

Ethan, S 3.411

Eun, B 1.115, 2.243

Evans, M 2.398

Evans, S 2.003

Evron, T 3.276

Exler, D 3.066

F

Fabo, D 3.039

Fabre, K 1.024

Fabricius, M E. 1.153, 2.014

Fadaie, F 3.237

Fadaie, F 2.182

Fagatele, L 2.293

Fahey, A 3.464

Fahimi, G 2.120

Faingold, C L. 2.230

Fajardo, M 1.354

Faktorovich, S 1.313

Falcone, T 2.324

Falip, M 1.307, 2.286, 2.287

Fanda, L 2.071

Fang, M 1.379

Fantaneanu, T 3.409

Fanto, E 2.205, 3.175, 1.352

Fanto, E 3.258

Farahmand, S 1.030

Farber, N B. 2.042

Farfel, G 3.202, 2.454, 3.453, 3.461, 3.463

Farias Moeller, R 3.426, 3.197

Farkas, M K. 2.250

Farkas, V 2.250

Farooq, O 2.016

Farooque, P 3.345, 2.145, 1.370, 2.333, 3.298

Farrand, S 2.010

Farrar, T 1.215

Farrell, K 1.412, 3.182

Farrell, M 1.398

Fasano, R E. 1.373, 1.169, 3.073, 3.145, 1.341

Faught, E 2.259, 3.414, 2.152

Faulkner, A 3.061

Fayed, I 2.319

Fay-McClymont, T 1.384

Fecci, P 1.337

Fecske, E 1.224, 1.275

Fedak Romanowski, E 2.331, 3.371

Federman, M 2.026

Fehr, C M. 2.457

Fehrmann, E 1.086

Feldman, L 3.327

Feldman, R 1.195

Feldstein, N A. 2.326

Felton, E A. 2.206, 1.336, 3.235

Feng, L 1.175

Ferastraoaru, V 1.192

Ferdinand, A 3.449

Ferguson, L 2.344

Ferlazzo, E 2.013

Ferlazzo, E 2.234

Ferlazzo, E 2.123

Fernández Fernández, MD, M 1.422

Fernandes, F 2.373

Fernandes, H 2.465

Fernandez, A 2.297

Fernandez, A 3.203

Fernandez Lima, M 3.123

Fernandez-Baca Vaca, G 3.184

Fernandez-BacaVaca, G 3.116

Fernandez-Carbonell, C 1.213

Ferrò, B 1.290

Ferrara, E 3.363

Ferrari, L 2.248

Ferrari, P 1.183

Ferraro, T N. 3.400

Ferreira, M 1.080

Ferrer, A 2.141

Ferri, R 3.164

Ferrier, C 2.044

Ferrigno, G 2.013

Ferro, M A. 2.295, 3.391

Ferry, J 2.246

Fertig, E J. 2.398

Fesler, J 3.210, 1.418

Fessler, J 3.137

Fialkow, A 1.439

Fiel, J 1.080, 3.054

Fields, M 3.449

Fields, M 1.313, 1.356

Fields, R 2.415

Filiano, J J. 3.398

Findlay, G 1.450, 3.115

Findlay, G 1.134

Fine, A L. 3.154

Finnegan, S G. 2.016

Finnegan, T 1.234

Finnell, R 3.231

Fish, K 1.015

Fisher, B 2.300, 3.369

Fisher, R 2.072

Fisher, R 1.087

Fishman, J 2.258, 1.328, 1.331, 3.305, 2.418


Fitzgerald, Z 3.097

Fitzsimons, M 1.396, 2.106

Flaeschner, N 2.174

Flamini, R 2.245, 3.287, 3.289

Flamm, C W. 3.275

Flaws, J 1.179

Fleegler, E 1.439

Fletcher, L 1.409, 1.419, 1.420

Flinker, A 1.379, 1.187, 2.071

Flores, Y 2.388

Flores Sobrecueva, A 2.177

Focken, T 1.285, 1.287, 3.273

Fogarasi, A 2.245, 3.287, 3.289

Fogarty, A 2.072

Foged, M T. 1.153

Fogerson, P M. 3.162

Foldes, S 2.022

Foldvary-Schaefer, N 2.217

Follett, L 1.330

Fong, J 2.178

Fonseca, E 2.283

Fonseca, E 2.114

Forcadela, M 2.156

Forcelli, P A. 2.083, 2.087, 3.278

Forn, C 1.464

Forrest, K 1.201

Forseth, C 3.235

Forseth, K 3.255

Foschi, N 1.306

Foster, B 2.191

Fountain, N 3.321, 1.438, 3.462

Fountain, N B. 3.092

Fowler, A 1.116

Fowler, D 2.419

Fowler, K 1.421

Fowler, K 1.469

Fox, J 1.146

Fox, J 3.360, 1.230

França, L G. 3.354

Franic, L 2.439

Frankel, W 1.108, 1.116

Frankowski, J C. 1.058

Fraser, R 3.372

Fraser, PhD, R 1.269, 2.353

Frasier, C R. 3.058

Frauscher, B 1.077, 2.043, 3.237, 3.149

Freedman, I 1.062, 3.254

Freeman, J 1.201

Freestone, D R. 1.068, 1.075, 3.081

Freitas, J 1.079

French, C 2.010

French, J A. 3.229

French, J A. 3.322, 1.195, 1.196, 3.260, 3.231, 1.412, 2.253, 3.240, 3.190, 3.300, 3.268

Freri, E 1.306, 2.123

Fricchione, G L. 1.270

Fried, I 1.032, 2.187

Friedman, D 1.425, 3.305, 1.196, 1.379, 3.432, 2.071, 3.199, 2.416, 2.417, 2.418, 2.419

Friedman, L K. 1.105, 1.106

Frijia, F 2.188

Frontera, A 1.431

Frost, M 1.362

Fu, A 3.410

Fu, N 2.438

Fu, W 3.191

Fuchs, H 2.102

Fuentes-Casiano, E 1.218

Fujii, M 2.400, 2.089, 3.167

Fujikawa, D 1.455

Fujikawa, M 1.131, 2.395

Fujimoto, A 2.169

Fujimoto, A 1.442, 3.349

Fujimoto, T 2.339

Fujioka, M 1.268

Fujiwara, H 3.471

Fujiwara, K 1.083, 1.223, 1.121, 1.090

Fukasawa, T 1.193

Fukuda, T 1.229

Fukumura, S 1.044

Fukusako, T 2.089

Fukushima, K 2.231, 2.282

Fulton, S 2.062

Fumeaux, N 1.173

Fung, C W. 2.375

Fung, J 2.375

Funke, M 2.329

Fureman, B E. 2.125, 1.412, 3.182

Furtado, M d. 1.283

Furuya, Y 2.231

G

Gómez-Ibáñez, A 2.260

Gaínza-Lein, M 1.241, 1.194, 2.394, 1.231, 1.232, 3.426, 3.401, 3.197

Gabriel, P 3.120

Gaddam, A 3.186

Gaddie, D 2.357, 2.360

Gadelmola, K 1.272

Gadelmola, K 1.271

Gadgil, N 3.341

Gage, M 1.055

Gage, M 1.045

Gagnon, C 2.393

Gagnon, L 2.112

Gaillard, W 1.081

Gaillard, W 3.258

Gaillard, W 1.353

Gaillard, W D. 1.231, 1.232, 3.426, 1.235, 3.087, 2.196, 3.338, 2.205, 1.406, 1.407, 1.346, 3.175, 3.401, 1.352, 3.197, 3.247

Gaitero, L 1.113

Galanopoulou, A S. 1.118, 1.288, 3.272

Gale, J 1.169

Galentine, W 3.446

Galer, B 2.406, 2.423, 2.424, 3.202, 2.454, 3.453, 3.461, 3.463

Galiano, M 2.260, 2.284

Galla, K 2.142

Gallagher, M J. 3.022

Gallardo, N 3.187

Galli, K 1.420

Galluzzo, D R. 2.027

Galovic, M 2.183, 2.184

Gama, H 2.240

Gambardella, A 2.123

Gammaitoni, A 2.406, 2.423, 2.424, 3.202, 2.454, 3.453, 3.461, 3.463

Gandy, M 1.374

Ganger, A 2.214

Ganghadaran, N 1.396, 1.398

Ganniger, A 2.021

Ganz-Benjaminsen, M 3.245

Gao, K 1.439

Gao, L 1.179

Garamendi-Ruiz, I 1.307, 1.310

Garayoa Irigoyen, V 1.307

Garcés, M 2.260

García, A 1.310

García Gomara, M 1.307

García-Morales, I 3.316

Garcia, E 2.427

Garcia, M 2.348

Garcia, P 3.321

Garcia Escrivá, A 1.307

Garcia Sosa, R 2.372

Garcia-Barragán, N 3.316

GarciaLosarcos, N 3.116

Garcia-Ramirez, J 2.323

Garcia-Tarodo, S 2.329

Gardella, E 3.221

Gardiner, S 1.402

Gardner, E 2.368

Garg, M 2.159

Gargaro, A 3.380

Garibay-Pulido, D 2.388, 2.063, 1.130

Garino, E A. 3.183

Garrett, R 2.223

Garson, S 3.348

Garton, H 2.331

Garzon, E 3.163

Garzon, MD, Y 1.422

Gasalla, T 1.291, 1.292, 1.293

Gasior, M 2.251

Gasmi, N 3.107

Gaspard, N 1.308, 1.368, 3.125

Gasparini, S 2.013

Gasser, G 1.055

Gaston, T E. 1.468, 3.464

Gattaz, W 2.373

Gaudio, E 1.320

Gautam, N 2.290

Gautier, N 2.086, 3.156

Gavrilova, R H. 1.022

Gavvala, J 2.066

Gawne, T 3.465

Gay, B 1.103

Gayevskiy, V 1.395

Gaykema, R P. 1.050

Ge, H 1.034

Gedansky, A 2.385

Gedela, S 1.265, 2.334

Gedela, S 3.333

Gedela, S 3.333

Gedzelman, E 3.229, 3.231


Gehlbach, B 3.088

Geiger, D 1.440

Geiger, E 3.402

Gelbart, B 1.201

Gelfand, A 3.430

Gelfand, M A. 2.453, 3.468

Gelinas, J 1.187

Genel-Castillo, M A. 1.278

Genetics Initiative, E 3.403

Genevieve, L 3.415

Genov, R 2.090

George, A L. 1.024, 2.126

George, A G. 1.054

George, M 3.323

Georges, B 3.107

Gerard, E 3.408, 3.233

Gerard, E 2.033

Gerard, E 3.229, 3.231

Gerkin, R 2.223

Gerlach, A 1.103

Germain, G 2.259

Germano, M 2.375

Germeyan, S 2.205

Gerrard, J 2.313, 2.333

Ghanam, I 1.319

Ghane, M 1.179

Ghani, N 1.187

Ghanta, M 2.025

Ghanty, I I. 1.397

Ghasemi Baroumand, A 2.014

Ghatan, S 1.356, 1.357, 3.138

Ghestem, A 2.084

Ghiasvand, S 1.010

Gholipour, T 2.189, 1.128

Ghosh, A 2.329

Ghosh, C 1.053

Giagante, B 2.347, 3.123

Giallonardo, A 2.123

Giardino, M 1.201

Gibson, M 2.370

Gibson, R 3.446

Gidal, B E. 1.330, 1.315, 1.300, 1.302, 1.234

Gill, D 3.384, 1.201, 3.399, 3.281, 3.093

Gill, R S. 1.257, 2.182, 3.237, 3.253

Gil-López, F 3.205

Gillard, M 2.225

Gillies, G 1.451

Gilling, K 3.417

Gilmore, E J. 2.027, 3.125

Gil-Nagel, A 1.298, 3.461

Giner, P 2.260, 1.307

Gioia, G A. 2.454

Giordano, F 3.339

Giordano, F 2.188

Giraldez, B G. 1.310, 2.301

Giraldez, T 1.174

Giralt, S A. 3.134

Girard, B 3.277

Girgis, F 2.310, 2.312

Giza, C 2.026

Gjini, K 1.134

Glasscock, E 2.086, 3.156

Glauser, T 1.231, 1.232, 3.426, 1.235, 3.401, 3.197

Gledhill, J M. 3.094

Gleichgerrcht, E 1.343

Gleichgerrcht, E 1.092

Glenn, K J. 3.304, 3.306, 3.307

Glenn, T 3.021

Gliske, S 3.038

Gliske, S V. 3.040

Gluckman, B 3.117

Glykys, J 1.004

Glynn, P 3.333, 1.410

Glynn, S 2.331, 3.131

Go, C 2.030

Gocmen, R 1.216

Goebel Madsen, C 3.245

Goenka, A 2.004

Goetsch, S 1.459

Goksen, Y 2.218

Golbeck, E 3.369, 2.451

Gold, J 2.012

Gold, J 3.120

Goldberg, E 1.023, 2.209

Goldberg, P 3.282, 3.211, 3.292

Goldberg, P Y. 1.458

Goldenberg, M 2.068

Goldenholz, D M. 1.068, 2.383, 1.192, 2.158, 3.076

Goldin, J 2.010

Goldman, A 2.066

Goldman, L 3.318

Goldstein, D 1.103

Goldstein, D 3.228, 3.401

Goldstein, J 3.426

Goldstein, J L. 1.231, 1.232, 1.235, 3.401, 3.197

Goldstein, L B. 3.407

Goldstein, L 3.234

Goldstein, N 2.209

Gom, R 1.071

Gomes, A 3.226

Gomes, B 1.080, 3.054

Gomes, F L. 1.080, 3.054

Gomez-Ibañez, A 1.464

Gonda, D 3.120

Gonen, O M. 2.198

Gong, H 2.453, 3.468

Gong, P 3.090

Gong, Q 2.171, 2.452

González, G 2.301

González Otárula, K A. 1.042, 3.223

Gonzalez, H F. 1.258, 1.259, 1.252, 2.091

Gonzalez, T 2.323

Gonzalez Montoya, V 2.407

Gonzalez Otarula, K 2.033, 3.233

Gonzalez-Castillo, J 2.199

Gonzalez-Giraldo, E 1.305

Gonzalez-Martinez, J A. 1.158, 1.185, 1.053, 3.327, 1.365, 2.410, 1.335, 3.035, 2.314

Gonzalez-Martinez, J A. 2.055

Goodale, S 1.259

Goodale, S E. 1.258, 1.252

Goodale, S E. 2.091

Goodchild, S J. 1.285, 3.273

Goodkin, H P. 1.019

Goodkin, H P. 1.231, 1.232, 3.426, 1.235, 1.406, 3.061, 3.197

Goodman, A M. 1.076

Goodman, B P. 1.202

Gooley, S 2.193

Goossens, M 3.082

Gorelik, D 3.318

Gorges, M 1.324

Gorman, G 1.052

Gorniak, R 1.033

Gossell-Williams, M 3.259

Gotman, J 1.260, 1.160, 1.077, 1.042, 2.043, 2.201, 3.149, 3.143

Goto, A 1.401

Gottoff, J 3.302

Gourmaud, S 2.404

Goy, E 2.220

Goyal, M 1.420, 1.421

Goyal, S 1.022, 3.352

Gozzo, F 3.339

Gröhn, O 1.097

Grünwald, J 3.151

Graça, J 2.240

Grabenstatter, H 3.159

Graber, K 3.153

Graber, S 3.355

Graf, D 3.326

Graf, D A. 2.299

Graham, J 3.228

Graham, J 2.419

Graham, L N. 3.259

Gramm, M 1.400

Granados, A 3.354

Granata, T 1.306, 2.123

Granner, M 3.088

Grant, G A. 1.392, 2.315, 2.076

Grant, P 1.041, 2.058, 1.043

Gray, A 1.440

Gray, R 2.462

Grayden, D B. 1.068, 3.081

Grayson, L 1.383, 1.468, 3.456

Greally, M 1.396

Grebe, H 1.291

Greco, T 1.457

Green, L 3.292

Greenwald, M 2.293

Greenwood, J E. 1.336

Gregg, N M. 3.154

Gregory-Flores, A 1.045, 1.055

Greiner, H M. 3.340

Greve, B 2.464

Greve, D 2.189

Greven, A 1.341

Grewal, S S. 3.324, 1.088, 1.366

Grier, E 1.198

Griffin, N G. 1.392

Griffith, J 3.334

Grimwood, M 1.287, 3.273

Grinenko, O 1.369, 3.035, 3.036

Grinnell, T 2.239, 2.240, 2.241, 2.242, 2.247, 3.293

Grinspan, Z 1.437, 2.108, 1.410, 2.109, 2.110, 1.412, 1.413, 3.179


Grinton, B E. 1.233

Grisotto, L 2.188

Griswold, M 1.253

Groover, O 1.197

Groppe, D M. 2.090, 3.383

Grosenbaugh, D K. 1.019

Gross, C 3.046, 3.060

Gross, D W. 2.167, 2.173

Gross, D W. 1.247

Gross, R E. 1.226

Gross, R E. 1.373, 1.033, 3.326, 1.169, 2.307, 3.073, 2.074, 1.338, 1.341, 1.343

Gross, W L. 3.387

Gross, W L. 1.256

Grossman, S 3.322

Grossman, T R. 1.458

Grova, C 1.160

Grova, C 2.056, 3.143

Gruenbaum, B 1.062, 3.254

Gruenbaum, S E. 3.062, 3.063, 3.008

Gu, F 3.005

Gu, Y 3.459

Guénot, M 3.107

Guan, R 1.436

Guan, Y 1.349

Gudlavaletti, A 2.281

Guerreiro, M 2.356

Guerrero López, R 2.301

Guerriero, R 3.334, 2.021

Guerrini, R 2.188, 1.201

Guerrini, R 1.022, 3.339, 3.237

Guger, C 3.151

Guha, R 1.219

Guignet, M A. 3.001

Guillen, M 1.354

Guilliams, K 2.021

Gulani, V 1.253

Gummadavelli, A 3.345

Gunduz, M T. 2.437, 3.446

Gunning, B 1.453

Gunny, R 1.251

Guo, A 1.178

Guo, D 1.059

Gupta, A 2.324, 2.054, 2.410

Gupta, A 2.038

Gupta, K 2.091

Gupta, K 1.104

Gupta, R 1.226

Guragain, H 1.035, 1.254, 1.086

Gurbani, A 2.147

Gurbani, S 2.147

Gurcharran, MD, K 1.413

Gurkoff, G 3.108

Gurkoff, G 3.109

Gurnani, S 3.049, 3.155

Gurnett, C 3.334

Gururangan, K 1.141, 3.195

Gustafson, M 1.224

Guterman, E L. 1.460

Gutiérrez-Gutiérrez, G 1.206

Gutierrez-Colina, A 2.358, 1.382

Gutterman, D 2.253

Guy, G 3.288

Guye, M 3.237

Guzmán, L 2.283

Gwaltney, C 1.196

Gwinn, R 1.167, 3.348

Gwyn, P G. 3.435

H

Höller, Y 1.378

Haas, K F. 1.258, 1.252

Haas, K F. 3.217

Haas, R 3.120

Habben, L 3.368

Habibi, M 3.422, 3.423

Hadar, E 1.336

Haddad, N 1.214

Haddad, N 1.429, 2.118

Hader, W 2.310, 2.312

Hadzic, A 2.409

Hagopian, S 2.280, 3.302

Hahn, C 2.030

Haider, H A. 3.125

Haines, K 2.232

Hajnal, B 3.039

Halasz, L 3.039

Halavacs, MPH, N 1.433

Halford, J 3.085, 1.470

Hall, A 1.149, 1.224

Hall, J 3.237, 3.223

Hall, J A. 1.260, 1.363, 3.149

Halliday, B 2.374

Halpern, C H. 2.076, 3.153

Halquist, M 1.056

Haltiner, A 1.167

Ham, J 3.214

Hamalainen, M 1.128

Hamandi, K 2.265

Hamann, S 3.073

Hamano, S 1.229

Hamaoka, T 2.089

Hamberger, M J. 3.383

Hameed, M 3.019

Hameed, M 3.335, 1.368, 3.155

Hamer, H 1.339, 3.458

Hamer, S 2.295

Hamilton, C 2.051

Hamilton, L 3.122

Hamilton, R 3.406

Hammond, D 1.181

Hammond, S 1.095, 1.100, 2.047, 3.095

Hampel, K 2.260

Hampl, J 2.214

Hampson, J 3.116

Hampson, J P. 1.454

Hamrouni, N 1.153

Han, J 2.363

Han, L 1.059

Han, Y 1.148

Han, Z 1.051

Hanakawa, T 2.194

Hanaya, R 2.339

Han-Burgess, E 1.323, 1.324, 1.325, 1.326, 1.327

Handy, L 1.117

Haneef, Z 2.066

Haney, D 3.202

Hannan, V 1.123, 1.127

Hantus, S 3.125, 3.210, 1.418, 3.097

Hara, K 2.266, 1.184

Hara, S 1.088

Harden, C L. 3.300

Harel, B 1.301

Harger, R 2.151

Harini, C 2.137, 3.335, 2.357, 2.360, 3.342, 1.359

Harper, R 2.170, 3.244

Harper, S 1.116

Harrer, S 3.174

Harridas, B 1.410

Harris, D 2.331, 3.131

Harris, N 1.097, 1.011

Harris, S 2.080

Harrison, T 2.397

Hartl, E 2.278

Hartshorn, A 1.312

Harvey, S 1.451

Hasan, A 1.287, 3.273

Hasbani, D 1.333

Hasegawa, H 3.352

Hasegawa, H 2.040

Hashimoto, S 1.184, 3.064

Hashizume, A 3.328, 2.093

Hashizume, A 1.157

Hasija, T 2.047

Hass, K 2.414

Hassan, A 3.025

Hassan, M 2.096

Hastings, S D. 3.004

Hasulak, N 1.379

Hatanaka, K 2.282

Hatcher, A 1.180

Hater, B 2.358

Hausman-Kedem, M 2.233

Haut, S R. 1.192

Havens, K 2.196, 3.338

Havens, K 1.346, 1.353

Hawkins, E 1.056, 3.044

Hawkins, N A. 1.031, 1.286

Haykal, M 3.450

Hayman, M 1.201

Hays, R 3.451

He, B 1.261, 1.266, 1.267

He, G 2.458

He, S 3.048, 1.012, 3.056

He, X 3.249

He, X 3.250

Head, G 3.466

Heath, J 1.411

Heavin, S 1.201

Heck, C 3.321

Heck, C N. 1.336

Hecox, K 3.426

Hedrich, T 2.056, 3.143

Hedrich, U B. 2.367

Heers, M 3.143

Heesch, J 2.298, 3.296, 3.297

Hegarty, S 3.433

Hegde, M 1.372, 1.392, 1.336

Hehn, F 2.341, 2.342

Heinen, F 2.011

Heinzen, E L. 1.392, 3.401

Heiss, J 1.081

Helbig, I 1.022, 2.367, 1.393, 3.221

Helbig, K L. 1.022, 2.367


Heller, A H. 3.295, 2.453, 3.468

Helmkamp, L 2.279

Helms, K 1.421

Helmstaedter, C 1.311

Henderson, J M. 2.076

Henin, S 1.379

Henninger, H 2.350

Henriksen, O 2.014

Henry, T 3.321

Henry-Barron, B J. 3.357

Hensch, T K. 3.049, 3.007

Henshall, D 3.458

Heo, K 2.461

HEP Investigators, 3.240, 3.190, 3.268, 3.243

Hepworth, G 1.321

Herlopian, A 3.125

Herman, P 1.062, 3.254

Herman, S T. 1.329, 1.412, 3.076

Hermann, B 2.206, 2.361, 3.235

Hermes, D 2.076

Hernandez, G 1.174

Hernandez, L 2.421

Hernandez-Rodriguez, H G. 2.177

Hernando, K 1.468

Herren, C 2.146

Herrero, J 3.150

Herron, J 1.086

Hertling, D 2.302

Herzog, A 1.426

Hesdorffer, D C. 1.437, 3.260, 2.125, 2.108, 2.110, 1.412, 3.268, 3.182, 2.419, 1.469

Hess, C 1.340

Hess, C 3.321

Hettrick, L 1.458

Hewitt, K 1.343

Heyne, H 2.377, 1.393

Hicks, R 1.415

Higashikubo, B 1.002, 3.028

Higdon, L 3.232

High, B 2.129

Higo, T 3.319, 2.088, 2.095

Higuchi, M 3.064

Hildebrand, M S. 2.365, 2.374, 1.451

Hill, C E. 1.460

Hill, M 3.158

Hillebrand, A 2.044

Himali, J 3.432

Hincapie, A 3.149

Hinn, A 3.425

Hinojo-Perez, A 1.045

Hirfanoglu, T 1.158

Hirfanoglu, T 2.055

Hirfanoglu, T 2.054

Hironaga, N 1.159

Hironaka, K 3.346

Hirose, S 1.401, 3.460

Hirsch, L J. 1.194, 1.277, 2.064, 2.313, 2.027, 3.298, 1.336, 3.125

Hitchcock, A 3.228

Hixson, J D. 1.323, 1.324

Hiyoshi, T 3.213

Ho, A C. 1.237

Ho, A L. 2.076

Ho, C 3.303

Ho, N T. 2.125, 3.182

Ho, R 2.005

Hoban, T 2.331

Hocker, S E. 1.142, 3.125

Hodgeman, R 3.127

Hodges, S 1.061

Hodgeson, N 3.007

Hofer, K 2.105

Hoffman, J E. 1.105

Hoffman, MD, C 1.413

Hoffmann, D 3.149

Hogan, R E. 1.302, 2.042

Hogue, O 2.344

Holden, S 1.002

Holder, C M. 3.256

Holder, D 1.188, 1.358

Holland-Bouley, K D. 3.340

Holley, A 1.061

Hollingsworth, G 1.390, 3.392, 3.399, 3.405

Hollis, C 2.010

Holmay, M 3.455

Holmes, M 3.199, 3.190

Holmes, M 1.210

Holmes, M D. 1.189

Holt, R 2.034

Holtkamp, M 3.309, 3.121

Holtzheimer, P 3.382

Honda, R 2.400, 2.328

Honda, R 1.350

Hong, M 2.455

Hong, S 2.322

Hong, S 1.246, 2.207, 3.253

Hong, S 1.257

Hong, S 3.237

Hong, S 2.182

Hong, S 2.309

Hong, Z 2.132

Honmou, O 1.044

Hope, O A. 2.433, 3.260, 2.338, 3.268, 2.340

Hopkins, C 2.458

Hori, J 3.187

Hori, T 2.400

Horinouchi, T 1.046

Horn, P S. 3.340

Horowitz-Kraus, T 1.382

Horvat, D 2.364

Hosoyama, H 2.339

Hossain, M 1.053

Hou, J 1.181, 1.210

Hou, Y 1.152, 1.385

Houck, K M. 2.066, 3.177

Howard, M 3.032

Howell, K 1.201, 1.390, 3.221

Hron, D 1.414

Hsieh, J 1.459

Hsieh, K 1.455

Hsin, Y 1.036, 3.098

Hsu, C 2.034

Hsu, E 3.109

Hsu, F 3.344, 2.306

Hu, W 1.017, 3.241, 3.193

Hua, A 1.194

Huang, H 1.423

Huang, R 3.224

Huang, Y 2.201

Hucek, C 3.467

Hudson, E R. 2.398

Hudson, M 1.101

Hueneke, S 1.420

Huesmann, G 3.299, 3.441, 3.248

Huff, J 3.359

Huganir, R 1.111

Hughes, E 1.022, 3.352

Hughes, I 3.368

Hughes, S 1.234

Hughes-Scalise, A 1.414

Huguenard, J R. 3.162

Huh, L 2.384

Huiskamp, G 2.044

Hull, J 3.023

Humphries, C J. 1.256, 2.206, 3.235

Humphries, C J. 3.387

Hunt, C 1.374

Hunt, R 1.058

Huntley, M 3.180

Huntsman, M 2.293

Huntsman, R 1.462

Hunyadi, B 3.459

Husain, A M. 1.431

Husari, K 2.113

Husari, K 3.224

Hussain, F 2.001

Hussain, F 1.425

Hussain, S 2.098, 2.298, 3.296, 3.297, 3.169

Hussein, H 3.066

Hussein, Z 2.246

Huttner, A 1.370

Huynh, H 3.097

Hwang, E 3.187

Hwang, G 2.206, 3.235

Hwang, S 3.410, 3.229, 3.231

Hwang, S 2.200

Hyder, F 1.062, 3.254

Hyder, S K. 2.083

Hynan, L 1.271, 1.272

Hyslop, A 1.354, 1.355

I

Ibhazehiebo, K 1.114

Ibrahim, G 3.351

Ibrahim, K 2.265

Ido, K 2.231, 2.282

Iffland, P 3.111

Iffland, P H. 1.129

Ignatiadis, S 1.321, 1.139

Ihara, Y 1.401

Iida, K 1.157, 3.328, 2.093

Iihara, K 1.039

Iimura, Y 1.040

Iimura, Y 3.319, 2.088, 2.095, 3.252

Ikeda, A 1.039, 2.065

Ikeda, H 1.236

Ikeda, H 3.206, 3.213

Ikeda, H 1.135, 1.236, 3.206

Ikeda, H 3.213

Ikedo, F 2.239


Ikegaya, N 2.194

Iliyasu, Z 3.418

Ilyas, A 3.071, 3.016

Ilyas, M 1.149

Imai, K 1.236, 2.268, 3.206

Immonen, R 1.101

Immonen, R J. 1.096, 1.097, 1.098, 1.099

Imoto, H 1.223

Imoto, H 3.167

Inaji, M 1.184

Inaji, M 2.266, 3.064

Inati, S 2.199, 1.081, 2.205, 3.165, 3.242, 3.258

Inati, S 3.242

India, S 3.268

Ingason, A 3.393

Ingram, J B. 2.449

Inman, C 3.073, 2.074

Inoue, A 3.375

Inoue, T 1.223, 1.177, 3.167

Inoue, T 2.304

Inoue, Y 1.135, 2.390, 1.236, 3.206, 3.213

Inoue, Y 1.322, 2.268

Intravooth, T 1.211

Inuzuka Nakaharada, L M. 3.163

Investigators, R 2.075

Iqbal, S 2.376, 2.377

Isbane, F 1.169

Ishibashi, Y 3.079

Ishida, K 2.328

Ishii, A 1.401

Ishii, M 1.322

Ishishita, Y 1.344

Isitan, C 2.060

Islam, W 1.062, 3.254

Ismail, A 3.439

Isom, L L. 1.051, 3.018, 1.073, 3.023, 3.068, 3.083, 3.058, 3.061

Isquith, P 2.454

Issa, N P. 1.445, 2.017, 2.018, 3.442

Itamura, S 1.442

Ito, Y 2.231

Itoh, M 2.400

Ivaturi, V 3.462

Iversen, P 3.356

Iwasaki, M 2.194

Iwasaki, M 2.400, 3.350, 2.045

Iyer, R 3.470

Iyoda, K 1.229

Izadi, A 3.108

Izadi, A 3.109

Izadyar, S 2.120

Izzi, F 2.249

J

Jóźwiak, S 2.135

Jackson, G 3.237

Jackson, G D. 1.263, 2.193, 3.080

Jackson, H N. 3.341

Jackson, M 1.232, 3.426, 1.439, 3.401

Jacobs, J 1.094, 2.007, 2.102, 2.134

Jacobs, M L. 1.258, 1.252, 1.256, 3.387

Jacobs, LMSW, R 1.413

Jacobson, A 2.022

Jacobson, M 2.378, 2.385

Jacobson, S 3.087, 1.081

Jadav, R 1.435

Jadeja, N M. 2.028

Jadhav, V 1.220

Jafar-najad, P 1.466

Jafarpour, S 1.194

Jafry, O 2.202

Jagadeeswaran, I 2.086

Jahodová, A 1.170

Jain, P 3.390

Jain, P 1.221

Jain, S 3.334

Jain, S 1.070, 1.465

Jalilianhasanpour, R 1.270

Jamal Omidi, S 3.116

James, F 1.113

Jamy, R 3.416

Jamy, R 3.139

Janca, R 1.170, 3.171

Jancovsk, N 1.466

Jang, I 3.306

Jang, S 3.015

Janio, E 3.187

Jankovic, M 1.057

Jankovic, M 1.065

Jannati, A 3.152

Janzarik, W 2.007

Jaraba, S 2.286, 2.287

Jarosiewicz, B 3.092, 2.046, 2.049

Jarrar, R 3.360, 2.251, 3.370

Javarayee, P 3.340

Jawhari, M 2.296

Jayadev, S 3.099

Jayakar, P 1.355

Jaynes, M 2.435

Jazayeri, D 3.228

Ježdík, P 1.170

Jean-Noel, N 1.424

Jehi, L 2.324, 2.410, 1.335

Jensen, F E. 1.021, 2.404, 3.017

Jensen, L 1.291

Jensen, M 2.406

Jeong, J 1.132, 1.138, 2.002, 2.327

Jeong, K 1.049

Jespersen, B 2.014

Jespersen, J 2.377

Jette, N 2.274, 1.434, 2.310, 2.312, 1.404, 2.346, 1.412, 1.417

Jewell, A 1.441, 3.438

Jezdik, P 3.171

Jha, A 2.348

Ji, M 3.296, 3.297

Jiang, C 1.048

Jiang, S 3.090

Jiang, Y 1.124, 1.127

Jiang, Y 3.090

Jimenez-Jimenez, D 2.070

Jin, B 1.365, 2.179, 2.127

Jin, J 3.168

Jin, K 3.350, 2.267

Jin, K 1.131, 2.395, 2.045

Jing, J 2.025

Jingushi, A 2.339

Jirsa, V 3.112

Jiruska, P 3.171

Jo, H 2.309

Jo, Y 2.195

Job, A 3.149

Jobst, B 1.033

Jobst, B 2.350

Jobst, B C. 3.133, 3.166, 3.147

Joe, J 2.097

Johannesen, K 3.221

John, K 3.214

Johnson, B 2.258

Johnson, C 3.248

Johnson, E 1.062, 3.254

Johnson, E 1.269, 2.353

Johnson, E L. 3.049

Johnson, J A. 2.311, 2.338, 2.351, 2.340

Johnson, J 1.285, 1.287, 3.273, 3.211

Johnson, K 1.117

Johnson, M 3.393

Johnson, S 1.437, 2.108

Johnson, V 3.110

Johnson,, L 1.440

Johnston, L 1.097

Jonak, C 1.112

Jonas, R 3.420

Jones, B 1.134, 1.450

Jones, B 2.458

Jones, J 2.361

Jones, J 2.334

Jones, J 3.061

Jones, M 1.284

Jones, M 3.434

Jones, M 1.449

Jones, N 2.462

Jones, N 2.010, 1.099, 1.101, 1.118, 1.288

Jones, S 1.139

Jones, S 1.253, 2.172, 1.335

Joohee, S 1.367, 2.181

Jordan, S 1.409

Jordan, Z 3.039

Jorrat, P 3.267

Jory, C 2.265

José Carlos Roche Bueno, J 1.307

Josephson, C 2.310

Josephson, C B. 2.274, 2.312

Joshi, A 3.153

Joshi, A 1.155

Joshi, C 3.347

Joshi, D 2.455

Joshi, P 2.431

Joshi, S 1.323, 1.324

Joshi, S 1.409, 2.331, 1.419, 1.420

Joshi, S 2.081

Joss, S 1.402

Juan, E 1.450, 3.115

Juengst, S 3.379

Juhasz, C 1.138, 2.327

Jung, A 3.293


Jung, C 3.295, 2.453, 3.468

Jung, Y 2.440, 3.279

Jurado, M 2.141

Jurisch-Yaksi, N 1.063

Justesen, A B. 2.035

Jutton, V 2.209

Juvany, R 2.286, 2.287

K

Kälviäinen, R 1.290

Kabbara, A 2.096

Kabir, N 3.290

KacarBayram, A 2.059, 2.116, 3.220

Kadam, S D. 1.280, 1.111

Kadambi, A 1.173

Kaddumukasa, M 2.122

Kaddumukasa, M N. 2.122

Kadekawa, J 3.346

Kadis, D S. 3.471

Kadom, N 1.343

Kagawa, K 1.157, 3.328, 2.093

Kagawa, Y 2.268

Kahane, P 2.043, 3.149

Kahen, B A. 1.105, 1.106

Kahlig, K M. 2.277

Kahriman, M 1.371, 1.218

Kaila, K 2.156

Kairys, A 3.377

Kaiwar, C 1.022

Kakacek, J 1.269, 2.391, 1.405

Kakara, M 3.222

Kakisaka, Y 1.131, 2.395

Kalamangalam, G P. 2.340

Kalayjian, L 3.231

Kalayjian, L 3.229

Kalss, G 1.378

Kalume, F 3.055

Kalyal, N 3.352

Kamada, K 3.151

Kamath, V 1.435

Kamberi, S 3.318

Kameyama, S 1.364

Kamin, M 3.304, 3.307, 1.303, 2.248

Kamineni, S 2.041

Kaminski, R M. 2.224, 2.226

Kamitaki, B 3.136

Kamnaksh, A 1.099

Kamp, M A. 1.457

Kandula, T 1.395

Kaneko, S 2.267

Kanemura, H 1.229

Kang, H 2.321, 2.330, 1.389, 2.157, 2.244

Kang, H 2.133

Kang, J 3.373

Kang, J 3.225

Kang, J 1.168, 2.443

Kang, S 1.309

Kang, S 1.024

Kang, X 1.134

Kanner, A M. 2.391, 3.260, 3.268, 3.246

Kanner, A M. 2.046

Kanno, A 1.163

Kano, M 1.083, 1.223, 1.121, 1.090

Kansakar, U 3.280

Kantamneni, T 2.324

Kanth, K 2.335

Kanyinji, C 3.362

Kao, A 3.209

Kapeller, C 3.151

Kaplan, A 2.005

Kapoor, S 3.321

Kapoor, T 1.144

Kapur, J 1.172, 2.081, 3.462

Kapur, K 1.241, 1.231, 2.261, 2.370, 1.232, 3.426, 1.100, 3.401, 3.095, 3.152, 3.197

Karagoz, T 1.216

Karakis, I 1.373, 1.197, 3.145

Karamintziou, S 1.060

Karanam, A 3.300

Karas, P 2.191

Karen, M 1.152

Karimi Tari, P 1.285, 1.287, 3.273

Karkar, K M. 3.119

Karkare, S 2.039

Karli Oguz, K 1.216

Karoly, P J. 1.068

Karoly, P J. 3.081

Kashida, Y 2.339

Kassiri, J 2.318

Kasteleijn- Nolst Trenite, D 2.285

Katabira, E 2.122

Katagiri, M 2.054, 2.055

Katagiri, M 1.157, 1.158, 3.328, 2.093, 2.179

Kataoka-Sasaki, Y 1.044

Katayama, J 3.328

Kato, H 3.282, 3.211

Katsarou, A 3.272

Katyal, C 2.408

Katyayan, A 3.343

Katzan, I 2.217

Kaufman, D 3.411

Kaufmann, T J. 1.366

Kaushal, S 3.278

Kaushik, G 1.114

Kawaguchi, M 1.193

Kawai, K 1.344

Kawai, K 1.082

Kawamura, K 3.252

Kawamura, K 2.095

Kawasaki, T 1.396

Kawatu, N 3.362

Kaye, E 3.448

Kaye, H L. 1.225, 3.152

Kayyali, H 1.224

Kayyali, H 2.296, 2.008, 2.009

Ke, C 3.407

Kearney, J A. 1.031, 1.024, 1.286, 1.309

Keating, R 2.319

Keating, R 2.103

Kebriaei MD, M 3.330

Keever, K M. 1.392

Keezer, M 2.310, 2.312

Keith, S 3.433

Keller, A 3.363, 2.154, 3.406

Kelley, K 2.388

Kelley, K 1.201

Kelley, S 3.426, 3.197

Kellogg, M 2.130, 2.305, 3.173, 2.413

Kelly, P 1.431

Kendall, K 1.391

Kent, P 3.043

Kentris, M 3.217

Keogh, B 3.348

Keppetipola, K 3.320

Kerber, K 1.094

Kern, J 3.425

Kerr, A 2.413

Kerr, D 2.373

Kerr, W 3.187

Keselman, I 2.067, 3.108

Kessler, S 1.305, 2.280, 3.302

Kettani, H 2.164

Khademi, S 3.024

Khadjevand, F 3.077, 3.470

Khalil, S 3.438

Khambhati, A 3.101

Khan, E 1.318

Khan, F 2.001

Khan, F 3.215

Khan, M 2.001

Khan, N 3.003

Khan, O 2.399

Khan, S 1.319

Khan, S 3.222

Khatri, V 1.274

Khera, Z 3.025

Khilari, M 2.057

Khodagholy, D 1.187

Khodair, R 1.429

Khoo, H 1.260

Khoo, H 2.201, 3.149

Khoshkhoo, S 1.058

Khurana, D 1.333

Khuvis, S 3.150

Kidokoro, H 1.193

Kikuchi, T 1.039, 2.065

Killen, J 3.465

Kim, A 1.358

Kim, D 2.238

Kim, D 3.373

Kim, D 2.330

Kim, E 2.455

Kim, E 2.195

Kim, G 1.242

Kim, H 1.181

Kim, H 2.321, 2.330, 2.133, 1.389, 2.157, 2.244

Kim, H 2.461

Kim, H 2.020

Kim, H 1.245

Kim, H 2.322

Kim, H 1.328, 1.432, 1.228

Kim, H 1.245, 2.020

Kim, I 1.086

Kim, J 3.189

Kim, J 2.294

Kim, J 1.262

Kim, J 2.440, 3.279

Kim, K 2.461

Kim, K 3.199

Kim, M 2.195


Kim, M 3.306

Kim, N 3.249

Kim, S 2.440, 3.279

Kim, S 3.189

Kim, S 2.330, 2.133, 1.389, 2.157, 2.244

Kim, S 2.321, 1.049, 2.330

Kim, S 3.111

Kim, S 2.414

Kim, S 1.125

Kim, T 3.279

Kim, W 2.294

Kim, W 1.049

Kim, Y J. 1.058

Kim, Y 1.242, 2.119

Kim, Y 3.373, 2.238

Kim, Y 3.367

Kimbugwe, J 3.117

Kimchi, E 1.173

Kinay, D 3.181

Kindilien, S 2.380

King, C 2.374, 2.375, 1.390, 3.392

King, J 2.019

King, M 1.396

King-Stephens, D 2.051

Kinnaman, B 1.149

Kinnear, K 1.167

Kinzy, T 2.217

Kiral-Kornek, I 3.174

Kiriakopoulos, E 2.391, 1.405

Kirk, E 1.395

Kiroski, I 1.316

Kirov, G 1.391

Kirschner, J 2.102

Kirschner, M 1.378

Kissani, N 1.214

Kitara Lagoro, MD, PhD, D 1.191

Kitazawa, Y 1.131

Kitazono, I 2.400

Kløvgaard, M 3.429

Klee, E W. 1.022

Kleen, J K. 3.122

Klein, P 1.303, 3.318, 2.254, 2.453, 3.468

Klink, K 2.392

Klotz, A 2.134

Kluger, G J. 1.022, 2.396

Knapp, L 2.250

Knappertz, V 1.296, 3.288

Knight, J 3.382

Knight, J C. 1.402

Knight, S J. 1.022

Knoth, I 2.355

Knoth, R L. 2.152

Knowlton, R C. 3.321, 2.210, 3.122, 2.073, 3.223

Knox, A 3.114

Knox, K 3.099, 3.274, 3.100

Knupp, K 1.314, 2.109, 2.129, 2.279, 3.179, 3.461

Ko, A L. 1.008

Ko, A 1.242, 2.330, 2.133, 2.119

Ko, T 2.322, 2.195

Kobayashi, E 1.160, 2.056, 3.237, 3.223, 3.143

Kobayashi, J 3.363, 2.154

Kobayashi, K 1.039, 2.065

Kobylarz, E J. 1.312, 1.144, 2.048, 3.133

Koch, P 3.326

Kochen, S 2.347

Kochen, S 3.123

Koeleman, B 3.228, 3.393

Koenig, J 1.018

Koepp, M J. 2.166, 2.183, 2.184

Koganti, M 2.041

Koh, S 2.369, 1.025, 2.414, 1.415

Kojimahara, N 1.229

Kokkinos, V 3.132

Kokkinos, V 2.303

Kokoszka, M 1.356, 1.357

Kolaczyk, E 2.092

Kolikonda, M 3.264

Komaki, H 1.229

Komarek, V 1.170, 3.171

Kondo, A 1.135

Kondo, S 1.268

Konduru, S 1.284

Koneval, Z 3.099, 3.274

Kong, D 1.018

Kong, J 1.242, 2.119

Koo, C 2.157

Koo, Y 1.245, 2.020

Koop, J 2.317

Koplowitz, B 1.302

Kordasiewicz, H 1.458

Korgaonkar, A 1.016

Koshimoto, R 2.328

Kosmider, L 1.056

Kossoff, E H. 3.426, 1.305, 3.197, 1.456

Kotagal, P 2.324, 2.247

Kothare, S V. 2.039, 2.241, 3.201

Kothare, S V. 2.396, 3.188

Kothur, K 3.093

Kotloski, R 3.103

Kotlyar, G 3.430

Kotulska, K 2.135

Koubeissi, M 2.001

Koubeissi, M 2.112

Koudriatvseva, T 2.234

Koukounas, Y 1.315

Kowalczyk, M 1.263, 2.193, 3.080

Kozek, L 3.027

Kramer, C 1.445

Kramer, M 2.092, 2.012

Kramer, M 3.037

Kramer, U 2.233

Kratochvil, Z 1.062

Kratochvil, Z 3.254

Krause, R 3.393

Krecke, K 2.335

Krefting, J 3.456

Kregel Gratton, M 2.409

Kreiman, G 3.033

Kremen, V 1.086, 3.077, 3.470

Krestel, H 1.074

Kreth, F 2.332

Kriegstein, A 2.460

Krishnagiri, M 3.269

Krishnamurthy, K 1.120

Krishnamurthy, R 2.334

Krishnan, B 1.253, 1.185, 3.327, 1.369

Krishnan, V 1.065

Krishnan, V 1.057

Krokosky, A 2.364

Kroner, B L. 2.125, 1.406, 2.110, 1.412, 3.182

Krsek, P 1.170, 3.171

Krueger, D 3.456

Krumholz, A 1.431

Krzeski, J 3.046

Krzysztof, B 3.382

Kubota, M 1.229

Kubota, T 1.193

Kubota, Y 2.400

Kubova, H 3.013, 3.014

Kucewicz, M 1.267, 3.470

Kuczyński, D 2.135

Kudr, M 1.170

Kuehn, S 1.088

Kuhlmann, J 1.088

Kuhlmann, L 3.081

Kumar, N 1.371

Kumar, P 3.156

Kumar, R 2.170, 3.244

Kumar, U 1.011

Kumata, K 3.064

Kundishora, A 1.062, 3.254

Kundrick, E 1.283

Kunieda, T 3.375, 2.065

Kunihiro, N 2.316

Kunii, N 1.082

Kuo, A 3.413

Kuo, C 2.203

Kuo, F 3.157

Kuo, J 2.192

Kurian, M 1.201

Kurisu, K 1.157, 3.328, 2.093

Kurita, T 1.046

Kuroad, N 3.349

Kuroda, N 1.442

Kurrasch, D 1.114

Kuruba, R 1.109, 1.110

Kusumi, I 1.046

Kuzeljevic, B 2.384

Kuzmanovski, I 2.463

Kuzniecky, R 1.092, 3.410, 3.188, 3.201, 3.240, 3.190, 3.243

Kverneland, M 3.356

Kwan, P 2.010, 3.421

Kwan, P 3.228, 1.139, 2.198, 2.162, 2.275

Kwan, R 1.285

Kwon, C 1.434, 1.417

Kwon, H 2.321

Kwon, J 3.425

Kwon, O 1.380, 3.373

Kwon, O 2.238

Kwon, S 2.200

Kyriakopoulos, P 3.409

Kyrychenko, A 2.250


L

La Vega-Talbott, M 1.356, 1.357

Löscher, W 1.282

López Cavanillas, M 1.307

López-Gallardo, S 1.206

López-González, F 2.260, 1.310

López-González, R 1.278

Labbe, S 2.396

Labib, A 3.297

Labiner, D M. 2.258, 1.433

Labiner, K 3.224

Labiner, K 2.113

Lacher, R 3.060

Lachner Piza, D 2.007

Lachner-Piza, D 1.094

Lacoursiere, C 1.392

Lacuey, N 3.116, 1.454

Ladeia-Frota, C 3.314

Ladha, H 3.139

Ladha, H 3.416

Ladino, L 1.278, 2.421

Lado, F 3.410, 3.411, 3.150

Lafontaine, M 2.355

LaFrance Jr, W 1.270, 2.001

LaFrancois, J 1.070, 1.465

Lagacé, M 2.355

Lagae, L 3.228, 1.292, 3.463

Lage, K 2.377

Lagrange, A H. 3.025

Lah, S 3.384, 1.375

Lai, S 2.018

Lai, S 2.017

Lai, W 3.048, 1.012, 3.056

Lai, W W. 3.453

Lai, Y 1.231, 1.232, 3.426, 1.235, 3.010, 3.197

Lakatos, P 3.150

Lal, D 1.333

Lal, D 1.022, 2.376, 2.377, 1.393, 1.397, 1.400

Lalgudi Ganesan, S 2.030

Laliberté, F 2.259

Lallas, M 1.188, 1.358

Laloyaux, C 1.294

Lam, S 3.341

Lam, S K. 3.331

Lammert, D 1.394

LaMothe, MSN, CPNP, RN, J 1.413

Lancman, M 3.386, 3.389, 3.374, 3.284, 3.286

Land, H 3.469

Landazuri, P X. 1.337

Landers, J 1.280

Landers, J 1.111

Landman, B A. 1.258, 1.252

Lane, G 2.033

Lane, R 1.458

Langer, J 1.219

Langfitt, J T. 3.321, 1.256, 3.387, 1.340

Lankford, J E. 2.340

Lapin, B 2.324, 2.410

Lapinlampi, N 3.161

Lapp, J 1.420

Laprairie, R 1.462

Lapus, R 1.205

Lardizabal, D 3.118

Lariviere, S 2.190, 2.207, 2.208

Larranaga, P 3.223

Larson, S 3.010

Larson-Prior, L 1.181

LaSarge, C L. 3.024

Lasky, L 1.441, 3.438

Lastra, C 1.318

Latreille, V 2.213

Lattanzi, S 1.306

Lau, L A. 1.014

Lauerer, R 2.367

Laugerman, M 1.330

Laurenza, A 2.254, 3.289, 3.291

Lauseker, M 2.278

Laux, L C. 2.372, 1.309, 2.126, 3.461

Lavrov, I A. 3.154

Lawn, N 3.421

Lawson, J A. 3.384, 3.281

Lawthom, C 3.214

Lax, N 1.052, 1.028

Laxer, K 3.321, 2.210, 1.340

Lazure, P 2.396

Le, J 3.187

Le, S 1.227, 2.192, 2.124

Leahy, L 1.301

Leahy, R M. 1.155, 3.035, 3.036

Leal, B 1.079

Leary, L D. 2.291

Leary, P 1.070

Leatherday, C 1.343

Leclercq, K 2.224

Lederer, D 3.436

Lee, A 2.263

Lee, A 1.447

Lee, B 2.436

Lee, B 2.305

Lee, C 2.366

Lee, D 2.461

Lee, E 2.005

Lee, E 1.115

Lee, G 1.006

Lee, H 2.133

Lee, H 2.440, 3.279

Lee, H 3.049, 3.007

Lee, H 1.027, 1.029

Lee, H 2.309

Lee, H 1.257, 3.237, 3.253

Lee, H 2.244

Lee, I 2.363

Lee, J 2.440

Lee, J 2.325

Lee, J 2.366

Lee, J 2.436

Lee, J 2.325

Lee, J 2.366

Lee, J 3.089

Lee, J 1.329, 2.189, 2.028, 3.125

Lee, J 2.321, 2.330, 2.133, 1.389, 2.157, 2.244

Lee, J 3.421

Lee, J 2.322

Lee, J 2.325

Lee, K 1.160

Lee, K 2.436

Lee, K 3.435, 1.367, 2.181

Lee, M S. 2.459

Lee, M R. 1.183

Lee, M 3.053

Lee, M 2.327

Lee, M 2.195

Lee, N 1.115

Lee, P 1.122

Lee, R W. 1.336

Lee, S 1.245, 2.020

Lee, S 1.389

Lee, S 2.200

Lee, S 1.058

Lee, W 2.080, 3.020

Lee, Y 2.297

Lee, Y 1.387

Lee, Y 2.200

Lee, Y 1.242, 2.119

Leemis, L 1.222

Leesch, W 1.222

Leff, A 2.204

Leffers, A 2.014, 3.245

Lega, B 1.033, 3.451

Legido, A 1.333

Legkaia, L 3.211

Legros, B 3.125

Legros, B 1.308, 1.368

Lehner-Gulotta, D 1.219

Lei, D 2.452

Leibovitch, E 3.087, 1.081

Leigh, S 3.258

Leiguarda, R C. 3.183

Lein, P J. 3.001

Leiphart, J 3.065

Leiser, S 3.105

Leite, J 1.248, 3.380

Lejeune, D 2.259

Lemieux, L 2.170

Lemieux, L 2.204

Lemke, J 1.393

Lemmon, M 2.437

Lenge, M 2.188, 3.237

Leonard, J 3.333

Leone, B 2.408

Leonhardt, G K. 2.204

Leppik, I 2.228

Lerche, H 1.022, 2.367, 3.393

Lesko, A 2.398

Leslie, G 3.166

Lester, S 2.121

Leu, C 3.393

Leung, C 3.282

Leuthardt, E 1.337

Leuwczuk, E 2.081

Leventer, R 3.399

Leventer, R 1.451

Levin, S 3.391

Levine, A 3.010

Levinson, R N. 3.400

Levitt, K 2.137

Levy, J 2.270, 2.425, 3.422, 3.423

Levy, S 1.194, 1.200

Lew, C 2.258

Lew, S 2.317

Lewis, D 2.443


Lewis, S 1.194, 2.394

Lewis de-los Angeles, P 3.395

Ley, M 3.301

Ley, M 1.317

Lhatoo, R 1.371

Lhatoo, S D. 1.218, 2.170, 2.122, 3.116, 3.244, 1.454

Li, D 1.166, 1.048

Li, H 3.090

Li, J 1.123

Li, J 3.035

Li, J 1.179

Li, J 2.417

Li, K 1.181

Li, K 2.168, 2.175

Li, K 3.354

Li, L 1.011

Li, L 2.419

Li, M 1.466

Li, P 2.308

Li, Q 1.118, 3.272

Li, T 1.078

Li, T 1.291

Li, W 3.048, 1.012, 3.056

Li, W 2.452

Li, X 1.166

Li, X 2.152

Li, Y 2.239, 2.240, 2.241, 2.242, 2.247

Li, Y 1.016

Li, Y 2.161

Li, Y 2.053

Li, Y 2.015

Liang, J 2.438

Liau, G 1.051

Libbon, R 3.377

Libenson, M 3.335

Libenson, M 3.128

Lidov, H G. 1.392, 2.180

Lightfoot, P A. 1.233, 2.156

Liguori, C 2.249

Liljenquist, K 2.406

Lillis, K P. 1.004, 1.013, 1.014, 3.317

Lim, H 1.462

Lim, S 2.186

Lima, E 3.378, 3.380, 2.356

Lin, C 3.439

Lin, C 1.366

Lin, J J. 2.306, 3.034, 3.135

Lin, L 1.329

Lin, S 3.273

Lina, J 1.160

Lindberg, U 3.245

Lindy, A 3.397

Liou, J 2.085

Liow, K 2.005, 2.453, 3.468

Lippé, S 2.355

Lippman-Bell, J 3.066

Lisgaras, C 3.041

Lisgaras, C 1.118, 1.288

Litovchenko, T 1.093

Litt, B 1.086

Litt, B 1.190, 3.101, 3.110, 1.423

Little, G 2.167

Liu, A A. 1.379

Liu, C 1.034, 3.208

Liu, C 1.051

Liu, C 3.363, 2.154

Liu, G 1.006

Liu, H 1.371, 1.218

Liu, J 3.057

Liu, J 3.117

Liu, J 2.250

Liu, L 3.241

Liu, L 3.118

Liu, P 2.112

Liu, R R. 1.198

Liu, R 1.034

Liu, S 3.170

Liu, W 1.118, 1.288

Liu, W 3.272

Liu, W 2.171

Liu, W 2.452

Liu, X 2.017, 2.018

Liu, X 3.442

Liu, Y 3.018

Liu, Z 1.349

Liu, Z 2.112

Liu, Z 3.241

Lo Russo, G 3.339

Lob, K 1.357

Lobanov, O 3.334

Locci, A 2.251

Lock, M 3.202, 2.454, 3.453, 3.461, 3.463

Lockhart, P 1.451

Lockrow, J 3.372

Loddenkemper, T 1.241, 2.001, 1.437, 1.194, 2.394, 1.231, 1.095, 1.232, 3.426, 1.089, 1.235, 1.439, 1.100, 2.247, 2.047, 3.401, 3.095, 3.128, 3.197

Loddenkemper, T 2.261

Loeb, J 3.422, 3.423

Lomax, L B. 1.198

Lomlomdjian, A 2.347

Long, A 2.334

Long, L 2.183

Longani, N 2.408

Lopes, J 1.079

Lopez, M 1.431

Lopez-Santiago, L F. 3.018, 3.083

LoPinto-Khoury, C 2.271

Lopour, B A. 3.034

Loring, D W. 1.373, 1.256, 3.387, 2.046, 2.049

Lorio, S 1.251

Lortie, A 3.237

Loureiro, R 2.465

Lovelace, J 1.112

Low, C 1.018

Lowder, L 2.307

Lowe, H 3.363, 2.154

Lowe, M 1.253

Lowe, M J. 1.256, 3.387

Lowenstein, D 1.195

Lowenstein, D H. 1.022, 3.190, 3.462

Lowenthal, R E. 1.302

Lowman, W 2.300, 3.369

Lu, C 2.005

Lu, Y 1.070

Lu, Y 1.148

Luan, G 1.349

Luan, G 1.078

Luan, G 1.148

Luat, A 1.132, 1.138, 2.327

Lucas, L 2.398

Lucas, T 3.101

Luders, H 3.116

Luedke, M W. 2.336

Lugo, J 1.061

Lui, E 2.198

Lumley, L 1.283

Luna-Munguia, H 2.185

Lundstrom, B N. 3.324, 1.366,

2.024, 3.130, 3.154

Lunney, M 2.310, 2.312

Luo, D 1.166

Luo, W 2.112

Luong, D D. 2.139, 1.452

Lutz, M T. 3.376

Luu, P 2.203

Lwin, M 3.365

Lybrand, Z 1.459

Lynch, J 1.396

Lynge, T 3.429

Lynn, F 3.320

Lyon, A 1.462

M

Ma, B 2.073

Ma, C 1.175

Ma, D 1.253

Ma, H 2.085, 3.069

Ma, Y 1.017, 3.241, 3.193

Ma, Y 3.291

Ma, Y 2.364

Málaga, I 2.396

Møller, R S. 1.022, 3.221

Mégevand, P 3.383

Macías García, D 2.445

MacAllister, W 1.384

Macaulay, R 2.104

MacClary, J 2.393

Macdonald, A 2.365

Macdonald, R L. 3.022

MacDougall, K 1.084

MacEachern, D B. 1.426

Macey, P 3.244

MacGarvie, D 3.457

Maciel, C 3.215

Maciel, C B. 3.298

Macintosh, R 1.395

MacIver, S 1.147, 1.133, 1.150, 1.262, 2.345

Mackay, M 1.201

Mackow, M 3.327

MacLean, J 1.270

MacMullin, P 3.007

Madan Cohen, J 3.447

Madan Cohen, J 1.385

Madani, N 2.296, 2.008, 2.009


Mader, E C. 1.443, 1.446

Mader-Joaquim, M 3.381

Madhavan, D 2.142

Madsen, J R. 1.392, 1.041, 3.335, 3.336, 1.368, 2.180, 2.058, 2.068, 1.043, 3.342, 1.359

Maeda, J 3.064

Maegaki, Y 1.229

Maehara, T 1.083, 2.266, 1.184, 1.121, 1.090

Maehara, T 3.064

Maekawa, T 1.159

Maertens, P 2.143

Magalhães, L 2.241

Maganti, R 1.134, 1.450, 1.284, 3.115, 2.206, 3.003, 3.235

Magee, A 1.086

Maggie, T 2.265

Maglio, L 1.174

Magnotti, J 2.191

Magruder, J 2.435

Mahadevan, A 1.161

Mahamud, Z 1.430

Maher, C 1.103

Maheshwari, A 3.053

Mahlberg, N 2.295

Mahmood, B 2.071

Mahmoudi, B 2.074

Mahmud, S 1.264

Mahulikar, A 3.222

Mahuwala, Z 2.337

Maialetti, A 2.234

Maikusa, N 2.216

Maio, V 3.433

Maixner, W 1.451

Majid, O 2.246

Majoie, M 1.289

Makar, S M. 3.435

Makedonska, I 2.250

Makelky, M 3.230

Maki, Y 1.193

Makke, Y 3.129

Maksikharin, A 3.338

Malay, P 3.388

Malcolm, J 2.307

Maldonado-Naranjo, A 2.314

Malerba, N 2.375

Malhotra, M 2.252

Malhotra, M 2.259, 2.152, 2.254, 2.255, 2.256, 2.257, 3.284, 3.285, 3.286

Maliia, D 2.094, 2.061, 2.078

Malik, H 1.005

Malik, I 3.352

Malik, R 2.433

Maljevic, S 1.466

Malmgren, K 2.310, 2.312

Malone, C 1.392

Malone, S 1.451

Maloney, E 3.431

Maloney, T 1.382

Malpas, C 1.139

Malpe, C 3.070

Malpe, C 3.410

Mancini, M 1.249, 2.168, 2.175

Mandalis, A 3.384

Mandel, A M. 2.326

Mandelstam, S 2.374

Mandle, H 1.426

Mandrekar, J 1.254

Mangano, F T. 3.340

Mani, R 3.269

Manjusha, T 1.435

Mann, D 2.250

Manninen, E 1.097

Mannix, R 3.007

Manns, J 3.073, 2.074

Manreza, M G. 2.160

Manske, J 3.227

Manville, R 1.069, 1.047, 3.051

Manzanares Téllez, I 3.205

Mao, D 3.263

Marafi, D 2.155

Marashly, A 2.317

Marawar, R 3.222

Marcuse, L 1.313, 1.356

Mares, P 3.013, 3.014

Margolis, A 1.315

Mariani, P 1.360, 3.332

Marie, P 3.277

Marinas Alejo, A 1.307

Marini, C 1.022

Marini, C 1.201

Mariyappa, N 1.161, 2.057

Markert, M 2.076

Markova, T 1.093

Marks, R 3.053

Markward, S 2.220

Marques, P T. 3.381

Marquetand, J 1.022

Marquez, K 1.225

Marquez-Bravo, L 2.185

Marr, E 3.441

Marras, C 3.339

Marrero-Rosado, B 1.283

Marrosu, F 3.164

Marsh, E 1.295, 1.296, 1.190, 2.100, 2.280, 3.302

Marsh, S 2.150

Marshall, A 1.372

Marshall, D 2.274

Marson, T 3.393

Martínez, A 1.307

Martínez Agredano, P 2.445

Martínez-Ulloa, P 1.310, 2.301

Martens, T 1.153

Marti, C 2.137

Martin, J 3.281

Martin, J 3.185, 3.212

Martin, J 3.120

Martin, K 1.433

Martin, M 2.258, 1.292, 1.293, 1.294

Martin, R C. 1.383, 3.074, 3.464, 3.465

Martin-Batista, E 1.174

Martinet, L 2.092, 3.042

Martinez, A 2.280, 3.302

Martinez, L 3.331, 3.020

Martinez, L A. 2.080

Martinez, R 1.445, 2.017, 2.018

Martinez, R 3.442

Martinez, R 2.428

Martinez Ferri, M 3.228

Martinez Juárez, I 2.421

Martinez Lizana, E 1.182

Martino, S 1.277

Martins, R 3.184

Martins, W 2.341, 2.342

Martins da Silva, A 1.079

Martins da Silva, B 1.079

Martyanov, A 1.409

Maruff, P 1.301

Marusic, P 3.171

Maruta, Y 3.167

Maruyama, S 2.339

Mary, S 3.436

Maschio, M 2.234

Masel, T 2.299

Maskali, F 3.277

Mason, S L. 1.276

Massager, N 1.368

Massey, C 2.079

Massot-Tarrús, A 2.260, 2.284

Masuda, H 1.364

Masuoka, L 2.251, 3.283

Matarese, C 2.146

Mathern, G 2.187, 3.194

Mathew, T 1.435

Mathis, J 2.206, 3.235

Mathur, S 3.336

Matias, C 1.248

Matory, A 2.019

Matricardi, S 1.306, 2.123

Matsubara, T 1.159

Matsuda, H 2.216

Matsuda, N 3.079

Matsudaira, T 3.213

Matsuhashi, M 1.039

Matsui, S 3.375

Matsumori, T 3.346

Matsumoto, J 2.026, 3.443

Matsumoto, R 1.039, 2.065

Matsumoto, S 3.375

Matsumoto, Y 3.350

Matsuo, T 3.251

Matsusaka, Y 2.316

Matsutani, K 1.322

Mattiello, R 2.342

Mattson, W 1.265

Matuarna, M 1.075

Mauri, J 2.260, 3.316

Mausolf, M 1.227

Maxwell, C 1.143

May, P 1.022, 2.377, 1.400

May, R C. 3.229, 3.231

Mayer, S A. 2.029

Mayer, T 1.244, 3.376, 3.417

Mayner, W 3.114

Maza, J 1.206

Mazarati, A 1.001

Mazuela, G 2.262

Mazumdar, M 1.434


Mazumder, R 1.191

Mazurkiewicz-Beldzinska, M 1.296

Mazzola, M 3.267

McAllister, A 2.334

McBrian, D K. 1.392

McBrian, D K. 2.326, 3.043

McCafferty, C 1.062, 1.176, 3.254

McCaleb, M L. 1.458

McCane, L 3.086

McCarren, H 2.232

McCarthy, D C. 3.466

McCarthy, S 1.113

McCartney, L 1.139

McConnell, M 2.441, 2.442

McCormack, M 1.396, 3.393

McCormack, M 1.398

McCormick, D 3.352

McCormick, K 2.458

Mccoy, B 3.290

McCrindle, J 1.412

McCutcheon, A 1.181

McDermott, D 1.165, 3.146

McDonald, C 1.372

McDonald, H E. 2.349

McDonald, M 3.446

McDonald, T J. 3.357

McDonough, T L. 1.203, 1.437, 2.326, 1.231, 1.232, 3.426, 2.108, 3.401

McElrath, T 3.231

McEvoy, A 3.321

McEvoy, A W. 2.168, 3.354, 2.175

McFarland, D 3.086

McFarland, R 1.052

McGarry, L 1.314

McGivney, D 1.253

McGoldrick, P 1.437, 2.239, 2.108, 1.356, 1.357, 3.469

McGowan, M 2.163

McGregor, A 2.062

McGuire, S 1.333

McHale, D 1.022

McIntosh, A 1.139

McKenzie, M B. 1.239

McKhann, G 3.321

McKhann, G M. 1.392, 3.383

McKhann, G M. 2.326, 3.043

McKimmy, D 3.298

McKnight, D 1.403

McKnight, D 3.397

McLachlan, R 1.084

McLellan, A 1.201

McLeod, G 1.449

McLeod, S 1.402

McManis, M H. 1.183

McManis, P 1.183

McMillan, T 2.206

McMillan, T 2.361

McMurray, R 3.308, 3.309, 3.310, 2.465

McNally, K 1.386

McNally, M A. 2.137, 3.152

McNamara, N 2.331

McNeish, A J. 1.463

McNutt, P 2.232

McPherson, T 3.456

McQueen, B 1.448

Mcquillan, L 1.451

McTague, A 1.201

Mead, E 3.134

Meade, C 2.349

Meador, K J. 3.229, 2.046, 2.049, 3.231, 3.240

Meagher, L 3.437

Medel-Matus, J 1.001

Medin, K 2.281

Mefford, H C. 2.367, 2.374, 2.375, 1.201, 1.390, 3.392, 3.399, 3.405

Mehaffey, M G. 2.374, 1.201, 3.392

Mehra, S 2.080

Mehta, A 3.383, 3.150

Mehta, D 2.263

Mehta, R 2.453, 3.468

Mei, D 1.022

Meier, S 1.462

Meierotto, E 1.375

Meisel, C 1.075, 2.101

Meisenhelter, S 3.147

Meisler, M 3.061

Melbourne-Chambers, R 3.259

Meletti, S 2.123

Melikyan, G 1.429, 1.214, 2.118

Melkonian, D 1.108

Mello, A P. 3.398

Mello, J 1.270

Melloni, L 1.379

Melnick, S M. 3.306

Melo, E 1.080, 3.054

Melo-Bicchi, M 2.128

Melvin, J 1.333

Mendelsohn, B A. 1.022

Mendiretta, A 3.043

Mendoza, M 3.378

Mendoza, M 3.125

Meng, T 2.235, 2.236

Menninga, N 1.315

Menon, U 1.416, 3.293, 3.215, 3.216

Mensen, A 1.450, 3.115

Mercedes, B 3.316

Mercier, J 3.086

Mercier, M 3.150

Mercuri, N 2.249

Merino Andreu, M 2.215

Merla, G 2.375

Merlet, I 2.096

Mesraoua, B 1.429

Mesraoua, B 2.118

Mesraoua, B 1.214

Messenheimer, J 2.253

Messer, R 1.314

Messina, S 2.181

Metcalf, C 3.359, 1.117, 2.222, 3.102

Meurs, A 3.082

Meyerand, B 2.206, 3.235

Miao, Q 1.026

Miceli, S 3.437

Michael, S 2.361

Michaelis, R 1.378

Micheletto, M J. 2.160

Michelucci, R 2.123

Michon, A 3.437

Middlebrooks, E H. 3.324, 1.366

Mihaylova, T 2.331

Mikati, M A. 1.231, 1.232, 3.426, 1.235, 1.392, 2.437, 3.446, 3.401, 3.197

Mikhaeil-Demo, Y 3.408

Mikhail, F 3.101

Miki, T 2.045

Mikulecka, A 3.014

Mikuni, N 1.163

Milh, M 2.245, 3.287, 3.289

Milioli, G 3.164

Millan, C 3.260, 3.246

Miller, A B. 3.455

Miller, D 1.446

Miller, I 1.295, 3.294, 1.355

Miller, J 1.156

Miller, J 3.321

Miller, K J. 2.076

Miller, L 3.077

Miller, L 3.470

Miller, L 1.374

Miller, L 1.375

Miller, N 2.362, 2.368, 2.369

Miller, P 1.421

Miller, W R. 3.424

Millichap, J J. 2.369, 1.024, 2.372, 1.309, 2.126, 3.394, 2.300

Milo, R 3.430

Mimaki, M 1.229

Minamihisamatsu, T 3.064

Minassian, B A. 1.458

Minato, E 3.192

Mindruta, I 2.094, 2.061

Minecan, D 2.331

Minen, M 3.268

Min-Hsien, W 3.324

Minnick, J 2.280

Minoche, A 1.395

Minogue, T 2.010

Minotti, L 3.149

Minthe, A 2.007

Mintz, M 2.242

Mintz, P 2.242

Mintzer, S 3.433, 3.232, 1.345

Mir, A 3.219

Miralles, A 1.206

Miro, J 2.286, 2.287

Mirro, E 2.051, 2.073, 2.315, 2.076, 1.336

Mirsattari, S 1.084

Mirsky, D 2.446

Misaghi, E 1.247, 2.173

Miserocchi, A 2.168, 3.354

Miserocchi, A 2.175

Mishra, S 1.053

Mishra, V 3.156

Miskin, C 1.318

Misra, S N. 2.372, 2.300

Misra, S N. 1.031

Mistry, A 2.454, 3.461, 3.463

Mitchell, B 2.449

Mitchell, R 2.345

Mitchell, W 1.298

Mitsudo, T 1.159


Mitsuhashi, T 3.252

Mitsuhashi, T 1.040

Mitsuhashi, T 3.319, 2.088, 2.095

Mittal, N 2.450, 3.200

Mittal, S 3.222

Mixon, E 1.421

Miyajima, M 1.083, 1.121, 1.090

Miyakoshi, M 1.132, 1.138

Miyani, D 3.425

Miyata, H 2.400

Miziara, C M. 2.160

Mnatsakanyan, L 2.306, 3.135

Modequillo, M 2.250

Modi, A C. 2.358, 1.382

Moffat, B A. 2.198

Moffet, E W. 1.450

Mogul, D 1.030

Mohamed, I 3.465

Mohamed, W 3.222

Mohammadpour Touserkani, F 2.261, 1.095, 2.047, 3.095

Mohammadpour Touserkani, F 1.100

Mohile, N 3.137

Moien-Afshari, F 3.047

Mole, S 2.368

Molina, D 3.270

Molinero, I A. 1.213

Molins, A 1.310

Molins Albanell, A 1.307

Molofsky, A V. 1.003

Molteberg, E 3.356

Monica, N 2.388

Monroe, S 1.423

Montanaro, D 2.188

Monteagudo, S 1.307

Monteith, S 3.348

Montemayor, D 1.271, 1.272

Montenegro, M 2.356

Montesdeoca, J 3.305, 2.416, 2.417, 2.418

Montgomery, M 1.413

Montouris, G 3.188, 3.201

Montoya, J 2.260, 3.312, 3.313

Mooij, A 2.044

Moon, C H. 2.178

Moon, U 3.111

Mooney, C 3.458

Moraes, J 1.321

Moraes, M 1.173

Morales Quezada, L 1.225

Morales-Morris, M 2.340

Moran, M 2.276

Moran, M 3.087

Morcom, R 3.214

Moreadith, R 1.468

Moreira, J 2.247

Moreira, K 1.401, 3.460

Morena, M 3.158

Moreno, R 2.373

Moretz, K 3.285, 3.286

Morgan, A K. 1.255

Morgan, C J. 3.074

Morgan, K 1.181

Morgan, L 1.231, 1.232, 3.426, 1.235, 3.197

Morgan, L C. 2.291

Morgan, O 2.397

Morgan, V L. 1.252, 1.256, 3.387, 2.091

Morioka, H 2.093

Morita, A 3.346

Morita-Sherman, M E. 1.335, 3.226

Morningstar, A 1.002, 1.003

Morningstar, M 1.265

Morofuji, Y 3.251

Morrell, M J. 3.092, 2.046, 2.048, 2.049, 2.050, 2.075

Morrison, C 3.240

Morrison, G 1.297, 1.300, 1.453

Morrison, G 3.202, 2.454, 3.453, 3.461, 3.463

Morrison, K 1.388

Morriss, N 3.007

Morrissey, M 3.334, 2.021

Morse, R P. 3.398

Mortati, K 3.263

Morton, L D. 3.126

Morton, M L. 1.197

Moseley, B 1.085, 2.464

Moshé, S L. 1.118, 1.288, 3.272, 1.417

Mosher, J C. 2.055

Mosher, J C. 1.158, 2.054

Mosher, J C. 1.155, 3.035, 3.036

Moss, L 2.351

Moss, R 1.068, 1.192, 2.264, 2.158, 3.076

Motika, P 3.396

Motoi, H 1.132, 1.138, 2.327

Mott, J 2.422

Moura, J 2.025

Mousseau, D 1.462

Mowrey, W B. 1.118, 3.272

Mtasuo, T 1.082

Mu, C 3.361

Mudigoudar, B 2.148

Mueller, B 1.313

Mueller, S 2.210

Mueller, S 3.321

Mueller, W M. 1.256, 3.387

Muglia, P 1.289

Muh, C R. 1.392

Muhle, H 1.022

Muhlhofer, W 3.439

Muir, A M. 2.375, 1.390, 3.392, 3.399

Mukae, N 1.039

Mulder, M 2.272

Muldoon, S F. 2.209

Mulkey, D 3.157

Mullatti, N 3.352

Mullen, S A. 2.156

Muller, L 3.381

Mullikin, J 2.112

Mullin, J 3.344

Mun Au Yong, H 3.192

Mundlamuri, R C. 1.161, 2.057

Munekata, N 1.046

Munsell, B 1.092

Muppidi, S 2.124

Murad, A 3.394

Murad, M 2.019

Murchison, C 2.130, 3.173

Murnane, K S. 2.227

Murnick, J 2.196, 3.338, 1.346

Murphy, R 3.441

Murphy, W 2.427

Murray, D 2.131

Murray, S 2.396

Murray, T A. 3.280

Murugesan, A 1.454

Musto, A 1.107

Mutboli, H 3.019

Muth, I 2.104

Mychasiuk, R 1.005, 3.089

Myers, C T. 1.390

Myers, C T. 2.367, 1.201, 3.392, 3.399

Myers, K 1.201

Myers, K A. 1.233

Myers, L 3.374

Myers, R 3.405

Myers, S 2.374, 1.125

Myers, S 1.124

Myers, T 2.444

Myette, M S. 3.454

Myren-Svelstad, S 1.063

Mysak, K 2.137

Mytinger, J R. 3.207

N

Na, J 1.389

Nabbout, R 1.295, 3.202, 1.470, 3.461, 3.463

Nachev, P 2.184, 2.348

Nada, S 1.214

Nadalin, J 3.037

Nadig, R 1.435

Nadkarni, D S. 3.443

Nadkarni, S 3.260, 3.268

Naduvil, M 2.324

Nagamitsu, S 2.089

Nagaraj, S 1.173

Nagatsuna, T 2.089

Nagesh, D 1.149

Nagle, K 2.350

Nair, D R. 1.155, 3.327, 3.036, 2.075

Nair, S 3.464, 3.465

Nair, V 2.206, 3.235

Najm, I 2.410

Najm, I M. 1.253, 1.185, 1.053, 3.327, 2.172, 1.365, 2.179, 2.127, 1.335, 3.035, 2.256

Nakae, T 1.039

Nakai, Y 1.132, 1.138, 2.002, 2.327

Nakajima, M 3.319, 2.088, 2.095, 3.252

Nakajima, M 3.144

Nakajima, T 1.344

Nakajo, K 2.316

Nakamoto, H 2.400

Nakamura, M 3.306

Nakanishi, D 2.160


Nakasato, N 1.131, 3.350, 2.395, 2.267, 2.045

Nakata, T 1.193

Nakken, K 3.356

Nam, S 1.242, 2.119

Namdari, R 1.287, 3.282, 3.211

Nandyala, A 1.150

Nangia, S 1.413

Naranjo, B 2.323

Naranjo Castresana, M 2.215

Narayana, S 1.164, 2.062

Narayana, S 2.077

Nariai, H 2.098, 3.169

Narvacan, K 2.318

Nashef, L 3.352

Nasser, M 2.016

Nasseri, M 1.086

Nasseri, M 3.222

Nath, A 2.191

Nathan, A 1.089

Natsume, J 1.193, 1.229

Navarro, M 3.297

Naveed, A 2.433

Navegantes, R 1.080, 3.054

Nayak, A 2.066

Naylor, D E. 3.029

Ndode-Ekane, X 1.096, 1.097, 1.098, 1.099, 1.101, 3.161

Neal, E G. 1.262

Neale, M 2.265

Nearing, B 1.120

Nebbioso, A 1.208

Nebet, E 3.052

Negoro, T 1.193

Nei, M 3.232, 1.345

Neill, S 2.307

Nelkenbrecher, K 1.285

Nelson, A 1.437, 2.108

Nelson, E 1.265

Nelson, M 1.179

Nemiroff, A 1.466

Nencka, A 2.206, 3.235

Nenert, R 3.074

Nespeca, M 3.120

Neupane, C 3.306

Newbold, E J. 2.459

Newell, T 3.359, 3.102

Newman, G C. 2.097

Newman, J 2.415

Newmeyer, D 1.462

Newton, H B. 3.435

Ng, M C. 1.239, 1.449

Ng, Y S. 1.052

Ng, Y 3.204

Ngo, L Y. 2.245, 2.252, 2.255, 2.256, 3.287, 3.289, 3.291

Ngo, L 2.442, 3.425

Nguyen, D 2.043, 2.310, 2.312, 3.237

Nguyen, D 2.232

Nguyen, J 2.360

Nguyen, J 2.357

Nguyen, J 1.411

Nguyen, K 2.293

Nguyen, L H. 3.105

Nguyen, M 2.130, 3.173

Nguyen, N 3.280

Ni, D 1.034, 3.208

Nica, A 3.315, 2.096

Nichol, K 2.462

Nichols, S 1.028

Nickels, K C. 2.109, 1.347, 3.154

Niestroj, L 1.399

Nieto Estevez, V 1.459

Nightscales, R 1.139

Niijima, S 1.229

Niizuma, K 3.350

Niknahad, A 1.176

Nikpour, A 1.375

Nikpour, A 1.374

Niquet, J 3.009

Nir, Y 1.032

Nishi, T 1.286

Nishida, T 2.390, 3.213

Nishida, T 1.322

Nishikawa, M 3.375

Nishimura, M 2.169

Nishimura, M 1.442

Nishimura, N 3.069

Niu, R 2.452

Niu, R 2.171

Njobvu, T 3.362

Nkole, K 3.362

Noachtar, S 2.278

Noachtar, S 2.011, 2.332

Nobis, W 2.033

Noe, K 2.391, 3.427, 1.217

Noebels, J L. 1.057, 1.026, 2.079, 1.180

Noha, M 3.346

Nolan, S 1.061

Nolan, T 1.181

Nomura, S 1.223, 1.177, 3.167

Norato, G 2.399, 2.205

Norcia, A 2.034

Nordli, D 2.250

Nordstrom, B 2.263

Normoyle, K P. 1.004, 3.011

Northrup, H 3.456

Nosadini, M 2.123

Novotny, E J. 1.231, 1.232, 3.426, 1.235, 3.197

Novotny, E J. 3.372

Novroski, A 3.178

Nowacki, T A. 1.247, 2.167

Nowicki, J 2.372

Nowicki, J 3.394

Nozzolillo, A 2.234

Numazawa, H 2.194

Numis, A 1.022

Nune, G 2.048

Nunez, M D. 3.034

Nuss, S 3.420

Nutt, A 1.305

Nuwer, M 1.186

Nwoke, O 3.235

Nyamu, S 1.404, 2.346

O

O’Donoghue, S 2.106

O’Brien, S 1.283

O’Brien, T J. 3.228, 1.139, 1.108, 2.010, 1.097, 1.098, 1.099, 3.260, 1.122, 3.089, 1.118, 2.252, 2.253, 3.268

O’Connor, C 2.259

Oaetes, S 1.022

Oakley, J C. 3.026

Obideen, M 3.124

Obot, P 3.031

O’Brien, T 3.228, 1.101

O’Brien, T J. 3.228, 1.096, 2.198, 1.288, 3.393

O’Bryan, J 1.194

Ochi, A 2.030

Ochi, S 1.163

Ocol, J 2.005

O’Connor, J B. 1.024, 1.309, 2.126

O’Connor, M A. 1.414

Odawara, A 3.079

Oddo, S 2.347, 3.123

O’Donnell, A 3.432

O’Dwyer, R 3.320, 3.227

Offord, J 3.023

Ogata, K 1.159

Ogawa, M 2.395

Ogden, P 2.396

Ogden, S J. 3.398

Ogier, M 3.107

Ogren, J A. 2.170, 3.244

Oh, A 1.432, 1.228

Oh, J 2.186

Ohara, S 2.304

Ohata, K 2.316

Ohta, K 2.266

Ojeda, J 1.206, 2.260, 3.316

Ojemann, J G. 1.008

Ojemann, S 1.165, 3.146, 2.352

Okai, Y 1.193

Okamura, A 3.328, 2.093

Okamura, Y 1.268

O’Kane, A 2.163

Okanishi, T 1.442

Okanishi, T 2.169

Okanishi, T 3.349

Okazaki, E M. 3.427, 1.217

O’Kelley, S 3.456

Okonkwo, J 2.019

Okumura, A 1.193

O’Leary, H 2.144

Olejniczak, P 1.446

Olin, B 1.120

Oliva Navarro, J 2.215

Olivan Usieto, J 1.307

Olive, M 2.114

Olivié García, L 2.301

Olivie, L 1.310

Olivier, A 1.363

Olson, A 1.045

Olson, H 3.404

Oluigbo, C 2.319, 2.196, 3.338, 1.346, 1.352

Oluigbo, C 1.353

Olum, S 1.191

Omidvarnia, A 3.080

Omidvarnia, A 2.193

Omole, A 3.017

Ondek, K 3.108, 3.109

Ono, K 1.424, 3.271

Ono, T 2.400, 2.328, 1.350


Onorati, F 1.091, 3.078

Opheim, G 3.245

Oppenheimer, J 1.439

Orach, MBChB, T 1.191

O’Regan, M 1.402

O’Reilly, E 3.431

Orihara, A 1.184

Orosz, I 2.187

Orozco-Hernández, J 1.278

Orozco-Suarez, S 3.045

Ortiz, M 2.250

Osada, Y 2.231

Osawa, S 2.400, 3.350, 2.045

Osborn, M 2.292

Osborne Shafer, P 1.207

Oshio, K 3.346

Osipowicz, K 3.250

Osman, G 2.029, 3.186, 3.125

Ospina, J 1.270

Osso-Rivera, H 1.354

Ostendorf, A P. 2.214

Ostendorf, A 1.231, 1.232, 3.426, 2.334, 3.197

Ostrowski, L M. 1.255, 1.102

Oswaldo Dávila, D 1.225

Otani, K 1.344

Otgonsuren, Z 1.410

Otoul, C 1.289

Otsubo, H 2.030

Otsubo, H 1.157, 3.328

Otsubo, H 3.144

Otsubo, T 2.339

Ouazzani, R 1.214

Ourselin, S 1.246, 1.249, 2.168, 3.354, 2.175

Owens, S 2.391, 1.405

Owusu, K A. 3.298

Ozaki, S 3.375

Ozenberger, K 2.270, 2.425, 3.422, 3.423

P

Pérez-Palma, E 2.376, 1.397

Paananen, T 1.098, 3.161

Paananen, T 1.101

Pacia, S 3.410

Pack, A M. 1.392

Pack, A M. 1.304, 3.043, 3.229, 3.231

Padda, K S. 1.373

Padma, V 1.348

Padulsky, MSN, CPNP, CNRN, K 1.413

Paganin, R 2.341, 2.342

Paglioli, E 2.341, 2.342

Pagnamenta, A T. 1.022

Pain, M 3.138

Paiva, M M. 3.378

Pal, D K. 1.022

Pal Attia, T 1.086, 3.077

Palade, A 3.321

Palanca, B 2.042

Paldino, M 2.191

Palmer, E 1.395

Palmini, A 2.341, 2.342

Palomba, M 3.134

Palotie, A 2.377

Pan, I 3.341

Pan, J 3.132

Pan, J 2.178

Pana, R 2.410

Pandey, D 2.270, 2.425, 3.422, 3.423

Panduranga, A 2.389

Pandya, D 3.434

Pang, T 1.120

Pankratz, J 2.206

Panov, F 1.356, 3.138

Panyavachiraporn, N 2.029

Papadelis, C 1.041, 1.100, 2.058, 1.043, 3.095

Papanikolaou, M 1.069

Papapetropoulos, S 2.459

Pappas, G 3.101

Paquola, C 2.190, 2.208

Parada, I 3.005

Pardini, J 2.223

Pardoe, H 3.240, 3.243

Paredes, M 2.460

Parejo, B 3.316

Parent, J 3.061, 2.331

Parent, J M. 3.018, 3.021, 3.083

Parent, J M. 1.073

Parikh, N 3.294

Parikh, P 1.418

Parikh, S 3.404

Paris, A 2.137

Parisi, J E. 2.405

Park, E 2.330

Park, E 1.041, 3.335, 1.368, 3.342

Park, J 3.306

Park, K 2.006

Park, S 2.019

Park, S 3.053

Park, S 1.380

Parker, B 3.027

Parker, W 2.214

Parko, K 2.220

Parnes, M 1.255, 1.102

Parratt, K 1.374

Parrent, A 1.084

Parres, C 2.103, 2.029

Parrino, L 3.164

Parsons, A 1.145

Parsons, L 1.273

Parthasarathy, J 2.334

Parvizi, J 1.141, 3.170

Pascual-Leone, A 3.152

Pasini, E 2.123

Pastori, C 3.329

Pasupuleti, A 1.407, 3.209

Patanvadiya, A 2.023

Patel, A 3.187

Patel, A 3.203

Patel, A 3.323

Patel, A D. 1.293, 1.298, 1.410, 1.412, 3.179, 1.386, 1.419, 3.452, 3.455

Patel, A 3.362

Patel, A 3.070

Patel, C 3.399

Patel, D 1.112

Patel, J 2.455

Patel, M K. 3.061

Patel, M K. 1.050

Patel, M 1.011

Patel, U 3.428, 1.361

Patel, V 2.187

Pati, S 3.416, 3.071, 3.016, 3.139, 3.465

Patodia, S 2.402

Patra, P H. 1.463

Patrick, K E. 1.386

Patten, A 2.245, 2.252, 2.254, 2.255, 2.256, 2.257, 3.284, 3.285, 3.286, 3.287, 3.289

Patten, S B. 2.274, 2.310, 2.312

Patterson, E 2.228, 1.086

Pattichis, A 2.010

Paty, J 1.196

Paul, B 1.372

Pauletto, G 2.123

Paulk, A 1.128

Paulson, O B. 1.153, 3.245

Pavkovic, I 2.039, 2.107

Pavlova, M 1.377, 2.343

Pavlova, M 2.213

Pawar, K 1.149, 1.224, 2.444

Payano, L 2.416, 2.418

Payne, D E. 3.081

Payne, E T. 1.231, 1.232, 3.426, 1.347, 3.197, 3.154

Paz, J T. 1.002, 1.003, 3.028

Peariso, K 1.231, 1.232, 3.426, 1.235, 3.060, 3.401, 3.197

Pearl, P L. 1.194, 2.370, 1.041, 3.335, 2.058, 1.043, 3.342, 3.172, 3.128, 1.359

Pedersen, M 2.193, 3.080

Pedersen, N 1.169, 1.343

Pedersen, N P. 1.072

Pedro, H 1.444

Pei, F 2.034

Peinhof, S 2.384

Peixoto, N 3.065

Peixoto-Santos, J 1.248

Peled, N 1.128

Pelgrims, R 1.063

Pellacani, S 2.188

Pellegrino, G 1.160, 2.056, 3.143

Pelliccia, V 3.339

Pelligrino, J 1.394

Pellumbi, N 3.186

Peng, A 3.048, 1.012, 3.056

Peng, S 1.036, 3.098

Pennell, P 3.231

Pennell, P B. 3.229, 3.300, 3.236

Penovich, P E. 1.276, 3.229, 3.231, 3.285

Pentagna, A 3.262

Pequito, S 3.101

Perales, M 3.134

Peraud, A 2.332

Percy, J 2.313

Pereira, A 2.242

Pereira, A 1.080, 3.054

Pereira, R 1.080, 3.054

Perez, D L. 1.270

Perez, E 3.008


Perez-Palma, E 2.377, 1.400

Perkins, F F. 1.183

Perkins, N 2.092

Perrenoud, Q 1.176

Perrine, K 3.374

Perry, M 1.298

Perucca, E 3.228

Perucca, P 3.228, 2.193, 1.101

Perucca, P 2.010, 1.098

Perven, G 3.451

Pesco Koplowitz, L 1.302

Pestana Knight, E 1.140, 2.324, 2.439, 3.266, 3.404, 1.467

Peter, S 3.393

Peters, J M. 1.392, 1.041, 2.180, 2.058, 3.342, 3.456

Petri, S 1.116

Petropoulou, K 1.394

Petrou, S 2.156

Petrou, S 1.103, 2.193

Petrou, S 1.466

Petrovski, S 3.228

Peyano, L 3.305

Pfammatter, J 1.284

Pfeifer, K 2.072

Pham, H 3.434

Phibbs, R 2.222

Phillips, J 1.113

Phillips, S 2.245, 3.287

Phillips, S 3.289

Phillips, T 1.071

Piña-Garza, J E. 1.292, 2.239

Piantino, J 1.231, 3.426, 1.235, 3.197

Piao, Y 1.034

Picard, R 1.091, 3.078

Picard, R 1.377

Pickard, A 3.203

Piedrabuena, A 3.183

Piera Balbastre, A 1.307

Pierre, E 1.253

Pierre-Louis, B 1.323, 1.324

Pieters, H 3.412

Pietrafusa, N 3.339

Pietzsch, E 2.147

Pillai, A 1.137

Pillai, J 2.271

Pilz, D T. 1.402

Pimpel, B 1.251

Pimstone, S N. 3.282, 3.211, 3.292

Pinborg, L H. 1.153, 3.245

Pinborg, L 2.014

Pindrik, J 2.334

Pines, A R. 1.202

Pinheiro, A 3.226

Pinna, G 2.251

Pinsky, A 3.023

Pinto, A 3.336

Pitkänen, A 1.096, 1.097, 1.098, 1.099, 1.101, 3.161

Pittman, Q 3.158

Pizarro, D 3.071, 3.016

Pizarro, D 3.465

Placidi, F 2.249

Plummer, C 3.132

Podkorytova, I M. 3.451

Poduri, A 2.376, 1.201, 1.390, 1.392, 1.393, 2.251

Pohl, D 2.295

Pohlmann-Eden, B 2.104, 2.105

Pok, J 1.175

Poke, G 2.375

Pollanen, M 3.406

Pollard, J 1.330

Pollard, J 3.094

Ponz de Tienda, A 1.307

Poolos, N P. 2.264, 1.008

Poongkunran, M 3.215

Poonmaksatit, S 1.140

Popa, I 2.094, 2.061, 2.078

Popat, R 3.195

Pope, A 3.093

Pope, K 1.451

Popli, G 2.140

Porges, MPH, I 1.422

Porras-Bettancourt, M 2.056

Porter, B E. 2.034, 1.392, 2.100

Posadas, K G. 3.292

Postma, T 2.183, 2.184

Powell, R 3.214

Powell, Z 1.028

Power, K 2.106

Power, K 1.396

Powis, Z 1.022

Poza, J 2.260

Prabhakaran, V 2.206, 3.235

Prabhu, S 2.180

Prasad, A N. 1.428

Prayson, R 2.403

Premoli, I 3.292

Prestupa, R 2.347

Price, C J. 2.204

Price, L 1.162

Prince, D A. 3.005

Princich, J 3.123

Principe, A 1.317, 3.301

Pringsheim, M 3.453, 3.463

Prior, A 2.411

Pritchard, J 2.128

Privitera, M 1.330, 1.296, 1.085

Procko, E 2.455

Prohl, A 2.180

Proix, T 3.084

Prosser-Loose, E 1.462

Protas, M 1.136

Pruess, T 2.222

Pruitt, A 2.086

PS, P 2.115

Psarropoulou, C 3.041

Puhakka, N 1.096, 1.097, 1.098, 1.099, 1.101

Puka, K 3.391

Puligheddu, M 3.164

Pullman, W E. 2.235, 2.236

Pun, R Y. 3.024

Punia, V 2.403, 2.314, 3.125, 3.210, 1.418, 3.097

Purcarin, G 2.146

Puri, N 2.343

Puri, N 1.377

Puri, V 2.273

Purtell, H 3.155, 3.152

Putra, M 1.055, 1.006

Putta, S 2.343

Putta, S 1.377

Puttachary, S 1.006

Puttick, C 1.395

Pylypyuk, V 2.202

Pyne, N 1.116

Pyzowski, P 1.225

Q

Qiao, L 3.208

Qin, J 2.438

Qiu, D 1.343

Qiu, J 3.007

Qiu, X 3.048, 1.012, 3.056

Qiu, X 3.288

Quach, M 3.140

Quach, M M. 2.066, 2.155

Quarells, R 1.440

Querol, R 1.310

Quigg, M 3.321

Quigg, M 1.340, 3.467

Quigg, M S. 3.092

Quintana, M 2.262, 2.114, 2.283

Quintana, M 2.141

Quintas, R 3.329

Quiroga, P 2.260

Quon, R 2.350

Quraishi, I H. 1.264, 2.064

R

R, S 1.435

Radhakrishnan, A 3.257

Radtke, R 3.096

Radwanski, R 3.069

Raedt, R 3.082

Raffo, E P. 3.277

Rafiuddin, A 2.432

Raghavan, M 1.256, 3.387, 3.235

Raghavendra, K 1.161, 2.057

Ragheb, J 1.355

Raghupathi, R 2.324, 1.369

Ragona, F 1.306

Rahangdale, R 3.125

Rahman, Z 1.215

Rahmati, N 1.004, 3.317

Rai, P 2.299

Rajagopalan, K 2.263

Rajagopalan, S 2.374

Rajan, J 1.161

Rajan, J 2.057

Rajaraman, R 2.026, 2.298, 3.296, 3.297


Rajasekaran, V 2.450, 3.200

RamachandranNair, R 3.364

Ramadoss, R 2.271

Ramalheira, J 1.079

Ramalingam, S 1.392

Raman, L 1.415

Ramazanian, G 3.077

Ramesha, S 3.326

Ramey, P 2.292

Ramon, C 2.057

Ramos, A B. 1.443

Ramos Salinas, H 3.440

Rampal, N 3.125

Rampp, S 1.339

Ramsay, R 3.293

Ramsay, R 1.416, 3.215, 3.216

Rana, A 1.107

Ranford, J 1.270

Rangel, R 1.079

Rani, M 3.244, 1.454

Rao, L 2.159

Rao, M B. 1.161

Rao, S 2.116

Rao, V R. 3.084, 2.052, 2.073, 1.336

Raoof, R 3.458

Rapuano, A 3.008

Rare Epilepsy Network, 2.125

Rashid, S 2.291

Rasic, G 1.107

Rath, S 3.447

Rathakrishnan, D 1.392

Rathakrishnan, R 3.168

Rathbun, E 2.383

Rathore, J S. 2.429

Rau, S 2.121

Raulik, L 2.151

Ravishankar, M 3.222

Rawal, P 3.124

Raynes, H 1.357

Razavi, B 2.048, 2.315, 2.076, 3.195

Reale-Caldwell, A 2.345

Reddy, D 1.109, 1.110

Reed, R C. 2.285

Rees, E 1.391

Rees, M I. 1.022

Regalia, G 1.377, 1.091, 3.078

Reger, K 1.414

Rehak, R 1.114

Rehman, R 1.431

Reid, A 3.057

Reid, C 1.466

Reider-Demer, M 3.325

Reinacher, P 2.007, 2.134

Reiner, B C. 3.400

Reinsberger, C 1.100, 2.047

Reisert, M 2.134

Remi, J 2.011

Ren, G 2.015

Ren, J 2.452

Rende, E 1.275

Renfroe, B 3.291

Rensing, N 1.059

Requena, M 2.114

Resnick, T 2.240

Resnick, T 2.255

Reuber, M 1.278

Reuber, M 3.321

Reuter, J D. 1.064

Reyderman, L 2.246

Reyes, A 1.372

Reyes, D 2.288

Reyes-Vaca, J G. 2.177

Reynolds, R 2.199

Reynolds, T 1.204

Rezaie, R 2.062, 2.077

Rezayee, M 2.130, 3.173

Rheims, S 3.107

Rho, J M. 1.237

Rho, J M. 1.316, 3.358, 3.361

Ribeiro, L 3.226

Ribot, R 3.246

Rice, J 2.279

Richard, G 1.403, 3.397

Richardson, M P. 3.352, 3.292

Richardson, R 2.303, 1.015, 2.178, 2.450, 3.132, 3.200

Richerson, G B. 3.088, 3.367

Ridel, K 2.251

Rigo, F 1.466

Rigo, R 2.286, 2.287

Riley, C 2.037, 3.466

Riley, K 3.071, 3.016

Rincon, F 3.203

Rini, J 2.143

Rishty, S 3.269

Ritaccio, A L. 1.199, 2.032, 2.069

Ritchie, H 3.425

Ritter-Makinson, S 3.028

Rivera, R 2.408

Rivera-Bonet, C 3.235

Rivera-Cruz, A 1.147, 1.133

Riviello, J J. 1.231, 3.426, 1.235, 3.341

Riviello, Jr, J J. 3.197

Riviello, Jr, J J. 1.232

Rizwan, G 3.057

Rizzi, S 2.188, 3.339

Roark, E 2.148

Robare, J 1.179

Robblee, J 2.212

Roberds, S 3.105

Robert, W E. 1.254

Roberts, A 1.117

Roberts, C 2.010

Roberts, C 1.298, 1.299

Roberts, M H. 2.380

Robertson, A 2.393

Robertson, J 1.324, 1.325, 1.326

Robertson, S 2.374

Robinson, D 1.122

Robinson, J 1.188, 1.358

Robinson, T 2.409

Rocamora, R 1.317, 3.301

Rocha, L 3.045

Roche, W P. 2.397

Rochez, D 2.016

Rochtus, A 3.228

Rochtus, A 2.376, 1.201

Rodrigues, P 1.284

Rodrigues, S 3.163

Rodrigues-Ruiz, A 3.145

Rodriguez, G 3.003

Rodriguez, R M. 2.299

Rodriguez, Y 3.218

Rodriguez-Leyva, I 2.177

Rodriguez-Osorio, X 2.260

Rodriguez-Uranga, J 2.260, 3.316

Roemisch, E 2.358

Roessler, K 1.339

Rogawski, M A. 2.228, 1.281, 3.275, 3.468

Rogawski, M A. 2.453

Roh, D 2.019

Rohaut, B 2.019

Rolinski, R 2.199

Rolle, C 2.072

Rollo, P 2.311, 2.351

Rolston, J D. 2.091

Romano, E 3.419

Romeo, A 3.071, 3.016

Romero, O 2.141

Ronen, G M. 2.295, 1.201

Roopchansingh, V 3.258

Roopra, A 3.003

Roovers, J 3.405

Rorden, C 1.092

Rosales, R 1.279

Roscioli, T 1.395

Rose, D F. 1.156

Rose, S 2.428, 2.017, 2.018, 3.442

Rosell-Negre, P 1.464

Rosen, A B. 3.392

Rosenbaum, P L. 2.295

Rosenberg, E 3.052

Rosenberg, M 3.440

Rosenberg, M 3.194

Rosenfeld, W 3.188

Rosenfeld, W 3.201

Rosenow, F 1.290

Rosenow, F 3.458

Rosenthal, E 2.025

Roshchina, Y 1.136

Rosillo, J C. 2.184

Rossi, M 1.130

Rossi, M A. 2.388, 2.202, 2.063

Rossi-Espagnet, C 3.339

Rossini, P G. 3.292

Roten, A 1.233, 2.036, 2.156, 3.239

Rotenberg, A 1.225, 3.049, 3.155, 2.068, 2.072, 3.007, 3.152

Roth, R 2.350


Rothermel, R 2.002

Roullet, J 2.370

Roy, A S. 2.218

Roy, S 3.174

Rozentals, G 3.291

Rozman, M 3.235

Rozman, M 1.256, 3.387

Rubboli, G 2.014, 3.221

Rubin, D B. 2.025

Rubinstein, D 1.033

Rueda, C 2.222

Ruffini, G 1.225

Rugg-Gunn, F 2.265

Ruiz-Giménez, J 2.260

Rum, R 2.345

Rummens, C 3.315

Rutecki, P 1.431

Rutecki, P A. 2.220, 3.103, 1.336

Rutka, J 3.351

Ryan, C 2.357, 2.360

Ryan, C 2.359

Ryan, C 2.393

Ryan, K 2.077

Ryan, N 2.109

Rychkova, M 3.421

Rymer, J 3.046

Ryther, R 3.334

Ryu, J 1.074, 1.062, 3.254

Ryvlin, P 3.429

Ryvlin, P 1.100

Rzezak, P 2.373, 3.378, 3.380, 2.356

S

S May, A 2.108

Sánchez Fernández, I 1.241, 1.231, 1.232, 3.426, 1.089, 1.235, 1.100, 3.401, 3.197

Sabaz, M 3.384

Sabers, A 3.429

Sabharwal, V 3.215

Sabo, U 3.418

Saboo, K 3.470

Sabsevitz, D S. 1.256

Sachdev, R 1.395

Sadeghi, M 3.222

Sadek, A 2.464

Sadek, A 2.382

Sadleir, L G. 2.367, 2.374, 2.375, 1.201, 1.390, 2.212, 3.392

Sadler, T L. 1.336

Sadowski, K 2.135

Sagane, K 2.282

Sagher, O 2.331

Sagi, V 2.003

Sahaya, K 2.422

Sahebkar, F 1.295, 1.299

Sahin, M 2.180, 3.155, 3.456

Said, R 2.113, 3.224

Saidi, H 3.249

Saindane, A 1.343

Saini, J 1.161, 2.057

Sainju, R K. 3.088

Saiz, R 3.316

Sajan, S 1.431

Sajatovic, M 1.371, 1.218, 2.122

Sajja, K 2.142

Sajobi, T 2.310, 2.312

Sajobi, T T. 2.274

Sakaguchi, Y 1.193

Sakaie, K 1.253

Sakamoto, N 2.400

Sakane, F 1.121, 1.090

Sakuraba, R 2.045

Sakurai, K 1.046

Sala, J 2.286, 2.287

Salah, A 1.038, 3.052

Salami, F 3.141

Salami, P 3.037, 3.042

Salamon, N 1.186, 2.187

Salanova, V 3.321, 1.087, 1.336

Salas-Puig, J 2.262, 2.114, 2.141, 2.283

Saldaña Díaz, A 2.284

Saleem, N 1.074

Salehizadeh, H 1.095

Sales, F 2.465

Saletti, P G. 1.118, 1.288

Salih, M 1.201

Salihu, A 3.418

Salim Khan, M O. 2.103

Salinsky, M 2.389, 2.220

Salman, M S. 2.448

Salmon, C 1.248

Salpekar, J 2.242

Salvador, R 1.225

Salzman, D 3.408

Sam, M 3.229

Sam, M 3.231

Samanamud, J 1.392

Samantha, C 1.203

Sampei, K 3.064

Samuels, A 1.444

San Juan Orta, D 1.225

Sanayei, A 2.218

Sanchez, A 3.232

Sanchez, J 2.262

Sanchez, R 1.025

Sanchez-Carpintero, R 1.470, 3.461

Sand, T 1.154

Sander, B 1.221

Sander, J 3.393

Sandhu, M 3.062, 3.008

Sandhu, M S. 3.063

Sands, T 1.203

Saneto, R P. 3.372

Sanganahalli, B 1.062, 3.254

Sani, S 3.320

SanInocencio, C 3.180

Sankar, R 2.159, 2.098, 3.169

Sankar, R 1.001

Sankaraneni, R 3.428, 1.361, 1.408

Sankonju, A 1.394

Sannagowdara, K 3.426, 3.197

Sansa Fayos, G 1.307

Sansalone, K 1.038

Sansalone, K 1.021, 3.075

Sansevere, A 1.241, 2.137, 3.127, 3.128

Santágueda, P 3.308, 3.309, 3.310

Santalucia, R 1.208

Santamarina, E 2.141

Santamarina, E 2.262, 2.114, 3.316, 1.307

Santamarina, E 2.283

Santana-Gomez, C 1.098

Santana-Gomez, C 1.001, 1.096, 1.097, 1.099, 1.101

Santaniello, S 3.091, 2.099

Santhakumar, V 3.030, 1.016

Santiago, C 1.225

Santiago-Castañeda, C 3.045

Santilli, N 1.207

Santomasso, B 3.134

Santoro, A 2.232

Santos, A 1.079

Santos, A 1.248

Santos, B 2.373, 3.262

Santoscoy, P 1.114

Saporta, A 3.246

Saposnik, G 1.427

Sarac, C 1.379

Sargsyan, A 1.108

Sarkis, R 1.377, 1.100, 2.343, 3.095

Sarma, G 1.435

Sartori, S 2.123

Sarwar, S 1.467

Sasaki, M 1.044

Sathe, A G. 3.462

Satheesh Nayak, C 1.185

Satish, A 2.181

Satishchandra, P 1.161

Sato, K 1.442

Sato, M 1.344

Sato, M 2.339

Sato, S 1.081

Satoh, A 1.059

Saunders, G W. 2.222

Saunders, K 2.226

Sauseville, R 3.466

Sauter, C S. 3.134

Saxena, A 3.466

Scafidi, J 2.163

Scandiuzzi, R 1.248

Scantlebury, M 1.237, 1.384

Scantlebury, M H. 1.066, 3.361, 1.119, 3.059

Scavone, J 2.250

Scemes, E 3.067, 3.031

Scerrati, M 2.168

Schöller, H 1.378

Schönberger, J 2.102


Schönberger, J 1.077

Schachter, S 1.120

Schad, C 2.423, 2.424

Schaefer, A 1.052

Schaffer, C 3.069

Schalk, G 2.069

Scharf, M 3.269

Scharfman, H 1.070, 1.465

Schedlbauer, A 3.108, 3.109

Scheffer, I E. 2.365, 2.367, 2.374, 2.375, 2.193, 1.201, 1.390, 2.212, 3.392, 3.399, 3.405, 1.451, 1.470

Scheffer, I E. 1.233, 3.221

Scheiwe, C 2.134

Scherrer, B 2.180

Schevon, C A. 1.037, 3.383

Schevon, C A. 1.037, 1.392, 3.043, 3.115, 2.085

Schidlitzki, A 1.282

Schiepek, G 1.378

Schiff, S 3.117

Schiller, K 1.164, 2.077

Schmid, E 1.378

Schmidt, S 1.269, 2.350

Schmitt, L M. 1.247, 2.167

Schmitt, S 1.146

Schneider, A 2.365, 3.392, 3.399, 3.405, 1.451

Schneider, A L. 1.390

Schneider, J 1.459

Schnell, E 1.104

Schobel, A 3.295

Schoenberg, M R. 2.345

Schoenike, B 3.003

Scholtz, H 3.261

Schomer, D L. 1.329

Schomer, M 3.091

Schommer, L 3.382, 2.350

Schorge, S 1.397

Schrader, D 2.384

Schrader, L M. 2.131

Schreiber, J M. 2.430, 3.175, 3.209

Schreier, P 2.047

Schroeder, L 3.046

Schroeter, K 2.392

Schteinschnaider, A 3.267

Schubert, J 1.022

Schuele, S 2.033

Schultz, C 1.283

Schultz, L 3.186, 3.125

Schultz, MPAS, PA-C, S 1.413

Schulz, A 2.368

Schulze-Bonhage, A 1.182, 1.094, 3.237

Schupper, A 3.185, 3.212

Schwarb, H 3.248

Schwartz, K 1.445

Schwartz, L 2.423, 2.424

Schwartz, L 1.256, 3.387

Schwartz, T 2.085, 3.069

Schwarz, N 2.367

Schwarz, S 3.146

Schweitzer, J 3.435

Sciberras, D 2.226

Scoggin, J L. 3.280

Scott, A 1.374

Scott, C 2.170

Scramstad, C 2.448

Scrivner, B N. 2.426

Scuffins, J 1.403

Sculier, C 3.436

Sears, L 3.288

Seethaler, M 2.278

Segal, D J. 2.080

Segal, E 1.136, 1.444, 3.386, 3.389, 3.285, 3.286, 3.469

Segawa, Y 3.302

Segovia-Oropeza, M 3.045

Seif-Eddeine, H 2.150, 2.223

Seifert, B 1.462

Seirup, J 1.410

Selioutski, O 3.072

Selladurai, G 3.238

Selmer, K K. 3.356

Selwa, L 2.331

Selway, R 3.352, 2.070

Semmelroch, M 1.250, 3.237

Sen, A 2.265

Sendi, M 2.074

Seneviratne, U 3.192

Seneviratne, U 1.321

Senger, D L. 3.358

Sen-Gupta, I 2.306

Seo, D 2.309

Seoane, P 3.123

Sepeta, L 2.205, 1.352, 3.247

Sepulveda, R 1.433

Sequeira, A 3.134

Sequeira, D J. 2.235, 2.236

Serafeimidou, E 1.463

Serafini, A 3.422, 3.423

Serafini, R 1.151

Serinolli, M I. 2.160

Serpa, M 2.373

Serrano, P 1.310

Serrano, V 2.160

Serratosa, J M. 1.310, 2.301

Seshadri, S 3.432

Seto, E 2.111, 3.177

Seunarine, K 1.251

Sever, R 2.345

Sewankambo, N 2.122

Seyal, M 2.006

Seyama, G 1.157, 2.093

Seyama, G 3.328

Shabbir, S 1.203

Shafer, RN, MN, P O. 2.391, 3.422, 3.423, 1.405

Shafi, M 1.225

Shafran, B 1.334

Shafran, B 2.153

Shah, G 3.134

Shah, L 1.456

Shah, L D. 3.400

Shah, M 2.329

Shah, M 2.102, 2.134

Shah, P 3.070

Shah, V 3.325

Shah, Y 2.039

Shahabi, H 3.036

Shahlaie, K 3.109

Shahlaie, K 3.108

Shaikh, T 3.402

Shain, C 1.392

Shaji, A 1.435

Shaker, H 3.450

Shakil, S 2.144

Shalev, R 3.399

Shamsuzzaman, A 3.334

Shamsuzzaman, A 2.021

Shankar, A 1.379

Shankar, R 2.265

Shao, X 1.017, 3.241, 3.193

Shapiro, K 1.422

Shapiro, M S. 3.004

Sharan, A 1.033, 2.175, 3.249, 3.250

Shariff, S Z. 1.427

Sharma, N 2.204

Sharma, R 3.306

Sharma, S 3.421

Sharma, S 1.045, 1.055

Sharpe, C 3.120

Sharpe, L 1.374

Shashi, V 2.437

Shaw, A 3.437

Shaw, S 2.386, 3.379

Shearer, J 3.361

Sheehan, T 1.232

Shegog, PhD, R 1.433

Sheidley, B 1.415

Sheikh, D 3.020

Sheikh, M 1.195

Sheikh, S 2.442, 3.425

Shella, T 3.266

Shellhaas, R 2.121, 2.109, 1.412, 2.331, 3.179

Shen, S 2.011

Sherrington, R 3.282, 3.211, 3.292

Sheth, K N. 2.027

Sheth, S 1.033

Sheth, S 1.392

Sheynina, T 1.093

Shibata, M 1.401

Shibuya, P 1.407

Shigekawa, S 3.375

Shigematsu, H 3.206

Shigeto, H 2.304

Shigeto, H 1.159

Shih, F 3.098

Shiloh-Malawsky, Y 1.470

Shim, K 2.330

Shim, W 2.195

Shimizu, K 1.184

Shimojo, M 3.064

Shimotake, A 1.039, 2.065

Shin, D 1.001

Shin, H 2.442, 3.425, 1.336

Shin, H 3.306


Shin, H 2.325

Shinnar, S 3.462

Shinohara, T 3.375

Shinozaki, T 1.082

Shirozu, H 1.364

Shiue, H J. 1.202

Shon, Y 2.309

Shor, O 3.012

Shoukat, M 2.025

Shoup, J A. 2.003

Shrestha, A 3.230

Shroff, S 1.448

Shu, H 3.005

Shuart, N G. 1.285, 3.273

Shuer, L 2.315

Shukla, G 2.038

Shultz, S R. 1.099, 1.122, 3.089, 1.118, 1.288

Shultz, S R. 1.096

Shum, J 2.071

Shuntaro, S 2.206

Siddiqi, M 2.118

Siddiqui, A 3.256

Siddiqui, S 3.280

Sideman, N 3.249

Sideridis, G 2.370

Sidhu, M 2.166

Sieu, L 1.175, 1.176

Sifuentes Saenz, M 1.022, 2.446

Silbergleit, R 3.462

Silbersweig, D 3.033

Siliquini, S 1.306

Sillau, S 1.165, 3.146

Sills, G J. 3.393

Silva, G 1.143, 1.333

Silvado, C E. 3.381

Silver, M 2.385

Silverberg, A 3.199

Silverman, J L. 2.080

Silverstein, B 2.002

Silverstein, F 2.121

Simakajornboon, N 2.320

Simeone, J 2.263

Simeone, K A. 3.160

Simeone, T A. 3.160

Simmonds, J 2.276

Simonsen, H 3.245

Simpson, H 2.162

Simpson, J 3.058

Simpson, L 2.349

Sinclair, D 2.318

Singer, S 1.265

Singh, A 3.305

Singh, A 2.416, 2.417, 2.418

Singh, G D. 2.412

Singh, J 1.222

Singh, J 2.180

Singh, N 1.199, 2.032

Singh, P 3.124

Singh, S 2.381, 3.428, 1.361, 1.408

Singh, S 2.274, 2.310, 2.312

Singh, T 1.393

Singla, A 2.016

Singla, S 1.176

Sinha, S 1.161, 2.057

Sinha, S R. 2.336, 3.096

Sinopoli, K 3.290

Sirven, J I. 1.202, 1.405

Sisodiya, S 1.393, 3.393

Sisodiya, S M. 1.022, 2.402

Sisterson, N 2.303

Siu, C 2.384

Sivaraaman, K 2.271, 3.269

Sivaraju, A 2.313, 2.333

Sivathamboo, S 2.010

Sivera Mascaró, R 1.307

Skaarup, C 2.035

Skarpaas, T L. 3.092, 2.046, 2.048, 2.049

Skidmore, C 3.203, 1.345

Skinner, H J. 3.435, 1.367, 2.181

Skjei, K 2.273

Skwarzynska, D 1.172

Slack, B 2.388

Slater, J 2.001

Slater, J D. 2.338, 2.340

Smart, S 3.218

Smeyers Durá, P 2.136

Smith, A W. 2.358

Smith, A W. 2.456

Smith, B 3.002

Smith, B 1.409

Smith, C 3.099

Smith, D 2.320

Smith, D 3.221

Smith, D H. 3.110, 3.017

Smith, G 1.096, 1.097, 1.098, 1.099, 1.101

Smith, J 3.379

Smith, K M. 2.405

Smith, K 1.181

Smith, K 1.224

Smith, L 2.376

Smith, L R. 3.271

Smith, L 1.201

Smith, M 3.385, 3.390, 3.391

Smith, M 1.391

Smith, M C. 3.227

Smith, M 2.222

Smith, R 2.105

Smolik, M 3.106

Smyth, M 3.334

Snead, C 1.221, 3.290

Sneed, P 3.321, 1.340

Snowden, A 2.407

Snyder, J 3.186

Snyder, K 3.242

So, E 3.130, 2.335

Sobayo, T 1.030

Socher, K 2.151

Soder, R 2.341, 2.342

Soh, H 3.053

Sohrabpour, A 1.261, 1.266, 1.267

Sojo, L 1.285

Solis, P 2.347, 3.123

Solomon, M 2.449

Somagawa, C 3.251

Somboon, T 2.217

Somerville, E 1.436

Somma, T 3.091

Sommer, B 1.339

Somoza, E 3.247

Sone, D 2.216

Song, D Y. 1.255, 1.102

Song, H 3.057

Song, I 1.032

Song, J 2.366

Song, J 2.325

Song, N 3.448

Song, W 3.306

Song, W 3.422, 3.423

Song, Y 2.183

Song, Y 3.382, 3.133

Sood, R 2.112

Sood, S 1.132, 1.138, 2.327

Sopelana, D 3.316

Soto, A 3.261

Soto Insuga, V 2.301

Sotuyo, N 1.023

Souirti, Z 1.214

Soul, J 2.137

Spagnolo Allende, A 1.392

Spain, E 3.458

Spampanato, J 3.106

Spanaki-Varelas, M 2.103, 3.186

Sparks, R 1.249, 2.168, 2.175

Sparks, R 3.354

Specchio, N 3.339, 2.251, 3.283

Speechley, K 3.391

Speed, D 3.393

Spencer, D C. 3.092

Spencer, D 3.345, 2.059, 2.116, 2.060, 2.145, 2.313, 1.370, 2.333

Spencer, E 2.092

Spencer, K 2.357, 2.360

Spencer, P 1.191

Sperling, M 1.032, 1.033, 1.303, 2.175, 3.260, 3.249, 3.250, 3.203, 3.268, 1.345

Spiedel, B 3.122

Spinelli, E 2.372

Spruill, T 3.305, 2.416, 2.417, 2.418

Spurgeon, B 2.147

Sputo, K 2.021

Srinivasan, S 3.043

St Louis, E K. 3.077

St.Clair, R 3.094

Staack, A M. 1.211

Staba, R 1.001, 1.032, 1.096, 1.097, 1.098, 1.099, 1.101, 2.187

Stabile, A 1.306, 2.123

Stacey, W 2.331

Stacey, W C. 3.038, 3.040

Stafstrom, C 3.426, 3.197


Staikova, E 1.373

Staley, K 3.050

Staley, K 1.060, 1.004, 1.013, 1.014, 3.317, 3.011

Stamberger, H 1.393, 3.399

Stamberger, H 3.405

Stamoulis, C 3.172

Stanfield, A 1.456

Stanford, E 1.370

Stanley, K E. 3.401

Stanley, T 2.375

Stavropoulos, I 2.265, 2.070

Stead, M 3.324, 1.035, 1.086, 1.366, 3.470

Steele, P 3.086

Stefan, H 1.339

Stefanidou, M 3.432

Steiger, H 1.457

Stein, J 1.033

Steinbart, D 3.121

Steinbrenner, M 3.121

Steinhoff, B J. 1.289, 1.211, 2.252, 2.257

Steiniger-Brach, B 1.290

Stephani, U 3.461

Štěrbová, K 3.083

Stern, E 3.033

Stern, J 1.186

Stern, J M. 1.212, 1.011, 3.187, 3.244

Stern, M 2.307

Sternberg, E 1.370

Steve, T A. 1.247, 2.167, 2.173

Steven, D 1.084

Stevens, S 3.410

Stevenson, M 2.422

Stewart, C P. 2.030

Stewart, E 3.384

Stewart, G R. 1.103

Stewart, K 1.402

Stickgold, R 1.377, 2.343

Stieglitz, T 1.094

Stillman, C 3.355

Stodberg, T 1.201

Stoehr, K 1.022

Stojic, A 2.403, 2.314

Stoll, J 2.297

Stone, M 1.283

Stone, S 3.335, 1.359

Story, T 3.455

Storzbach, D 2.220

Stott, C 2.462

Stott, C 1.295

Stoub, T 3.246

Stoyell, S M. 1.255, 1.102

Strandheim, J 1.154

Stredny, C 2.394

Streiner, D 2.295

Streltzov, N 3.382, 2.350

Striano, P 3.393

Strobbe, G 2.014

Strom, L 3.377

Struck, A 1.134, 1.450, 2.206, 3.235

Struyven, R 2.180

Study Group, C 2.367

Study Group, T 3.456

Stufflebeam, S M. 1.255, 1.128

Stufflebeam, S M. 2.189, 1.102, 2.058, 1.043

Sturges, B 1.086

Suarez Cedeno, G 2.433

Subendran, J 3.390

Subramaniam, T 3.194

Subramanian, G 3.281

Subramanian, L 2.460

Suchdev, K 3.222

Suchita, I 2.291

Suchomelova, L 3.009

Sud, M 3.392

Sudo, S 2.400

Suehiro, S 3.375

Sueiras, M 2.283

Sueri, C 2.013

Sugai, K 3.346, 1.229

Sugano, H 3.319, 1.040, 2.088, 2.095, 3.252

Sugie, H 1.229

Sugiura, A 1.132, 1.138, 2.002

Suhara, T 3.064

Sukumar, D 2.271

Suller Marti, A 1.084

Sullivan, B 1.280

Sullivan, B 1.111

Sullivan, J 3.288

Sullivan, J 2.212, 2.251, 2.109, 3.202, 3.463

Sullivan, L 1.147

Sullivan, S 2.319

Sumi, Y 2.266

Sumida, A 2.338

Sumitomo, K 1.322

Sumsky, S 3.091, 2.099

Sun, H 3.042

Sun, H 2.081

Sun, J 1.461

Sun, Q 1.007

Sun, T 2.017, 2.018, 3.442

Sun, Y 2.068

Sun, Y 2.411

Surimohanram, S 3.118

Surya, N 2.381, 1.408

Suslovic, W 3.087

Sutcliffe, A 1.238

Suthana, N 3.258

Suttle, L 1.388

Sutton, B 3.248

Sutula, T 3.103

Suzanne, L 1.407

Suzuki, H 1.163

Suzuki, H 3.319, 1.040, 2.088, 3.252

Suzuki, H 2.400

Suzuki, I 3.079

Suzuki, J 1.277

Suzuki, K 3.350

Suzuki, M 1.177

Suzuki, M 1.223, 3.167

Suzuki, Y 1.083, 1.121

Suzuki, Y 1.163

Svendsen, L L. 1.022

Swaminathan, P 3.018, 3.083

Swamy, S 1.435

Swanson, S J. 1.256, 3.387

Sweney, M 2.293

Swensen, M 3.066

Swift, K 1.074

Swinford, S 3.427

Syed, A 2.001

Syed, T 2.001

Sykuta, A 1.330

Symonds, J D. 1.299, 1.201, 1.397, 1.402

Szabo, C A. 1.433, 3.104, 3.270, 2.291

Szaflarski, J P. 1.076, 1.256, 1.330, 1.383, 1.468, 2.426, 2.464, 3.074, 3.125, 3.387, 3.464, 3.465, 3.469

Szaflarski, M 2.426, 3.469

Szu, J 1.112

T

Töllner, K 1.282

Tabu, K 1.191

Tacke, M 2.011

Tadokoro, Y 2.390

Tagawa, M 3.375

Taghibiglou, C 3.047

Takacs, D S. 3.177

Takado, Y 3.064

Takahashi, H 1.082

Takahashi, M 3.064

Takahashi, R 1.039, 2.065

Takahashi, Y 1.236, 2.268

Takase, T 2.245, 3.287, 3.289

Takayama, Y 2.194

Takeda, M 2.380

Takeda, Y 1.046

Takeoka, M 3.336, 3.342, 3.343

Takeuchi, M 1.322

Takeyama, H 1.039

Takumi, I 3.346

Takuwa, H 3.064

Tallavajhula, S 3.434

Talos, D M. 1.021, 1.038, 2.404, 3.075

Tamilia, E 1.041, 1.100, 1.043, 2.058, 3.095

Tan, C 3.280

Tan, I 2.402

Tan, N C. 2.412

Tan, Y 2.412, 3.223

Tanabe, S 3.467

Tanabe, T 1.229

Tanaka, F 1.131

Tanaka, H 2.304

Tanaka, M 1.193, 1.229


Tanaka, N 2.058, 1.043

Tanaka, S 1.350

Tanaka, S 2.400

Tanaka, T 2.088, 3.252

Tanaka, Y 3.460

Tanaka, Y 3.346

Tandon, N 2.311, 3.255, 2.338, 2.351, 2.340

Tang, R 1.419

Tang, S 1.022

Tang, W 1.123, 1.125

Tang, W 1.126

Tang, Y 2.171, 2.452

Tang-Wai, R 1.462

Taniguchi, G 1.268

Tanoue, Y 2.316

Tanritanir, A 2.261

Tantikittichaikul, S 1.142

Tao, J X. 2.428, 2.017, 2.018, 3.442

Tapper, J 3.259

Tarkunde, Y 3.053

Tarquinio, D 2.144

Tarrant, S 3.362

Tasker, R 3.128

Tasker, R C. 1.231, 1.232, 3.426, 1.235, 3.401, 3.197

Tassi, L 3.339

Tatachar, P 2.372

Tatachar, P 3.395

Tateishi, Y 3.251

Tatsuoka, C 1.371, 1.218

Taubøll, E 3.356

Tayah, T 2.115

Taylor, J A. 1.064

Taylor, K 1.155, 3.327

Taylor, L 1.297, 1.300, 1.453

Tayo, B 1.297, 1.453

Tchapyjnikov, D 1.231, 1.232, 3.426, 1.235, 3.401, 3.197

Tcheng, T K. 1.379, 2.050, 2.052

Teagarden, D 1.197

Tecoma, E 3.321

Teijeira Azcona, A 1.162, 2.149

Tellapragada, N 3.235

Tellez-Zenteno, J 2.310, 2.312, 1.462, 2.457

Tellez-Zenteno, J 1.278, 2.421

Templer, J 3.408

Tenney, J R. 1.156, 3.471

Terada, K 1.135, 1.291, 2.390

Teran, F A. 3.367

Terman, S W. 1.460

Terpiluk, V 2.347

Terra, V 3.381

Terrin, S 3.262

Terry, D 1.273

Teskey, G C. 1.054, 1.005, 1.071, 1.066, 3.158, 2.082

Testa, F 1.194, 1.200

Tetsuka, M 1.344

Tfelt-Hansen, J 3.429

Thébault-Dagher, F 2.355

Thadani, V 3.166, 3.448

Thandar, A 1.365, 2.179, 2.127

Thayer, Z 1.374

Thayer, Z 1.375

Thennarasu, K 1.161, 2.057

Theodore, W 3.242

Theodore, W 1.068, 2.199, 1.081, 2.205, 1.352, 3.258

Thevathasan, W 2.036, 3.239

Thewamit, R 3.175

Thio, K 3.334, 3.190

Thippeswamy, T 1.045, 1.055, 1.006

Thodeson, D 1.230, 1.459

Thom, M 2.402

Thomas, B 3.087

Thomas, G 1.144

Thomas, G P. 3.133

Thomas, H M. 1.388

Thomas, J 3.168

Thomas, M S. 2.338, 2.340

Thomas, R H. 1.391

Thomas, R H. 1.022

Thomas, R D. 2.016

Thompson, E 2.437

Thompson, K 3.009

Thompson, M 1.383

Thompson, N 1.269, 1.440

Thompson, P 2.166

Thompson, S A. 2.338, 2.340

Thompson-Rogers, C 2.431

Thomson, K 3.359, 3.102

Thorn, E L. 1.255, 1.102

Thornton, R 1.251

Thorsby, P 3.356

Thorsteinsdottir, J 2.332

Thurman, D 1.432, 3.414

Tian, N 1.469

Tichý, M 1.170

Tidball, A 3.021

Tidball, A M. 3.018

Tierney, T 1.355

Tilley, E 1.028

Tillman, H 3.462

Timmons, B 2.295

Tiplady, K 1.407

Tirol, F G. 2.379

Tisdall, M 1.251

Tivarus, M 1.256, 3.387

Tiwari, D 3.046, 3.060

Tobimatsu, S 1.159

Tobochnik, S 1.037

Toda, K 2.400

Toda, K 2.328, 1.350

Todaro, M 3.228

Toga, A W. 1.097

Togo, M 1.039

Tokiwa, T 1.177

Tolchin, B 1.277

Toledano, R 3.316

Toledo, M 1.453

Toledo, M 2.262, 2.114, 2.283

Toledo, M 1.289, 2.260

Toledo, M 2.141

Tomasek, M 3.171

Tomatsu, S 1.074

Tombridge, K 2.311, 2.351

Tominaga, T 3.350, 2.045

Tomko, S 3.334, 2.021

Tomlinson, A R. 1.404, 2.346

Tomlinson, G 1.221

Tomlinson, S B. 1.190, 2.100

Tomson, T 3.228

Tong, B A. 2.340

Tong, X 2.171, 2.452

Tonn, J 2.332

Tononi, G 1.450, 3.115, 3.114

Topjian, A 1.231, 1.232, 3.426, 1.235, 3.197

Torres, M 1.433

Torres-Barba, D 3.187

Tortosa, D 2.260

Toth, E 3.071, 3.016

Toub, J 2.398

Tous, E 1.319

Tousseyn, S 1.185

Tracey, J 1.033

Tracy, J 3.249

Tracy, J 3.250

Trammel, E R. 2.042

Tran, C 2.209

Tran, D 2.306

Tran, T 1.431

Trandifir, C 1.420

Traynelis, S 1.025, 2.374, 1.123, 1.124, 1.125, 1.126, 1.127

Treiman, D M. 2.237

Treit, S 2.167

Trencevska, G 2.463

Trevathan, E 3.418

Trimmel, K 2.166

Tringali, G 3.329

Trinka, E 1.378

Tripathi, M 1.348

Tripathi, M 3.321

Tripathi, M 1.348

Tripathi, R 3.244

Trobliger, R 3.386, 3.389, 3.374

Trott, K 1.273

Trott, K 2.214

Trucculo, W 3.084

Trudeau, P 1.147

Truong, L 3.281

Truty, R 2.369

Tsai, C 1.027

Tsai, J 2.034

Tsai, M 3.303

Tsai, P 1.020

Tsao, C 2.378, 2.385, 1.274

Tsien, R 1.038, 3.052

Tsiropoulos, I 3.429

Tsuboyama, M 1.359

Tsuboyama, M 2.058, 3.095

Tsuchida, T 2.163

Tsutsumi, H 1.044

Tucker, D 2.203

Tuggle, S 3.074

Tupal, S 2.230

Turnbull, D 1.052, 1.028

Turnbull, J 1.458

Turner, C 2.364

Turner, Z 1.456

Turovets, S 1.181

Twanow, J E. 2.214

Twele, F 1.282

Tymchuk, S 2.124

Tyrlik, M 3.318

Tyrlikova, I 3.318

Tzingounis, A 3.053


U

Uda, H 2.316

Uda, T 2.316

Udow, S 2.448

Uehara, T 1.159

Ueno, T 2.395

Uhler, M D. 3.018

Uldall, P 3.429, 2.014

Uliel-Sibony, S 2.233

Ulyanova, A 3.110

Umaba, R 2.316

Umar, A 3.124

Umetsu, Y 3.291

Unal Cangul, S 1.216

Unroe, B 3.264

Upadhyayula, P 3.185, 3.212

Urakawa, M 2.089

Urban, A 2.303, 2.178, 2.450, 3.132, 3.200

Uribe-Cardenas, R 1.413

Urushihata, T 3.064

Usami, K 1.168

Usami, K 2.065

Ustine, C 2.206, 3.235

Ustun ozek, S 3.181

Usui, N 1.135

Uthman, B 2.118

Uysal, B 2.367

V

Vélez Gómez, B 2.445

Vabson, B 1.328, 1.331

Vaca, F 1.074

Vaddiparti, A 1.385

Vaddiparti, A 1.152

Vadera, S 3.344, 2.306, 3.135

Vaghasia, U 2.147

Vaiana, M 2.209

Vaid, S 3.018

Vaidya, V 3.360

Vainchtein, I D. 1.003

Vajapey, G 2.437

Vajda, F 3.228

Vajjala, V S. 2.237

Vakharia, V N. 1.249, 2.168, 3.354, 2.175

Valcarce-Aspegren, M 1.176

Valdez, J N. 1.325, 1.326

Valdez-Gonzalez, K 1.444

Vale, F 1.133, 1.262, 2.345

Valencia, I 1.333

Valente, K 1.209, 2.373, 3.380

Valente, K D. 3.378, 2.356, 3.262

Valenti, E 3.135

Valentin, A 1.162, 3.352, 2.070

Valiante, T A. 2.090

Van Asperen, J 2.226

Van Bogaert, P 1.208, 3.436

Van den Haute, C 3.082

van der Linden, H 1.209, 2.373

van der Linden, V 1.209

Van Dooren, V 2.184

Van Ess, P J. 2.235, 2.236

Van Gompel, J J. 3.324, 1.035, 1.086, 1.088, 1.366, 2.335, 3.470

Van Harn, M 2.029

Van Hecke, A 1.208

Van Hirtum-Das, M 1.188, 1.358

Van Huffel, S 3.459

van Klink, N E. 2.044

Van Marter, L 3.231

van Mierlo, P 2.014

Van Ness, P C. 2.066

Van Paesschen, W 1.289

Van Paesschen, W 1.022, 3.459

van Vliet, E A. 1.003

Vanatta, L 3.360, 3.370

Vandamme, S 1.324

Vandecasteele, K 3.459

Vandeput, S 3.459

Vandergrift, W A. 1.092

Vangala, S 1.032

VanHaerents, S 3.408, 3.198

Vankov, E 1.212

VanLandingham, K 1.296, 3.288, 1.470

VanLandingham, K 1.298, 1.300

Vannest, J 1.382

Vanoye, C 1.024

Varelas, P 2.029

Vargas, L 1.149

Varma, P 1.459

Varner, J 2.464

Vasoli, V 1.086

Vasquez, A 1.231, 1.232, 3.426, 1.235, 3.401, 3.197

Vaughan, D N. 1.263

Vaughn, B 3.425

Vavoulis, D V. 1.022

Vega, C 2.359, 3.152

Vega, M 3.379

Vegh, D 1.335

Veilleux, M 3.237

Velakoulis, D 2.010

Velakoulis, D 1.139

Velasco, T R. 1.248, 3.380

Velasquez, A 2.019

Veldman, T 3.096

Velisek, L 1.106, 3.031

Veliskova, J 1.106, 3.067, 3.031

Vellareddy, A 1.055

Velmurugan, J 1.161

Venkat, A 3.311

Venkat, V 3.096

Venticinque, J 1.265

Ver Hoef, L 3.238, 3.074

Verdier, K 3.027

Verducci, C 1.425

Verdugo, C 1.063

Verhagen, R 1.450, 3.115

Verma, A 1.448

Verma, S 3.331

Vernillet, L 3.304, 3.307

Verrier, R 1.120

Vestergaard, M B. 3.245

Vettel, J 3.101

Viale, R 2.341, 2.342

Viarasilpa, T 2.029

Vibbert, M 3.203

Vidaurre, J 1.204

Vieira, M 2.239

Vieira, M 2.242

Vieluf, S 1.100, 2.047

Vigevano, F 3.339

Vilella, L 1.454

Viles, W 2.092

Villa, B 3.358

Villalba, S 3.156

Villalobos, A 2.323

Villalobos, R 2.323

Villamar, M F. 3.407

Villani, F 3.329, 1.306, 2.123

Villani, I 2.393

Villani, V 2.234

Villanueva, V 1.296, 2.260, 3.308, 3.309, 3.310, 1.464, 2.465

Villemarette-Pittman, N R. 1.443

Villeneuve, N 3.461

Viloria Alebesque, A 1.307

Vimla, A 3.401

Vincentiis, S 2.373, 3.380, 3.262

Visser, M 1.464

Vitez, M 2.385

Vitkovskiy, P 1.062, 3.254

Vizthum, D 3.357

Vlachos, I 3.071

Vlaskamp, D R. 2.212

Vlaskamp, D R. 3.399

Voets, N 1.343

Vogrin, S 2.349

Voinescu, P 3.236

Voitiuk, A 1.093

Vollmar, C 2.011

Vollmar, C 2.332

Vollmar, C 2.166

Von Allmen, G 1.205, 2.329, 2.340

von Ellenrieder, N 1.260, 1.077, 1.042, 2.043, 2.201, 3.149

Vonck, K 3.082

Vos, S B. 1.246, 1.249, 2.166, 2.168, 2.170, 2.175, 2.204, 2.184

Vos de Wael, R 2.190, 2.207, 2.208

Voss, C M. 1.028

Voyles, S 3.119, 3.085

Vrba, D 1.170

Vrba, J 1.170

Vu, T 3.338, 1.407, 3.209

Vu, T 1.353

Vuong, K A. 2.184

Vuong, S 1.462

Vuu, I 2.228, 2.272

W

Waagepetersen, H 1.028

Wabulya, A 2.442, 3.425

Wada, M 2.328

Wade, S L. 1.382

Wadman, W 3.082


Wagley, P 1.172, 3.061

Wagner, F F. 2.377

Wagner, J N. 3.006

Wagner, K 3.341

Wagner-Egea, P 1.130

Wagnon, J L. 3.061

Wagstyl, K 1.250, 1.251

Wahby, S 2.310

Wahby, S 2.312

Waheed, S 2.337

Wainwright, M S. 1.232

Wainwright, M S. 1.231, 3.426, 1.235, 3.401, 3.197

Walbert, T 3.186

Waldbrook, M 1.285, 3.273

Waldman, G 2.387

Waldman, Z 1.032, 1.033, 1.011

Waldron, K 1.423

Walia, H 2.217

Walker, K 1.283

Wall, A K. 1.054

Wallace, A 3.125

Wallace, E 1.284, 3.003

Wallace, G 3.399

Wallace, G 3.247

Wallace, J 2.072

Wallach, T 3.094

Wallis, G J. 3.006

Walston, V 2.413

Walter, K 3.137

Walters, M 2.275

Wanda, P 1.033

Wandschneider, B 2.166, 2.204

Wang, D 2.015

Wang, D 3.411

Wang, D 2.460

Wang, F 2.053

Wang, H 2.142

Wang, J 2.132

Wang, J 1.015

Wang, J 1.148

Wang, J 3.090

Wang, J 1.166, 1.048

Wang, L 3.290

Wang, M 2.310, 2.312

Wang, N 2.150, 2.223

Wang, P 1.458

Wang, Q 1.178, 2.015

Wang, Q 2.112

Wang, S 2.179, 2.127, 1.467

Wang, S 2.179, 2.127

Wang, S 1.201

Wang, S 3.120, 3.185, 3.212

Wang, X 1.194, 2.261

Wang, X 2.015

Wang, X 1.461

Wang, X 1.017, 3.241, 3.193

Wang, X 1.034, 3.208

Wang, X 2.053

Wang, Y 2.190, 2.208

Wang, Y 2.331

Wang, Y 3.324

Wang, Y 2.161

Wang, Z 1.250, 1.253, 1.185, 2.172, 2.055, 1.467

Wang, Z 2.190, 2.207, 2.208

Wang, Z 2.179, 2.127

Wang, Z 2.207

Ward, B 3.235

Ward, M 1.340

Ward, M 3.321

Ward-Mitchell, R 3.407, 2.337

Warfield, S 2.180

Wargacki, S 3.295, 2.453, 3.468

Wark, J 1.122

Warncke, J 1.056

Warner, N 1.167, 3.348

Warning, A 2.358

Warnock, R 1.324

Warren, A 1.263, 2.036, 3.239

Warren, T J. 3.160

Wasade, V 3.186

Wasterlain, C 3.009

Wastling, S J. 1.246

Watanabe, H 3.375

Watanabe, K 1.193

Watanabe, M 1.083

Watanabe, Y 2.328, 1.350

Watanage, E 3.346

Watkins, M 2.329

Watson, M 3.412, 3.377

Way, E M. 3.126

Weas, S 1.439

Weatherspoon, S 2.148

Webb, D 1.396

Weber, D 3.368

Weber, P B. 2.051

Weber, Y G. 1.022, 1.393

Webster, E 1.289

Webster, R 3.384

Wechsler, R T. 2.252, 3.284

Weckhuysen, S 1.393

Weckhuysen, S 1.022, 3.083, 3.405

Weeber, E J. 2.080

Weed, N J. 3.392

Wei, H 1.048

Weil, A 3.237

Weinberg, G 3.368

Weiner, H 3.075

Weiner, H 1.038

Weinstock, A 1.298

Weinstock, A L. 2.016

Weisenberg, J 3.334

Weisholtz, D 2.218, 3.033

Weiss, S 1.032, 1.033, 1.011, 2.187

Welker, K 1.254

Wells, E 3.087

Welty, T 1.330

Welzel, L 1.282

Wendling, A 1.211

Wendling, F 2.096

Wengert, E R. 1.050, 3.061

Wenzel, F 2.174

Werbaneth, K 1.227

Werhahn, K J. 1.289

West, P J. 2.222

Westerveld, M 3.435

Westover, M 1.325, 2.012, 2.025, 3.125, 3.168, 3.042

Whalley, B J. 2.229

Whalley, B J. 3.052, 1.463, 2.462

Wheatley, B 2.318

Wheatley, B 1.247

Wheeler, C 3.370

Wheless, J W. 1.320, 1.164, 2.241, 2.062, 2.148, 2.077, 3.284, 3.285, 3.286, 3.294

Whitaker, K 1.250

White, E 2.010

White, H 3.099, 3.274, 3.100

White, J 1.025

White, J 2.272

White, M 1.396

Whitehouse, W P. 2.276

Whiting, M 3.299

Whitmire, L 3.119, 3.085

Whitney, R 3.363, 2.154, 3.406

Whittemore, V 1.195

Whitton, S 3.118

Whyte, L 1.298

Whyte, S 1.028

Wiberg Larsson, H 3.245

Wichman, C 2.142

Wicker, E 2.087

Widdes-Walsh, P 1.022

Widjaja, E 1.221, 3.390

Wiebe, S 2.274, 3.391, 2.310, 2.312

Wienholt, L 3.093

Wiggs, E 2.205

Wijayath, M 1.215

Wilcox, K S. 2.222

Wilcox, K S. 3.359, 1.117, 3.006, 3.102

Wilfong, A 1.295, 1.231, 1.232, 3.426, 1.235, 3.401, 3.370, 3.197

Wilke, M 3.258

Wilkons, S 2.118

Williams, A 3.406

Williams, A 1.007

Williams, B 1.270

Williams, B 1.196, 2.254, 2.255, 2.256, 2.257, 3.284, 3.285, 3.286

Williams, B 2.252

Williams, C 1.134

Williams, C M. 1.463

Williams, J 1.421

Williams, J 1.324

Williams, K 1.231, 1.232, 3.426, 1.235, 3.401, 3.197

Williams, P 2.464

Williams, R S. 3.272

Williams, S 1.423


Williams, S 1.053

Williamson, J 2.081

Willie, J T. 1.373, 1.226, 3.326, 1.169, 2.307, 3.073, 2.074, 1.338, 3.145, 1.341, 1.343

Wilman, A 2.173

Wilner, A N. 1.331

Wilson, A M. 2.289

Wilson, C 1.420

Wilson, C 2.005

Winawer, M 3.260, 3.268

Winawer, M R. 1.392

Winesett, P 1.456

Winkel, B 3.429

Winnike, H B. 3.088

Winquist, R 1.287, 3.273

Winston, G P. 1.246, 1.249, 2.166, 2.170

Winston, J 2.168, 2.348

Wirrell, E 2.369, 1.201, 1.347

Wirrell, E 3.461

Wise, M 1.210

Wise, M V. 1.189

Wiszniewski, W 3.396

Witt, J 1.311

Witt, T C. 1.336

Witte, R J. 1.254, 2.335

Wittmann, M 2.277, 3.276

Wodushek, T 2.352

Wolak, J 2.300, 3.369

Wolf, J A. 3.110

Wolf, S 1.437, 2.239, 2.108, 1.356, 1.357

Wolff, M D. 1.005, 1.066

Wolford, C 3.437

Wolking, S 1.022

Wombles, C M. 3.435

Wong, C 1.215

Wong, J C. 2.227

Wong, K 1.122

Wong, M 1.470

Wong, M 1.059, 3.334, 3.105

Wong, S 3.269

Wong, T 1.374

Wong, V S. 2.422, 2.413

Wong-Kisiel, L 3.130, 1.347, 2.335

Wood, M 2.225

Wood, T C. 1.246

Woodard, V 2.140

Woodman, M 3.112

Woods, L 2.222

Woodworth, D 2.187

Woolley-Roberts, M 2.229

Woolnough, O 3.255

Worden, L 2.012

Worrell, G A. 1.261, 1.032, 1.033, 3.324, 1.035, 1.086, 1.266, 1.088, 1.267, 1.366, 3.130, 3.137, 3.077, 3.470

Wosny, T 2.303, 1.015

Wray, L 1.453

Wright, D 1.097

Wszalek, T 3.248

Wu, C 2.175

Wu, C 2.228

Wu, E 1.058

Wu, G 1.185

Wu, J 1.074

Wu, J 3.191

Wu, J 2.098, 3.169, 3.456

Wu, M 3.090

Wu, S 2.428, 2.017, 2.018, 3.442

Wu, T 2.231

Wu, W 2.183

Wu, X 1.109, 1.110

Wu, Y 3.090

Wusthoff, C 1.420

Wyatt, D J. 3.295

Wychowski, T 3.137

Wyllie, E 2.324

X

Xiang, J 2.053

Xiang, X M. 1.446

XiangWei, W 1.124

XiangWei, W 1.127

Xiao, B 2.183

Xiao, F 2.166, 2.183

Xiao, F 2.452

Xiao, G 1.255, 1.102

Xiao, Y 2.171

Xiaofeng, W 1.335

Xiaozhen, H 1.335

Xin, W 2.368

Xing, Y 1.166, 1.034, 1.048

Xu, C 2.161, 3.208

Xu, Q 2.448

Xu, Q 2.207

Xu, Y 3.407

Xue, F 1.166, 1.048

Xue, J 3.090

Xue, X 3.411

Y

Yadav, P 2.337

Yaksi, E 1.063

Yalnizoglu, D 1.216

Yamakawa, K 3.028

Yamakawa, T 1.177

Yamakawa, T 1.083, 1.121, 1.090

Yamamoto, H 1.193

Yamamoto, H 3.346

Yamamoto, T 1.332

Yamamoto, T 2.194

Yamamoto, Y 1.236

Yamamoto, Y 2.268

Yamano, M 2.390

Yamao, Y 1.039, 2.065

Yamashita, T 2.089

Yamazoe, T 2.201

Yan, G 3.321, 1.340

Yan, H 3.351

Yan, J 2.015

Yan, Q 2.116, 3.220

Yan, X 1.048

Yanagisawa, E 2.266

Yang, E 1.392

Yang, H 3.382

Yang, H 1.178

Yang, L 1.267

Yang, L 3.191

Yang, M 2.005

Yang, M 2.129

Yang, R 2.250

Yang, T 3.373, 2.238

Yang, W 1.007

Yang, W 3.090

Yang, X 1.166, 1.034, 1.048

Yang, X 2.015

Yang, X 1.201

Yang, Z 3.090

Yano, K 1.268

Yardi, R 2.410

Yardi, R 1.335

Yasu, T 1.350

Yasuda, C L. 3.226

Yasuda, H 2.089

Yasuoka, S 1.067

Yates, S 1.323, 1.324

Ye, S 1.267

Ye, Z 1.451

Yeagle, E 3.150

Yeh, H J. 1.212

Yeh, H 1.011

Yendle, S 1.201

Yeon, G 1.242, 2.119

Yerra, R 2.010

Yerram, S 3.118

Yeruva, R 3.264

Yeshidinber, A 3.371

Yeshokumar, A K. 1.434, 1.404, 2.346

Yi, Y 3.225

Yim, C 1.115, 2.243

Yogo, N 3.292

Yokoi, R 3.079

Yokota, H 2.187

Yokoyama, R 1.163

Yoo, J 1.313

Yoo, J 1.264

Yoo, J W. 2.159

Yoshida, K 1.039, 2.065

Yoshimoto, K 2.339

Yoshimura, Y 2.266

Yoshinaga, H 1.229

Yoshinaga, K 2.194

Yoshioka, T 2.400

Yoshitomi, S 2.245, 3.287, 3.289

Yoshor, D 2.066

You, X 3.258

You, X 2.199, 2.205, 1.352, 3.247

Youn, S 2.133

Young, J 3.138

Young, M 3.135


Youssofzadeh, V 3.141

Yousuf, A 2.331

Yowtak Guillet, J 2.333

Yozawitz, E 1.437, 1.213, 2.108

Yu, H 2.091

Yu, H 3.402

Yu, K 1.180

Yu, T 1.034, 2.053, 2.161, 3.208

Yu, W 3.321, 1.340

Yuan, H 2.374, 1.123, 1.124, 1.125, 1.126, 1.127

Yuan, Y 3.018, 3.083

Yuan, Y 3.061

Yuan, Z 1.166

Yum, M 2.322

Yum, M 2.195

Yuskaitis, C 2.137

Yuzyuk, T 3.090

Z

Zaccariello, M 1.347

Zachery, A 2.205

Zack, M 1.469

Zafar, S 2.025

Zaghloul, K 1.033, 1.081, 2.205, 3.165, 3.242

Zagorchev, L 2.203

Zagorchev, L 2.174

Zagzag, D 1.392

Zaher, N 2.178, 2.450, 3.132, 3.200

Zahid, A 2.276

Zahoor, S 2.434

Zak, M 3.363, 2.154, 3.290

Zaman, T 1.023

Zamponi, N 1.306

Zanetti, G 3.164

Zara, F 3.393

Zarabla, A 2.234

Zarnegar, R 2.164, 2.165

Zarpellon, V 2.341, 2.342

Zarroli, K 3.467

Zavalin, K 3.025

Zaveri, H P. 2.024, 3.062, 2.313, 3.063, 2.333, 3.008

Zawar, I 2.439

Zazubovits, N 1.260, 2.201

Zelano, C 2.033

Zelano, J 1.430

Zelleke, T 2.196, 3.209

Zelmann, R 2.043

Zempel, J 3.334

Zeng, L 1.009

Zeng, Q 1.201

Zeng, R 3.386, 3.389

Zhai, F 3.353

Zhang, B 2.207

Zhang, B 1.059

Zhang, C 1.017, 3.241, 3.193

Zhang, C 1.007

Zhang, G 1.394

Zhang, G 1.034, 2.053, 2.161

Zhang, I 2.218

Zhang, J 3.241, 3.193

Zhang, J 2.455

Zhang, J 1.125

Zhang, J 1.123

Zhang, K 1.017

Zhang, K 3.241, 3.193

Zhang, L 2.452

Zhang, L 3.057

Zhang, L 3.048, 1.012, 3.056

Zhang, M 3.179

Zhang, M 1.166

Zhang, M 3.064

Zhang, R 1.271

Zhang, W 3.330, 1.362

Zhang, X 1.140, 3.097

Zhang, Y 1.290

Zhang, Y 1.201, 3.090

Zhang, Z 2.190, 2.207, 2.208

Zhao, B 3.241

Zhao, B 1.017

Zhao, C W. 1.175

Zhao, G 3.235

Zhao, L 3.191

Zhao, M 2.085, 3.069

Zhao, W 2.350

Zhao, X 1.458

Zhao, Y 1.073

Zhong, N 2.139, 1.452

Zhou, B 2.452

Zhou, C 3.022

Zhou, D 2.171, 2.452

Zhou, J 1.148, 3.353

Zhou, Y 2.112

Zhu, B 2.207

Zhu, B 1.058

Zhu, L 1.205

Zhu, X 3.048, 1.012, 3.056

Zhu, Z 1.125

Ziegler, C 3.264

Zierath, D 3.274

Zijlmans, M 2.044

Zimin, L 1.177

Zimmerman, R 3.323

Zimmermann, W 2.222

Żołnowska, D 2.228, 3.275

Żołnowska, M 1.295

Zorlu, M 2.164, 2.165

Zou, G 3.391

Zuberi, S M. 1.299, 1.201, 1.390, 1.397, 3.461

Zuberi, S M. 1.402

Zubkov, S 1.274

Zubkov, S 2.378

Zuliani, L 2.123

zur Linden, A 1.113

Zurita, J 3.316, 1.310

Zutshi, D 3.222

FIND IT FAST!Quick Ways to Search for the Abstract You Want

2018 AES GUIDE TO POSTER ABSTRACTS

Over 1,350 posters in New Orleans? Browse through this abstract guide to

target the science you don’t want to miss.

Indexed two ways for your convenience. Find the science you seek by author or by

poster number within category.

Abstract search is also available on the AES mobile app.

AES GUIDE TO POSTER ABSTRACTS 88 MEETING.AESNET.ORG





AES WEBSITE

The latest epilepsy science is at your fingertips when you visit the AES

Annual Meeting abstracts database.

Find all the 2018 poster session abstracts online. Search by author,

topic, title, and more. Previous years (back to 2007) are also available.

Search now:aesnet.org/abstracts

Session 1: Saturday, 12 PM–6 PMFirst authors present 12 PM–2 PM

Session 2: Sunday, 10 AM–4 PMFirst authors present 12 PM–2 PM

Session 3: Monday, 8 AM–2 PMFirst authors present 12 PM–2 PM

The 2018 Guide to Poster Abstracts and 2018 AES Online Abstract Searchare supported by Greenwich™ Biosciences, Inc.

At Eisai, human health care is our goal. We give

our fi rst thoughts to patients and their families

as well as helping to increase the benefi ts health

care provides. Our therapies are designed

to make a difference and have an impact on

patients’ lives. We are Eisai, where medicine is

more than just our business — it’s our passion.

Our passion ignites progress

CORP-US2153 ©2018 Eisai Inc. All rights reserved. Oct 2018 www.eisai.com/us

CORP-US2151 Our passion ignites progress.indd 1 10/30/18 1:06 PMAES program cover.indd 2 10/30/18 3:39 PM





Fonts: Azo SansImages: Epidiolex_bottle.psd (CMYK; 300 ppi, -300 ppi; Users:rdrozdalski:Desktop:EPID... Folder:Links:Epidiolex_bottle.psd), GREENWICH BIOSCIENCES PLC_4c.ai (Users:rdrozdalski:Desktop:EPID...ks:GREENWICH BIOSCIENCES PLC_4c.ai), Epiodiolex_Tagline_Sch_4C_v01 copy (1).ai (Users:rdrozdalski:Desktop:EPID...lex_Tagline_Sch_4C_v01 copy (1).ai)

EPIDIO25369_ AES_ProgramAd_REL_C00_01.indd Radek D 10-26-2018 12:53 PMPrint Scale: NoneInk Density: 300%

Bleed: 8.75" x 11.25"Trim: 8.5" x 11"Safety: 7" x 10"

Folded Size: NoneGutter: NoneScale: 1" = 1"

Colors: Cyan Magenta Yellow Black

Client: GREENWICH

BIOSCIENCE

Job Description: EPIDIOLEX AES

Program AD - NO Brief

Summary

Job #: EPIDIO25369

Stage: DISK RELEASE

Round: C00_01

©2018 Greenwich Biosciences Inc. All rights reserved. EPX-03796-1018

Pavilion D

NOWAVAILABLE

Finally, there’s a whole new path to explore

Greenwich Biosciencesis growing innovationStep into the growing and manufacturing process with a virtual reality experience all day on Saturday and Sunday. Additional presentations include:

• EPIDIOLEX Product Overview | Saturday 1-2 PM• Patient Support Resources Overview | Sunday 3-4 PM

Visit EPIDIOLEXhcp.com

Booth 401

Follow the footprints in the exhibit hall and discover EPIDIOLEX® (cannabidiol) Cv

S:7”S:10”

T:8.5”T:11”

B:8.75”B

:11.25”

AES program cover.indd 1 10/30/18 3:39 PM

Documents

AES ANNUAL MEETING abstract- FINAL-low... · THIS GUIDE TO POSTER ABSTRACTS IS SUPPORTED BY GREENWICH BIOSCIENCES, INC. AES ANNUAL MEETING 2018 NEW ORLEANS NOV 30 - DEC 4 AES WEBSITE